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Neuropathic pain (NeP), defined as pain caused by a lesion or disease of the 
somatosensory nervous system, is associated with more severe pain for patients than 
nociceptive pain and with suffering, disability, impaired health-related quality of life, 
and increased health care cost. Thus, the early identification of NeP in patients with 
chronic pain disorders is crucial for targeting appropriate management as NeP 
conditions require a different therapeutic approach compared to conditions 
characterised by nociceptive pain. No data exist on the prevalence of NeP in patients 
with neck-arm pain disorders, but there are indications that NeP is underdiagnosed in 
musculoskeletal conditions.  
 
Nerve-related neck-arm pain is heterogeneous with differing clinical presentations 
associated with varying pain types (nociceptive/neuropathic) and pain mechanisms 
(for example peripheral and central sensitisation). To improve patient outcomes, 
requires identification of such differences and the appropriate classification of 
patients with nerve-related neck-arm pain conditions. Specifically, the 
characterisation of patients with respect to the mix of NeP and nociceptive pain is of 
therapeutic relevance.  
 
Various clinical tools (clinical classification systems, NeP screening questionnaires) 
and laboratory tests (quantitative sensory testing (QST)) have been recommended for 
the assessment of NeP components in patients with chronic pain, however data on 
assessment of patients with nerve-related neck-arm pain is scarce. The overall aim of 
this doctoral research was to investigate the clinical characteristics of patients with 
nerve-related neck-arm pain and to establish the somatosensory profiles of patients 
with these nerve pain conditions. The thesis explored the characterisation of two 
specific patient groups: patients with painful cervical radiculopathy and patients with 
non-specific neck-arm pain associated with heightened nerve mechanosensitivity 
(NSNAP). Five studies were conducted. 
 
The first study used specific classification systems to determine: (i) the inter-
examiner agreement in classifying patients with cervical radiculopathy and patients 
with NSNAP; and (ii) the diagnostic accuracy of these clinical examiners, using the 
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opinion and consensus of two experts as a reference criterion. The results 
demonstrated high percentage agreement with moderate Kappa coefficients between 
examiners in classifying both patient groups, supporting the reliability of the 
classification systems used. Compared to the expert opinion, the examiners were able 
to accurately classify 80% of cases with these specific clinical neck-arm pain 
presentations. 
 
The second study investigated the clinical assessment of NeP in a cohort of 152 
patients referred to a neurosurgery triage clinic for assessment of their neck/upper 
limb pain associated with a suspected nerve lesion. The aims of this study were to 
investigate in this cohort: (i) the clinical application of a newly developed grading 
system for the assessment of NeP and (ii) to investigate the level of agreement in 
detecting likely NeP between this model and two NeP questionnaires, the Leeds 
Assessment of Neuropathic Symptoms and Signs Pain Scale (LANSS) and the 
painDETECT questionnaire (PD-Q). The proposed diagnostic grading system could 
readily be applied to this cohort of patients with neck/upper limb pain, however its 
application required a considerable amount of time and specific expertise due to the 
complexity of pain presentations. This diagnostic approach might not be feasible in 
primary care settings. Both questionnaires failed to identify a large number of 
patients with clinically classified NeP. The diagnostic accuracy of LANSS and PD-Q 
for the identification of NeP in patients with neck/upper limb pain appears therefore 
limited. 
 
The third study aimed to establish the somatosensory profile or phenotype of patients 
with cervical radiculopathy and patients with NSNAP, using the full battery of 
laboratory QST. QST is a valuable tool for the assessment of sensory alterations and 
may assist in the interpretation of underlying pain mechanisms. Somatosensory 
profiles were compared to healthy control subjects and to patients with fibromyalgia. 
Distinct sensory profiles were demonstrated for each group. Patients with cervical 
radiculopathy were characterised by localised loss of function in all primary sensory 
fibers tested (C, Aδ, Aβ), findings consistent with peripheral neuronal damage. 
These deficits were not present in patients with NSNAP. Both neck-arm pain groups 
demonstrated a gain of function with the presence of cold hypersensitivity and this 
was the dominant sensory characteristic in patients with NSNAP. Both neck-arm 
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pain groups differed from patients with FM, the latter characterised by a widespread 
gain of function in most nociceptive parameters. 
 
The fourth study was designed to determine the presence of NeP components in the 
two neck-arm pain groups, using the PD-Q and QST, comparing side-to-side 
differences of QST parameters in the maximal pain area and corresponding 
dermatome. A side-to-side difference has been reported to increase the sensitivity to 
detect sensory abnormalities. Patients with cervical radiculopathy demonstrated a 
significant difference in mechanical and vibration detection thresholds between the 
symptomatic and asymptomatic side in both body regions tested, with a loss of 
function seen on the symptomatic side. The PD-Q score on a group level did not 
suggest the presence of NeP, but 30% of individuals were identified by PD-Q as 
having NeP components. Patients with NSNAP did not demonstrate a clinically 
significant side-to-side difference in any QST parameters of any body region tested 
and the PD-Q score suggested that nociceptive pain was the dominant pain type in 
this group. 
 
The aim of the fifth study was to investigate if the self-reported somatosensory 
profile of patients with cervical radiculopathy and of patients with fibromyalgia, as 
indicated by responses to verbal sensory descriptors items of PD-Q, corresponded 
with their sensory phenotype demonstrated by QST, using healthy control QST data 
as reference criteria. Patients with radiculopathy demonstrated a match between their 
self-reported sensory phenotype and QST sensory phenotype for all sensory 
descriptors, except for sensitivity to light touch. The QST sensory phenotype of 
patients with FM was not consistently reflected by responses to verbal descriptors 
from the PD-Q. The findings of the study support the use of the PD-Q as a tool to 
characterise somatosensory profiles in patients with cervical radiculopathy, but not in 
patients with FM. 
 
This doctoral research demonstrated that clinical classification systems are useful in 
differentiating the clinical presentations of patients with nerve-related neck-arm pain 
and in identifying NeP components in the cohorts. Distinct clinical and 
somatosensory profiles were documented in patients with cervical radiculopathy and 
patients with NSNAP, suggesting differences in the underlying pain types and 
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mechanisms. These findings may assist clinicians in better targeting appropriate 
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Chapter 1 - Introduction 
The traditional approach to musculoskeletal as well as neuropathic pain (NeP), the 
latter defined as “pain caused by a lesion or disease of the somatosensory nervous 
system” (Jensen et al. 2011, p2204), involves the classification and management of 
patients according to the aetiology or location of the lesion (Jensen et al. 2009). This 
approach has its shortcomings (Baron 2006; Jensen 2002), particularly for the 
management of patients with non-specific nerve-related neck-arm pain, where the 
aetiology and pathology of the disorder may remain equivocal and the contribution 
of pain mechanisms remains largely unexplored. A mechanism-based classification 
approach has been proposed (Baron 2006; Jensen and Baron 2003; Woolf et al. 
1998) that supplements the traditional classification scheme and aims to guide 
patient management. This approach is based on the hypothesis that different clinical 
signs and symptoms may reflect different underlying pathophysiological mechanisms 
of pain generation (Hansson 2002; Jensen and Baron 2003). It is assumed that 
targeting treatment towards the dominant neurophysiological mechanisms underling 
the patient’s pain may improve clinical outcomes, although this assertion has yet to 
be substantiated (Cruccu and Truini 2009).  
 
Nerve-related neck-arm pain disorders are heterogeneous with clinical signs and 
symptoms and pattern of pain and sensory abnormalities varying widely between 
individuals. While a neuropathic mechanism is commonly implied in the genesis of 
some disorders such as painful cervical radiculopathy (Haanpää et al. 2009), patients 
are likely to present with a mix of nociceptive and NeP, referred to as mixed pain 
syndrome (Attal and Bouhassira 2004; Baron and Binder 2004; Behrman et al. 2007; 
Gálvez et al. 2007; Pérez et al. 2009; Portenoy 2006). Both NeP and mixed pain can 
be intense forms of pain, and patients with these disorders are characterised by 
impaired physical and mental quality of life and a substantial level of disability, 
leading to increased health care costs compared to patients with nociceptive pain 
(Berger et al. 2004; Gálvez et al. 2007; Pérez et al. 2009). Characterisation of these 
patients with respect to the mix of nociceptive and NeP, and the possible dominance 
of one pain type in mixed pain syndromes is of therapeutic relevance (Baron and 
Tölle 2008), as NeP in particular requires targeted management. Heterogeneity of 
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patients with cervical radiculopathy may partly explain the variability in 
responsiveness to pharmaceutical intervention in this patient cohort (Saldaña et al. 
2010). 
 
This thesis will focus on two sub-groups of patients with nerve-related neck-arm 
pain: patients with painful cervical radiculopathy and patients with non-specific 
neck-arm pain associated with heightened nerve mechanosensitivity (NSNAP). The 
latter is characterised clinically by pain in response to limb movements that cause 
nerve elongation (Elvey 1997). The mix of NeP and nociceptive pain has not yet 
been defined in these groups. While patients with these conditions can present with 
similar pain characteristics and sensory symptoms, the pathophysiology, the pain 
type and the underlying pain mechanisms do likely differ. Recognition of differences 
between these pain conditions is important for targeting appropriate best-evidence 
management.  
 
Identification of the clinical presentation of cervical radiculopathy and NSNAP as 
well as the identification of NeP in patients with nerve-related neck-arm pain 
remains a challenge to clinicians due to a lack of diagnostic gold standards. Clinical 
classification systems have been proposed for the two specific neck-arm pain 
disorders (Elvey 1997; Radhakrishnan et al. 1994). Although they have been 
employed in classifying patients with NSNAP (Allison et al. 2002; van der Heide et 
al. 2006), their reliability has never been investigated. Similarly, a classification 
system for the presence of NeP (Treede et al. 2008) and NeP screening tools 
(Bennett et al. 2007; Bouhassira and Attal 2011) have been recommended by the 
Neuropathic Pain Special Interest Group (NeuPSIG) of the International Association 
for the Study of Pain (IASP) to assist clinicians in recognizing NeP (Haanpää et al. 
2011). Whilst their application has been demonstrated in patients with various pain 
disorders (Attal et al. 2011; Ciaramitaro et al. 2010; Freynhagen et al. 2006; Geber et 
al. 2009; Guastella et al. 2011; Haanpää et al. 2009; Hallström and Norrbrink 2011), 
it has not yet been documented in patients with neck/upper limb pain.  
 
The first part of research described in this thesis (Studies 1 and 2) aimed to 
investigate this gap in knowledge by utilizing these clinical classification systems for 
the characterisation of patients with nerve-related neck-arm pain. The first study 
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involved the determination of (i) the inter-examiner agreement in classifying patients 
with cervical radiculopathy and patients with NSNAP, and (ii) the diagnostic 
accuracy of the examiners, using the consensus and opinion of clinical experts as the 
gold standard for comparison.  
 
The second study explored the usefulness of the grading system of NeP (Treede et al. 
2008) and the usefulness of two NeP screening tools, the Leeds Assessment of 
Neuropathic Symptoms and Signs pain scale (LANSS) (Bennett 2001) and the 
painDETECT questionnaire (PD-Q) (Freynhagen et al. 2006), in the identification of 
NeP in a cohort of patients with neck-arm pain. 
 
The aim of the second part of the thesis (Studies 3, 4) was to characterise patients 
with C6 or C7 cervical radiculopathy and patients with NSNAP, using quantitative 
sensory testing (QST), and to explore the similarities and differences in sensory 
parameters and underlying pain types. For these studies only patients with NSNAP 
whose pain mapped to the C6 or C7 dermatome were recruited.  
 
A highly sophisticated QST protocol used to establish the somatosensory profile of 
patients as precisely as possible, has been developed by the German Research 
Network on Neuropathic Pain (DFNS) (Rolke et al. 2006a; Rolke et al. 2006b). 
Using this protocol in patients with diabetic neuropathy and postherpetic neuralgia, 
sub-groups of patients with distinct somatosensory profiles have been identified 
(Maier et al. 2010), highlighting the heterogeneity within one aetiology. No study to 
date has established the complete QST somatosensory profile of patients with 
cervical radiculopathy and patients with NSNAP, using this DFNS QST protocol. To 
better characterise the presentation of both patient groups with neck-arm pain, 
comparison was made to healthy control subjects and to patients with fibromyalgia 
(FM), a chronic pain disorder characterised by widespread pain, fatigue and sleep 
disturbance in the absence of evidence of tissue damage (Wolfe et al. 2010) along 
with sensory alterations that appear to mimic NeP symptoms (Blumenstiel et al. 
2011; Klauenberg et al. 2008; Martinez-Lavin et al. 2003; Pfau et al. 2009). A better 
understanding of different somatosensory phenotypes in these neck-arm pain groups 
will provide further insight into some of the potential underlying pain mechanisms 
and potentially assist with guiding therapy. 
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In the final part of this thesis (Study 5), the value of the PD-Q as a tool for 
somatosensory profiling was investigated. The PD-Q has been used to characterise 
somatosensory profiles in patients with painful lumbar radiculopathy/radicular pain 
(Mahn et al. 2011), diabetic neuropathy, postherpetic neuralgia (Baron et al. 2009) 
and FM (Rehm et al. 2010). However, the questionnaire assesses self-reported 
symptoms, but does not measure perceptions elicited in response to predetermined 
sensory stimuli, as in QST. No study to date has documented if patients’ subjective 
responses to sensory descriptors of the PD-Q corresponded with their sensory 
phenotype as demonstrated by QST. A  
 
The management of patients with nerve-related neck-arm pain relies upon accurate 
differential diagnosis/classification and identification of underlying pain types/mix of 
pain as well as pain mechanisms. The findings of this project will contribute further 
to the reliability and validity of clinical assessment tools used to identify patients 
with cervical radiculopathy and patients with NSNAP and to identify NeP in patients 
with these pain disorders. The studies will also provide an insight into the potential 
underlying pain types and pain mechanisms in patients with cervical radiculopathy 
and patients with NSNAP. The enhanced understanding about these pain 
presentations may assist clinicians in targeting treatment more specifically at the 
involved pain mechanisms. 
1.1 Aims of the PhD project 
The aims of the PhD project were: 
i) To determine the inter-examiner agreement and diagnostic 
accuracy of two clinical examiners in classifying patients with 
painful cervical radiculopathy and patients with NSNAP, using 
specific classification systems. 
ii) To investigate the application of a clinical classification system of NeP 
and the diagnostic accuracy of two NeP screening tools in a cohort of 
patients with neck/upper limb pain. 
iii) To establish the somatosensory characteristics of patients with painful 
cervical radiculopathy and patients with NSNAP and to compare these 
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between groups and compare with healthy control subjects and patients 
with FM.  
iv) To investigate if the self-reported somatosensory profile of patients with 
cervical radiculopathy and patients with FM, as indicated by responses to 
verbal sensory descriptors items of the PD-Q, corresponded with the 
sensory phenotypes demonstrated by QST. 
 
 










































Figure 1.1 Studies of the thesis 
1-6 
1.2 Hypotheses of the PhD  
Hypotheses of Study 1 
• There would be a high inter-examiner agreement in classifying patients with 
cervical radiculopathy and patients with NSNAP, using specific classification 
systems.  
• There would be a high agreement in patient classification between two clinical 
examiners using the specific classification systems and two independent experts. 
• The diagnostic accuracy of the clinical examiners would be high, using the 
opinion and consensus of the experts as a reference criterion. 
Hypotheses of Study 2 
• The grading system of the NeuPSIG classification model would be applicable in 
patients with neck/upper limb pain. 
• The level of agreement in detecting likely NeP in patients with neck/upper limb 
pain between the NeuPSIG classification model and the LANSS and PD-Q 
would be high.  
Hypotheses of Study 3 
• The sensory phenotypes between patients with cervical radiculopathy and 
patients with NSNAP would be different.  
• In patients with cervical radiculopathy localised sensory abnormalities would be 
restricted to the maximal pain area and to the area of dermatomal sensory loss. 
• In patients with NSNAP sensory abnormalities would be found only in the 
maximal pain area.  
• Sensory profiles of the neck-arm pain groups would differ from that of patients 
with FM. 
Hypotheses of Study 4 
• In patients with cervical radiculopathy, there would be a significant side-to-side 
difference between the symptomatic and asymptomatic side in the previously 
(Study 3) documented sensory alterations in their maximal pain area and the 
affected dermatome. 
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• In patients with NSNAP, there would be a significant side-to-side difference 
between the symptomatic and asymptomatic side in the previously (Study 3) 
documented sensory alterations in their maximal pain area. 
• Patients with cervical radiculopathy would be more likely to present with NeP 
components and therefore to score higher on the PD-Q than patients with 
NSNAP. 
Hypothesis of Study 5 
• The self-reported somatosensory profile of patients with painful cervical 
radiculopathy and of patients with FM, as indicated by responses to verbal 
sensory descriptors items of PD-Q, would corresponded with their sensory 
phenotype as demonstrated by QST. 
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Chapter 2 –Literature Review 
Key factors in developing a targeted holistic approach to management of patients 
with nerve-related neck-arm pain include the identification of the cause of pain, an 
appropriate clinical classification system for patients with neck-arm pain, the 
identification of differences in clinical pain presentations and the recognition of 
underlying pain types and involved pain mechanisms.  
2.1 Heterogeneity of nerve-related neck-arm pain 
The diversity of patients with nerve-related spinal neck-arm pain is reflected in the 
different clinical presentations and underlying pain types (nociceptive/neuropathic) 
and related pain mechanisms. A conceptual model is proposed with one end of the 
spectrum comprising pain conditions due to a nerve lesion as seen in cervical 
radiculopathy, the other end containing clinical presentations with very vague signs 
of a nerve disorder, characterised by non-specific neck-arm pain associated with 
heightened nerve mechanosensitivity (NSNAP) (Allison et al. 2002; Elvey 1997; 
Hall et al. 1997). Heightened nerve mechanosensitivity is a feature of nerve trunk 
pain (Dilley et al. 2005) which is regarded as a nociceptive pain (Marchettini et al. 
2006) or inflammatory pain (Bennett 2006). It is characterised clinically by pain in 
response to limb movements that cause nerve elongation and local tenderness on 
nerve trunk palpation (Allison et al. 2002; Coppieters et al. 2003; Elvey 1997; van 
der Heide et al. 2006). The condition can present as a discrete disorder without any 
signs of nerve damage such as sensory or motor loss, abnormalities on imaging or 
nerve conduction studies (Coppieters et al. 2003; Elvey 1997; van der Heide et al. 
2006). Patients with cervical radiculopathy and NSNAP may demonstrate similar 
clinical characteristics such as pain with or without negative sensory signs and/or 
positive sensory signs, however the mix of nociceptive and NeP components may 
vary. Each individual patient’s pain might be somewhere on a continuum between 
“purely nociceptive” and “purely neuropathic” (Horowitz 2007), and the 
determination of the “pain mix” and possible dominance of one pain type is of 
therapeutic relevance, as NeP in particular requires targeted management (Baron et 
al. 2010a; Harden and Cohen 2003). 
2-2 
2.2 Taxonomy of nerve-related neck-arm pain disorders and 
neuropathic pain 
A variety of terminologies are used for the description of peripheral nerve-related 
neck-arm pain disorders such as cervicobrachial pain (Salt et al. 2011), 
cervicobrachialgia (Voerman et al. 2000); radicular pain (Bogduk 2009; Merskey 
and Bogduk 1994), radiculopathy (Bogduk 2009; Merskey and Bogduk 1994), 
neuralgia, brachialgia, neuropathy, neurogenic pain (Merskey and Bogduk 1994), 
neuropathic pain (NeP) (Merskey and Bogduk 1994; Treede et al. 2008), and nerve 
trunk pain (Asbury and Fields 1984; Bennett 2006; Marchettini et al. 2006). One 
difficulty with various terminologies is a lack of consensus in the definition of some 
of these terminologies. For example the terms radiculopathy and radicular pain are 
often used interchangeably in the literature (Bono et al. 2011; Freynhagen et al. 
2008; Mahn et al. 2011), but are in fact different entities (Bogduk 2009). 
Radiculopathy is defined as a neurological state in which conduction is blocked in 
axons of a spinal nerve or its roots, resulting in a loss of sensory and/or motor 
function (Bogduk 2009; Merskey and Bogduk 1994), and it may or may not be 
associated with the presence of pain. Radicular pain is defined as pain perceived in a 
limb caused by ectopic discharges from a dorsal root or its ganglion (Bogduk 2009). 
Radiculopathy and radicular pain may exist in isolation or coexist. The two 
syndromes can be part of a continuum, and radiculopathy may occur subsequent to 
radicular pain as the underlying disease progresses.  
 
The former definition of NeP according to IASP referred to “pain initiated or caused 
by a primary lesion or dysfunction of the nervous system” (Merskey and Bogduk 
1994). This definition created controversy particularly because of the term 
“dysfunction”, which many authors considered renders the definition too vague 
(Jensen et al. 2002; Max 2002; Merskey 2002; Rasmussen et al. 2004). A new 
definition was proposed by NeuPSIG (Treede et al. 2008) and was recently endorsed: 
“pain caused by a lesion or disease of the somatosensory nervous system” (Jensen et 
al. 2011). This new definition replaces the term “dysfunction” with “disease” to 
distinguish NeP from pain such as that caused by neuroplastic changes in response to 
strong nociceptive stimulation. The term “nervous system” is replaced with the term 
“somatosensory system” to distinguish NeP from pain caused by lesions in other 
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parts of the nervous system. Thus, using this definition a motor radiculopathy 
accompanied by nociceptive neck pain would not be classified as a NeP condition. 
This distinction is important because the management may require quite different 
targeted approaches. NeP can be classified into central and peripheral NeP. In the 
context of this thesis, the term NeP refers to peripheral NeP, unless specified 
otherwise. 
2.3 Epidemiology  
Epidemiological data on cervical radiculopathy are scarce. Radhakrishnan et al 
(1994) performed a large retrospective population based study and reported an 
annual age-adjusted incidence rate of 83.2 per 100 000 in total, with a mean age at 
diagnosis 47.9 ± 13.4 years and a male predominance. The male to female ration of 
the adjusted rates was 1.7. However, it was stated that these data should be 
considered conservative, as patients with mild symptoms of radiculopathy might not 
have sought medical attention and therefore might have been under-reported. It is not 
clearly demonstrated if every patient in the study by Radhakrishnan et al (1994) 
demonstrated a neurological deficit, meaning that patients with just radicular pain 
might also have been included in the analysis. A door-to-door survey in Sicily on 
7653 individuals found a prevalence of 3.5 per 1000, with similar age distribution 
(Salemi et al. 1996). Again, these data did not necessarily reflect just the presence of 
radiculopathy, as they also seemed to include individuals with radicular pain without 
signs of nerve root damage. A systematic review on the burden and determinants of 
neck pain in the general population found an incidence rate of 0.055 per 1000 
persons per year of disc herniation with radiculopathy (Hogg-Johnson et al. 2008). 
The course of clinical improvement of patients with cervical radiculopathy is not 
well documented. While some patients might demonstrate complete recovery with 
conservative management, others might still present with symptoms after 10 years 
and/or undergo surgery (Casey 2011). 
 
The prevalence of NSNAP disorders is not known and only anecdotal data exists. 
Clinical signs of heightened nerve mechanosensitivity was shown in 30 out of 120 
patients with cervicobrachial pain syndrome (Allison et al. 2002), however it was not 
stated if the condition presented as a discrete disorder without any clinical signs of 
2-4 
nerve damage. Clinical signs of heightened nerve mechanosensitivity were also 
demonstrated in patients with chronic whiplash (Quintner 1989; Sterling et al. 
2002b). Out of 40 patients with nerve-related low back and leg pain, 10% 
demonstrated features of heightened nerve mechanosensitivity as a discrete disorder 
without any clinically established neurological deficits, and in 57% heightened nerve 
mechanosensitivity coexisted with clinical signs of nerve root damage such as 
sensory and strength/reflex deficits (Schäfer et al. 2009).  
 
Data on the prevalence of NeP in chronic neck/upper limb pain conditions are 
scarce. There are indications that NeP is underdiagnosed in musculoskeletal 
conditions (Jespersen et al. 2010). In two large cohorts of patients with chronic low 
back pain (with or without leg pain), the prevalence of NeP components was found 
to be 37% and 54.7% (Freynhagen et al. 2006a; Kaki et al. 2005). The differences in 
prevalence may relate to the use of different NeP screening tools (see section 2.9.3) 
as well as the observation that NeP and nociceptive pain components vary in the 
back and leg of patients with low back pain (Attal et al. 2011). NeP is typically 
associated with more severe pain for patients than nociceptive pain (Bouhassira et al. 
2008; Freynhagen et al. 2006a; Torrance et al. 2006), and with suffering, disability, 
impaired health-related quality of life (Berger et al. 2004; Berger et al. 2008; Doth et 
al. 2010; Freynhagen et al. 2006a; Meyer-Rosberg et al. 2001; O'Connor 2009; 
Saldaña et al. 2010a; Saldaña et al. 2010b) and increased health care use 
(Freynhagen et al. 2006a; Saldaña et al. 2010a; Saldaña et al. 2010b).  
2.4 Clinical presentation of nerve-related neck-arm pain 
2.4.1 Clinical presentation of cervical radiculopathy 
The classic clinical picture of cervical radiculopathy includes neck pain with 
radicular pain radiating down the arm, paraesthesia in arm and hand in conjunction 
with sensory deficits and/or motor deficits in a dermatomal/myotomal distribution. 
However, the degrees and frequencies of sensory and motor changes vary as well as 
the symptoms of paraesthesia and pain (Radhakrishnan et al. 1994). Radicular pain is 
described as lancinating in quality, shocking and electric, and travels along a narrow 
band, in the territory supplied by the affected axon (Bogduk 2009; Marchettini et al. 
2006; Merskey and Bogduk 1994; van Zundert et al. 2006). However, clinical studies 
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have shown that segmental origin of radicular pain cannot be determined by its 
distribution (Bogduk 2009). Slipman et al (Slipman et al. 1998) demonstrated that 
although the distribution of symptom provocation on cervical nerve root stimulation 
resembled the classic dermatomal maps for these nerve roots, symptoms were 
frequently provoked outside of the distribution of these dermatomal maps. Another 
study demonstrated non-dermatomal pain distribution in patients with cervical nerve 
root pain in 69.7% of cases (Murphy et al. 2009). Radiculopathy may occur in 
isolation or in association with radicular pain, somatic referred pain (pain occurring 
in a region of the body innervated by nerves or branches of nerves other than those 
that innervate the actual source of pain (Merskey and Bogduk 1994)), nerve trunk 
pain or local somatic spinal pain. 
 
For patients with painful cervical radiculopathy, the disorder is associated with 
disability (Chien et al. 2008; Saldaña et al. 2010a; Saldaña et al. 2010b), impaired 
physical health and negative impact on mental health with increasing chronicity of 
the disorder (Daffner et al. 2003; Meyer-Rosberg et al. 2001). Patients presenting 
with axial neck pain and radicular symptoms are reported to be much more disabled 
than patients with just neck pain or just radicular pain alone, and the condition has a 
greater impact on mental health status on younger patients (younger than 40 or 40 – 
60 years) compared to patients over 60 years of age (Daffner et al. 2003). Mood 
disorders such as anxiety and depression (Freynhagen et al. 2006a; Saldaña et al. 
2010b; Schmidt et al. 2009) and sleep/fatigue disturbances are frequently reported in 
patients with radiculopathy (cervical/lumbar) (Freynhagen et al. 2006a; Meyer-
Rosberg et al. 2001; Saldaña et al. 2010b; Starkweather), and more frequently 
compared to patients with nociceptive pain disorders (Freynhagen et al. 2006a; 
Saldaña et al. 2010b; Schmidt et al. 2009), contributing to impaired mental health. 
Furthermore, the frequency and severity of these comorbidities in, for example 
patients with lumbar radiculopathy is similar to that reported in patients with 
‘typical’ NeP conditions such as diabetic neuropathy and postherpetic neuralgia 
(Mahn et al. 2011). 
 
Radiculopathies related to spinal column diseases are said to be amongst the most 
common causes of NeP (Haanpää et al. 2009). However, it is not clear if these 
presentations are always characterised by predominantly NeP components as they are 
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increasingly referred to as mixed pain syndromes (Attal and Bouhassira 2004; Baron 
and Binder 2004; Behrman et al. 2007; Freynhagen et al. 2006b; Gálvez et al. 2007; 
Hansson and Haanpää 2007; Pérez et al. 2009; Portenoy 2006), but can also be 
classified as a NeP condition (Attal et al. 2008; Bennett 2001; Portenoy 2006; Unal-
Cevik et al. 2010). Again, the definition of radiculopathy or diagnostic criteria for 
radiculopathy varies between publications and this hinders study comparisons and 
generalisability. No study has yet investigated the predominant underlying pain type 
in patients with clearly defined painful cervical radiculopathy. This was one of the 
aims of Studies 3 and 4 (Chapter 6, 7) in this thesis. 
 
2.4.2 Clinical presentation of non-specific neck-arm pain associated with 
heightened nerve mechanosensitivity 
Patients with NSNAP present with pain that is provoked or aggravated by limb 
movements that cause lengthening/elongation of the affected nerve. Depending on 
the severity of heightened nerve mechanosensitivity, and compared to the 
asymptomatic side, such limb movements will be restricted in range due to an 
evoked pain response (Allison et al. 2002; Coppieters et al. 2003; van der Heide et al. 
2006). Shoulder abduction is often limited in range as it has been documented that 
this movement causes increased tension in the brachial plexus (Elvey 1988; Ginn 
1988) and median nerve (Kleinrensink et al. 1995; Wright et al. 1996). Standard 
clinical neurological examination and electrodiagnostic studies are usually normal 
unless this clinical presentation exists in concurrence with a nerve lesion, as seen in 
cervical radiculopathy (Chien et al. 2008). 
 
The concept of heightened nerve mechanosensitivity is not new, with literature on 
the assessment of heightened nerve mechanosensitivity in the lower and upper limb 
dating back to 1880 (Supik and Broom 1994) and 1887 respectively (Poore 1887). 
Whilst the straight leg raise test is widely used in medicine for the examination of 
patients with heightened nerve mechanosensitivity with lower back and leg pain 
(Devillé et al. 2000; Freynhagen et al. 2008; Kobayashi et al. 2003; Samuelsson and 
Lundin 2002), the analogous upper limb tests have not gained much recognition in 
the medical field and seem to be used predominantly by physiotherapists (Allison et 
al. 2002; Butler 2000; Coppieters et al. 2006; Coppieters et al. 2003; Elvey 1997; 
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Sterling et al. 2002b; van der Heide et al. 2006; Wainner et al. 2003). However, their 
application has been accepted as part of the standard clinical examination of patients 
with neuromusculoskeletal pain disorders (Petty and Moore 2001), as the presence of 
heightened nerve mechanosensitivity may have implications for treatment. 
 
2.4.3 Clinical presentation of neuropathic pain 
Patients with cervical radiculopathy and patients with NSNAP may present with 
NeP. Peripheral NeP is generally characterised by pain and sensory abnormalities in 
the area corresponding to the innervation territory of the damaged nerve structure 
(Baron 2009; Chong and Bajwa 2003; Hansson 2002; Jensen and Baron 2003). In 
addition to pain, the core signs include sensory deficits, that is negative sensory 
symptoms, indicating a loss of function due to the reduction of afferent input caused 
by the nerve lesion. In addition to these negative sensory signs, various positive 
sensory symptoms, indicating a gain of function, can be present including 
paraesthesia or dysaesthesia, spontaneous (not stimulus-induced) ongoing pain, 
spontaneous electric shock like sensations and evoked pain (hyperalgesia, allodynia) 
(Baron and Binder 2004; Baron and Tölle 2008; Dworkin 2002). A small percentage 
of patients with peripheral nerve injury may however present with nearly pure 
positive sensory signs with no demonstrable sensory deficit (Baron 2009). The 
quality of NeP is often described as a shooting or burning quality, with tingling or 
electrical sensations and numbness (Bouhassira and Attal 2011) whereas nociceptive 
pain is frequently described as an ache (Dworkin et al. 2009; Merskey and Bogduk 
1994), dull and throbbing (Rasmussen et al. 2004). While all the above symptoms, 
signs and pain descriptors are not universally present and no single characteristic is 
pathognomonic for NeP (Behrman et al. 2007; Hansson et al. 2007), a combination 
of sensory descriptors can help to discriminate between nociceptive and NeP groups, 
as demonstrated with the use of various NeP screening tools (see section 2.9.3) 
(Bennett 2001; Bennett et al. 2005; Bouhassira et al. 2005; Krause and Backonja 
2003). 
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2.5 Aetiology and pathophysiology of nerve-related spinal neck-
arm pain  
Radicular pain and conduction block in radiculopathy can be caused by lesions that 
directly compromise the dorsal root ganglion mechanically or indirectly compromise 
the spinal nerve and its roots by causing ischemia or inflammation of the axons 
(Merskey and Bogduk 1994). The most common causes for cervical radiculopathy 
and radicular pain are cervical spondylotic changes such as spurring of the vertebral 
body, uncovertebral joints, facet joints or a combination of these factors causing 
foraminal stenosis and cervical disc herniation. These features can act mechanically 
as a space-occupying lesion affecting the axons (Merskey and Bogduk 1994). The 
most common level of root compression is C7, followed by C6 (Radhakrishnan et al. 
1994). Although degenerative changes of the cervical spine may be very obvious on 
imaging studies, clinically the disease might not be severe or even symptomatic 
(Friedenberg and Miller 1963; Kuijper et al. 2011). Myelograms, computed 
tomographic scans and magnetic resonance images (MRI) have revealed abnormal 
spinal findings in 20 - 40% of subjects without any history of pain (Boden et al. 
1990; Hitselberger and Witten 1968; Matsumoto et al. 1998; Wiesel et al. 1984). In a 
cohort of 78 symptomatic patients with pain and clinically established unilateral 
cervical radiculopathy, false-positive results of nerve root compression on MRI were 
found in 45% of cases, either on the contralateral asymptomatic side or at levels 
above or below the clinically affected level (Kuijper et al. 2011). Hence, mechanical 
compression per se is not directly related to pain production.  
 
Compression of a nerve root may induce numbness, but usually does not cause pain 
(Lindahl 1966; Rydevik et al. 1984; Sunderland 1981). Pain typically becomes part 
of the compression syndrome when the blood supply to nerve fibres is seriously 
impaired; when intraneural fibrosis is impairing the nutrition of nerve fibres 
(Sunderland 1981); or in the presence of inflammation (Ahlgren and Garfin 1996; 
Garfin et al. 1991; Murphy 1977). The effects of nerve fibre compression and 
impaired blood supply are supported by the observation that the blood flow in the 
affected nerve root of patients undergoing discectomy increased in patients who 
reported pain resolution after surgery compared to patients not reporting any relief of 
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symptoms, suggesting that in the latter group the experienced symptoms may be 
partly due to the blood flow restriction (Hida et al. 2003).  
 
The influence of inflammation on pain perception was documented in human 
experiments in patients with lumbar radicular pain (Greenbarg et al. 1988; Kuslich et 
al. 1991; Smyth and Wright 1958). In these patients gentle mechanical manipulation 
of involved or inflamed nerve roots elicited radicular pain but mechanical 
stimulation of normal nerve roots was pain free. It has been demonstrated in animal 
experiments that compression and inflammation can induce nerve dysfunction and 
pain behaviours and that the combination of both may induce more nerve root injury 
than each factor per se (Rothman and Winkelstein 2007; Takahashi et al. 2003). 
Furthermore, the magnitude and duration of compression and inflammation are 
further key factors in modulating nerve function (Takahashi et al. 2003; Winkelstein 
and DeLeo 2002). 
 
A further mechanism for compression linking with pain provocation, lies in the 
involvement of the dorsal root ganglia. Animal studies have shown that minimal 
stimulation/compression of intact dorsal root ganglia induced prolonged repetitive 
firing in sensory axons (Howe et al. 1977; Wall and Devor 1983). It therefore seems 
likely that compression of the dorsal root ganglia can play a role in the generation of 
radicular pain (Bogduk 2009; Howe et al. 1977). Furthermore, in vivo studies on rats 
demonstrated a significant correlation between the duration of nerve root 
compression and mechanical allodynia, defined as pain in response to non-noxious 
mechanical stimulus, and microglial activation in the dorsal horn; the longer the 
sustained compression, the greater the pain sensitivity and spinal glial reactivity 
(Rothman et al. 2010). Similarly, a correlation was observed in rats between 
increased severity of nerve root injury elicited by nerve root ligation, and mechanical 
allodynia and greater spinal glial activation (Winkelstein and DeLeo 2002). Spinal 
glia cells release neurotransmitters and pro-inflammatory cytokines such as tumor 
necrosis factor (TNF)-α, interleukin (IL) – 1 and IL-6, suggesting these have a direct 




Nerve root dysfunction and pain can also be induced by inflammation and chemical 
irritation without any mechanical compression of nerve tissue (Marshall and 
Trethewie 1977; Olmarker et al. 1993; Peng et al. 2007; Smyth and Wright 1958; 
Yabuki et al. 1998). Inflammation can be caused by injury or by an autoimmune 
reaction from exposure to disc tissues resulting in release of cytokines (TNF-α) 
(Bobechko and Hirsch 1965; Gertzbein et al. 1975; Rothman et al. 2009). 
Breakdown products from a degenerating nucleus pulposus might leak out and 
induce a chemical radiculitis along the nerve root (Marshall and Trethewie 1977). A 
clinical study by Peng et al (Peng et al. 2007) demonstrated a significant correlation 
between the site of annular tear and the side of radiating leg pain in patients with 
discogenic low back pain with no disc herniation. In this study, abnormalities of 
electromyogram (EMG) and reduced motor nerve conduction velocity were found on 
the side of radiating leg pain, consistent with nerve injury in the absence of nerve 
compression (Peng et al. 2007). Other causes of radicular pain such as malignancy 
(Kuijper et al. 2009), infection (De Burca 2009; Feinberg et al. 2007; Kuijper et al. 
2009; Polston 2007) and vascular causes (Benney et al. 2011) have also been 
reported. 
 
Sensitisation of nerve tissue by mechanical, chemical or inflammatory means 
(Kuslich et al. 1991; Owen et al. 1994; Smyth and Wright 1958) can increase the 
affected nerve’s sensitivity to mechanical stimuli. Preliminary data from animal 
studies have documented that with induced inflammation, intact nerve fibres can 
become mechanosensitive to pressure at the lesion site and mechanosensitive to 
stretch in the absence of any concurrent signs of axonal damage (Bove et al. 2003; 
Dilley et al. 2005; Eliav et al. 2001). The majority of responsive fibres responded to 
less than 5% stretch, which is within the range of human in vivo nerve stretch seen 
during normal limb movements (Dilley et al. 2003). This model of heightened nerve 
mechanosensitivity may account for pain provoked in patients with NSNAP with 
upper limb movements that induce lengthening of the affected nerve. 
 
A further proposed mechanism for heightened nerve mechanosensitivity is the 
activation of the nervi nervorum which are located in peripheral nerve sheaths (Amir 
et al. 2006; Eliav et al. 1999; Marchettini et al. 2006; Quintner and Bove 2001). 
Electrophysiological studies demonstrated that at least some of the nervi nervorum 
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function as nociceptors, as they responded to noxious mechanical, chemical and 
thermal stimuli (Bove and Light 1995; Bove and Light 1997). Further, it has been 
shown that the nervi nervorum contain neuropeptides including substance P and 
calcitonin gene-related peptide. Release of these neuropeptide may assist in 
initiating neurogenic inflammation, hence contributing to nociception and pain 
perception (Bove and Light 1997; Sauer et al. 1999).  
2.6 Pain mechanisms 
Distinct subtypes of pain exist: nociceptive, inflammatory, neuropathic and 
functional pain (Woolf 2004b). Nociceptive pain is defined as a transient pain in 
response to a noxious stimulus/ stimulation of nociceptive primary afferents. The 
initiating event is impending or actual tissue damage. Strictly speaking, in the 
absence of tissue damage, nociceptive pain is a physiological pain rather than a 
clinical pain (Backonja 2003). However, the term nociceptive pain is commonly used 
for pain in response to damage to non-neuronal tissues with the nociceptive system 
being intact (Baron and Tölle 2008), such as in osteoarthritis or inflammatory pain 
(Campbell and Meyer 2006). In the context of this thesis, the latter definition of 
nociceptive pain will be used. In contrast, NeP is initiated by structural damage to the 
nociceptive nervous pathway accompanied by a loss or gain in sensitivity. Functional 
pain is characterised by hypersensitivity to pain resulting from abnormal central 
processing of normal input in the absence of any peripheral abnormality or tissue 
damage such as in patients with FM (Woolf 2004b). Despite the different causes of 
nociceptive, neuropathic and functional pain, they do present with similar 
characteristics, such as spontaneous pain in the absence of any stimulus, an 
exaggerated pain response to noxious input (hyperalgesia) or evoked pain such as 
pain in response to light touch (allodynia). There may be commonalities, but also 
differences in the underlying mechanisms between the pain types. For example 
peripheral sensitisation of nociceptors due to changes to the chemical environment 
after tissue damage is not a prerequisite for functional pain. 
 
Nociception and associated pain are normally elicited by activity in C-fiber 
nociceptors with slowly conducting unmyelinated axons and Aδ nociceptors with 
thinly myelinated axons. The receptive properties of these afferent neurons are 
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determined by their expression of transducing ion-channel receptors (Woolf 2004b). 
When tissue damage occurs, inflammatory mediators activate and sensitise sensory 
afferents by producing changes in the expression of membrane ion-channels, 
resulting in ongoing nociceptive input and spontaneous neuronal discharge. 
Compared to nociceptive pain, and as an example, the increased expression of 
voltage-gated sodium channels is suggested to play a key role in the pathogenesis of 
NeP (Amir et al. 2006; Baron 2006). Higher sodium channel density not only occurs 
at the site of a nerve lesion, but also in the nerve root and intact dorsal root ganglion 
with subsequent increased ectopic discharges and higher mechanosensitivity (Chen 
et al. 2004; Dilley et al. 2005). This ectopic excitability is suggested to be a 
contributor to spontaneous NeP such as spontaneous burning pain and electric-shock-
like sensations (Baron 2006; Woolf 2004a). 
 
Peripheral inflammation may induce upregulation of temperature-sensitive ion 
channels (Knowlton et al. 2010; Obata et al. 2005), leading to peripheral sensitisation 
of C-nociceptors and associated symptoms of cold or heat hyperalgesia (Baron 2006) 
in inflammatory and NeP disorders. Peripheral nerve injury may also cause changes 
in neighbouring uninjured nerve fibers, contributing to pain signalling (Baron 2006; 
Woolf 2004a). Release of nerve growth factors may trigger the release of TNF-α and 
channel and receptor expression, potentially altering the excitability of uninjured 
afferents (Baron 2006; Wu et al. 2002). Furthermore, a switch in the phenotype of 
neurons has been reported (Woolf and Salter 2000), thus that brain-derived-
neurotrophic-factors and substance P, that are normally expressed in C-fibers, can be 
expressed in A-fibers (Woolf 2004a). Hence, these A-fibers may be able to produce 
central changes such as mechanical allodynia that are normally induced by C-fibers 
input. 
 
As a consequence of peripheral nociceptor hyperactivity, secondary changes can 
occur in second-order neurons in the spinal cord dorsal horn, contributing to central 
sensitisation. A cascade of events takes place that is induced by the release of 
transmitters from nociceptive terminals, leading to synaptic plasticity, facilitating 
nociceptive input. For example, prolonged firing of C-fibre nociceptors causes 
release of substance P and glutamate which acts on postsynaptic N-methyl-D-
aspartate (NMDA) receptors in the spinal cord. Activation of NMDA receptors 
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causes second order spinal cord neurons to become hyperresponsive, so that 
normally undetected inputs provoke an expansion of neuronal receptive fields. 
Innocuous stimuli such as light touch may elicit pain such as dynamic mechanical 
allodynia and areas outside an injured site develop secondary hyperalgesia presenting 
as tenderness (Baron 2006). Peripheral nerve injury also activates spinal cord glial 
cells which further enhances excitability of wide dynamic range neurons by releasing 
cytokines and growth factors and increasing glutamate formation (Rothman et al. 
2010). One mechanism of increased dorsal horn excitability that is associated with 
sensation and nerve fibre loss applies only to NeP (Baumgärtner et al. 2002). It is 
proposed that the loss of afferent input from large myelinated fibres leads to 
hypoactivity of the inhibitory interneurons and may facilitate spontaneous activity in 
nociceptive neurons (Baumgärtner et al. 2002). 
 
Peripheral and central sensitisation are physiological processes occurring with any 
kind of tissue injury and represent temporary plasticity of the nociceptive system, 
and is typically associated with a reversible modulation of the nociceptive system 
(Woolf and Salter 2000). Disinhibition may also contribute to enhanced pain 
processing. As indicated previously, within the spinal cord, inhibition is mediated by 
inhibitory interneurons. Cell death of these interneurons, as seen after nerve injury, 
may diminish the tight inhibitory control on dorsal horn neurons (Woolf and 
Mannion 1999). In addition, descending inhibitory inputs from the brain stem may be 
altered, with a loss of the normal inhibitory restraint of CNS excitability, and 
descending facilitatory mechanisms may play a role in increased sensory 
transmission after inflammation and peripheral nerve injury (Woolf 2004b). 
Furthermore, psychosocial factors such as emotions, cognition and attention cause 
changes in cortical and subcortical areas, hence playing an integral role in pain 
perception (Neugebauer et al. 2009).  
 
Hyperalgesia is a common sensory symptom in nociceptive as well as NeP and is 
based on the facilitation of the nociceptive system, either due to peripheral 
sensitisation of nociceptors and central sensitisation of spinal cord neurons or 
reduced descending inhibition of increased facilitation, or a mixture of all (Treede 
and Magerl 2000). It is suggested that in NeP states, hyperalgesia due to central 
sensitisation occurs predominantly in the close vicinity of the affected peripheral 
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nerve, whereby a deficit in descending inhibition typically has remote effects in other 
body areas (Magerl and Klein 2006). 
2.7 Assessment and classification of patients with painful cervical 
radiculopathy 
2.7.1 Clinical assessment of patients with painful cervical radiculopathy 
Numerous musculoskeletal disorders such as myofascial pain syndromes, lateral 
epicondylitis, and de Quervain’s tenosynovitis may mimic radicular symptomatology 
(Ahlgren and Garfin 1996; Cannon et al. 2007; Dalton and Jull 1989; Dillin et al. 
1986; Lauder 2002). Therefore specific diagnostic criteria are required in order to 
distinguish cervical radiculopathy from other pathologies. Due to a lack of diagnostic 
gold standards the diagnosis of painful cervical radiculopathy is largely clinical. The 
clinical diagnosis is based on the findings of a comprehensive clinical examination 
(Kuijper et al. 2009; Wainner and Gill 2000) incorporating the medical history, an 
assessment of both musculoskeletal and related neural tissues and a neurological 
bedside examination of somatosensory and motor function (Cruccu et al. 2010; 
Hansson 2002; Jepsen et al. 2006; Wainner et al. 2003). Moderate to substantial 
inter-examiner reliability (Landis and Koch 1977) has been documented for clinical 
tests of nerve function (sensory testing, reflexes and manual muscle testing) in the 
upper limb (Jepsen et al. 2006; Jepsen et al. 2004; Schmid et al. 2009) and for 
clinical nerve root provocative tests such as the Spurling’s test (Spurling and Scoville 
1944), the Valsalva manoeuvre and neck distraction test (Wainner et al. 2003). 
Generally, the existing literature appears to indicate high specificity and low 
sensitivity for the latter three tests (Tong et al. 2002; Viikari-Juntura et al. 1989; 
Wainner et al. 2003), indicating the need for better discriminative tools to identify 
patients with cervical radiculopathy.  
 
Results of medical investigations (e.g. imaging, electrodiagnostic tests) may aid in 
the diagnostic work-up of painful cervical radiculopathy (Bono et al. 2011; Kuijper 
et al. 2009; Treede et al. 2008), however, as already outlined, sometimes clinical 
findings do not correlate with radiological findings. MRI is the method of choice to 
confirm correlative nerve compression, particular to detect disc protrusion, whereas 
computerised tomography (CT) is possibly superior in showing foraminal stenosis by 
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bony prominence (Kuijper et al. 2009). The diagnostic value of electromyography 
(EMG) is still a matter of debate (Bono et al. 2011; Kuijper et al. 2009; Plastaras and 
Joshi 2011; Tsao 2007). The sensitivity of EMG in detecting radiculopathy is limited 
by several factors (Plastaras and Joshi 2011) that can lead to false-negative results. 
Firstly, radiculopathies that are predominantly sensory cannot be confirmed by EMG 
(Dillingham 2002; Dillingham and Lauder 2005; Plastaras and Joshi 2011), as the 
EMG investigates myotomal pattern of abnormalities. Secondly, a myotomal pattern 
of abnormalities may not be identified if axonal compromise is not severe enough; 
and thirdly, the appearance of abnormalities is time-dependent and may not appear 
until some weeks after axonal damage (Plastaras and Joshi 2011; Tsao 2007). Nerve 
conduction studies (NCS) are useful to rule out other conditions like median or ulnar 
neuropathies or polyneuropathies, but have little value in confirming radiculopathy 
(Dillingham 2002; Kuijper et al. 2009). Sensory NCS typically are normal in patients 
with radiculopathy because the location of the nerve root lesion is proximal to the 
dorsal root ganglion (Dillingham 2002; Plastaras and Joshi 2011; Tsao 2007). Motor 
NCS are only abnormal if substantial motor axon loss (up to 50%) has occurred. 
Furthermore routine motor NCS performed in the upper limb assess muscles 
predominantly subserved by the C8 and T1 nerve roots, hence these NCS may be 
insensitive for the most common C6 and C7 radiculopathies (Plastaras and Joshi 
2011; Tsao 2007). 
 
2.7.2 Classification of patients with cervical radiculopathy 
No single examination item (clinical or medical investigation) on its own is 
diagnostic. Therefore the diagnosis of cervical radiculopathy should be based on a 
combination of items. Wainner et al (Wainner et al. 2003) identified a test item 
cluster of 4 clinical items for the identification of cervical radiculopathy, using 
electrophysiological examination as reference criterion for radiculopathy. The 
proposed cluster included a median nerve-biased nerve provocation test (NPT) 
(NPTMEDIAN) (Elvey 1997), cervical rotation less than 60º, the neck distraction test 
and the Spurling’s test (Spurling and Scoville 1944). If all four items were present, 
the probability of the presence of cervical radiculopathy increased to 90%. However, 
the analysis included only 16 patients with cervical radiculopathy, limiting 
generalisability of the findings. Interestingly, this prediction rule did not include any 
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clinical signs of nerve root dysfunction such as loss of sensory or motor function 
which are the characteristic of defined radiculopathy (Bogduk 2009). The clinical 
items rather relate to pain provocation tests. Thus, these test items are likely to be 
positive in patients with radicular pain, but this may not be associated with nerve 
root damage.  
 
Radhakrishnan et al (Radhakrishnan et al. 1994) proposed certain sets of diagnostic 
criteria to confirm the presence of definite radiculopathy (see Study 1, Chapter 4, 
Table 4.1). Although this classification system is 16 years old, it is still 
recommended (Rubinstein et al. 2007), however the reliability has never been 
assessed. The first set of diagnostic criteria relates to electromyographic evidence of 
acute denervation or identification of an affected cervical root at surgery. The second 
set includes clinical signs of sensory and motor nerve root impairment and the third 
set incorporates clinical findings such as the presence of pain with positive sensory 
symptoms or motor impairment as well abnormalities on myelography, computer-
assisted myelography, or magnetic resonance imaging at the clinically relevant level 
correlating with cervical radiculopathy. The system has some shortcomings, as the 
first two sets of criteria do not make any reference to pain, and the last set does not 
include computed-tomography scans which are recognised as a confirmatory tests for 
nerve root compression (Bono et al. 2011; Treede et al. 2008). Additionally, as 
defined in the last set of diagnostic criteria, the presence of neck pain with 
paraesthesia and a demonstrable abnormality on imaging does not necessarily 
implicate the presence of radiculopathy. However, including appropriate 
amendments to these sets of diagnostic criteria, the classification system may be 
feasible for the identification of painful radiculopathy. This was investigated in 
Study 1 (Chapter 4). 
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2.8 Assessment and classification of patients with non-specific 
neck-arm pain associated with heightened nerve 
mechanosensitivity 
2.8.1 Clinical assessment of patients with NSNAP 
Analogue the straight leg raise test, examination procedures (Neurodynamic Tests or 
NPT) have been developed to examine heightened nerve mechanosensitivity in the 
upper limb (Bragard 1929; Butler 1991; Elvey and Hall 1997; Poore 1887; 
Shacklock 2005). Moderate to substantial inter-examiner reliability has been 
documented for these NPTs in the upper limb (Jepsen et al. 2006; Schmid et al. 
2009; Vanti et al. 2010; Wainner et al. 2003). Anatomical experiments have verified 
that the NPTMEDIAN, which will be used in this thesis, has the highest specificity 
amongst the upper limb tests (Kleinrensink et al. 2000; Kleinrensink et al. 1995), that 
is it did not cause significant tension in other nerves.  
 
An abnormal response to a NPT is defined as the reproduction of the patient’s 
symptoms together with reduced range of motion in the symptomatic limb compared 
to the asymptomatic side (Elvey 1997; Hall and Elvey 1999). A second condition for 
a positive test is that the symptoms can be influenced by changing the amount of 
nerve provocation by alteration of proximal or distal joint positions. This clinical 
evaluation is used to differentiate symptoms of neural origin from local 
musculoskeletal pathology. Many structures are stressed during the NPT (McLellan 
and Swash 1976; Moses and Carman 1996; Wilson et al. 1994) any of which can 
contribute to a painful response to the test (Di Fabio 2001). However, using a 
combination of limb and spine movements it is possible to move and bias mechanical 
stress to neural structures (Kleinrensink et al. 1995; Wilson et al. 1994; Zorn et al. 
1995). The NPTMEDIAN has been shown to discriminate between referred and local 
sources of upper limb pain (Selvaratnam et al. 1994). Furthermore, the application of 
an experimental in vivo human pain model provided indirect support for the validity 
of the testing procedure. Hypertonic saline-induced pain in the thenar muscles of 
healthy volunteers did not alter the responses to the NPTMEDIAN (Coppieters et al. 
2006), suggesting that the NPTMEDIAN did not provoke predominant strain on the 
thenar muscles, but may be on neural tissues.  
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Nerve trunk palpation may further aid in the assessment of mechanical nerve 
sensitivity (Bragard 1929; Butler 2000; Elvey 1997; Elvey and Hall 1997; Jepsen et 
al. 2006; Poore 1887; Quintner and Bove 2001; Shacklock 2005). Mechanical 
hyperalgesia of peripheral nerve trunks has been demonstrated in the symptomatic 
arm of patients with painful cervical radiculopathy (Chien et al. 2008; Hall and 
Quintner 1996) suggesting peripheral nerve sensitisation. However, the diagnostic 
value of nerve trunk palpation for the evaluation of patients with neck-arm pain is 
not known, and one has to keep in mind that palpation over a nerve trunk may 
simultaneously stimulate other tissue in close vicinity such as fascia and muscles that 
may provoke a pain response. Furthermore, a heightened pain response to nerve 
trunk palpation or to a NPT is not necessarily a corollary of peripheral nerve 
sensitisation. Patients with whiplash associated disorders demonstrated decreased 
pressure pain thresholds over upper limb peripheral nerve trunks in both the 
symptomatic and asymptomatic arm (Sterling et al. 2002a), and similarly abnormal 
responses to the NPTMEDIAN were observed in both arms (Sterling et al. 2002b). This 
bilateral increased sensitivity of neural structures to pressure and movement suggests 
a more global generalised hypersensitivity. So the NPT is really just another clinical 
sign, which taken alone is not diagnostic for any specific syndrome. 
 
2.8.2 Classification of patients with NSNAP 
The response of a patient to a single NPT is of limited value for the identification of 
nerve trunk pain and associated heightened nerve mechanosensitivity. Test responses 
must be interpreted within the clinical context of a number of other assessment 
procedures before a classification of heightened nerve mechanosensitivity as a 
clinical sign, can be made. A set of classification criteria has been proposed (Elvey 
1997) and this includes: (i) an abnormal response to a NPT, (ii) a correlating active 
movement dysfunction (e.g. limitation of range of motion of shoulder abduction 
and/or pain on shoulder abduction, and which increases with addition of cervical 
contralateral flexion and/or with wrist extension as loading manoeuvres) and (iii) an 
abnormal response on clinically relevant nerve trunk palpation (hypersensitivity 
compared to the asymptomatic side). This classification system has been applied in 
various studies (Allison et al. 2002; Hall et al. 1997; van der Heide et al. 2006) and 
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while reliability has been established in patients with low back and leg pain (Schäfer 
et al. 2009), the reliability has not yet been established in patients with neck-arm 
pain. 
 
In summary, patients with painful cervical radiculopathy and patients with NSNAP 
may demonstrate similar clinical pain patterns, but their clinical presentations 
typically differ. Identification of such differences and the appropriate classification 
of patients with these neck-arm pain conditions is important, to enable clinicians to 
provide appropriate best-evidence management. The classification of these patients is 
largely clinical, and while specific classification systems have been proposed for 
both pain conditions, their reliability has never been established. This was the focus 
of Study 1 presented in Chapter 4.  
2.9 Assessment and classification of patients with neuropathic 
pain 
2.9.1 Clinical assessment of patients with neuropathic pain 
The diagnosis of NeP is based on findings of clinical examination and diagnostic 
tests (Cruccu et al. 2010; Haanpää et al. 2011; Haanpää et al. 2009). The clinical 
examination comprises the patient’s medical history, pain drawings including 
location, description and intensity of pain, pain behaviours, and a neurological 
examination, including sensory testing. Pain distribution in the innervation territory 
of the affected nerve structure and a history indicative of a nerve injury or disease 
provide hints for the possible presence of NeP (Treede et al. 2008). For the 
assessment of somatosensory functions, sensory testing of touch, vibration, cold, 
warmth and pinprick is recommended (Haanpää et al. 2011). However, no consensus 
is evident for which type of sensory testing is obligatory for the assessment of NeP, 
as for example the two NeP screening tools that contain physical examination items 
do not include the assessment of vibration and thermal stimuli (Bennett 2001; 
Bouhassira et al. 2005). 
 
Furthermore, sensory abnormalities found in the patient’s area of pain do not 
necessarily indicate the presence of NeP. Sensory aberrations have been reported in 
patients with nociceptive pain, in experimental pain models on humans and in 
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patients with no identifiable underlying pathology such as FM (Blumenstiel et al. 
2011; Geber et al. 2008; Leffler et al. 2000; Magerl and Treede 2004; Pfau et al. 
2009; Westermann et al. 2011). In addition, cold hypersensitivity, a common sequel 
of nerve injuries (Landerholm et al. 2010; Taylor et al. 2010), has also been 
documented in patients with depression but without pain (Klauenberg et al. 2008).  
 
Currently it is recommended that sensory testing in patients with unilateral pain 
should be compared to the contralateral mirror side (Haanpää et al. 2011; Haanpää et 
al. 2009) however, there is evidence the asymptomatic side may be misleading as a 
true control (Baron 2006). Bilateral sensory changes have been documented in 
patients with trigeminal neuropathy (Jääskeläinen et al. 2005; Leffler and Hansson 
2008), cervical radiculopathy (Chien et al. 2008), and non-NeP (Leffler et al. 2003). 
Bilateral sensory alterations may suggest neuronal plasticity in the mediation of 
sensory input from the contralateral side (Davis et al. 2011) and activation of 
inhibitory mechanism interacting bilaterally (Leffler et al. 2003). Despite the 
complexity of sensory alterations, studies have shown that sensory examination can 
discriminate patients with NeP from patients with nociceptive pain (Bennett 2001; 
Bouhassira et al. 2005; Dworkin et al. 2007; Rasmussen et al. 2004; Scholz et al. 
2009).  
 
Findings of diagnostics tests such as imaging techniques, neurophysiological tests 
and skin biopsies complement the diagnostic work-up for the presence of NeP 
(Baron and Tölle 2008; Cruccu et al. 2010; Haanpää et al. 2011). While these 
diagnostic tests do not distinguish between painful and painless nerve lesions, they 
do supplement the differential diagnosis of a peripheral nerve lesion or disease. 
 
2.9.2 Classification of patients with neuropathic pain 
The identification of NeP in patients with ‘typical’ NeP conditions such as 
postherpetic neuralgia is reported to be much easier compared to the identification of 
NeP in conditions with mixed nociceptive and neuropathic pain characteristics such 
as radiculopathy (Attal and Bouhassira 2004; Behrman et al. 2007; Rasmussen et al. 
2004). There may be various degrees of neuropathic components, also referred to as 
pain ‘being more or less neuropathic’ (Attal and Bouhassira 2004; Bennett et al. 
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2006). In order to address this spectrum of NeP, two previous studies in patients with 
chronic pain of various aetiologies grouped patients according to the ‘increased 
suspicion’ of NeP (e.g.‘definite’, ‘possible’ or ‘unlikely’) (Bennett et al. 2006; 
Rasmussen et al. 2004). This concept was also adopted by the NeuPSIG and a 
grading system with different levels of certainty about the presence of NeP (no, 
possible, probable, definite) was developed (Treede et al. 2008). This new diagnostic 
approach is based on a stepwise process that requires a history-derived working 
hypothesis, based on pain distribution and history suggesting a relevant lesion, and 
confirmatory evidence from a neurological examination and diagnostic tests (e.g. 
neuroimaging, neurophysiological methods). The application of this grading system 
has been recommended for use in primary care (Haanpää et al. 2009) and its use has 
been reported in some case studies (Geber et al. 2009; Haanpää et al. 2009), and 
more recently in a prospective study following thoracotomy (Guastella et al. 2011). 
However, the applicability of this grading system in identifying NeP in patients with 
neck-arm pain has not yet been investigated. This was the aim of Study 2 (Chapter 5) 
in this thesis. 
 
2.9.3 Neuropathic pain screening tools 
NeP screening tools have been developed in order to assist clinicians and non-
specialists in identifying NeP. Several screening tools were developed for the 
identification of NeP in general; the LANSS (Bennett 2001), the self-reported 
version of LANSS (S-LANSS) (Bennett et al. 2005), the PD-Q (Freynhagen et al. 
2006a), the Douleur Neuropathique en 4 questions (DN4) (Bouhassira et al. 2005), 
the Neuropathic Pain Questionnaire (NPQ) (Krause and Backonja 2003) and the ID-
Pain (Portenoy 2006). These questionnaires are based on verbal pain descriptors, 
with or without items relating to a physical sensory examination. There are 
differences between the tools in the methodology of their developmental and 
validation studies. Some studies used the consensus of two experts as reference 
criterion (Bouhassira et al. 2005; Freynhagen et al. 2006a), while others used only 
the opinion of one expert clinician (Bennett 2001; Bennett et al. 2005; Portenoy 
2006). Furthermore, the populations studied varied in their proportion of patients 
with peripheral NeP due to a specific aetiology. The DN4 was the only one to 
include patients with central NeP syndromes. In addition, the type of sensory 
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descriptors used and the different weighting in the total scores varies between the 
questionnaires, making comparisons difficult. These variations may also explain the 
observed differences in performance between questionnaires when applied in the 
same patient population (Hallström and Norrbrink 2011). However, despite the 
methodological differences, certain items seem to overlap and have been considered 
as the ‘core symptoms’ for NeP, including tingling, numbness, burning, electric 
shock and touch-evoked pain (Bouhassira and Attal 2011). The sensitivity of the 
screening tools reported in their original validation studies ranges from 66% (NPQ) 
to 85% (LANSS, PD-Q) and specificity from 74% (NPQ) to 90% (DN4). For the ID-
Pain, sensitivity and specificity were not reported. The questionnaires and their 
translated versions have been widely used for the identification of NeP in patients 
with various pain disorders (Bouhassira and Attal 2011) and in epidemiological 
studies (Baron et al. 2009; Bouhassira et al. 2008; Freynhagen et al. 2006a; Rehm et 
al. 2010; Torrance et al. 2006), although they have not yet been validated for the 
latter purpose (Cruccu et al. 2010; Haanpää et al. 2011). 
 
NeP screening tools should not replace clinical judgement (Bouhassira and Attal 
2011; Haanpää et al. 2011; Hansson and Haanpää 2007) given that patients with non-
NeP such as patients with FM or hip osteoarthritis also use sensory descriptors 
common to NeP, as demonstrated by their responses to the LANSS (Giske et al. 
2009; Martinez-Lavin et al. 2003) and PD-Q (Amris et al. 2010; Gwilym et al. 2009; 
Rehm et al. 2010). However, a high score on these questionnaires is not sufficient to 
conclude that these pain conditions are neuropathic. 
 
All NeP screening tools except the ID-Pain (Portenoy 2006) were developed based 
on dichotomous groups: patients with NeP and patients with nociceptive pain. 
Patients with mixed pain presentations were excluded in the developmental studies 
and this approach limits the generalisability of the results to a typical clinical 
population presenting with mixed pain presentations (Behrman et al. 2007; Bennett 
2001). None of the screening tools have been validated in patients with nerve-related 
neck-arm pain of mixed pain. Based on the observation that pain qualities in patients 
with mixed pain presentations may differ from those obtained in patients with NeP 
(Behrman et al. 2007; Rasmussen et al. 2004), further questionnaires were 
developed, such as the expanded version of the Short-form McGill Pain 
2-23 
Questionnaire (SF-MPQ-2) (Dworkin et al. 2009) and the Pain Quality Assessment 
Scale (Jensen et al. 2006; Victor et al. 2008). While these questionnaires may assist 
in characterisation of the symptoms of patients with both neuropathic and non-NeP, 
they are not designed as NeP screening tools.  
 
Two NeP screening tools, the LANSS and PD-Q, were applied in this thesis, 
primarily because both questionnaires have been validated in patient cohorts 
including patients with low back and leg pain (Freynhagen et al. 2006a; Unal-Cevik 
et al. 2010). Hence, the questionnaires might be transferable to patients with neck-
arm pain, although no study has yet investigated their usefulness in detecting NeP in 
patients with nerve-related neck-arm pain. This was one of the aims of Study 2 
(Chapter 5). Furthermore, both questionnaires appeared to demonstrate the same 
level of diagnostic accuracy in identifying NeP in their original validation study 
cohorts. However, it is unknown if they show similar performance when applied to 
an identical patient cohort as in Study 2 (Chapter 5). If this were the case, the use of 
the PD-Q would be preferable in primary care, as it would save valuable practitioner 
time. 
 
The LANSS (Bennett 2001) (Appendix 4), was developed utilising a total of 60 
patients, 30 patients with distinct clinical diagnostic categories of NeP (including 5 
patients with lumbar and 2 patients with cervical radiculopathy) and 30 patients with 
non-NeP. The questionnaire demonstrated a sensitivity of 83% and specificity of 
87% and was further validated in another cohort of 40 patients (sensitivity 85%, 
specificity of 80%) (Bennett 2001). The questionnaire is applied in an interview 
format and contains five sensory descriptor items and two clinical examination items. 
The validity and reliability of LANSS has been well established in numerous studies 
in patients with peripheral NeP (Bennett 2001; Pérez et al. 2006; Rejas et al. 2006; 
Unal-Cevik et al. 2010; Yucel et al. 2004), demonstrating sensitivity between 70.2% 
- 89.9% and specificity between 90.3% and 96.6% (Rejas et al. 2006; Unal-Cevik et 
al. 2010; Yucel et al. 2004). The study by Rejas et al (Rejas et al. 2006) included 156 
patients. Although the aetiology of all patients was not specified, 22 patients had 
been clinically classified as having mixed pain. Sensitivity and specificity values 
were 81.8% and 89.4% respectively for the whole patient sample, and 85.9% and 
90.3% respectively when patients with mixed pain were excluded from the analysis. 
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Hence, sensitivity reduced slightly with the presence of mixed pain presentations, but 
the proportion of mixed pain presentations was small (14%). The sensitivity of 
LANSS was also substantially lower (29.5%) in a cohort of 168 patients with cancer 
which is considered a mixed pain presentation (Baron and Tölle 2008; Mercadante et 
al. 2009), however these results need to be interpreted with caution given the 
different pathology involved. To date, there are no reports on the discriminative 
ability of LANSS in large cohorts of patients with musculoskeletal mixed pain. 
 
The PD-Q (Freynhagen et al. 2006a) is a self–reported tool consisting of seven 
weighted sensory descriptor items, plus one item relating to temporal pain 
characteristics and one item relating to spatial pain characteristics (Appendix 4). The 
questionnaire was designed to identify NeP components specifically in low back pain 
patients with and without referred pain (Freynhagen et al. 2006a). The PD-Q was 
developed and validated in 392 German patients with clinically diagnosed pain of 
predominantly either nociceptive or neuropathic origin and demonstrated a 
sensitivity of 85% and specificity of 80%. However, the proportion of patients with 
clinical diagnosis of neuropathic back and/or leg pain was not stated in the 
publication. The NeP population used in the study included: “patients with 
postherpetic neuralgia, painful polyneuropathy, nerve trauma and low back pain 
(solely of the lumbar vertebrae, sacrum and coccyx)” (Freynhagen et al. 2006a). The 
presence of lumbar radiculopathy/radicular pain was not mentioned. Hence it 
remains unclear if the identification of NeP in this cohort related to NeP back pain or 
NeP leg pain as neuropathic and nociceptive components of patients with LBP do 
vary in the back and leg (Attal et al. 2011).  
 
The PD-Q is easy to implement in clinical practice, is available in various languages 
including English (Amris et al. 2010; Morsø et al. 2011; Steegers et al. 2008), and 
the translated versions have been used for the identification of NeP in patients with 
low back pain (Beith et al. 2011; Morsø et al. 2011), patients with thoracic surgery 
(Steegers et al. 2008) and patients with chronic musculoskeletal pain (Jespersen et al. 
2010). However, its reliability and revalidation of translated versions have been 
reported in only one study in Swedish patients with central NeP due to spinal cord 
injury (Hallström and Norrbrink 2011). In that group of patients reliability was 
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moderate and diagnostic accuracy was lower than that reported in the original study 
(sensitivity 67.9%, specificity 83%).  
 
NeP screening tools fail to identify 10 - to 20% of patients with clinically diagnosed 
NeP (Bennett et al. 2007) and do not provide any information on the underlying 
cause of the pain condition. A study by Attal et al (Attal et al. 2008) demonstrated 
that symptoms of pain were very similar for patients with various NeP aetiologies, 
thus symptoms alone were not discriminant enough to indicate the underlying 
pathology (Attal et al. 2008). Therefore the clinical assessment, as outlined under 
sections 2.7 and 2.9.1 is argued as crucial in order to establish the presence of a 
nerve lesion/disease and the presence of NeP in patients with nerve-related neck-arm 
pain. Furthermore, Scholz et al (Scholz et al. 2009) documented that in patients with 
low back and leg pain sensory symptoms obtained from patients using an interview 
format were less sensitive for the distinction between NeP and non-NeP than 
physical examination items. Hence, the physical examination of sensory signs, using 
clinical examination or QST, is an important aspect of clinical examination when 
discriminating the underlying pain types. 
 
2.9.4 Quantitative sensory testing 
Commonly used QST measures are thermal, pressure and pinprick sensation 
exploring the function of small unmyelinated C-fibres and small myelinated Aδ 
fibres as well as touch and vibration threshold assessing the function of large 
myelinated Aβ fibres (Hansson et al. 2007). For the assessment of NeP, QST is 
complementary to bedside examination as the site of measurement is determined on 
the basis of prior clinical examination (Backonja et al. 2009; Hansson et al. 2007). 
Compared to bedside assessment, QST allows a more precise and reliable assessment 
of the magnitude of sensory loss and quantification of thermal and mechanical 
hyperalgesia/allodynia (Chong and Cros 2004; Eliav et al. 2004; Hansson et al. 2007; 
Rolke et al. 2006b; Shy et al. 2003). In contrast to nerve conduction studies which 
can assess only a loss of function in myelinated nerve fibers, QST can also assess 
small nerve fiber function and a gain of function (Krumova et al. 2010). Thus, in the 
context of NeP, while QST can be used to support a hypothesis as to whether or not a 
nerve lesion is present, it cannot indicate the location of the lesion. Sensory 
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aberrations may be due to a dysfunction anywhere along the sensory pathway 
between the peripheral sensory receptor apparatus and the brain (Chong and Cros 
2004; Shy et al. 2003). Sensory aberrations have also been documented in patients 
with non-NeP (Blumenstiel et al. 2011; Geber et al. 2008; Klauenberg et al. 2008; 
Leffler et al. 2000; Leffler et al. 2003; Pfau et al. 2009; Westermann et al. 2011).  
 
QST is not an objective assessment of pain or sensibility. It is a psychophysical 
assessment in which an objective stimulus is applied and a subjective response from 
a participant recorded. Hence, participant’s responses are influenced by cognitive 
factors (Backonja et al. 2009) and psychosocial and psychological components 
(Rhudy and Meagher 2000; Shy et al. 2003). Furthermore, factors such as age, 
gender and site of stimulation, the environment of a test laboratory and instructions 
given to the participants do have an impact on QST measures. Therefore 
standardisation of testing protocols is important to facilitate reliability and 
comparison of QST data between studies. The DFNS (Rolke et al. 2006a; Rolke et 
al. 2006b) has developed such a standardised QST protocol that was employed in this 
thesis (see Chapter 3, section 3.6.1).  
 
The DFNS protocol has been applied in numerous studies (Blumenstiel et al. 2011; 
Freynhagen et al. 2008; Klauenberg et al. 2008; Koroschetz et al. 2010; Maier et al. 
2010; Pfau et al. 2009; Westermann et al. 2011) and 117 investigators in 15 different 
countries have been trained in this method (Magerl et al. 2010). Reference data have 
been obtained in Germany from 180 healthy control subjects which were stratified 
for 5 age groups. To compare a patient’s QST data profile with control data 
independent of the different units of measurement across QST parameters, the DFNS 
proposed a z-transformation of data, based on the healthy control data (Rolke et al. 
2006a; Rolke et al. 2006b). However, so far reference data have only been obtained 
for three body regions, which may not necessarily correlate with the patients’ 
maximal pain area (Blumenstiel et al. 2011; Maier et al. 2010). Hence calculating z-
scores based on data not obtained in the same body region, as has been documented 
by some (Blumenstiel et al. 2011; Maier et al. 2010), may potentially bias the results.  
 
QST has proven to be a valuable assessment to characterise painful syndromes and to 
help interpret the pain mechanisms underlying clinical pain presentations (Aasvang 
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et al. 2008; Chien et al. 2008; Gottrup et al. 2000; Jääskeläinen et al. 2005; Taylor et 
al. 2010; Werner and Kehlet 2010). Studies on patients with nerve-related spinal 
neck-arm pain comparable to the cohorts assessed in this dissertation are however 
scarce. Only one study has documented sensory alterations in patients with cervical 
radiculopathy (Chien et al. 2008) and one study in patients with dermatomal neck-
arm pain without any clinical signs of nerve root damage (Voerman et al. 2000), 
however the latter study did not report the presence of heightened nerve 
mechanosensitivity. In both these studies, sensory deficits were documented in the 
patients’ dermatomal area, suggestive of nerve damage, but not necessarily indicative 
of the presence of NeP. Similarly, vibration hypoaesthesia was reported in peripheral 
nerve innervation territories in patients with non-specific arm pain due to office 
work-related upper limb pain (Greening and Lynn 1998; Greening et al. 2003; 
Tucker et al. 2007). However, none of these QST studies in patients with neck-arm 
pain, performed QST in the area of maximal pain, as is required for the assessment 
of NeP (Haanpää et al. 2011). Chien et al (Chien et al. 2008) examined sensory 
alterations in the area of the cervical spine which may have been the maximal pain 
area for some patients, although this was not specified. Likewise, while studies in 
patients with lumbar radiculopathy reported QST measures in affected dermatomal 
distributions, QST was not reported for the patients’ maximal pain area (Freynhagen 
et al. 2008; Nygaard et al. 2000; Nygaard and Mellgren 1998; Quraishi et al. 2004; 
Samuelsson and Lundin 2002; Zwart and Sand 2002; Zwart et al. 1998). 
Furthermore, the studies on patients with neck-arm pain (Greening and Lynn 1998; 
Greening et al. 2003; Tucker et al. 2007; Voerman et al. 2000) and cervical 
radiculopathy (Chien et al. 2009) did not incorporate the assessment of all 
somatosensory modalities (thermal, pressure, pinprick sensation, light touch and 
vibration), and therefore a complete sensory phenotype for these patient groups has 
not been documented. 
 
Widespread hypersensitivity to pressure and cold stimuli has been documented in 
patients with cervical radiculopathy suggesting augmented central pain processing 
(Chien et al. 2008). Similarly, widespread pressure sensitivity and the presence of 
cold hypersensitivity have been demonstrated in patients with FM as well as 
enhanced temporal summation of pain from mechanical and thermal stimulation 
(Berglund et al. 2002; Blumenstiel et al. 2011; Hurtig et al. 2001; Klauenberg et al. 
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2008; Koroschetz et al. 2010; Kosek and Ordeberg 2000; Pfau et al. 2009; Staud et 
al. 2003; Staud et al. 2001). As no local somatic abnormality has been found that is 
likely to explain the cause of FM (Goldenberg 2009; Wolfe et al. 2010), aberrations 
in pain inhibitory and pain facilitatory mechanisms as well as central 
sensitisation/augmentation of sensory input have been associated with enhanced pain 
sensitivity in patients with FM (Banic et al. 2004; Desmeules et al. 2003; Julien et al. 
2005; Lannersten and Kosek 2010). Although patients with cervical radiculopathy 
and patients with FM may have some sensory parameters in common, the underlying 
pain mechanisms likely differ. No study has yet explored commonalities or 
differences in somatosensory profiles of patients with nerve-related neck-arm pain 
and patients with FM. 
2.10 Somatosensory profiling 
The mechanism- or symptom based classification of NeP is based on the hypothesis 
that different clinical signs and symptoms reflect different underlying 
pathophysiological mechanism of pain generation (Baron 2006; Jensen and Baron 
2003; Woolf et al. 1998). As one specific symptom may be generated by several 
entirely different underlying mechanisms (Woolf and Salter 2000), a combination of 
positive and negative sensory phenomena, namely a symptom profile, may better 
predict underlying pain mechanisms (Baron 2009; Cruccu and Truini 2009). 
However, this symptom based approach is not to be seen in isolation, but as part of 
the overall patient examination. 
 
2.10.1 QST as tool for somatosensory profiling 
The DFNS QST protocol consists of a battery of tests measuring all relevant 
submodalities of the somatosensory system (Rolke et al. 2006a; Rolke et al. 2006b) 
(see Chapter 3, Methods). Using this protocol, complete somatosensory profiles have 
been established for patients with NeP (Freynhagen et al. 2008; Maier et al. 2010) 
and non-NeP conditions (Blumenstiel et al. 2011; Klauenberg et al. 2008; Pfau et al. 
2009; Westermann et al. 2011). Sub-groups of patients with NeP with distinct 
somatosensory profiles have been identified in patients with diabetic neuropathy and 
patients with postherpetic neuralgia (Maier et al. 2010), illustrating the heterogeneity 
of patients within one aetiology. Such heterogeneity has not yet been shown in 
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patients with nerve-related neck-arm pain, but if it exists, it may be part of the 
explanation for the variability in responsiveness to pharmaceutical intervention in 
patients with cervical radiculopathy (Saldaña et al. 2010a). Other factors such as 
genetic disposition may also contribute to the variance in treatment response. 
However, although attempts have been made to correlate specific individual sensory 
profiles with the likely underlying mechanisms (Baron 2006; Baron et al. 2010a), a 
firm link between the two has not yet been established, and it is still unknown 
whether patients with different somatosensory phenotypes respond differentially to 
treatment (Maier et al. 2010). 
2.10.2 painDETECT as tool for somatosensory profiling 
Self-reported NeP questionnaires such as the Neuropathic Pain Symptom Inventory 
(NPSI) (Bouhassira et al. 2004) and the PD-Q (Freynhagen et al. 2006a) can also 
assist clinicians in characterising patients with NeP. The PD-Q has been used, not as 
a discriminative tool for NeP, but as a tool to identify somatosensory profiles in 
patients with painful lumbar radiculopathy/radicular pain (Mahn et al. 2011), in 
patients with diabetic neuropathy and postherpetic neuralgia (Baron et al. 2009) and 
in patients with FM (Rehm et al. 2010). Using a cluster analysis, all studies 
documented the presence of sub-groups of patients with distinct somatosensory 
profiles, hence aiding in the symptom-based classification of patients with persistent 
pain. However, whilst the assessment of evoked pain (brushing, cold, pressure) in the 
NPSI was verified with QST data of mechanical and thermal hyperalgesia, such a 
verification has not been reported for the PD-Q. Hence, it is unknown if self-reported 
responses to the PD-Q (light touch, pressure, cold and heat) correspond with sensory 
profiles as demonstrated by QST. Furthermore, the usefulness of the PD-Q in the 
characterisation of patients with nerve-related neck-arm pain has never been 
documented and this was the focus of Study 5 (Chapter 8) in this thesis. 
2.11 Treatment of nerve-related neck-arm pain 
The heterogeneity of nerve-related neck arm pain disorders and the likely presence of 
a mix of nociceptive and NeP in patients with cervical radiculopathy and patients 
with NSNAP highlights the importance of targeted treatments. Various management 
approaches are available such as pharmacological treatment (Attal et al. 2010; Baron 
et al. 2010b; Saldaña et al. 2010b), physiotherapy (Salt et al. 2011) including manual 
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therapy (Allison et al. 2002; Coppieters et al. 2003; Leininger et al. 2011), cognitive 
and behavioural interventions (Daniel et al. 2008; van de Wetering et al. 2010) as 
well as surgical intervention in case of cervical radiculopathy (Bono et al. 2011). A 
detailed review of the treatment options and evidence of their efficacy or lack there 
of is beyond the scope of this thesis. However, it is worth mentioning that studies of 
evidence are currently constrained by the difficulty of differentiating sub-groups of 
patients with nerve-related neck-arm pain and the effect heterogeneous study groups 
have on the power of clinical trials. 
2.12 Summary 
Patients with cervical radiculopathy and NSNAP may present with similar pain 
characteristics and sensory symptoms, but based on current literature, the 
pathophysiology, the pain types, and the underlying pain mechanisms are likely to 
differ. Identification of these differences may be important for targeting best-
evidence management. 
 
While classification systems for the identification of patients with cervical 
radiculopathy and NSNAP have been in place for over 14 years, no research has yet 
documented the reliability of these classification systems. Furthermore, guidelines 
have been established for the assessment of NeP in patients with persistent pain 
disorders, including the application of a clinical grading system of the certainty of 
presence of NeP and the application of NeP screening tools. However, the usefulness 
of these tools for the identification of NeP and determination of the dominant pain 
type(s) in patients with nerve-related neck-arm pain has not yet been investigated. 
QST has been recommended for the assessment of NeP components and for 
complete somatosensory characterisation of patients with persistent pain. The 
establishment of somatosensory profiles, using QST or the PD-Q, may assist in the 
interpretation of the pain mechanisms underlying clinical pain presentations. To date, 
no study has documented the QST somatosensory profiles of patients with cervical 
radiculopathy and patient with NSNAP. Additionally, no study has verified if the 
self-reported sensory phenotypes of patients with cervical radiculopathy obtained 
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Chapter 3 - Methodology 
In this chapter the methodology employed in the studies ‘QST somatosensory 
profiles in patients with cervical radiculopathy are distinct from those in patients 
with non-specific neck-arm pain (Study 3, Chapter 6) and ‘Neuropathic pain 
components are common in patients with cervical radiculopathy, but not in patients 
with non-specific neck-arm pain’ (Study 4, Chapter 7) and ‘Self-reported 
somatosensory profiles correspond with quantitative sensory testing phenotypes in 
patients with cervical radiculopathy, but not in patients with fibromyalgia’ (Study 5, 
Chapter 8) is presented. As there were some similarities between studies, and due to 
the brevity required for journal articles, a detailed description of the methods is 
provided here. 
 
The methodologies used in the studies ‘Clinical classification and sub-grouping of 
patients with neck-arm pain’ (Study 1) and ‘Classification of neuropathic pain in 
neck/upper limb pain: application of a grading system and screening tools”’ (Study 
2) are outlined in Chapters 4 and 5 respectively. Approval to conduct these studies 
was obtained from the Human Research Ethics Committee at each of the 
participating institutions (Appendix 1). The study protocols and recruitment 
procedures adhered to the ethical guidelines of the Declaration of Helsinki.  
3.1 Study design 
A cross sectional study design was used for Studies 3 - 5. The aim of Study 3 was to 
establish the QST somatosensory profiles of patients with cervical radiculopathy and 
patients with NSNAP. The profiles of these two patient groups were also compared 
to healthy control (HC) subjects and a positive control group, patients with FM.  
 
In Study 4 the side-to-side differences in QST parameters and the presence of NeP 
components were investigated in patients with painful cervical radiculopathy and 
patients with NSNAP. 
 
Study 5 investigated whether the self-reported somatosensory profile of patients with 
painful cervical radiculopathy and patients with FM, as characterised by responses to 
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verbal sensory descriptors from PD-Q corresponded with the sensory phenotype as 
demonstrated by QST. 
3.2 Subjects and recruitment 
Four groups of subjects were recruited for Studies 3 to 5:  
i. Patients with neck-arm pain due to the presence of a C6 or C7 cervical 
radiculopathy  
ii. Patients with NSNAP with pain in a C6 or C7 dermatomal distribution  
iii. Patients with FM and  
iv. Asymptomatic HC subjects, age matched to the patient groups.  
Data from all four subject groups were used for Study 3, whereas Study 4 included 
only patients with cervical radiculopathy and patients with NSNAP and Study 5 
included only patients with cervical radiculopathy and patients with FM. The same 
patients with cervical radiculopathy were used for Studies 3, 4 and 5 and the same 
patients with NSNAP were used for Studies 3 and 4. 
3.2.1 Recruitment 
Patient cohorts were recruited from: 
• General private physiotherapy, medical, rheumatology and neurosurgery 
practices within the Perth metropolitan area and surrounds.  
• Physiotherapy and pain management departments at five hospitals (Sir 
Charles Gairdner Hospital, Royal Perth Hospital, Fremantle Hospital, 
Rockingham Hospital, Bentley Hospital) (Appendix 2). 
• The Neurosurgery Outpatient Department and Neurosurgery Triage Clinic at 
Sir Charles Gairdner Hospital. As part of obtaining ethical approval to recruit 
patients from the Neurosurgery Triage Clinic the PhD candidate had offered 
to clinically assess and triage patients referred to this clinic. All referrals of 
patients with neck/upper limb symptoms to the Neurosurgery Triage Clinic 
between September 2007 and November 2010 were reviewed by the 
candidate. Patients with referrals suggesting a unilateral nerve disorder were 
selected and clinically examined.  
• The local community via radio and newspaper advertising.  
• Patients with FM were also recruited from FM support groups.  
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• Healthy control subjects were recruited from the general population by 
personal invitation and word of mouth. 
 
For recruitment of patients from a) and b), health professionals were given written 
information with the specific inclusion criteria for each patient group (see 3.2.2). The 
initial selection criteria for patients recruited from the local community via radio and 
newspaper advertising and from the Neurosurgery Triage Clinic were one sided 
neck-arm pain, symptom duration of 3 to 18 months and an age range from 18 to 65 
years of age. 
 
Patients with cervical radiculopathy and patients with non-specific neck-arm pain 
associated with heightened nerve mechanosensitivity  
Potential subjects underwent an initial phone screening examination to ascertain they 
satisfied the inclusion and exclusion criteria (see screening tool Appendix 3; 
selection criteria sections 3.2.2.1 and 3.2.2.2; and flow chart of recruitment Figure 
3.1). Telephone screening did not apply to patients attending the Neurosurgery 
Triage Clinic, as their visit was their formal appointment at the clinic. Prior to 
inclusion in the study, all patients underwent a comprehensive clinical examination 
in order to further determine they met the inclusion criteria (see assessment form 
Appendix 3). The clinical assessment comprised the patient’s history, pain drawings 
including location, description and intensity of pain, documentation of pain 
behaviours, musculoskeletal and related neural tissues assessments and neurological 
bedside examination of somatosensory and motor function plus a review of results 
from any other medical investigations that were available (e.g., imaging, 
electrophysiology). The assessment of each patient required on average one hour.  
 
As there is no universally accepted gold standard for the diagnosis of painful cervical 
radiculopathy and NSNAP, expert opinions were used to verify the pain conditions, 
as consistent with previous studies (Bennett 2001; Freynhagen et al. 2006; 
Freynhagen et al. 2008). The consensus of a Fellowship-trained neurosurgeon and a 
Fellowship-qualified Specialist in Musculoskeletal Physiotherapy (Fellow of the 
Australian College of Physiotherapists) were used as the gold standard for the 
diagnosis of cervical radiculopathy. The expert opinion of the Specialist 
Musculoskeletal Physiotherapist was used as the reference standard for the 
3-4 
classification of patients with NSNAP. The neurosurgeon was not asked to classify 
patients with NSNAP as the assessment of heightened nerve mechanosensitivity in 
the upper limb is not common practice for neurosurgeons. The patient’s records, 
including the findings of the clinical examination and the available investigations, 
were reviewed by both experts using a blinded design. Where there was not 
consensus between the experts and clinical examiner, subjects were excluded from 
the data analyses.  
 
In total 886 patients were recruited, 464 patients were clinically examined and 41 
fulfilled the inclusion criteria (Figure 3.1). All recruitment, screening procedures and 
the clinical examination of potential subjects in this study, implementation of testing 
protocols and data analyses presented in this thesis were performed by the PhD 










Patients with fibromyalgia 
All patients had to fulfil the diagnostic criteria for FM according to the 1990 
American College of Rheumatology (ACR) (Wolfe et al. 1990) which include 
widespread pain of at least 3 months duration in combination with tenderness at 11 
or more of 18 specific anatomical sites. These diagnostic criteria were current at the 
time of recruitment. All patients underwent an initial phone screening examination to 
ascertain they satisfied the inclusion and exclusion criteria (see screening tool 
Appendix 3 and selection criteria section 3.2.2.3). Prior to participation, the 
diagnosis of FM was confirmed by assessing nine paired points as defined by the 
ACR Criteria (Wolfe et al. 1990) and two control points (at the center of the right 
forearm and the right thumb nail) using a pressure algometer (Somedic AB, Farsta, 
Sweden). The algometer was placed on the examination site, and pressure was 
gradually increased by 1 kg/s with an application rate of 50 kPa. The patients were 
asked to press a button when the sensation at the examination site changed from one 
of pressure to one of pain. Pressure testing was stopped at that moment and the result 
was recorded as positive if the maximal pressure was ≤ 4kg. If no pain was elicited at 
≤ 4kg, the test results were recorded as negative. The patient’s clinical history was 
taken, including the pain locations using a body chart and identification of the 
maximal pain area as this was the site to be tested by QST (see Appendix 3 
assessment form).  
 
3.2.2 Subjects 
3.2.2.1 Patients with cervical radiculopathy  
Inclusion criteria 
• Unilateral dermatomal pain distribution consistent with specific radicular 
distributions (C6/C7)  
• Age 18 to 65 years  
• Symptom duration of 3 to 18 months (This symptom duration was chosen to 
represent the clinical profile of patients with chronic pain. A symptom 
duration below 3 months is considered a sub-acute stage. The influence of 
psychological factors on pain perception with increasing symptom duration 
has been well established in the literature. In order to ensure some 
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homogeneity of the patient cohort, a cut-off of 18 months symptom duration 
was chosen.) 
• Pain intensity ≥ 2 on a visual analogue scale (VAS) 
• Signs of C6 or C7 nerve root dysfunction such as sensory impairment and 
motor impairment (either myotomal weakness and/or absent or diminished 
reflexes) 
• Demonstrable clinically relevant abnormality on imaging studies (Bono et al. 
2011; Treede et al. 2008) indicating compromise of the exiting nerve root at 
the relevant spinal level. 
Exclusion criteria  
• Pain in contralateral side mirroring the maximal pain area  
• Pain in contralateral upper limb 
• A history of lumbar surgery and/or sciatica or other musculoskeletal disorders 
that potentially might affect the sensation in the foot to be tested 
• Pain and/or nerve lesion in ipsilateral lower limb/foot of the symptomatic 
side 
• Other neurological or psychiatric disease 
• Evidence of medical or metabolic disease 
• A history of cardiovascular disease  
• The subject is unable to achieve an equal amount of glenohumeral abduction 
in the asymptomatic limb that is available in the symptomatic limb 
• Insufficient level of English (subjects had to be able to understand and fill out 
the self report questionnaires. They had to be able to understand the 
instructions and requirements for the QST procedures and be able to give a 
reliable response that did not depend on translation.) 
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3.2.2.2 Patients with non-specific neck-arm pain associated with heightened 
nerve mechanosensitivity 
Inclusion criteria 
• Unilateral neck/upper limb pain and/or paraesthesia or dysaesthesia  
• Age 18 to 65 years 
• A symptom duration of 3 to 18 months  
• Pain intensity ≥ 2 on a VAS 
• An absence of neurological deficits (i.e. absence of signs of radiculopathy) 
• Evidence of increased upper quarter nerve sensitivity to movement (Elvey 
1997) with adverse responses to the NPTMEDIAN 
• Clinical signs of a musculoskeletal dysfunction at the relevant cervical spinal 
level C5/6 or C6/7 (Elvey 1997) 
Exclusion criteria  
• The same criteria were used as for patients with cervical radiculopathy  
 
3.2.2.3 Patients with fibromyalgia 
Inclusion criteria 
• Age 18 to 65 years 
• Symptoms duration ≥ 3 months (No limit was set with regard to symptom 
duration as patients typically present with symptoms for many years and are 
often not diagnosed with the condition for the first few years of onset of 
symptoms (Häuser et al. 2011). Therefore limiting the symptom duration to 
18 months would not only have restricted the recruitment of patients, but the 
chosen symptom duration would not have reflected the typical symptom 
duration seen in this patent cohort.) 
• Pain intensity ≥ 2 on a VAS 
• Widespread pain 
• 11 out of 18 tender points 
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Exclusion criteria  
• A history of lumbar surgery and/or sciatica or other musculoskeletal disorders 
that potentially might affect the sensation in the foot to be tested 
• Pain and/or nerve lesion in ipsilateral lower limb/foot of side to be tested by 
QST 
• Other neurological or psychiatric disease 
• Evidence of medical or metabolic disease 
• History of cardiovascular disease  
• Insufficient level of English as described above (see 3.2.2.1)  
3.2.2.4 Healthy control subjects 
Inclusion criteria 
• Age 18 – 65 years 
Exclusion criteria 
• A history of current or chronic upper quarter musculoskeletal pain condition 
and/or paraesthesia and/or nerve lesion 
• A history of current or chronic pain and/or paraesthesia and/or nerve lesion in 
the lower limbs 
• A history of lumbar surgery and/or sciatica or other musculoskeletal disorders 
that potentially might affect the sensation in the foot to be tested 
• Other neurological or psychiatric disease 
• Evidence of medical or metabolic disease 
• A history of cardiovascular disease  
• Intake of medication influencing pain perception 
• Insufficient level of English as described above (see 3.2.2.1) 
3.3 Sample sizes 
A sample size of 25 in each patient group was estimated to be sufficient to detect a 
clinically significant difference in pressure pain thresholds of 36% between groups 
and between the symptomatic and asymptomatic arm (Rolke et al. 2006a) with a 
power of 80% and 5% level of significance. The sample size calculation was based 
on QST data from a sample of healthy control subjects with a mean (SD) PPT of 512 
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(191.6) kPa. A difference of 36% in mean PPTs between sides has been reported to 
be clinically significant (Rolke et al. 2006a). 
3.4 Ethics and Consent 
All study protocol and recruitment procedures were approved by the Human 
Research Ethics Committee of Curtin University and Sir Charles Gairdner Hospital, 
Royal Perth Hospital and the South Metropolitan Area Health Service which 
incorporates Fremantle Hospital, Rockingham Hospital and Bentley Hospital 
(Appendix 1). All studies adhered to the ethical guidelines of the Declaration of 
Helsinki. All subjects received a study information sheet and gave written informed 
consent prior to inclusion into each study (Appendix 2). All subjects received a $20 
(AUS) voucher to reimburse their travel expenses and they received free parking. 
3.5 Measures 
A  Patient groups  
3.5.1 Pain intensity 
Average pain intensity over the week preceding the testing session was determined 
using a 10 cm VAS with the end points 0 cm (no pain) and 10 cm (maximum 
tolerable pain) (Appendix 4). High reliability (Crossley et al. 2004; Gallagher et al. 
2002; Zusman 1986), validity (Crossley et al. 2004; Gallagher et al. 2002; Jensen et 
al. 1989; Ohnaus and Adler 1975), and responsiveness (Crossley et al. 2004; 
Gallagher et al. 2002) for this pain rating scale have previously been demonstrated. 
The strongest and average pain intensity over the four weeks preceding the testing 
session and pain intensity at the time of completing the questionnaires were 
documented on a numeric rating scale (NRS) as part of the PD-Q (0 = no pain, 10 = 
maximum pain). 
3.5.2 Self-reported pain and disability 
The Neck Disability Index (NDI) is a ten-item questionnaire used to assess disability 
in patients with neck pain (Vernon and Mior 1991). Four of the items relate to 
symptomatology (pain intensity, headache, concentration, sleeping) whilst the 
remaining six items relate to activities of daily living (personal care, lifting, reading, 
work, driving and recreation). There are six potential responses to each item ranging 
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from no disability (0) to total disability (5). Thus the sum of all scores ranges from 0 
(no disability) to 50 (maximum disability). A score of < 4 indicates no disability, a 
score of 5 – 14 mild disability, a score of 15 – 25 moderate disability, 25 – 34 severe 
disability and scores ≥ 35 complete disability (Vernon and Mior 1991). Good 
reliability and validity of the NDI have been demonstrated (Chan Ci En et al. 2009; 
McCarthy et al. 2007). The NDI is the most widely used and most strongly validated 
instrument for assessing self-rated disability in patients with neck pain (Pietrobon et 
al. 2002; Vernon 2008). A copy of the NDI is provided in Appendix 4. 
3.5.3 Kinesiophobia 
Fear avoidance behaviour was quantified using the Tampa Scale of Kinesiophobia 
(TSK) (Vlaeyen et al. 1995) (Appendix 4). The questionnaire consists of 17 items 
that relate to fear of movement and fear of (re) injury. Questions are answered on a 
4-point Likert style scale, ranging from ‘strongly disagree’ to ‘strongly agree’. A 
total score is calculated after inversion of the individual scores of questions 4, 8, 12 
and 16. Scores range from 17, indicating no kinesiophobia, to 68 (Lundberg et al. 
2004). A score ≥ 40 is considered to indicate significant kinesiophobia (Crombez et 
al. 1999). The reliability of the TSK is considered moderate-to-good (Swinkels-
Meerwisse et al. 2003; Vlaeyen et al. 1995) and good validity has been demonstrated 
(Roelofs et al. 2004). 
3.5.4 Neuropathic pain components 
Two NeP screening tools were used in this thesis to identify the likely presence of 
NeP components; the LANSS (Bennett 2001) and the PD-Q (Freynhagen et al. 2006) 
(Appendix 4). The LANSS is applied in an interview format and contains five 
sensory descriptor items and two clinical examination items (testing for allodynia 
with cotton wool and altered pinprick threshold tested in the main pain area with a 23 
gauge needle). The scoring of the items ranges from 0 to 5, with the items of the 
presence of ‘tingling’, signs of autonomic dysfunction (skin color change) and the 
presence of allodynia scoring highest (score of 5). A score of ≥ 12 suggests that the 
responder’s pain is of predominantly neuropathic origin and a score of < 12 indicates 




The PD-Q (Freynhagen et al. 2006) consists of one descriptor relating to temporal 
and one to spatial pain characteristics and of seven weighted sensory descriptors. The 
lowest weight for each descriptor is 0, indicating that the person does not experience 
the relevant sensation, and the highest weight is 5, indicating that the person feels the 
sensation very strongly. PD-Q classifies patients into three groups. A score of 0 – 12 
indicates a negative result and a NeP component is unlikely. A score of 13 – 18 is an 
unclear or ambiguous result that does not preclude a NeP component. A score of ≥ 
19 indicates a positive result and NeP is likely (Freynhagen et al. 2006). 
 
B All subjects  
3.5.5 Sleep quality 
Sleep quality over the week prior to data collection was rated by all subjects on a 10-
cm VAS with the end points 0 cm (good sleep) and 10 cm (bad sleep) (Hurtig et al. 
2001). Sleep disturbance was assessed by asking the subject if he/she awakened tired 
or non-refreshed; fatigue was assessed by asking: “Are you fatigued?”(Wolfe et al. 
1990). Both questions allowed for answers: “never”, “seldom”, “often or usually”, 
“always” and were collapsed to a dichotomous scale. “Often or usually” or “always” 
was scored as positive, and other replies as negative (Appendix 4). 
3.5.6 Health related quality of life  
The short form-36 health questionnaire (SF-36v2®) (Ware 2000) was used to assess 
health related quality of life. The questionnaire contains 36 items measuring health 
on eight dimensions: physical functioning, role physical, bodily pain, role emotion 
and mental health plus one time that measures health transition (Appendix 4). Two 
composite scores can be calculated: a physical composite summary score and a 
mental composite summary score. A higher score indicates better health status. The 
SF-36 has sufficient reliability and validity to be used for measuring health related 
quality of life of patients with peripheral NeP conditions (Meyer-Rosberg et al. 
2001). A licence was purchased for use of this questionnaire. 
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3.5.7 Psychological factors 
The Hospital Anxiety and Depression Scale (HADS) was used to screen for the 
presence of depression and anxiety (Zigmond and Snaith 1983) (Appendix 4). Seven 
items relate to anxiety and seven to depression. Each item has four potential 
responses, which are scored from 0 to 3. The responder is blinded to these scores. 
Individual scores for anxiety and depression are generated with a maximum score of 
21 for each subscale. Scores of ≤ 10 for each are considered within normal range. 
The HADS has been demonstrated to be a valid screening tool in patients with 
musculoskeletal disorders (Härter et al. 2001). 
 
All questionnaires were administered before the QST testing was performed. The 
sensory testing component of the LANSS questionnaire was performed at the area of 
maximal pain just prior to administration of the QST testing protocol. 
3.6 Quantitative Sensory Testing  
3.6.1 Testing protocol 
Standardised QST measures were recorded according to the QST protocol of the 
DFNS (Rolke et al. 2006a; Rolke et al. 2006b), using the same equipment and 
standardised instructions (Appendix 5). This protocol comprises a battery of 
standardised tests in the following standardised order:  
• Thermal detection and pain thresholds 
• Mechanical detection threshold  
• Mechanical pain threshold  
• Stimulus-response functions: mechanical pain sensitivity and dynamic 
mechanical allodynia  
• Wind-up ratio – the perceptual correlate of temporal pain summation for 
repetitive pinprick stimuli 
• Vibration detection threshold 
• Pressure detection and  pain thresholds  
 
These tests are used to detect loss or gain of sensitivity of small and large afferent 
sensory fibres. The QST protocol of DFNS was chosen for this study, as it comprises 
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all somatosensory submodalities mediated by different primary afferents (C-, Aδ-, 
Aβ-) and therefore can be used to characterise the somatosensory phenotype of 
chronic pain patients. The test/retest and inter-observer-reliability of this protocol for 
measurements within two days was good except for measurements of wind-up ratio 
and the number of paradoxical heat sensations (Geber et al. 2011). Video clips of the 
individual testing procedures are available as supplementary material under Rolke et 
al (Rolke et al. 2006a). 
 
Thermal detection and pain thresholds and paradoxical heat sensation 
Thermal detection thresholds for the perception of cold (CDT) and warm (WDT) and 
cold and heat pain thresholds (CPT, HPT) were measured using the MSA Thermotest 
system (Somedic AB, Farsta, Sweden). The method of limits was used (Chong and 
Cros 2004). All thresholds were obtained with ramped stimuli (1° C/s) which were 
terminated when the subject pressed a button. The subject was asked to press the 
stop-button as soon as the slightest change of temperature (for detection threshold) or 
the first painful sensation (for pain threshold) was felt (Appendix 5). The baseline 
temperature was set at 32˚C; cut-off temperatures were 5˚C and 50˚C. The contact 
area of the thermode was 2.5 x 5cm. Cold and warm detection thresholds were 
measured first. The number of paradoxical heat sensations was determined during the 
thermal sensory limen procedure (the difference limen for alternating cold and warm 
stimuli), followed by cold pain and heat pain thresholds, The mean threshold 
temperature of three consecutive measurements was calculated. 
 
Mechanical detection threshold 
The mechanical detection threshold (MDT) was determined with a standardised set 
of modified von Frey hairs (Optihari2-Set, Marstock Nervtest, Germany) that exert 
forces upon bending between 0.25 and 512mN. Subjects were asked to indicate when 
they felt the slightest light touch of the filament (Appendix 5). A force of 16mN was 
used as the starting force. The filament was gently applied perpendicular to the skin 
and then slightly bent. If the touch was felt, filaments with lower force were then 
applied in a descending manner until the subject felt no sensation. Subsequently the 
order of application was reversed until the subject felt a sensation. This procedure 
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was repeated five times. The final threshold was the geometric mean of five series of 
ascending and descending stimulus intensities (Rolke et al. 2006b). 
 
Mechanical pain threshold 
Mechanical pain threshold (MPT) was measured using a set of seven custom-made 
weighted pinprick stimulators (flat contact area of 0.2 mm diameter) with fixed 
stimulus intensities (8 16, 32, 64, 128, 256, and 512 mN) (MRC Systems GmbH, 
Germany). A needle with 8 mN was used as the starting force. The tip of the needle 
was gently placed perpendicular to the skin surface, then the weight was applied. The 
subject was asked to indicate if the sensation was felt as being ‘sharp’ or ‘blunt’ 
(Appendix 5). If the sensation was felt as ‘blunt’, the next higher needle was applied 
in sequence until the subject felt a sharp sensation. Then the order of application was 
reversed until the subject felt a blunt sensation. The final threshold was the geometric 
mean of five series of ascending and descending stimulus intensities. 
 
Stimulus-response functions: mechanical pain sensitivity for pinprick stimuli and 
dynamic mechanical allodynia for stroking light touch 
Mechanical pain sensitivity (MPS) was assessed using the same weighted pinprick 
stimuli as for MPT. These seven pinprick stimuli were applied in a balanced order, 
each one was applied five times. Subjects were asked to give a pain rating for each 
stimulus on a NRS (0 = no pain, 100 = most intense pain imaginable) (Appendix 5). 
Pain in response to light touch (dynamic mechanical allodynia; DMA) was assessed 
using a cotton wisp (3mN), a cotton wool tip fixed to an elastic strip (100mN) and a 
brush exerting a force of 200-400mN. Each was applied five times with a single 
stroke of approximately 1-2cm in length over the skin. They were intermingled with 
the pinprick stimuli in balanced and standardised order and subjects were asked to 
give a rating on the same scale as for pinprick stimuli (Appendix 5). MPS was 
calculated as the geometric mean of all numerical ratings for pinprick stimuli and 
DMA as the geometric mean of all numerical ratings across all three different types 
of light touch stimulators. 
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Wind-up ratio – the perceptual correlate of temporal pain summation for repetitive 
pinprick stimuli 
The perceived magnitude of a single pinprick stimulus (256 mN) was compared with 
that of a series of 10 pinprick stimuli of the same force repeated at a 1/s rate. The 
time interval of 1 second was standardised using a metronome (Korg MA-30, Japan). 
The repeated stimuli were given within a small area of 1cm2. First a single stimulus 
was applied and the subject was asked to give a pain rating for this stimulus. Then 
the repeated stimuli were applied and the subject was instructed to give a pain rating 
representing the pain over that whole series of 10 pinpricks using a 0 – 100 NRS 
(Appendix 5). Single pinprick stimuli were alternated with the series of 10 stimuli 
until both were performed five times at five different skin sites within the same body 
region. The mean pain rating of trains divided by the mean pain rating to single 
stimuli was calculated as wind-up ratio. 
 
Vibration detection threshold 
A Rydel-Seiffer tuning fork (64Hz, 8/8 scale) (Martin, Tuttlingen, Germany (Figure 
3.2) was used for the measurement of vibration detection threshold (VDT) (Figure 
3.2). Both arms of the fork bear calibrated weights at their ends. A nine-point 
arbitrary scale from 0 to 8 and the shape of an elongated triangle beside the scale are 
imprinted on each weight. Once the tuning fork starts to vibrate, the triangle on each 
arm appears as two virtual, intersecting triangles. With decreasing vibration of the 
arms, the intersection moves exponentially up the scale. The subjects were asked to 
say “now” as soon as the vibration was no longer felt (Appendix 5). The nearest 
value (to the closest half-point) to the point of intersection of triangles was then 
recorded as the vibration threshold. The thresholds were determined as a 
disappearance threshold with three stimulus repetitions (Rolke et al. 2006b). The 
tuning fork was placed over a bony prominence in the body area to be tested. If no 




Figure 3.2 Tuning fork 
 
Pressure pain threshold  
Pressure pain threshold (PPT) was measured using a pressure algometer with a probe 
size of 1cm and an application rate of 50 kPa/s (Somedic AB, Farsta, Sweden). The 
subjects were asked to push a button when the sensation changed from one of 
pressure alone to one of pressure and pain. Triplicate recordings were taken and the 
mean value of these was used for analysis. 
3.6.2 Measurement sites 
QST testing was performed for all patients in their maximal pain area (as determined 
by the patient) and also in the corresponding area of the contralateral asymptomatic 
(control) side. For patients with FM, given the presence of bilateral pain, the most 
painful side was chosen as the symptomatic side, and the less painful side as the 
control side. If patients could not determine a most painful side, control and 
symptomatic side were determined randomly by the rolling of a die. The test sites in 
HC subjects were matched to the maximal pain areas in the patients with neck/arm 
pain and FM. It was anticipated that patients would indicate the area of upper 
trapezius muscle as their main pain area, therefore bilateral reference data were 
obtained in 26 HC for this site. However, during the course of patient recruitment it 
became apparent, that many patients experienced their main pain in other body 
regions. Therefore unilateral measurements for all other pain areas were obtained in 
8 HC, including 3 from the trapezius group. Consequently data were available from 
at least eight healthy control subjects to standardise the patient data in accordance 
with established methodology (Blankenburg et al. 2010). In HC subjects, the 
‘symptomatic’ side was determined randomly by rolling a die. 
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Additionally, patients with cervical radiculopathy were tested precisely in the distal 
area of their dermatomal sensory deficit (C6 or C7, as determined by bedside 
examination) and the corresponding contralateral control site. Patients with NSNAP 
were tested in their distal area of pain/paraesthesia and the corresponding 
contralateral control site. For practical reasons, it was not possible to match each site 
of distal sensory deficit or pain or paraesthesia exactly with a HC and FM test site. 
Therefore, the thenar eminence was determined to be representative of the C6 
dermatome and the dorsum of the hand representative of the C7 dermatome. The 
PPT for dermatome C7 was assessed over the palmar interossei muscles between 2nd 
and 3rd metacarpal as test sites overlying muscles rather than over tissues with a low 
compliance (bone) are recommended (Rolke et al. 2005). VDT was measured over 
the 3rd metacarpophalangeal joint for C7 dermatome and over the radial styloid 
process for the C6 dermatome. C6 and C7 dermatomes were assessed bilaterally in 
patients with FM and in 26 HC subjects. Fifty percent of HC subjects and 45% of 
patients with FM were tested in the C6, and the remaining were tested in the C7 
dermatome. The dorsum of the foot ipsilateral to the painful side served as intra-
individual control site for each subject. VDT of the foot was recorded over the 
medial malleolus (Rolke et al. 2006a; Rolke et al. 2006b). 
 
All measurements were conducted on each subject by the same investigator (BT) in a 
laboratory with a constant room temperature. The investigator was blind to the 
results of all questionnaires. BT had previously visited the teaching centre of DFNS 
for familiarization with the testing procedures and protocol. Testing was conducted 
in a standardised order (control side tested prior to symtomatic side) (Rolke et al. 
2006b) but testing of the different body regions was performed in a random order 
(determined by rolling a die). In order to familiarise subjects, all tests were first 
conducted over a demonstration area that was not later tested during the QST 
session. Standardised verbal instructions (Rolke et al. 2006a) were given to all 
subjects (Appendix 5). Subjects were asked to close their eyes during testing. For 
each body region to be tested, the subject’s positioning remained unchanged, 
however the positioning did vary between individuals, depending on which position 
was most comfortable. Utmost attention was made to ensure that the body region to 
be tested was positioned in such a way that the stimuli for measuring MDT, MPT 
and MPS could be applied perpendicular to the skin surface. Testing of the full 
3-19 
protocol took approximately 30 minutes per test area (5 areas), with the total 
examination time taking 2.5 hours. The subjects were requested to refrain from using 
non–steroidal antiinflammatory drugs and analgesics on the day of examination. All 
measurements were recorded on a specific data collection sheet (see Appendix 6).  
3.7 Nerve Provocation Test (NPTMEDIAN) 
After completion of the QST protocol, peripheral nerve mechanosensitivity was 
assessed with the NPTMEDIAN in patients with cervical radiculopathy and patients 
with NSNAP. The NPTMEDIAN is comprised of a number of components including 
shoulder girdle fixation, glenohumeral abduction to 90°, external rotation, forearm 
supination, elbow extension, and wrist and finger extension (Butler 1991; Elvey and 
Hall 1997; Quintner 1989). Sensory and pain responses to the testing manoeuvre 
have been documented in more than 390 healthy control subjects (Bell 1987; 
Kenneally et al. 1988; Lohkamp and Small 2011; Rubenach 1985). The reliability of 
this test has been established in the normal and patient population in laboratory 
settings as well as in clinical settings (Coppieters et al. 2002; Lohkamp and Small 
2011; Schmid et al. 2009). In this thesis glenohumeral abduction, shoulder girdle 
fixation, forearm supination and wrist and finger extension were prepositioned so 
that only elbow extension had to be performed as the primary movement of the test 
(see 3.7.1.2, Figure 3.3). Shoulder external rotation was not incorporated in this 
method, as the role of this position in loading of neural structures is unclear (Ginn 
1988; Kleinrensink et al. 1995). The chosen testing procedure has previously been 
applied in healthy subjects and patients with cervicobrachial pain and demonstrated 
excellent reliability (Intraclass-Correlation Coefficient (ICC) (0.925) (van der Heide 






Figure 3.3 Set up of testing procedure of NPTMEDIAN. The two green arrows indicate the 
location of the goniometer. The red arrow indicates the abduction frame. The blue arrow 
points to the stop button.  
 
Test position 
The subject was positioned supine on a plinth with the arm not being tested resting at 
the side of the body and the hand placed on the abdomen to operate an external 
trigger (Figure 3.3). The subject’s upper body was positioned on a wooden board 
with protractor markings on each side that were indicating angles of shoulder 
abduction in 50 intervals. These markings were used to measure and to standardise 
the available range of shoulder abduction. The arm being tested was positioned in an 
abduction brace at the available abduction angle. The head was placed in a neutral or 
non-pain provocative position and rested comfortably on folded towels. Shoulder 
girdle depression was standardised using an air-filled pressure sensor (Stabilizer, 
Chattanooga, Australia) folded in three and placed between the apparatus and the 
subject's shoulder. The reliability of this device has been established in an earlier 
study (Edgar et al. 1994). Wrist and finger extension were standardised using a rigid 
(Thermoplastic) splint strapped onto the forearm and hand. The angle of elbow 
extension was measured by a computer-linked electro-goniometer (SG110 
Biometrics Ltd, United Kingdom) attached to the subject’s forearm and upper arm. 




In some patients, pain limited the degree of shoulder abduction on the symptomatic 
side. Therefore, it was necessary to test the symptomatic arm first so that testing of 
the asymptomatic arm could be performed at the same abduction angle. As many 
patients presented with a high irritability of their pain condition, it was decided that 
the starting position should not be a provocative pain position. In the case of a patient 
with constant pain, BT moved the symptomatic arm into shoulder abduction to the 
range just before the increase of pain. The arm was then fixed with Velcro straps into 
the abduction brace. 
 
The starting position for testing was shoulder girdle fixation (inflation of the pressure 
sensor to 40mm/Hg), tolerable shoulder abduction, elbow flexion (900), wrist and 
finger extension (the latter fixed by a Thermoplastic splint). In order to familiarize 
the subject with the procedure, the NPTMEDIAN was performed once prior to the 
actual test. The NPTMEDIAN was performed on the subject three times with a between-
trial interval of 10 seconds. BT extended the elbow over a standard time frame of 10 
seconds within each trial. The subject was asked to press an external trigger at the 
first onset of pain or increase of their resting pain (P1) and at a second time point 
when he/she reached their pain tolerance (P2). Elbow extension was performed to the 
end of range or to P2. At the completion of this test, the subjects were asked to 
indicate where the pain was felt during the elbow movement and whether the pain 
provoked by the testing manoeuvre was similar to their usual neck/arm pain. This 
information was recorded on a body chart (Appendix 6). Subjects were also asked to 
rate any pain intensity on a VAS before and after the NPTMEDIAN. The testing 
procedure was performed each time by the same examiner and the arm remained at 
the same shoulder abduction angle in the abduction frame throughout all four trials. 
The NPTMEDIAN was then performed in exactly the same way on the asymptomatic 
side. The angle of elbow extension at the onset of pain (P1) and at pain tolerance 
(P2) was recorded on the assessment sheet (Appendix 6). If the patient did not 
experience an onset of pain or pain did not limit the movement, a value of ‘0’ was 
recorded for P1 or P2. 
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3.8 Reliability of QST protocol and responses to the NPTMEDIAN 
For all testing protocols, a series of reliability studies were conducted. Measurements 
were taken as outlined above in 21 healthy subjects. Not every person was tested for 
all QST parameters, however all parameters were tested across the cohort of 21 
subjects. Three repeated measures on the same day were taken for CDT, WDT, CPT, 
HPT, VDT, PPT, P1 and P2 and duplicate measurements on different days (interval 
varying between 1 to 13 days) for MDT, MPT, MPS and WUR. The thenar eminence 
was chosen as testing site for thermal thresholds, MDT, MPT, MPS and WUR. VDT 
was measured over the radial styloid process and over the 3rd metacarpophalangeal 
joint. PPT was measured over the thenar eminence and the dermatome C7 (palmar 
interossei muscles between 2nd and 3rd metacarpal). The Intraclass Correlation 
Coefficient (ICC3,1) was calculated for each parameter. Reliability coefficients were 
interpreted according to the following guidelines (Portney and Watkins 2009): 
 
Poor = ICC < 50 
Moderate = 0.50 < ICC < 0.75 
Good = ICC > 0.75 
 
The results indicate good reliability for 3 repeated measures on the same day for 
CPT, HPT, VDT, PPT, P1 and P2 and moderate reliability for CDT and WDT (Table 
3.1). Reliability of duplicate measurements for MPT and MPS was good (Table 3.1). 
and reliability for MDT and WUR was moderate. None of the subjects experienced 
allodynia or any paradoxical heat sensation. 
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Table 3.1  
Intraclass Correlation Coefficients (ICC (3.1)) of three repeated measures for cold 
detection threshold (CDT), warm detection threshold (WDT), cold pain threshold 
(CPT), heat pain threshold (HPT), vibration detection threshold (VDT), pressure pain 
threshold (PPT), elbow extension at onset of pain (P1) and at the limitation of 
movement due to pain (P2), and of two repeated measures for mechanical detection 
threshold (MDT), mechanical pain threshold (MPT), mechanical pain sensitivity 
(MPS) and wind-up ratio (WUR). 
Variable Measurement site ICC Lower limit Upper limit 
CDT thenar eminence .509 .156 .802 
WDT thenar eminence .554 .207 .825 
CPT thenar eminence .938 .846 .980 
HPT thenar eminence .938 .846 .980 
VDT  radial styloid process .934 .837 .979 
VDT  3rd metacarpophalangeal joint .947 .867 .983 
PPT  thenar eminence left .918 .801 .973 
PPT  thenar eminence right .920 .805 .974 
PPT  C7 dermatome left .939 .848 .980 
PPT  C7 dermatome right .879 .717 .960 
MDT thenar eminence .693a .228a .901a 
MPT thenar eminence .946a .811a .984a 
MPS thenar eminence .844a .456a .955a 
WUR thenar eminence .728a .055a .922a 
P1 Left arm .980 .949 .994 
P2 Left arm .994 .984 .998 
P1 Right arm .982 .953 .994 
P2 Right arm .993 .981 .998 
aICC based on mean ratings. 
 
3.9 Statistical Analysis 
Data were analysed with the Statistical Package for Social Sciences (SPSS Version 
17.0) for MacOS X 10.5.8. QST data were first entered into an excel-spreadsheet 
provided by DFNS which automatically generated thresholds and average ratings, 
and numbers of observed paradoxical heat sensations. The obtained data were 
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entered into an SPSS data file, together with the raw data of the responses to the 
NPTMEDIAN. 
 
QST data were log-transformed (log10 units) prior to statistical analysis except HPT 
and VDT which were normally distributed as raw data (Rolke et al. 2006a; Rolke et 
al. 2006b). To compare a patient’s QST data profile with control data independent of 
the different units of measurement across QST parameters, the patients’ data were z-
transformed for each single parameter using the following expression:  
Z-score = (X single proband – Mean health controls)/SD healthy controls (Rolke et al. 2006b). Z-
values were calculated based on the included healthy control group data. This 
approach allowed site specific normalisation of QST data, where each individual 
parameter was related to its region and age specific reference range and was 
displayed as the number of standard deviations above or below the healthy control 
mean. Z-values above ‘0’ indicate a gain in function i.e. the patient is more sensitive 
to the tested stimulus compared with HC (hyperalgesia, allodynia, hyperpathia), 
whilst z-scores below ‘0’ indicate a loss of function, referring to a lower sensitivity 
(hypoaesthesia, hypoalgesia) of the patient. The exact statistical analyses used for the 
studies in Chapter 6 to 8 are outlined in the respective chapters. Significance was 
accepted at p < 0.05 for all analyses. 
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4.1 Abstract 
Study Design. A cohort study of patients with neck-arm pain sub-grouped into two 
different neck-arm pain presentations based on the application of specific 
classification systems. 
Objective. To assess the inter-examiner agreement in classifying patients using 
specific classification systems; to assess the agreement between two clinical 
examiners and two clinical experts and to assess the diagnostic accuracy of the two 
clinical examiners. 
Summary of Background Data. Whilst patients with neck-arm pain may 
demonstrate similar clinical characteristics, their clinical presentation and underlying 
pain mechanisms can differ. Identification of these differences may assist the 
classification of patients which is important for provision of targeted best evidence 
based management. 
Methods. Forty patients with unilateral neck-arm pain were examined by two 
clinicians and, using specific classification systems, classified into (i) cervical 
radiculopathy, (ii) non-specific neck-arm pain associated with heightened nerve 
mechanosensitivity (NSNAP), (iii) other. The classifications were compared to those 
made independently by two experts, based on a review of patients’ clinical 
assessment notes and the experts’ clinical opinion. The experts’ opinion was used as 
the reference criterion to assess the diagnostic accuracy of the clinical examiners in 
classifying each patient group. 
Results. There was an 80% agreement between clinical examiners, 80% between 
experts and 70% - 80% between clinical examiners and experts in classifying 
patients with cervical radiculopathy (kappa between 0.41 and 0.61). Agreement was 
72.5% – 80% in classifying patients with heightened nerve mechanosensitivity 
(kappa between 0.43 and 0.52). Clinical examiners’ diagnostic accuracy was high 
(radiculopathy: sensitivity 79% – 84%; specificity 76% - 81%; NSNAP: sensitivity 
78% – 100%; specificity 71% - 81%).  
Conclusions. Compared to expert opinion, clinicians were able to identify patients 
with cervical radiculopathy and patients with NSNAP in 80% of cases, our data 




The diversity of nerve-related disorders in patients with neck-arm pain is reflected in 
the variety of terminologies used, such as cervicobrachial pain (Salt et al. 2011), 
radicular pain (Bogduk 2009; Merskey and Bogduk 1994), radiculopathy (Bogduk 
2009; Merskey and Bogduk 1994), neuralgia, brachialgia, neuropathy, neurogenic 
pain (Merskey and Bogduk 1994), neuropathic pain (Jensen et al. 2011; Treede et al. 
2008), and nerve trunk pain (Asbury and Fields 1984; Bennett 2006; Marchettini et 
al. 2006). Nerve trunk pain is regarded as nociceptive (Marchettini et al. 2006) or 
inflammatory pain (Bennett 2006) and is characterised by signs of heightened nerve 
mechanosensitivity such as local tenderness on palpation over accessible nerve 
trunks (Bennett 2006; Elvey 1997; Quintner and Bove 2001) and pain in response to 
limb movements that cause nerve provocation (Elvey 1997; Quintner and Bove 
2001). Nerve trunk pain can be present in the absence of nerve damage (Bennett 
2006; Bove et al. 2003; Dilley et al. 2005; Eliav et al. 2001; Marchettini et al. 2006), 
but can also occur in combination with neuropathic pain (Bennett 2006; Marchettini 
et al. 2006). 
 
In this study two groups of patients were investigated: (i) patients with painful 
cervical radiculopathy and (ii) patients with neck-arm pain associated with 
heightened nerve mechanosensitivity (NSNAP). Whilst these patients may 
demonstrate similar clinical characteristics such as pain with or without negative 
and/or positive sensory signs, their clinical presentation and underlying pain 
mechanisms may differ. Identification of such differences and the appropriate 
classification of patients with these neck-arm pain conditions is important for the 
provision of appropriate best evidence management. 
 
Due to a lack of diagnostic gold standards the classification of these patient groups is 
largely based on the findings of a comprehensive clinical examination (Butler 2000; 
Coppieters and Butler 2001; Elvey 1997; Kuijper et al. 2009; Wainner and Gill 2000) 
incorporating the medical history, an assessment of both musculoskeletal and related 
neural tissues, a neurological bedside examination of somatosensory and motor 
function (Cruccu et al. 2010; Hansson 2002; Jepsen et al. 2006; Wainner et al. 2003) 
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and clinical nerve provocation tests (NPT) in the upper limb (Butler 2000; Elvey 
1997; Rubinstein et al. 2007). Upper limb NPTs are analogous to the straight leg 
raise test which is used for the assessment of nerve mechanosensitivity in the lower 
limb (Devillé et al. 2000; Freynhagen et al. 2008). Results of medical investigations 
(e.g. imaging, electrodiagnostic tests) can also aid in the diagnostic work-up of neck-
arm pain (Kuijper et al. 2009; Treede et al. 2008). Whilst moderate to substantial 
inter-examiner reliability (Landis and Koch 1977) has been documented for clinical 
tests of nerve function (sensory testing, reflexes and manual muscle testing) (Jepsen 
et al. 2006; Jepsen et al. 2004; Schmid et al. 2009) and for NPTs in the upper limb 
(Jepsen et al. 2006; Schmid et al. 2009; Vanti et al. 2010; Wainner et al. 2003), no 
study has investigated the reliability of the overall decision as to whether the primary 
clinical presentation is a cervical radiculopathy or demonstrates characteristics of 
heightened nerve mechanosensitivity. For the diagnosis of painful radiculopathy, the 
opinion and consensus of experienced clinicians/experts has been used for validation 
of patient classifications (Freynhagen et al. 2008), and this approach will be applied 
in the current study. 
 
Radhakrishnan et al (1994) proposed certain sets of diagnostic criteria for the 
presence of definite radiculopathy (Table 4.1). Although this classification system is 
16 years old, it is still recommended (Rubinstein et al. 2007), however the reliability 
has never been assessed. For the clinical presentation of heightened nerve 
mechanosensitivity, a set of classification criteria has also been established (Elvey 
1997) (Table 4.2), but the reliability of these criteria has not yet been evaluated in 
patients with neck-arm pain. The purpose of this study was threefold: to determine 
the inter-examiner agreement in classifying patients using these specific 
classification systems; secondly to assess the agreement in patient classification 
between two clinical examiners using the specific classification systems and two 
independent experts; and thirdly to determine the diagnostic accuracy of the clinical 
examiners using the opinion and consensus of the experts as a reference criterion. 
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Table 4.1  
The classification criteria used in this study to detect definite painful cervical 
radiculopathy (Radhakrishnan et al. 1994) in patients with neck-arm pain are 
outlined below. Category I, or II or III had to be met for the classification of definite 
painful cervical radiculopathy. 
Category Criteria 
I a) Electromyographic evidence of acute denervation in cervical 
paraspinal muscles and/or in a myotome 
or 
b) Identification of an affected cervical root at surgery 
II a) Sensory changes in a dermatomal distribution 
and 
b) Weakness, atrophy or fasciculation in a myotomal distribution 
and 
c) Unilateral diminished deep tendon reflexes 
III a) Demonstrable abnormality on myelography, computer-assisted 
myelography, or magnetic resonance imaging correlating with 
cervical radiculopathy 
or 
b) Demonstrable abnormality on computed tomography scan at 
the clinically relevant level correlating with cervical 
radiculopathya 
with 
c) Neck pain, arm pain or combined neck and arm pain 
and 
d) Paraesthesia, hyperaesthesia, or dysaesthesia in a nerve root 
distribution 
or 
e) Muscle weakness 
and  
f) Any of category IIa 
aCriterion added to existing criteria. Computed tomography scans are deemed as valid 
confirmatory tests for nerve root compression (Bono et al. 2011; Treede et al. 2008), 
therefore Criterion IIIb was added. Signs of nerve root compression on imaging plus the 
presence of neck-arm pain with paraesthesia or muscle weakness do not necessarily 
implicate the presence of a cervical radiculopathy. Therefore Criterion IIIf was added. 
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Table 4.2  
The classification criteria used in this study to detect the clinical presentation of 
heightened nerve mechanosensitivity. The presence of Criteria I and II are essential 
for the classification of heightened nerve mechanosensitivity, Criterion III may or 
may not be present (+/-). 
Criteria  
I Abnormal response to a nerve provocation test (reproduction of pain 
in the area of the patient’s symptoms, plus reduced range of motion 
compared to the asymptomatic side, plus symptom response altered 
with addition of movements designed to elongate and add mechanical 
load on the peripheral nerves to be assessed (Elvey 1997)  
II A correlating active movement dysfunction (e.g. limitation of range of 
motion of shoulder abduction and/or pain on shoulder abduction, 
which increased with addition of cervical contralateral flexion and/or 
with wrist extension as loading manoeuvres) (Elvey 1997) 
III An abnormal response on clinically relevant upper limb nerve trunk 
palpation (hypersensitivity compared to the asymptomatic side) 
(Elvey 1997) 
 
4.3 Materials and Methods 
4.3.1 Study population 
The study was conducted between February 2008 and May 2009. The patients with 
neck-arm pain were recruited from private physiotherapy, medical, and neurosurgery 
practices; physiotherapy, pain management, neurosurgery outpatient and triage 
clinics at five metropolitan hospitals; and via radio and newspaper advertising. The 
study protocols and the recruitment procedures were approved by the Ethics 
Committees of all participating institutions (Appendix 1). The inclusion criterion was 
unilateral neck pain with upper limb pain and/or paraesthesia. Exclusion criteria were 
the presence of a central nervous system disease (except cervical spinal cord 
compromise) and an insufficient level of English. Patients were screened by phone or 
in the clinic to establish they satisfied these criteria. Forty patients participated (21 
males; 19 female; mean ± SD age 47 ± 10.6 years; duration of symptoms 16.2 ± 27.4 
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months). The protocol was explained to all patients and all patients consented in 
writing prior to entering the study. 
4.3.2 Clinical examination and classification 
The two clinical examiners were experienced clinically active physiotherapists with a 
minimum of a postgraduate Masters qualification in musculoskeletal physiotherapy. 
One examiner was a Specialist in Musculoskeletal Physiotherapy (Fellow of 
Australian College of Physiotherapists) with 28 years experience, the other had 17 
years of experience as a Musculoskeletal Therapist. The independent expert 
clinicians who were consulted to provide the reference standard for diagnostic 
accuracy were a Neurosurgeon (Fellowship-trained spinal Neurosurgeon) and a 
Specialist in Musculoskeletal Physiotherapy. The Expert Specialist 
Physiotherapist did not exceed the qualifications of the Specialist 
Physiotherapist. 
 
The diagnostic criteria used to detect the presence of a painful cervical radiculopathy 
were based on the publication by Radhakrishnan et al (1994) and are listed in Table 
4.1. If the patients met any one of the three categories for the classification of 
radiculopathy, they were assigned to this group. If patients fulfilled any of these 
three categories and they demonstrated clinical signs of heightened nerve 
mechanosensitivity, they were still classified as radiculopathy. 
 
The presence of heightened nerve mechanosensitivity was defined as evidence of 
increased peripheral nerve sensitivity to mechanical stimuli including NPTs and 
nerve palpation (Elvey 1997). The underlying concept for these NPTs is that 
sensitised nerve tissue may become non compliant to limb movements that cause 
nerve elongation (Elvey 1997) and that pain responses are provoked in response to 
these limb movements, resulting in movement restriction. In addition, mechanical 
pressure over sensitised nerve tissue such as in palpation over nerve trunks may 
provoke a hyperalgesic response (Elvey 1997; Hall and Quintner 1996; Quintner and 
Bove 2001). The criteria for this classification are demonstrated in Table 4.2. The 
classification of NSNAP could relate to spinally mediated nerve sensitivity, as well 
as to clinically diagnosed distal/peripheral neuropathies (eg. carpal tunnel syndrome, 
ulnar nerve neuropathy). In patients where co-morbid condition(s) existed (e.g. 
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frozen shoulder plus ulnar nerve neuropathy), patients were still classified as 
presenting with NSNAP, as long as the relevant classification criteria were met. 
 
Patients were allocated to one of the two examiners. The order of testing by the two 
examiners varied, but for practical reasons, could not be randomised. A 
comprehensive clinical examination, as outlined in the introduction, was performed 
by the first examiner and results of any medical investigations such as imaging and 
electrodiagnostic studies were reviewed. Ten patients had not any imaging of the 
cervical spine performed. Nine patients had imaging performed, but no relevant 
abnormality was reported. Within an interval of 26 days, the second examiner 
performed a similar full clinical examination and nominated a classification. A 
hierarchical approach was used to classify patients into either: radiculopathy, or 
NSNAP or other. Both examiners were blind to the other’s classification and 
examined the patients entirely independently. Patients were asked not to provide the 
second examiner with any information that was given to the patient during the first 
examination. The assessment sheets together with the determined classification were 
placed in a sealed envelope and handed to an independent blinded person for data 
entry and analysis. 
 
The two experts independently received a copy of each examiner’s patient notes plus 
the results of any medical investigations, without any information on the 
classification criteria. The Neurosurgeon classified patients into either: radiculopathy 
or other. The Specialist Musculoskeletal Physiotherapist classified patients into 
radiculopathy, NSNAP or other. In addition, both experts were given a choice to use 
a fourth classification of ‘undecided’, if they were unable to make a classification 
based on the information provided to them. The experts’ classifications were based 
on their clinical opinion. A clinical examination by the independent experts was not 
possible for logistic and ethical reasons. Assessment by four practitioners would 
have imposed a considerable burden on the patients. Moreover, repeated assessment 
could potentially cause a flare-up of the patient’s pain condition raising ethical 
concerns. 
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4.3.3 Statistical analysis 
A total sample size of 40 subjects (including patient groups) was needed to detect an 
80% agreement between two raters, if the null kappa was 0.6 and the true kappa was 
0.9 (Flack et al. 1988). A Kappa between 0.40 and 0.60 indicates moderate 
agreement, a Kappa between 0.61 and 0.80 indicates a substantial strength of 
agreement and a Kappa of 0.81 to 1.00 an almost perfect strength of agreement 
(Landis and Koch 1977). Statistical analyses were carried out with SPSS, Version 
15.0. The Kappa coefficient, with prevalence and bias index, and the percentage 
agreement were calculated to determine the proportion of agreement between: 
1. The two examiners in classifying 
a) patients across all categories (‘radiculopathy, NSNAP, other)  
b) patients with radiculopathy  
c) patients with NSNAP 
2. The two experts in classifying patients with radiculopathy  
3. The two examiners and the two experts in classifying patients with 
radiculopathy  
4. The two examiners and one expert in classifying patients with NSNAP  
Due to differing numbers of classifications between raters (1 - 4), classifications had 
to be pooled to allow a pairwise comparison (Figure 4.1).  
 
The consensus of experts in classifying patients with radiculopathy was used as the 
gold standard to determine the diagnostic accuracy (sensitivity, specificity) of both 
examiners. The opinion of one expert was used as reference criterion to determine 
the diagnostic accuracy in classifying patients with heightened nerve 
mechanosensitivity. The receiver operating characteristic (ROC) curves were 
graphed and the areas under the curve (AUC) plus their 95% confidence intervals 
were measured. This value of AUC equals the probability of correctly classifying 





4.4.1 Agreement between examiners 
Examiners agreed in classifying 27 out of 40 patients (Kappa 0.46, 95% CI 0.24 to 
0.68) (Table 4.3), yielding a 67.5% agreement. For the classification of patients with 
radiculopathy, the percentage agreement was 80% and the Kappa coefficient was 
0.60 (95% CI 0.35 to 0.85) (Table 4.4). For the classification of patients with 
NSNAP, percentage agreement was 72.5% and the Kappa coefficient was 0.43 (95% 
CI 0.16 to 0.70). 
 
 
Table 4.3  
The frequencies of patients (N = 40) classified by two Musculoskeletal 
Physiotherapists as having cervical radiculopathy, non-specific neck-arm  
pain associated with heightened nerve mechanosensitivity (NSNAP) or  
another pain condition, are shown below.  
   Examiner 2b   







a  Radiculopathy 16 3 0 19 
NSNAP 3 10 0 13 
Other 2 5 1 8 
Total 21 18 1 40 
aMusculoskeletal Physiotherapist. 




For the 13 patients classified differently by the clinical examiners, there were 
different findings recorded in the examiners’ patient notes in 12 cases: three related 
to reflex testing, three to strength testing, four to neural tissue testing, and two to 
inconsistent patient responses. In five of these cases the two experts agreed, in two 
cases the Specialist Musculoskeletal Physiotherapist classified the patient as NSNAP 
and the Neurosurgeon as other (i.e. they agreed the patient did not have a 
radiculopathy) and in the remaining five cases one expert chose the undecided 
option. 
4-12 
Table 4.4  
The kappa coefficient, 95% Confidence Interval (CI) and % agreement, prevalence 
and bias index in classification of patients with cervical radiculopathy and patients 
with non-specific neck-arm pain associated with heightened nerve mechanosensitivity 
(NSNAP) are shown for two examiners. 






 Cervical radiculopathy 
Examiner 1 - Examiner 2# 0.60 0.35 - 0.85 80 0.00 0.05 
Expert 1 - Expert 2* 0.61 0.39 - 0.83 80 0.15 0.20 
Examiner 1 - Expert 1  0.41 0.16 - 0.66 70 0.15 0.20 
Examiner 1 - Expert 2 0.60 0.35 - 0.85 80 0.05 0.00 
Examiner 2 - Expert 1  0.59 0.36 - 0.82 80 0.20 0.15 
Examiner 2 - Expert 2 0.60 0.35 - 0.85 80 0.00 0.05 
 NSNAP 
Examiner 1 - Examiner 2 0.43 0.16 - 0.70 72.5 0.22 0.12 
Examiner 1 - Expert 2 0.50 0.21 - 0.79 77.5 0.45 0.10 
Examiner 2 - Expert 2 0.52 0.29 - 0.75 80 0.32 0.22 
#Examiner 1 = Musculoskeletal Physiotherapist, Examiner 2 = Specialist 
Musculoskeletal Physiotherapist. 
*Expert 1 = Neurosurgeon, Expert 2 = Specialist Musculoskeletal Physiotherapist. 
 
 
4.4.2 Agreement between experts 
The frequencies of patients classified by the two experts as having cervical 
radiculopathy, NSNAP, or another pain condition or where no decision could be 
made is demonstrated in Table 4.5. For the classification of patients with 
radiculopathy, the agreement was substantial at 80% with a Kappa of 0.61 (95% CI 




The frequencies of patients (N = 40) classified by two experts as having  
cervical radiculopathy, non-specific neck-arm pain associated with heightened  
nerve mechanosensitivity (NSNAP), or another pain condition, or where no  
decision could be made, are shown. 
  Expert 1a  






Radiculopathy 19 0 0 19 
NSNAP 1 8 0 9 
Other 2 3 0 5 
No decision 5 1 1 7 
Total 27 12 1 40 
aNeurosurgeon. 
bSpecialist Musculoskeletal Physiotherapist. 
 
4.4.3 Agreement between examiners and experts 
There was 70% to 80% agreement between examiners and experts in classifying 
patients with cervical radiculopathy and patients with NSNAP. Kappa coefficients 
indicated moderate agreement (Table 4.4). 
4.4.4 Diagnostic accuracy of both examiners 
Using the consensus of the two experts as the gold standard, Examiners 1 and 2 
demonstrated a sensitivity of 79% and 84% and a specificity of 81% and 76% 
respectively in classifying patients with cervical radiculopathy. For Examiner 1, the 
AUC was 0.80 (95% CI .65 to .94) and for Examiner 2, the AUC was 0.80 (95% CI 
0.66 to 0.95), indicating that both examiners chose the correct diagnosis 80% of the 
time. Using the opinion of Expert 2 as the reference criterion for the presentation of 
NSNAP, Examiner 1 demonstrated a sensitivity of 78% and specificity of 81% 
(AUC: .79; 95% CI 0.61 to 0.97), Examiner 2 a sensitivity of 100% and specificity 
of 71% (AUC: 0.85; 95% CI 0.74 to 0.97). 
4.5 Discussion 
To our knowledge, this is the first study to investigate the use of classification 
systems to assess the inter-examiner agreement in classifying patients with painful 
cervical radiculopathy and patients with NSNAP. There was high percentage 
4-14 
agreement with moderate Kappa coefficients between raters in classifying both 
patient groups, supporting the reliability of the classification systems used. It can be 
argued that for this study kappa statistics might not be as meaningful as the 
percentage agreement. Kappa takes into account the agreement occurring by chance. 
This chance adjustment supposes that, when not completely certain, raters simply 
guess. Considering that all raters in this study based their classification on a thorough 
and methodical diagnostic work up, this is a highly unrealistic scenario.  
 
Both examiners demonstrated high sensitivity in classifying patients with cervical 
radiculopathy. Considering physiotherapists’ expanding role in extended scope of 
practice (Kersten et al. 2007) such as triaging patients in emergency departments 
(Anaf and Sheppard 2007; Lau et al. 2008) or neurosurgery clinics, high diagnostic 
accuracy and the risk-benefit implications of making wrong decisions are important. 
This is of particular significance for patients where alternative medical management 
is vital to managing their condition effectively, such as in patients with significant 
nerve root compromise or with dominantly neuropathic pain features. Both 
examiners were highly skilled and experienced. It is unclear if less experienced 
physiotherapists would have achieved similar outcomes. 
 
There are limitations with strictly applying classification systems without 
incorporating a component of clinical judgement. For example, a patient presented 
with C6 radicular pain and sensory dermatomal deficit, no motor impairment, 
heightened nerve mechanosensitivity and no clinically relevant abnormality on 
cervical imaging. The classification based on the clinical opinion of both experts was 
that of a (sensory) radiculopathy. However, based on the applied classification 
system, this was not defined as radiculopathy as not all criteria of Category II were 
met. Therefore both examiners classified this patient as presenting with NSNAP. 
Furthermore, the criteria of Category II do not allow a differentiation between 
sensory and motor radiculopathy. Such differentiation is clinically important as each 
condition is indicative of a nerve root lesion and may need specific intervention.  
 
The percentage agreement in classifying patients with NSNAP was between 70% 
and 80%, consistent with findings in patients with low back related leg pain (Schäfer 
et al. 2009). Sensitivity and specificity values for this classification were high in our 
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study, however results have to be considered in light of the small number of patients 
classified by the expert (n = 9). The classification system for NSNAP was clinically 
feasible. Future studies with a larger sample size are recommended to attest further to 
the reliability. 
 
The main limitation of this study relates to the fact that the experts did not clinically 
assess the patients. However while the study design could be strengthened by the 
experts examining the patient, this would also add considerable responder burden for 
the patients. The clinical examiners differed in their recording of clinical 
examination findings and consequently in their classification of 12 patients which 
appears to have impeded the experts’ decision making in five cases where one expert 
chose not to make a diagnosis. Nevertheless, despite this discordance the experts 
demonstrated agreement in classifying seven out of these 12 patients. Considering 
the dynamic nature of a pain experience and possible changes in patient’s signs on 
the day of examination, a 100% agreement would be unlikely. Furthermore, 
heightened nerve mechanosensitivity is not a disease process comparable to axonal 
damage seen in patients with radiculopathy. It is rather a clinical presentation, which 
can be transient and can fluctuate. 
 
It can be argued that the time interval between patient examinations may create 
potential for disagreement between the examiners. Eight patients were not assessed 
on the same day, however the examiners’ classification differed in only one of these 
patients. Further, the importance of the clinical examination assisting in differential 
diagnosis becomes apparent, as one expert was not able to classify seven patients of 
our cohort. For purely logistic reasons, the experts were not able to clinically assess 
the patients.  
 
One further limitation to the study lies in the hierarchical order of applying the 
classification systems. This approach treats the clinical pain presentations as being 
mutually exclusive, and this does not reflect the clinical presentation of our cohort of 
patients with neck-arm pain. For example, 7 out of 15 patients classified by all 4 
raters with cervical radiculopathy also demonstrated clinical signs of heightened 
nerve mechanosensitivity. A further 5 patients out of these 15, demonstrated some 
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signs of heightened nerve mechanosensitivity, but did not meet all criteria used for 
this specific classification.  
 
Methodological considerations 
Whilst the straight leg raise test is widely used in medicine to identify heightened 
nerve mechanosensitivity in lumbar/lower limb pain (Devillé et al. 2000; Freynhagen 
et al. 2008), this is not the case for the upper limb equivalent NPTs. These upper 
limb equivalents seem to be used predominantly by physiotherapists (Allison et al. 
2002; Coppieters et al. 2006; Coppieters et al. 2003; Elvey 1997; Sterling et al. 2002; 
van der Heide et al. 2006; Wainner et al. 2003) and their diagnostic value remains 
unclear (Rubinstein et al. 2007). While the NPT with bias to median nerve 
demonstrated 97% sensitivity in identifying patients with cervical radiculopathy 
(Wainner et al. 2003), this NPT is not widely used by neurosurgeons. Thus, the 
Neurosurgeon in the current study was not asked to classify patients with NSNAP. 
 
Two criteria were added to the classification system for radiculopathy that were 
deemed clinically relevant for the classification of radiculopathy. In addition, the 
Radhakrishnan et al (Radhakrishnan et al. 1994) classification system did not 
mention the presence of neck and/or arm pain for criteria I and II and this should be 
considered if the system is used for the classification of painful radiculopathies. The 
system was useful for identification of patients with radiculopathy demonstrating 
good sensitivity and specificity. However, sensitivity and specificity may even yield 
higher levels, if the criteria of category II of the classification system would allow 
for a differentiation between the presence of sensory and motor radiculopathy. 
 
In conclusion, this study demonstrated that the two examiners were able to 
distinguish between presentations of painful cervical radiculopathy and NSNAP in 
patients with neck-arm pain. Compared to the expert opinion, the examiners were 
able to identify 80% of cases with these specific clinical neck-arm pain 
presentations. As patients may demonstrate similar clinical characteristics for both 
presentations, such as radicular pain and paraesthesia, the identification of 
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5.1 Abstract 
A new diagnostic grading system of certainty for the presence of neuropathic pain 
(NeP) has been proposed by the Neuropathic Pain Special Interest Group (NeuPSIG) 
of the International Association for the Study of Pain. We have investigated: (i) the 
clinical application of this grading system in patients with neck/upper limb pain with 
a suspected nerve lesion and; (ii) the level of agreement in detecting likely NeP 
between this model and two NeP questionnaires; the Leeds Assessment of 
Neuropathic Symptoms and Signs Pain Scale (LANSS) and painDETECT (PD-Q). 
One hundred and fifty two patients (age 52 ± 12 years; 53% male) completed both 
questionnaires and underwent a comprehensive clinical examination. Patients were 
graded using the NeuPSIG system as; no NeP, possible, probable or definite NeP. 
The system proved feasible for application in this patient cohort, although required 
considerable time and clinical expertise. Both questionnaires failed to identify a large 
number of patients with clinically classified definite and probable NeP (LANSS 
sensitivity 22%, specificity 88%; PD-Q sensitivity 64%, specificity 62%). The 
lowered sensitivity scores in our study contrast with those in the original validation 
studies of LANSS and PD-Q and may result from differences in the clinical 
characteristics of the populations studied. Both questionnaires seemed unsuitable for 
the identification of NeP components in this cohort of patients with neck/upper limb 




Classification of neuropathic pain (NeP) can be confusing with the different 
definitions and classification criteria in use (Bennett et al. 2007; Bennett et al. 2006; 
Merskey and Bogduk 1994; Rasmussen et al. 2004; Treede et al. 2008). The previous 
definition of NeP by the International Association for the Study of Pain (IASP): 
“pain initiated or caused by a primary lesion or dysfunction in the nervous system” 
(Merskey and Bogduk 1994) has now been replaced by a new definition: “pain 
arising as a direct consequence of a lesion or disease affecting the somatosensory 
system” (Jensen et al. 2011). In addition, as no gold standard exists for the diagnosis 
of NeP, a grading system with different levels of certainty about the presence of NeP 
(no, possible, probable, definite) has been developed by the Neuropathic Pain Special 
Interest Group (NeuPSIG) of the IASP (Treede et al. 2008). This new diagnostic 
approach is based on a stepwise process that requires a history-derived working 
hypothesis (based on pain distribution and history suggesting a relevant lesion), and 
confirmatory evidence from a neurological examination and diagnostic tests (e.g. 
neuroimaging, neurophysiological methods). The application of this grading system 
has been demonstrated in some case studies (Geber et al. 2009; Haanpää et al. 2009), 
and more recently in a prospective study following thoracotomy (Guastella et al. 
2011), but not in patients with neck/upper limb pain. 
 
Questionnaires are used as screening tools to aid identification of suspected NeP 
(Bennett et al. 2007; Cruccu et al. 2010). The Leeds Assessment of Neuropathic 
Symptoms and Signs Pain Scale (LANSS) (Bennett 2001) classifies patients into two 
groups, patients with or without pain of predominantly neuropathic origin, and is 
applied in an interview format. The LANSS contains five sensory descriptor items 
and two clinical examination items. LANSS was developed utilising 60 patients with 
distinct clinical diagnostic categories of NeP and non-NeP, and demonstrated a 
sensitivity of 83% and specificity of 87%, and was further validated in 40 patients 
(sensitivity 85%, specificity of 80%) (Bennett 2001). 
 
The painDETECT questionnaire (PD-Q) (Freynhagen et al. 2006) is another NeP 
screening tool, with the additional concept of grading for the certainty of the 
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presence of NeP. PD-Q classifies patients into three groups: a NeP component is 
unlikely, results are ambiguous, or a NeP component is likely. The questionnaire is a 
self–reported tool consisting of seven weighted sensory descriptor items, plus one 
item relating to spatial pain characteristics and one item relating to temporal 
characteristics. PD-Q was developed and validated in 392 German patients with 
clinically diagnosed pain of predominantly either nociceptive or neuropathic origin 
and demonstrated a sensitivity of 85% and specificity of 80%.  
 
LANSS and PD-Q appear to demonstrate the same level of diagnostic accuracy in 
identifying NeP. However, it is unclear if they have similar performances when 
applied to a single patient cohort presenting with mixed musculoskeletal and 
peripheral NeP conditions. If this were the case, the use of PD-Q would be preferable 
in primary care, as it would save valuable practitioner time. 
 
The aims of this study were to investigate:  
(i) the clinical application of the grading system of the NeuPSIG 
classification model in patients with neck/upper limb pain and; 
(ii) the level of agreement in detecting likely NeP in patients with neck/upper 
limb pain between the NeuPSIG classification model and the LANSS and 
PD-Q.  
5.3 Materials and methods 
5.3.1 Study population 
The study (prospective) was conducted between June 2008 and December 2009 
inclusive. One hundred and sixty six patients with neck/upper limb pain and 
suspected nerve lesion had been referred to an outpatient neurosurgery triage clinic 
in a large metropolitan hospital by their general practitioner or from other 
departments within the hospital. The patients were selected from the neurosurgery 
triage waiting list for another concurrent study by the authors. The current study was 
part of a quality assurance activity and was registered with the Quality Improvement 
Unit of the hospital and endorsed by the local Ethics Committee.  
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5.3.2 Clinical examination 
All patients were examined by a highly qualified clinician with a postgraduate 
Masters qualification in musculoskeletal physiotherapy and with extensive clinical 
experience in triaging musculoskeletal and neuropathic pain disorders in a tertiary 
neurosurgical setting. The clinical assessment comprised of taking the patient’s 
history, pain drawings including location, description and intensity of pain, 
documentation of pain behaviours, musculoskeletal assessments and neurological 
examination. Sensory testing of light touch and pinprick sensation was performed in 
the most painful area (Jensen and Baron 2003), consistent with previously 
documented methodology (Bennett 2001; Bouhassira et al. 2005; Weingarten et al. 
2007) and compared with findings in the contralateral corresponding control site. In 
patients with bilateral pain, proximal or distal pain-free sites were used for control 
testing (Haanpää et al. 2011; Haanpää et al. 2009). Patients were asked to report the 
stimulus intensity (normal, less = hypoaesthesia; more = hyperaesthesia) and quality 
(normal or other: paraesthesia, dysaesthesia, allodynia) compared to the control site. 
Sensory testing was also performed in both upper limbs for determination of 
dermatomal sensory deficits and in both lower limbs, if spinal cord compromise was 
suspected. Finally, available results from any other investigations (i.e. imaging, 
nerve conduction studies (NCS)) were reviewed to identify any evidence of a 
lesion/disease of the somatosensory system. Based on all the above findings patients’ 
pain conditions were categorised according to the NeuPSIG classification model 
(Table 5.1) into either no NeP, possible, probable or definite NeP. As some patients 
presented with multiple pain areas, the classification for NeP was applied to the 
patient’s maximal pain area. The validation of patient classification on the basis of 
consensus of two clinicians has been applied in previous studies (Bouhassira et al. 
2005; Freynhagen et al. 2006), while others used only a single expert clinical 
judgement (Bennett 2001; Bennett et al. 2005; Weingarten et al. 2007). Our approach 
has been adopted by the research community (Bennett et al. 2007; Haanpää et al. 
2011) and encountered the problem of limited resources for patient assessment by 
two examiners. 
5-6 
Table 5.1 Proposed grading system for neuropathic pain (Treede et al. 2008). 
1. Pain with a distinct neuroanatomically plausible distribution 
2. A history suggestive of a relevant lesion or disease affecting the 
peripheral or central somatosensory system 
3. Demonstration of the distinct neuroanatomically plausible distribution 
by at least one confirmatory test (presence of negative or positive 
sensory signs concordant with the distribution of pain)a 
4. Demonstration of the relevant lesion or disease by at least one 
confirmatory test (e.g. neuroimaging, neurophysiological methods)b 
Definite neuropathic pain (NeP): all (1-4); probable NeP: 1 and 2, plus either 3 or 4; possible NeP: 1 
and 2, without confirmatory evidence from 3 or 4 (Adapted from Treede et al (2008)) 
aIn our study only sensory abnormalities in the main pain area were classified as a confirmatory 
response. If no abnormalities were found in the main pain area, but sensory changes existed in further 
distal areas (e.g. distal dermatomal sensory changes in patients with cervical radiculopathy), this was 
classified as not fulfilling Criterion 3. 
bIf imaging results were used for radiological confirmation of nerve compression, only reports 
indicating significant/severe cervical foraminal stenosis and compromise of the exiting nerve root at 
the clinically relevant level were deemed as a confirmatory test. If the report stated “mild to moderate 
foraminal narrowing” with no mention of nerve root compromise, this was classified as a non-
confirmatory test. 
 
5.3.3 Questionnaires  
The LANSS was chosen for this project as it has been documented in several studies 
to be a reliable and valid tool for the identification of NeP (Bennett 2001; Pérez et al. 
2006; Unal-Cevik et al. 2010; Yucel et al. 2004). The PD-Q is a much more recent 
tool, is easy to implement in clinical practice, is available in English and has been 
applied in English speaking populations (Gwilym et al. 2009). In contrast to all other 
NeP screening tools (Bennett et al. 2007), PD-Q was designed for identifying NeP 
components specifically in low back pain patients with and without referred pain. 
The PD-Q might be transferable to neck pain conditions and therefore seemed 
appropriate to be used for our patient cohort. 
 
All participants completed the PD-Q prior to clinical examination whilst they were in 
the waiting room. No specific instructions were given to patients on how to complete 
the questionnaire, consistent with the PD-Q format. The PD-Q asks patients to mark 
their main pain area on a body chart. The weighted sensory item descriptors relate to 
this marked main pain area. A PD-Q score of ≤ 12 indicates that a NeP component is 
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unlikely, and a score of ≥ 19 indicates a likely presence of a NeP component 
(Freynhagen et al. 2006). Scores between 13 and 18 reflect an ambiguous result. The 
LANSS was administered in an interview format at the end of the clinical 
examination. The required testing for the LANSS (testing for allodynia with cotton 
wool, altered pinprick threshold with 23 gauge needle) was performed during the 
overall neurological bedside examination. A score of < 12 indicates that neuropathic 
mechanisms are unlikely to contribute to the patient’s pain and a score of ≥ 12 
suggests that NeP mechanisms are likely to be contributing to the pain presentation. 
 
In addition, sleep quality over the last week was rated by patients on a 10-cm visual 
analogue scale (VAS) with the endpoints defined as 0 cm (good sleep) and 10 cm 
(bad sleep) (Hurtig et al. 2001). The strongest and average pain intensity over the last 
four weeks and pain intensity at the time of the assessment were documented on a 
numeric rating scale (NRS) as part of the PD-Q (0 = no pain, 10 = maximum pain). 
5.3.4 Statistical analysis 
Data were analysed using the Statistical Package for Social Sciences (SPSS Version 
17.0). One-way ANOVA was used to compare patient characteristics between pain 
classification groups (no, possible, probable, and definite NeP) that were normally 
distributed. The Kruskal-Wallis test was used to compare symptom duration between 
pain classification groups, as this variable was not normally distributed. Frequencies 
of pain descriptors were calculated. A pairwise comparison was performed between:  
• clinical classification and LANSS;  
• clinical classification and PD-Q; 
• LANSS and PD-Q.  
The Kappa coefficient and 95% confidence intervals were calculated for all 
comparisons as well as the percentage of agreement. As the LANSS uses a 
dichotomous scale, PD-Q and the clinical classification score were transformed into 
dichotomous variables: PD-Q scores < 19 were defined as no NeP and ≥ 19 as NeP. 
For the clinical classification, no, possible and probable NeP were all grouped as no 
NeP. Sensitivity and specificity were calculated for the LANSS and PD-Q, using the 
clinical classification as the “gold standard”. Sensitivity was calculated by dividing 
the number of patients identified by the questionnaires as having NeP by the total 
number of patients clinically classified with definite NP and multiplied by 100. 
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Specificity was calculated by dividing the number of patients identified by the 
questionnaires as having no NeP by the total number of patients clinically classified 
as having no NeP and multiplied by 100. 
 
Furthermore, given the concept of grading the certainty of the presence of NeP in 
both the clinical classification model and PD-Q, an analysis was performed to 
compare the agreement in classifying patients as having NeP, no NeP and 
unclear/ambiguous classification. It was felt important to also investigate if the 
questionnaires were able to identify patients who were clinically classified as having 
probable NeP, consistent with other studies (Guastella et al. 2011; Unal-Cevik et al. 
2010). To enable these comparisons, three categories per classification were defined 
as follows: LANSS (scores 0 – 8 = no NeP (Bennett et al. 2006), 9 – 11 unclear, 12 – 
24 NeP), PD-Q (scores 0 – 12 = no NeP, 13 – 18 = unclear, 19 - 38 = NeP) and 
clinical classification (no NeP, possible as unclear cases, and probable and definite 
combined as NeP). The Kappa coefficient and 95% confidence intervals were 
calculated for all comparisons, as well as the percentage of agreement. Significance 
was accepted at p < 0.05 for all analyses. 
5.4 Results 
Of the 166 patients with neck/upper limb pain who attended the neurosurgery triage 
clinic, 13 did not experience any pain or only paraesthesia at the time of assessment. 
One patient was excluded from data analysis due to errors in completing the PD-Q, 
so analyses were performed on 152 patients.  
5.4.1 Patient characteristics 
The patients’ characteristics are shown in Table 5.2. No listed characteristic was 
significantly different between the pain classification groups. Patients more likely to 
have NeP demonstrated a tendency to higher maximal pain scores during the 
preceding 4 weeks. A wide spectrum of pain diagnoses/pain presentations was 
represented (Table 5.3). Ninety-five patients (62.5%) presented with conditions 
likely to include NeP (radiculopathy, radicular pain, cervical myelopathy and carpal 
tunnel syndrome) and 57 patients (37.5%) with predominantly 
musculoskeletal/nociceptive conditions.  
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Table 5.2 Characteristics of patients (N = 152) with neck/upper limb pain classified according to the NeuPSIG grading system as having  
no, possible, probable or definite neuropathic pain. 
 No NeP Possible NeP Probable NeP Definite NeP p 
N 15 27 65 45  
Age (years)a 58.0 (14.4) 51.2 (10.0) 51.1 (12.0) 52.6 (11.0) 0.211* 
Gender (women/men) 5/10 14/13 33/32 20/25 0.609* 
Symptoms duration (months)b  18.0  
(3.0 – 240.0) 
9.0  
(2.0 – 126.0) 
17.0  
(1.5 – 228.0) 
10.0  
(1.0 – 204.0) 
0.098** 
Pain now (NRS 0 – 10)a 3.6 (2.4) 4.5 (2.3) 4.8 (2.3) 
(n = 64) 
4.7 (2.2) 0.337* 
Maximal pain intensity during last 4 weeks  
(NRS 0 – 10)a  
6.7 (2.6) 7.1 (2.5) 7.5 (2.3) 
(n = 63) 
7.8 (1.9) 0.271* 
Average pain intensity during last 4 weeks  
(NRS 0 - 10)a  
5.1 (2.8) 6.0 (2.4) 5.9 (2.0) 
(n = 63) 
6.0 (1.9) 0.644* 
Sleep quality during last week (VAS 0 – 10 cm)a 4.9 (2.2)  
(n = 13) 
5.6 (2.6)  
(n = 19) 
5.4 (2.8) 
 (n = 60) 
5.3 (2.2)  
(n = 38) 
0.396* 
N on antidepressants, anticonvulsants or opioids 2 (13.3 %) 6c (22.2 %) 21d (32.3 %) 16e (35.5 %)  
N on analgesics (paracetamol, NSAIDS) 2 (13.3 %) 8 (29.6 %) 15 (23.1 %) 17 (37.8%)  
a Mean ± SD; b Median and range; c n = 1 also on analgesic, d n = 10 also on analgesic, e n = 7 also on analgesic; * ANOVA.  
** Kruskal - Wallis Test; NeP: neuropathic pain.
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Table 5.3 Pain diagnoses/pain presentationsa and neuropathic pain classifications in patients (N = 152) with neck/upper limb pain. 
  Clinical classification LANSS painDETECT 


















N 152 15 27 65 45 129 23 46 36 70 
Radiculopathy           
Cervical radiculopathyb 33   9 24 24 9 7 7 19 
Sensory cervical radiculopathyc 11  1 4 6 9 2 3 3 5 
Sensory cervical radiculopathy with carpal 
tunnel syndrome 
1    1 1   1  
Motor radiculopathyd 3   2 1 3  1 2  
Motor radiculopathy with signs of unilateral 
carpal tunnel syndrome 
1   1  1  1   
Motor radiculopathy with signs of bilateral 
carpal tunnel syndrome 
1   1  1   1  
Radicular pain           
Radicular neck/arm pain with distal 
paraesthesia in dermatomal distribution 
19  4 11 4 16 3 2 5 12 
Radicular neck/arm pain 11  1 7 3 10 1 3 4 4 
Radicular neck/arm pain with non dermatomal 
distal paraesthesia 
8  2 5 1 6 2 1 2 5 
Radicular pain with bilateral hand paraesthesia 
(signs of carpal tunnel syndrome) 
3   2 1 3   1 2 
Neck pain 13 5 4 3 1 13  7 3 3 
Neck pain with unilateral pain areas/paraesthesia           
Neck/arm pain 5  2 3  4 1  2 3 
Neck pain with distal dermatomal paraesthesia 3 1 1 1  3  2  1 
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Table 5.3 continued 
  Clinical classification LANSS painDETECT 


















Neck/shoulder pain with paraesthesia hand 2  2   2  1  1 
Neck pain with paraesthesia hand 1   1  1  1   
Neck pain with signs of carpal tunnel 
syndrome 
1 1    1    1 
Neck/shoulder pain 1  1   1  1   
Neck/arm/thumb pain 1 1    1  1   
Post cervical surgery neck/arm pain 1   1  1    1 
Neck/thoracic/arm pain 1   1  1  1   
Neck/thoracic pain 1 1    1  1   
Neck/face pain 1 1    1  1   
Neck pain with bilateral pain areas/paraesthesia           
Neck pain/headache 5 2  3  5  4  1 
Neck pain with bilateral arm paraesthesia 2 1  1  2  1  1 
Neck pain with bilateral paraesthesia hands 2 1 1   2  2   
Neck pain with bilateral arm pain and 
paraesthesia 
1   1   1   1 
Neck pain with bilateral arm and hand 
paraesthesia 
1  1   1    1 
Neck pain with bilateral arm pain and hand 
paraesthesia 
1  1   1    1 
Neck pain with bilateral arm pain/paraesthesia 
and hand paraesthesia 
1   1  1    1 
Neck pain with bilateral signs of carpal tunnel 
syndrome 
1   1  1   1  
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Table 5.3 continued 
  Clinical classification LANSS painDETECT 


















Whiplash injury related pain 6  4 2  4 2 1 2 3 
Cervical myelopathy 2    2 2  1  1 
Carpal tunnel syndrome 2   2  2  1  1 
Other           
Post surgical face and arm pain (removal of 
brain tumor) 
1    1  1   1 
Arm pain with bilateral hand paraesthesia 1  1   1  1   
Bilateral forearm pain with signs of carpal 
tunnel syndrome 
1  1   1   1  
Shoulder pain with paraesthesia arm 1 1    1  1   
Hand pain 1   1  1   1  
Complex regional pain syndrome type 1 1   1   1   1 
aAs determined by clinician based on history, examination results (neurological and musculoskeletal status) and results of investigations. 
bDermatomal pain/symptom distribution plus sensory dermatomal deficit plus myotomal deficit (either reflex absent/diminished or myotomal weakness). 
cDermatomal pain/symptom distribution plus sensory dermatomal deficit, no myotomal deficit. 
dDermatomal pain/symptom distribution plus myotomal deficit, no sensory dermatomal deficit. 




Clinical presentations ranged from the presence of a single pain area to multiple 
causally related pain areas (e.g. neck pain with referred or projected arm pain and 
paraesthesia) or multiple independent areas (e.g. neck/arm pain with signs of carpal 
tunnel syndrome). Some patients experienced bilateral symptoms (n = 24). Apart 
from the pain presentations shown in Table 3, 24 patients presented with additional 
pain areas, which were independent of their main pain area/main complaint (low 
back pain (LBP) n = 11, LBP with leg pain n = 4, leg pain n = 3, shoulder pain n = 5, 
wrist pain n = 1). Seventy patients had various co-morbidities such as diabetes, 
thyroid dysfunction, hepatitis B and C, heart and lung disease, migraine, irritable 
bowel syndrome, cancer, polymyalgia rheumatica, Parkinson’s disease, transient 
ischemic attack, gout, fibromyalgia, epilepsy, brain aneurysm and depression and 
anxiety disorders.  
5.4.2 Clinical classification of neuropathic pain 
The assessment of each patient required on average a 45 minutes consultation. The 
NeuPSIG grading system was applied for each patient using a hierarchical order 
(Table 5.1). If criteria 1 and 2 were satisfied, the level of evidence for criteria 3 and 4 
was evaluated and a classification of probable or definite NeP was made. Fifteen 
patients were classified as no NeP, 27 as possible NeP, 65 as probable NeP and 45 as 
definite NeP (Table 5.3).  
 
Criterion 1 
Fifteen patients were classified as having no NeP as their pain distribution was not in 
a distinct neuroanatomically plausible distribution. 
 
Criterion 2 
Seventy patients with spinal pain could not recall a specific onset of their pain, 
therefore it was not possible to establish an exact temporal link between history and 
pain distribution. An insidious onset is common for the development of pain 
associated with spinal degenerative changes (Roth et al. 2009) and it was determined 






Sensory abnormalities in the main area of pain were demonstrated in 41 out of the 65 
patients classified as having probable NeP and in all patients with definite NeP. 
Fifty-two patients presented with more than one sensory abnormality (no NeP, n = 1; 
possible NeP, n = 0; probable NeP, n = 24; definite NeP, n = 27). Five patients 
demonstrated allodynia. The presence of hyposensitivity to one or several modalities 
(light touch, pinprick) (n = 44) was more common than hyperaesthesia (n = 31). Ten 
patients presented with mixed hypo- and hypersensitivities.  
 
Seven patients classified as having probable NeP and three patients with possible 
NeP, did not have any sensory abnormalities in their main pain area. However, all 
these patients demonstrated sensory deficits in a distal dermatomal distribution, and 
this combined with the clinical history supported the likely presence of a nerve 
lesion. According to our interpretation these cases did not satisfy Criterion 3. In three 
patients with probable NeP, no sensory abnormalities were found in the main area of 
pain, but sensory abnormalities were present in a distal, non-dermatomal distribution, 
and were not causally related to the main area of pain. These cases were also 
interpreted as not fulfilling Criterion 3. For two patients, sensory abnormalities were 
not recorded in the area of maximal pain (neck pain), but in a projected pain area 
(arm), and this was interpreted as a confirmatory test for Criterion 3. In 14 patients 
classified as probable NeP, no sensory abnormalities were found in the main pain 
area or in distal dermatomal areas, but confirmatory tests of nerve compression were 
available to determine the classification of probable NeP (NCS: n = 1; surgery: n = 1; 
Computerised Tomography (CT) or Magnetic Resonance Imaging (MRI): n = 12). 
CT scans and MRI are deemed to be valid confirmatory tests for nerve root 
compression (Bono et al. 2011; Treede et al. 2008). 
 
Criterion 4 
Imaging results of the cervical spine to allow possible radiological confirmation of 
nerve compression were available for 140 patients (plain radiography n = 7; CT n = 
108; MRI n = 25). Considering the possibility of false positive findings on imaging 
(Lehto et al. 1994; Matsumoto et al. 1998), we adapted a very conservative approach 
and defined only reports indicating significant/severe cervical foraminal stenosis and 
compromise of the exiting nerve root at the clinically relevant level as a confirmatory 
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test. Plain radiography was not considered as a confirmatory test. Results of nerve 
conduction studies were available for six patients. Of nine patients without any 
diagnostic tests, three were classified with probable NeP, three with possible and 
three with no NeP. 
5.4.3 Pain descriptors 
The frequency of reported pain descriptors from patients classified as having no NeP, 
possible, probable or definite NeP are shown in Figure 5.1. The description of 
electric shock type pain occurred only in the probable and definite NeP groups. 
Tingling sensations and the presence of sharp pain was most frequently reported in 
the probable and definite NeP groups (20% - 28.9%) and not at all in the no NeP 
group. Other pain descriptors associated with NeP (e.g. numb, hot, shooting) were 
also not used in the no NeP category and occurred infrequently in the probable and 
definite group (4.4% - 12.3%). Burning sensation and the descriptor ache were 
reported in all groups in the following proportions: burning pain 26.7% in no NeP, 
22.2% in possible NeP, 32.3% - 35.6% in probable and definite NeP respectively; 
ache 33.3% in no NeP, 11.1% in possible NeP, 24.6% in probable and 26.7% in 
definite NeP. Spontaneous pain was reported in 62 patients during the clinical 
examination and on the LANSS with increased frequency and increased likelihood of 






Figure 5.1 Histogram of the frequency of pain descriptors volunteered by 152 
patients with neck/upper limb pain, classified as no neuropathic pain (NeP), possible 
NeP, probable NeP and definite NeP. 
 
 
5.4.4 Agreement between clinical classification and questionnaires where 
patients were classified as having NeP or no NeP  
5.4.4.1 LANSS and clinical classification of NeP 
The LANSS classified 23 patients with predominantly NeP (median score 14.0, 
interquartile range (IQR) 4.0; mean score 14.3, standard deviation (SD) ± 2.0) and 
129 patients without predominantly NeP (median score 7.0, IQR 6.0; mean score 6.0, 
SD ± 3.8) (Table 5.3). There was agreement between the LANSS and the clinical 
classification in 104 of the 152 cases (no NeP: n = 94, NeP: n = 10; Kappa 0.12, 95% 
CI -0.04 to 0.28) (Table 5.4), which yielded a 68.4% agreement.  
Using the clinical classification as the gold standard, LANSS demonstrated a 
sensitivity of 22% and specificity of 88%. Out of 48 discordant cases between 
LANSS and clinical classification, 16 patients (33%) scored very close to the cut off 
score (11 patients scored 11; 5 patients scored 10).  
5-17 
Table 5.4  
Frequencies of neuropathic pain (NeP) in patients (N = 152) with neck/upper limb 
pain, using two classification categories: no NeP – NeP. 
  Clinical classification  
  No NeP NeP Total 
LANSSa No NeP 94 35 129 
NeP 13 10 23 
 Total 107 45 152 
    
  Clinical classification  
  No NeP NeP Total 
painDETECTb No NeP 66 16 82 
 NeP 41 29 70 
 Total 107 45 152 
    
  painDETECT  
  No NeP NeP Total 
LANSSc No NeP 77 52 129 
 NeP 5 18 23 
 Total 82 70 152 
a68.4% of agreement between clinical classification and LANSS. 
b62.5% of agreement between clinical classification and painDETECT. 
c62.5% of agreement between LANSS and painDETECT. 
 
 
Twelve patients who were classified as having NeP according to the NeuPSIG 
model, demonstrated hypoaesthesia to light touch (stroking with cotton wool) in their 
area of maximal pain. However in the LANSS, only allodynia is scored as a relevant 
sensory abnormality in response to light touch. If hypoaesthesia was scored as a 
relevant sensory abnormality for NeP, all these patients would have been classified 
as having NeP. In this case, the percentage of agreement would increase to 76.3% 
and LANSS sensitivity would increase to 48% and specificity would reduce to 77%. 
One question in the LANSS addresses symptoms of possible autonomic nervous 
system dysfunction (Question 2: “Does your pain make the skin in the painful area 
look different from normal?”). This question, like the verbal descriptor of tingling 
sensation and testing of allodynia, yields the highest score (score = 5) that is 
obtainable for a single question in LANSS. Thirteen patients out of 152 (no NeP n = 
7, NeP n = 6) reported symptoms of possible autonomic nervous system dysfunction. 
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5.4.4.2  PD-Q and clinical classification of NeP 
The PD-Q classified 70 patients with a likely NeP component (median score 22.0, 
IQR 6.0; mean score 23.2, SD ± 3.7) and 46 cases with an unlikely NeP component 
(median score 9.5, IQR 5.25; mean score 8.7, SD ± 3.4) (Table 5.3). In 23.9% of 
cases (36/152), results were unclear (median score 15.5, IQR 3.0; mean score 15.5, 
SD ± 1.6). There was agreement between the PD-Q and the clinical classification in 
95 cases (no NeP: n = 66, NeP: n = 29; Kappa 0.23, 95% CI 0.07 to 0.37) (Table 
5.4), yielding 62.5% agreement with a sensitivity of 64% and a specificity of 62%. 
Out of the remaining 57 cases, a larger number of patients (n = 41) were classified as 
having NeP with PD-Q compared to the clinical classification, which indicated no 
NeP. Most of these patients scored highly (≥ 4) on the verbal descriptors for the 
presence of burning pain, tingling sensation, numbness and sudden pain.  
5.4.4.3 Agreement between questionnaires  
There was agreement between LANSS and PD-Q in classifying NeP in 95 of the 152 
cases (no NeP: n = 77, NeP: n = 18; Kappa 0.21, 95% CI 0.09 to 0.33) (Table 5.4), 
yielding a 62.5% agreement between questionnaire outcomes. For the discordant 57 
cases, a NeP component was demonstrated in only five patients for LANSS, but in 
52 patients for PD-Q. Questions in the LANSS refer to how the patient’s pain felt 
over the last week. Seven patients did not experience much pain in the week prior to 
the assessment, but answered the PD-Q questions in relation to how their pain had 
felt in the past 4 weeks. This resulted in the PD-Q score indicating NeP.  
 
The PD-Q and LANSS have a number of questions in common. These include the 
presence of a tingling/prickling sensation and burning sensation, if light touch is 
painful in the area of pain and if pain can come on suddenly. However, when 
comparing responses to the common questions from the two survey tools, 20 patients 
answered the questions affirmatively in the PD-Q, resulting in the classification of 
NeP, but responded in the negative in the LANSS. The main discrepancies related to 
the presence/absence of burning pain (n = 13), sensitivity to light touch (n = 12) and 
sudden pain (n = 9). In the remaining 25 discordant cases and in five cases scoring 
positive on the LANSS but negative on PD-Q, discrepancies were found in responses 
to the above named descriptors in 15 patients. However, had patients answered these 
questions in PD-Q as answered in LANSS, the final score of PD-Q (NeP or no NeP) 
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would not have changed. In 15 patients all questions were answered equally in both 
questionnaires, but due to scoring differences the overall outcome differed.  
 
 
5.4.5 Agreement between clinical classification and questionnaires where 
patients were classified as having NeP, no NeP or where the 
classification is unclear 
5.4.5.1 LANSS and clinical classification of NeP 
There was agreement between the LANSS and the clinical classification in 38 cases 
(no NeP: n = 14, unclear: n = 1, NeP: n = 23; Kappa 0.04, 95% CI -0.01 to 0.09) 
(Table 5.5), which yielded a 25.0 % agreement. 
5.4.5.2 PD-Q and clinical classification of NeP 
There was agreement between the PD-Q and the clinical classification in 77 cases 
(no NeP: n = 11, unclear: n = 8, NeP: n = 58; Kappa 0.17, 95% CI 0.06 to 0.28) 
(Table 5.5), which yielded a 50.7 % agreement.  
5.4.5.3 Agreement between questionnaires  
There was agreement between LANSS and painDETECT in classifying NeP in 67 
cases (no NeP: n = 40, unclear: n = 9, NeP: n = 18; Kappa 0.19, 95% CI 0.09 to 0.29) 
(Table 5.5), resulting in 44.1 % agreement between questionnaire outcomes. 
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Table 5.5  
Frequencies of neuropathic pain (NeP) in patients (N = 152) with neck/upper limb 
pain, using three classification categories: no NeP – unclear – NeP. 
  Clinical classification  
  No NeP Unclear NeP Total 
LANSSa No NeP 14 26 47 87 
Unclear 1 1 40 42 
 NeP 0 0 23 23 
 Total 15 27 110 152 
    
  Clinical classification  
  No NeP Unclear NeP Total 
painDETECTb No NeP 11 10 25 46 
 Unclear 1 8 27 36 
 NeP 3 9 58 70 
 Total 15 27 110 152 
    
  painDETECT  
  No NeP Unclear NeP Total 
LANSSc No NeP 40 25 22 87 
 Unclear 3 9 30 42 
 NeP 3 2 18 23 
 Total 46 36 70 152 
a25% of agreement between clinical classification and LANSS. 
b50.7% of agreement between clinical classification and painDETECT. 




The NeuPSIG’s proposed diagnostic grading system (Treede et al. 2008) was 
feasible for application in this cohort of neck/arm pain patients with a suspected 
nerve lesion. LANSS (Bennett 2001) and PD-Q (Freynhagen et al. 2006) failed to 
identify a large number of patients with clinically classified definite and probable 
NeP. The PD-Q demonstrated a higher sensitivity, but a lower specificity than 
LANSS. 
 
Clinical examination and classification 
The NeuPSIG classification model has been recommended for use in primary care 
and by non-specialists (Haanpää et al. 2009). In the current study, the majority of 
patients were referred by their general practitioner and were therefore representative 
of patients seen in primary care. The clinical assessment and classification of our 
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cohort necessitated considerable time and specific clinical expertise. Considering an 
average general practice consultation time of 15 minutes (Bindman et al. 2007; 
Campbell 2007), health professionals working in primary care may not have time for 
an appropriate in-depth clinical assessment or have the requisite knowledge and 
skills to apply this grading system. 
 
In our study, 82 patients (54%) indicated the neck/trapezius/scapula/shoulder area as 
their main area of pain which correlates with specific cervical nerve root pain 
distributions (Tanaka et al. 2006), but is also a common area for musculoskeletal 
pain and referred somatic pain (Dalton and Jull 1989). Mixed nociceptive and NeP 
pain mechanisms, which were likely to co-exist in our patient sample, have been 
acknowledged by numerous authors (Backonja 2003; Baron and Binder 2004; 
Freynhagen et al. 2006; Marchettini et al. 2006; Treede et al. 2008). Furthermore, 
musculoskeletal disorders can also present with sensory abnormalities (Geber et al. 
2008; Leffler et al. 2003; Westermann et al. 2011) and are common in suspected 
cervical radiculopathy (Cannon et al. 2007), thus can mimic nerve lesions (Lauder 
2002). In the context of predominant pain mechanism, the value of sensory pain 
descriptors has been raised (Baron et al. 2010; Bouhassira and Attal 2011). The 
combination of some items can discriminate between non-NeP and NeP groups 
(Bennett 2001; Bennett et al. 2005; Bouhassira et al. 2005; Dworkin et al. 2007; 
Krause and Backonja 2003), however their relevance and incorporation into the 
NeuPSIG grading system is under debate (Behrman et al. 2007; Hansson and 
Haanpää 2007; Marchettini 2005; Treede et al. 2008). In our study, the most 
dominant discriminators between the no NeP group and all others were the sensory 
descriptors electric shock, followed by tingling, sharp and spontaneous pain, 
numbness, hot and shooting. Unlike other studies (Bennett 2001; Bennett et al. 2005; 
Bouhassira et al. 2005; Dworkin et al. 2007; Krause and Backonja 2003), pain 
descriptors were volunteered, not chosen from a nominated descriptors list, thus 
lending credence to their existence. Our data suggest that the assessment of pain 
descriptors might be a valuable adjunct to determine the predominant pain type. The 
descriptor ache, commonly associated with nociceptive pain (Bennett 2006; Dworkin 
et al. 2009; Marchettini et al. 2006; Merskey and Bogduk 1994; Scholz et al. 2009),  
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was reported in our patients with NeP components, consistent with other studies 
(Dudgeon et al. 2005; Scholz et al. 2009; Wilkie et al. 2010) and with mixed pain 
presentations. 
 
For the diagnosis of NeP, sensory abnormalities have to be present within the 
neuroanatomically correlated pain area (Baron and Tölle 2008; Haanpää et al. 2011; 
Haanpää et al. 2009; Jensen and Baron 2003). The wording of this definition 
(Criterion 3) by Treede et al (Treede et al. 2008) as: “the presence of negative or 
positive sensory signs concordant with the distribution of pain” may however be 
open to different interpretations and could influence patient classification. 
‘Concordant’ can be defined as: “being in agreement with” (Collins 1991), allowing 
for interpretations including “sensory abnormalities have to spatially overlap the area 
of pain” or “sensory abnormalities are associated with the pain distribution and 
innervation territory of the affected nervous structure, but they do not necessarily 
overlap the pain area”. For example, hypoaesthesia in a dermatomal distribution, (as 
seen in radiculopathy), could indicate a lesion of the somatosensory system, but its 
presence does not necessarily indicate the presence of NeP in an associated proximal 
main pain area. This interpretation is consistent with the proposition that 
radiculopathies involve a mixed type pain (Baron and Binder 2004; Gálvez et al. 
2007; Marchettini et al. 2006) and that nerve lesions can be pain free (Landerholm et 
al. 2010; Taylor et al. 2010).  
 
Pain questionnaire classification of NeP 
The sensitivity of LANSS and PD-Q was much lower compared to previously 
reported studies (Bennett 2001; Freynhagen et al. 2006), and may partly be explained 
by the differences in clinical characteristics of respective study cohorts. Both 
questionnaires were validated in specific pain clinic populations with and without 
NeP, and patients with mixed pain were excluded (Bennett 2001; Freynhagen et al. 
2006). In contrast, our cohort consisted of mixed pain aetiologies (e.g. spinal 
degenerative conditions, radiculopathy, musculoskeletal) suggesting the possibility 
of a substantial proportion of mixed pain presentations. The diagnostic accuracy of 
both questionnaires diminished further with the classification of patients with NeP 
(probable and definite NeP combined), non-NeP and unclear cases. 
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The presence of mixed pain presentations seems to influence the discriminative 
ability of LANSS. Whilst LANSS demonstrated high sensitivity (70% - 89%) and 
specificity (94.2% - 96.6%) in patient groups resembling the cohorts in the validation 
study (Unal-Cevik et al. 2010; Yucel et al. 2004), sensitivity reduced slightly from 
85.9% to 81.8% with the inclusion of mixed pain presentations in a cohort of 156 
patients (42.9% NeP, 14% mixed pain) (Rejas et al. 2006). In a large sample of 
patients with cancer, which was labelled as having a mixed pain mechanism (Baron 
and Tölle 2008; Mercadante et al. 2009), sensitivity was 29.5% (Mercadante et al. 
2009), similar to our data. 
 
The LANSS may be most sensitive in patient cohorts who demonstrate mainly 
positive sensory gains (paraesthesia, hyperaesthesia, allodynia) rather than negative 
sensory signs. Specifically, only 3.3% of our patients demonstrated allodynia, and a 
positive response to the question of autonomic dysfunction was found in only 8.5% 
of patients compared to 90% and 55% respectively in the LANSS validation study 
(Bennett 2001). Similar observations to ours have been reported in patients with low 
back-related leg pain (Scholz et al. 2009). In the original LANSS studies (Bennett 
2001) a significant association between allodynia and hyperalgesia was found, 
however in our cohort, hyposensitivity seemed to be more frequent than 
hypersensitivity, consistent with findings from previous studies (Rasmussen et al. 
2004; Scholz et al. 2009). In addition, the pain descriptor tingling, which is scored 
very highly in the LANSS, was only reported by 27% of patients with probable and 
definite NeP and burning sensation by only 34% of patients. The specificity of 
LANSS was comparable to previous studies (Bennett 2001; Mercadante et al. 2009; 
Rejas et al. 2006; Unal-Cevik et al. 2010; Yucel et al. 2004), indicating its usefulness 
in ruling out NeP components in patients with chronic musculoskeletal pain. 
 
The PD-Q demonstrated a sensitivity of 64% which is similar to the sensitivity 
(68%) reported in spinal cord injury patients with central NeP (Hallström and 
Norrbrink 2011), however our calculated sensitivity might not truly reflect the 
identification of NeP components. As a self-reported tool, the PD-Q is open to 
individual interpretation. Eight of our patients failed to identify their main area of 
pain on the PD-Q body chart and 45 patients indicated additional, multiple pain areas 
(78% related to LBP and leg pain). Thus, it is possible that in 35% of our patient 
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cohort the responses given in PD-Q might not have been related just to the main area 
of pain. Out of these 53 patients, 36 were clinically classified as definite and 
probable NeP patients and PD-Q identified 24 of these patients. Our findings support 
the statement that the discriminative ability of NeP screening tools is only reliable 
when applied to one specific painful area (Bouhassira and Attal 2011). Hence, in a 
recent study using a computer version of the PD-Q (Junker et al. 2008) for sensory 
profiling of patients with lumbar radiculopathy/radicular pain, patients were asked to 
mark their main pain area on predefined body regions (Mahn et al. 2011). Out of our 
29 patients classified by PD-Q and the clinical assessment as having NeP, there were 
inconsistent responses to the common questions between LANSS and PD-Q in 25% 
of cases. If responses to these questions had been similar in the PD-Q as in LANSS, 
the sensitivity of PD-Q would have reduced to 48.9%. It would seem important to 
give patients specific instructions on how to complete the PD-Q.  
 
With a lack of published studies documenting clinical diagnostic accuracy and 
reliability of PD-Q in patients with peripheral NeP and lack of evidence of clinical 
validation of the English version of the questionnaire (Attal 2010; Bouhassira and 
Attal 2011), the validity for use of PD-Q in patients with neck/arm pain may be 
questionable. It is unclear if the lowered sensitivity of PD-Q in our study might be 
related to variations in patient cohorts, as specific patient characteristics were not 
reported in the original validation study (Freynhagen et al. 2006). 
 
Fundamental differences also exist between LANSS and PD-Q design, i.e. the 
timeframe of the presenting pain, the number and type of items included, the 
phrasing of the questions and the scoring method. Whilst LANSS uses fixed scores 
for each question, sensory descriptor items are weighted in PD-Q, thus responses 
could be vulnerable to psychological factors such as catastrophizing and 
hypervigilance, and potentially contribute to an overall higher score. These 
differences in questionnaire design, together with the low level of agreement 
between instruments, would not support the interchangeable use of LANSS and PD-
Q. Furthermore, the discriminative ability of these tools in identifying NeP 
components in patients with neck/upper limb pain of mixed aetiology is 
questionable. Our findings strongly support the notion that the results of NeP 
screening tools should always be used in conjunction with comprehensive clinical 
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assessment of the patient and should not replace clinical judgement (Cruccu et al. 
2010; Haanpää et al. 2011; Hansson and Haanpää 2007).  
 
Limitations of study 
The publication regarding the grading of NeP by the NeuPSIG (Treede et al. 2008) 
does not specify the type of sensory testing required for the assessment of NeP. 
Sensory testing of thermal sensibility was not performed in this study, our approach 
being consistent with previous methodology (Weingarten et al. 2007), but it is 
possible that this might have increased the number of patients demonstrating sensory 
alterations. The clinical classification of patients in this study was performed by one 




The NeuPSIG’s proposed diagnostic grading system could readily be applied to a 
cohort of patients with neck/upper limb pain. This diagnostic approach might not be 
feasible in primary care settings for patients with complex pain presentations due to 
the time and specific expertise required for classification. The diagnostic accuracy of 
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6.1 Abstract 
The aim of this study was to establish the somatosensory profiles of patients with 
cervical radiculopathy and patients with non-specific neck-arm pain associated with 
heightened nerve mechanosensitivity (NSNAP). Secondly we compared the sensory 
profiles to healthy control (HC) subjects and a positive control group, patients with 
fibromyalgia (FM). Quantitative sensory testing (QST) of thermal and mechanical 
detection and pain thresholds, pain sensitivity and responsiveness to repetitive 
noxious mechanical stimulation was performed in the maximal pain area, the 
corresponding dermatome and foot of 23 patients with painful C6 or C7 cervical 
radiculopathy, 8 patients with NSNAP in a C6/7 dermatomal pain distribution, 31 
HC and 23 patients with FM. For both neck-arm pain groups, all QST parameters 
were within the 95% confidence interval of HC data. Patients with cervical 
radiculopathy were characterised by localised loss of function (thermal, mechanical, 
vibration detection p < 0.009) in the maximal pain area and dermatome (thermal 
detection, vibration detection, pressure pain sensitivity p < 0.04), consistent with 
peripheral neuronal damage. Both neck-arm pain groups demonstrated increased cold 
sensitivity in their maximal pain area (p < 0.03) and the foot (p < 0.009), and this 
was also the dominant sensory characteristic in patients with NSNAP. Both neck-arm 
pain groups differed from patients with FM, the latter characterised by a widespread 
gain of function in most nociceptive parameters (thermal, pressure and mechanical 
pain sensitivity p < 0.027). Despite commonalities in pain characteristics between the 




This study focused on two nerve-related spinal neck-arm pain presentations: painful 
cervical radiculopathy and non-specific (i.e. no clinical signs of the presence of a 
radiculopathy) neck-arm pain associated with heightened nerve mechanosensitivity 
(hereafter NSNAP). The latter is characterised in experimental studies (Dilley et al. 
2005; Eliav et al. 2001) by peripheral nerve sensitivity to mechanical stimuli and 
clinically by pain in response to limb movements that cause nerve elongation 
(Allison et al. 2002; Chien et al. 2008; Elvey 1997; van der Heide et al. 2006) and 
local tenderness on nerve trunk palpation. Heightened nerve mechanosensitivity, a 
feature of nerve trunk pain, is regarded as a nociceptive (Marchettini et al. 2006) or 
inflammatory pain (Bennett 2006). It can coexist with painful cervical radiculopathy 
(Chien et al. 2008), but can also occur independently in patients with neck-arm pain 
(Elvey 1997; van der Heide et al. 2006). The latter applied to our chosen cohort. 
 
While patients with the two above named neck-arm pain conditions can present with 
similar pain characteristics and sensory symptoms, the pathophysiology, the pain 
type (nociceptive/neuropathic) and the underlying pain mechanisms do likely differ. 
Identification of differences between these pain conditions is important for the 
provision of appropriate best-evidence management. Moreover, the possible 
dominance of one pain type is of therapeutic relevance (Baron et al. 2010a; Harden 
and Cohen 2003), and may account for individual differences in responsiveness to 
anti-neuropathic agents, such as pregabalin, as documented in recent clinical trials of 
patients with lumbar and cervical radiculopathies (Baron et al. 2010b; Saldaña et al. 
2010).  
 
One approach to assist in the interpretation of pain mechanisms underlying clinical 
pain presentations is the use of quantitative sensory testing (QST) (Chien et al. 2008; 
Jääskeläinen et al. 2005; Landerholm et al. 2010; Maier et al. 2010; Taylor et al. 
2010). To our knowledge, no study has profiled patients with unilateral NSNAP 
comparable to our cohort, and only one study documented sensory abnormalities in 
patients with cervical radiculopathy (Chien et al. 2008). However, in the latter, 
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recordings were not taken from the patients’ maximal pain area, as is required for the 
assessment of NeP components (Haanpää et al. 2011; Treede et al. 2008).  
 
The purpose of this study was to establish the somatosensory profiles of patients with 
painful cervical radiculopathy and patients with NSNAP in order to explore 
differences or commonalities in sensory parameters. For each group, sensory profiles 
were documented in the area of maximal pain, in the respective dermatome and in 
the foot as a remote control site and were compared to healthy control (HC) data. In 
order to better characterise the neck-arm pain presentations, a group of patients with 
fibromyalgia (FM) was included as a positive control group to allow comparison to a 
group with widespread pain. We chose the presentation of FM as this pain disorder is 
characterised by enhanced sensitivity to a wide array of somatosensory stimuli and 
features of central pain processing mechanism in the absence of demonstrable local 
somatic abnormality (Goldenberg 2009; Wolfe et al. 2010). The significance of the 
study was the potential for better understanding of pain characteristics and sensory 
signs in different patient groups to assist clinicians in targeting management of these 
patient sub-groups. We hypothesised that: (1) the sensory phenotypes between the 
two neck-arm pain groups would be different; (2) in patients with cervical 
radiculopathy localised sensory abnormalities would be restricted to the maximal 
pain area and to the area of dermatomal sensory loss; (3) in patients with NSNAP 
sensory abnormalities would be found only in the maximal pain area; and 4) sensory 
profiles of the neck-arm pain groups would differ from that of patients with FM. 
6.3 Materials and methods 
The study protocol and recruitment procedures for this cross-sectional study were 
approved by the local Ethics Committee of all participating institutions and adhered 
to the ethical guidelines of the Declaration of Helsinki.  
6.3.1 Study population 
Patients were recruited from physiotherapy and pain management departments at five 
local metropolitan hospitals in Perth, Western Australia; a neurosurgery triage clinic 
and a neurosurgery outpatient department at a large tertiary hospital; general private 
neurosurgery, medical and physiotherapy practices; from the local community via 
radio and newspaper advertising and from FM support groups. 
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Patients with painful C6 or C7 cervical radiculopathy (n = 23; 8 female; mean age 
46.3 ± 9.6 years) had to fulfil the following inclusion criteria: unilateral neck pain 
and arm pain/paraesthesia distribution consistent with radicular distributions; 
symptom duration of 3 to 18 months; pain intensity ≥ 2 on a visual analogue scale 
(VAS); signs of C6 or C7 nerve root dysfunction such as motor impairment (either 
absent or diminished reflex and/or myotomal weakness) and sensory impairment; 
and a demonstrable clinically relevant abnormality on imaging studies (Bono et al. 
2011; Treede et al. 2008) indicating compromise of the exiting nerve root at the 
relevant spinal level. The inclusion criteria for patients with NSNAP (n = 8; 7 
female; mean age 45.1 ± 14.9 years) were: unilateral neck pain and arm 
pain/paraesthesia distribution consistent with C6/C7 distribution; absence of any 
signs of nerve root dysfunction i.e. absence of radiculopathy, symptom duration of 3 
to 18 months; pain intensity ≥ 2 on a VAS; and evidence of increased peripheral 
nerve sensitivity to mechanical stimuli (Elvey 1997). The latter included pain in 
response to a nerve provocation test in the upper limb (Elvey 1997; Sterling et al. 
2002; Wainner et al. 2003), a test analogous to the straight leg raise test in the lower 
limb (Devillé et al. 2000; Freynhagen et al. 2008). Exclusion criteria for both patient 
groups consisted of evidence of metabolic or medical disease; other neurological or 
psychiatric disease; a history of lumbar surgery and/or sciatica or other 
musculoskeletal disorders that potentially might affect the sensation in the foot to be 
tested; a history of cardiovascular disease; and an insufficient level of English. A 
comprehensive clinical examination was conducted by one clinician (author BT) on 
all potential participants in order to confirm that patients satisfied the requirements 
for inclusion into the study.  
 
The consensus of two clinical experts, a Fellowship-trained spinal neurosurgeon and 
a Specialist Musculoskeletal Physiotherapist (Fellow of the Australian College of 
Physiotherapists), was used to verify the diagnosis of cervical radiculopathy, as 
consistent with a previous study (Freynhagen et al. 2008). The classification of 
NSNAP was verified by the Specialist Musculoskeletal Physiotherapist. Whilst the 
straight leg raise test is widely used to assess heightened nerve mechanosensitivity in 
the lower limb (Devillé et al. 2000; Freynhagen et al. 2008), the upper limb analogue 
(Elvey 1997) is less widely used in medicine although it has been extensively 
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investigated in musculoskeletal physiotherapy (Coppieters et al. 2006; Sterling et al. 
2002; van der Heide et al. 2006; Wainner et al. 2003). Therefore the neurosurgeon in 
the current study was asked to determine if patients with NSNAP did have a 
radiculopathy or not. Both experts were blinded to the clinician’s patient 
classification, and independently reviewed the patient notes including the findings of 
the clinical examination plus the results of any medical investigations. Three patients 
were excluded from data analysis as the experts did not make the same diagnosis as 
the clinical examiner. 
 
Patients with FM (n = 22; 20 female; mean age 46.1 ± 11.5 years) underwent an 
initial telephone screening examination to verify they met the inclusion and 
exclusion criteria. Inclusion criteria were the diagnostic guidelines for FM presented 
by the American College of Rheumatology (ACR) (Wolfe et al. 1990) which include 
widespread pain of at least 3 months duration in combination with tenderness at 11 
or more of 18 specific anatomical sites. These guidelines were current at the time of 
recruitment, however the clinical profile of our FM group appears to also correspond 
with the new diagnostic criteria (Wolfe et al. 2010) (Table 6.1). Nine patients had 
been diagnosed with FM by a rheumatologist, 8 patients by their general practitioner 
by exclusion (negative blood tests) and positive tender point count, 4 patients by a 
medical specialist (specific specialty unknown to the patient), and in one patient the 
origin of the diagnosis was not recorded. Prior to participation, tender point count 
was confirmed using a pressure algometer (probe size 1cm2) (Somedic AB, Farsta, 
Sweden), and assessing nine paired points as defined by the ACR Criteria (Wolfe et 
al. 1990) and two control points (at the centre of the right forearm and the right 
thumb nail). The exclusion criteria for patients with FM were the same as for the 
neck-arm pain groups. All patients were requested to refrain from taking non–
steroidal anti-inflammatory medications and analgesics on the day of examination. 
 
Thirty-one HC subjects, matched for age to the patient groups (15 female, 45.6 ± 
12.5 years), were recruited from the local community. Subjects with a history of 
current pain or a chronic pain condition or any of the additional exclusion criteria 
described for the patient groups were excluded, including taking medications that 
influence pain perception. 
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Table 6.1  
Demographics and profiles of healthy control (HC) subjects, patients with cervical radiculopathy (CxRAD), patients with neck-arm pain 
associated with heightened  nerve mechanosensitivity (NSNAP ) and patients with fibromyalgia (FM).  
 HC  
(n = 31) 
CxRAD  
(n = 23) 
NSNAP  
(n = 8) 
FM  
(n = 22) 
p-value 
ANOVA 
Age (years), (SD) 45.6 (12.5) 46.3 (9.6) 45.1 (14.9) 46.1 (11.5) 0.992 
Gender (female, n) 15 8 7 20  
Symptom duration (months)*  7.6 (4.1) 8.1 (3.0) 124.9 (83.1)c, e <0.001 
Average pain intensity during last week (VAS)*  5.2 (2.0) 6.0 (1.5) 7.3 (1.2)c <0.001 
Maximal pain intensity during last 4 weeks (NRS 0-10)*  7.2 (2.2) 7.6 (0.6) 8.3 (1.2) 0.116 
Average pain intensity during last 4 weeks (NRS 0-10)*  5.0 (2.1) 5.1 (0.6) 6.2 (1.3)d 0.043 
Sleep quality during last week (VAS)*  2.9 (2.6) 5.3 (2.7)b 5.9 (2.2)b 6.8 (2.3)a <0.001 

































Hospital Anxiety and Depression Scale     
Anxiety score (HADS)# 3.0 (5.0) 6.0 (5.0)b 8.0 (4.2)b 12.0 (6.2)a, c, f <0.001## 
Within normal range (≤ 10), n  29 (93%) 21(91%) 6 (75%) 7 (32%)  
Depression score (HADS)# 1.0 (1.0) 3.0 (4.0)a 3.5 (5.5)b 6.0 (4.2)a, d <0.001## 
Within normal range (≤ 10), n  31 (100%) 21 (91%) 8 (100%) 19 (86%)  
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Table 6.1 continued 
 HC  
(n = 31) 
CxRAD  
(n = 23) 
NSNAP  
(n = 8) 
FM  
(n = 22) 
p-value 
ANOVA 
SF-36      
Physical Component# 57.7 (3.7) 40.6 (12.6)a 46.4 (12.0)b 36.4 (11.9)a, f <0.001## 
Mental Component# 56.0 (7.6) 52.3 (17.4)b 48.4 (20.5)b 30.8 (21.5)a, d, f <0.001## 
Neck Disability Index  16.2 (7.7) 13.4 (5.9) 19.7 (4.0)f 0.032 
Tampa Scale of Kinesiophobia  40.9 (8.1) 36.7 (7.5) 38.4 (5.4) 0.281 
Patients with medication, n   15 (65.2%) 3 (37.5%) 12 (54.5%)  
Current medication◊      
Selective serotonin reuptake inhibitor, n   1 (4.3%) 1 (12.5%) 7 (31.8%)  
Serotonin-norepinephrine reuptake inhibitor, n  2 (8.7%)  2 (9.1%)  
Tricyclic antidepressant, n  1 (4.3%)  3 (13.(%)  
Tetracyclic antidepressant, n    1 (4.5%)  
Antiepileptics, n  2 (8.7%)    
Opioids, n  4 (17.4%)  1 (4.5%)  
Benzodiazepine, n  2 (8.7%)    
Analgesics, n  7 (30.4%) 1 (12.5%) 3 (13.(%)  
Non-steroidal anti-inflammatories, n  7 (30.4%) 2 (25%)   
*Data are mean (SD); #Data are median (IQR); ##Kruskal–Wallis Test; ###Fisher’s Exact Test. 
aSignificantly different to HC (p < 0.001); bSignificantly different to HC (p < 0.05); cSignificantly different to CxRAD (p < 0.001);  
dSignificantly different to CxRAD (p < 0.05); eSignificantly different to NSNAP (p < 0.001); fSignificantly different to NSNAP (p < 0.05). 
◊Multiple answers possible. 
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6.3.2 Questionnaires  
The following questionnaires were used to characterise the patient groups. They were 
administered before the QST testing was performed. 
• Disability was assessed using the Neck Disability Index (NDI) (Vernon and 
Mior 1991), a well validated ten-item questionnaire (Vernon 2008). Scores of 
< 4 indicate no disability, 5 – 14 mild disability, 15 – 25 moderate disability, 
25 – 34 severe disability, and > 35 complete disability (Vernon and Mior 
1991).  
• Fear avoidance behaviour was quantified using the Tampa Scale of 
Kinesiophobia (TSK) (Vlaeyen et al. 1995). This questionnaire consists of 17 
items that relate to fear of movement and fear of (re) injury. A score ≥ 40 is 
considered to indicate significant kinesiophobia (Crombez et al. 1999).  
• Average pain intensity over the last week was determined with a VAS with 
the end points 0 cm (no pain) and 10 cm (maximum tolerable pain) (Jensen et 
al. 1989). The strongest and average pain intensity over the last four weeks 
was recorded on a numeric rating scale (NRS) (0 = no pain, 10 = maximum 
pain).  
• Symptom duration was recorded via face to face interview. 
 
The following questionnaires were employed to enable clinical characterisation of 
the patient groups and HC. 
• The short form-36 health questionnaire (SF-36v2®) (Ware 2000) was used to 
assess health-related quality of life.  
• The Hospital Anxiety and Depression Scale (HADS) is a self-administered 
questionnaire to screen for the presence of psychological factors (Zigmond 
and Snaith 1983). Two independent scores for anxiety and depression are 
generated with a maximum score of 21 for each parameter. Scores of ≤ 10 for 
each are considered within normal range.  
• Sleep disturbance was determined by asking: ”Do you awake tired or non-
refreshed?” Fatigue was assessed by asking: ”Do you feel fatigued?” (Wolfe 
et al. 1990). Both sleep and fatigue questions allowed for answers: “never”, 
“seldom”, “often or usually”, “always”. “Never” or “seldom” was scored as 
negative, and other replies as positive. In addition, all subjects had to rate 
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their sleep quality over the last week on a 100-cm VAS with the end points 0 
cm (good sleep) and 10 cm (bad sleep) (Hurtig et al. 2001).  
6.3.3 Quantitative sensory testing  
Standardised QST was performed according to the QST protocol of the German 
Research Network on Neuropathic Pain (DFNS) (Rolke et al. 2006a; Rolke et al. 
2006b) by one investigator (BT) in a laboratory with a constant room temperature. 
This protocol comprises all of the somatosensory sub-modalities that are mediated by 
different primary afferents (C-, Aδ-, Aβ-) as outlined in the following sections. Good 
test/retest- and inter-observer-reliability of this protocol has been demonstrated for 
all sub-modalities except wind-up ratio and the number of paradoxical heat 
sensations (Geber et al. 2011). QST measurements were taken from the main pain 
area nominated by the patients (upper trapezius muscle n = 24; paravertebral cervical 
spine n = 4; paravertebral thoracic spine n = 13; above and below spine scapula n = 
3; upper arm n = 6; forearm n = 2; just lateral above the elbow n = 1). For patients 
with FM, the most painful side was assessed. Bilateral measurements in the upper 
trapezius muscle were obtained in 26 HC and unilateral measurements in all other 
pain areas in 8 HC, including 3 from the trapezius group, in accordance with 
established methodology to standardise the data (Blankenburg et al. 2010). For 
patients with radiculopathy, QST was also performed unilaterally in the dermatomal 
area of sensory loss (C6 or C7 dermatome) as determined precisely during clinical 
examination, and for patients with NSNAP in the area of distal paraesthesia or pain 
(C6 or C7 dermatomal distribution). Patients with FM were randomly assessed in the 
C6 dermatome (thenar eminence) (n = 10) or C7 dermatome (dorsum hand) (n = 12). 
HC subjects were tested bilaterally in the C6 (n = 13) and C7 (n = 13) dermatome. 
All patients and 26 HC subjects underwent QST on the dorsum of the foot ipsilateral 
to the symptomatic side as a remote control site (Rolke et al. 2006a; Rolke et al. 
2006b). In HC subjects, the ‘symptomatic’ side was determined randomly by rolling 
a die.  
 
Thermal detection and pain thresholds and the number of paradoxical heat 
sensations 
Thermal thresholds were measured using the MSA Thermotest system (Somedic AB, 
Farsta, Sweden) with a 12.5cm2 probe. The baseline temperature was set at 32˚C; 
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cut-off temperatures were 5˚C and 50˚C. All thresholds were obtained with ramped 
stimuli (1° C/s) which were terminated when the subject pressed a button. First, cold 
and warm detection thresholds (CDT, WDT) were assessed, followed by the 
determination of the number of paradoxical heat sensations during the thermal 
sensory limen procedure, and finally the measurement of cold and heat pain 
thresholds (CPT, HPT). The mean threshold temperature of three consecutive 
measurements was calculated. 
 
Mechanical detection threshold 
The mechanical detection threshold (MDT) was determined using a standardised set 
of modified von Frey hairs (Optihari2-Set, Marstock Nervtest, Germany) that exert 
forces upon bending between 0.25 and 512mN. Five ascending and five descending 
series of stimuli were applied. The final threshold was the geometric mean of these 
series of ascending and descending stimulus intensities (Rolke et al. 2006a).  
 
Mechanical pain threshold 
The mechanical pain threshold (MPT) was measured using a set of seven custom-
made weighted pinprick stimulators (flat contact area of 0.2 mm diameter) with fixed 
stimulus intensities (8, 16, 32, 64, 128, 256, and 512 mN) (MRC Systems GmbH, 
Germany). Five ascending and descending series of stimuli were applied and the 
subjects were asked to indicate if the sensation was felt as being ‘sharp’ or ‘blunt’. 
The final threshold was the geometric mean of the five series of ascending and 
descending stimulus intensities. 
 
Stimulus-response-function: mechanical pain sensitivity for pinprick stimuli and 
dynamic mechanical allodynia  
Mechanical pain sensitivity (MPS) was assessed using the same weighted pinprick 
stimulators as for MPT. The pinprick stimuli were applied five times. Subjects were 
asked to give a pain rating for each stimulus on a NRS (0 = no pain, 100 = most 
intense pain imaginable). Dynamic mechanical allodynia (DMA) was assessed by 
light stroking with a cotton wool tip fixed to an elastic strip (100mN), a cotton wisp 
(3mN), and a brush exerting a force of 200 - 400mN. The stimuli were applied five 
times and were intermingled with the pinprick stimuli in balanced and standardised 
order. Subjects were asked to give a rating on the same scale as for pinprick stimuli. 
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MPS was calculated as the geometric mean of all numerical ratings for pinprick 
stimuli and DMA as the geometric mean of all numerical ratings elicited by light 
touch stimulators. 
 
Wind-up ratio to repetitive pinprick stimuli 
The perceived magnitude of a single pinprick stimulus (256 mN) was compared with 
that of a series of 10 pinprick stimuli of the same force repeated at a 1/s rate. The 
repeated stimuli were given within an area of 1cm2. Subjects were instructed to give 
a pain rating for the first stimulus and for the whole series of 10 pinpricks using a 0 – 
100 NRS. The mean pain rating of five series of repeated pinprick stimulation 
divided by the mean pain rating of five single stimuli was calculated as wind-up 
ratio. 
 
Vibration detection threshold 
The vibration detection threshold (VDT) was measured using a Rydel-Seiffer tuning 
fork (64Hz, 8/8 scale). The threshold was determined as a disappearance threshold 
with three stimulus repetitions (Rolke et al. 2006a). Measurements were taken over 
bony prominences unless the maximal pain area did not exhibit a bony surface (n = 
12), in which case, measurements were taken over adjacent soft tissue. 
Measurements in the dermatomal area of patients with cervical radiculopathy and 
patients with NSNAP were recorded over bony prominences. For patients with FM 
and HC subjects, VDT of dermatome C6 was measured over the radial styloid and 
VDT of dermatome C7 was measured over the third 3rd metacarpophalangeal joint. 
VDT of the foot was recorded over the medial malleolus (Rolke et al. 2006a; Rolke 
et al. 2006b) in all patients and HC. 
 
Pressure pain threshold 
The assessment of pressure pain thresholds (PPT) is the final test of the QST 
protocol. The PPT was determined using a pressure algometer with a probe size of 
1cm and an application rate of 50kPa/s (Somedic AB, Farsta, Sweden). The subjects 
were asked to push a button when the sensation changed from one of pressure alone 
to one of pressure and pain. The mean value of triplicate recordings was used for 
analysis. 
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6.3.4 Statistical analysis 
Data were analysed using the Statistical Package for Social Sciences (SPSS Version 
17.0). QST data were log-transformed prior to statistical analysis (Rolke et al. 
2006b) except HPT and VDT which were normally distributed as raw data. To 
compare and illustrate patients’ QST data profiles with the group mean of age-
matched healthy controls patients’ data were z-transformed for each single parameter 
by using the following expression: Z-score = (X single proband – Mean healthy controls)/SD 
healthy controls (Rolke et al. 2006b). Z-values were calculated based on the included HC 
group data (data from trapezius muscle and dermatomes from left and right body side 
pooled). For clarity of data presentation, the algebraic sign of z-score values for each 
parameter was adjusted so that it reflects the individual patient’s sensitivity for each 
parameter. Z-values above ‘0’ indicate a gain of function, meaning the patient is 
more sensitive to the tested stimuli compared with HC, a z-value below ‘0’ indicates 
as loss of function, meaning a reduced sensitivity of the patient.  
 
Differences of z-score QST data between the 3 patient groups and controls and tested 
body regions were compared using a two-way analysis of covariance (ANCOVA) 
with tested body areas (maximal pain area, dermatome, foot) as the within-subjects 
factor. Group (patients/controls) and the potential confounding factor gender were 
entered as between-subjects factors. Anxiety and depression were entered as 
covariates to account for potential influence of these factors on pain responses 
(Rhudy and Meagher 2000). If individual confounding factors did not demonstrate a 
significant effect, they were removed from the model. The LSD (LSD; least 
significant difference) post-hoc test was used to identify differences between body 
regions for variables that showed a statistical significant difference on ANCOVA. A 
univariate analysis was conducted for each QST parameter with post-hoc analyses 
(LSD-post hoc tests) to assess specific group differences within one tested body 
region. Any confounding factor that was found to be significant in the ANCOVA 
model was included in the univariate analysis. Frequencies of sensory abnormalities 
lying outside of the 95% confidence interval (i.e. z-score < -1.96 or > 1.96 standard 
deviation) of our HC were calculated within each group for each test site. Age, 
symptom duration, pain intensity, sleep quality, scores of the NDI and TSK were 
compared between groups using a one-way ANOVA. Post hoc comparisons were 
calculated using LSD-post hoc tests. Differences in frequency of sleep disturbance 
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were determined by means of the Fisher’s exact test. Anxiety and depression scores 
and the physical and mental component summary scores of the SF-36 were compared 
between groups using the Kruskal-Wallis Test. If there was a difference between 
groups, further pairwise analyses were performed using the Mann-Whitney-U Test. 
Significance was accepted at p < 0.05 for all analyses. 
6.4 Results 
6.4.1 Patient characteristics 
A summary of the demographics is presented for each group in Table 6.1. There 
were no statistically significant differences between the two neck-arm pain groups in 
any of the measures including pain intensities, symptom duration, sleep quality, fear 
avoidance behaviour, anxiety and depression scores, physical and mental component 
summary score of the SF-36 and NDI scores. The NDI indicated moderate disability 
for patients with cervical radiculopathy and mild disability for patients with NSNAP. 
Both neck-arm pain groups differed from HC with significantly poorer sleep quality, 
lower physical and mental component summary scores of the SF-36 and higher 
anxiety and depression scores, however over 75% of anxiety and 91% of depression 
scores fell within the normal range. Compared to patients with FM, both neck-arm 
pain patient groups demonstrated a significantly shorter symptom duration, lower 
anxiety scores and higher mental component score of the SF-36. Patients with 
cervical radiculopathy showed lower average pain intensity during the last week and 
the last 4 weeks prior to testing and a lower depression score compared to patients 
with FM. Patients with NSNAP demonstrated a significantly higher physical 
component score of the SF-36 and lower score on the NDI compared to patients with 
FM. 
 
In the cervical radiculopathy group, 11 patients presented with a C6 radiculopathy 
and 12 patients with a C7 radiculopathy. The most common pain descriptors used by 
patients with radiculopathy for their neck pain were constant pain (n = 17), ache (n = 
10), dull (n = 7), burning (n = 6) and sharp (n = 6), and for their arm pain constant 
pain (n = 11), burning (n = 7), ache (n = 6) and shooting (n = 5). Eight patients with 
cervical radiculopathy indicated their arm pain as the maximal pain area. All patients 
reported the presence of paraesthesia (pins and needles, tingling or numb sensation) 
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in their arm. Seventeen patients reported spontaneous pain. In the patient group with 
NSNAP, 7 patients presented with pain in a C7 dermatomal distribution and one 
patient with pain in a C6 dermatomal distribution. The most common pain 
descriptors for the neck pain were constant pain (n = 5), burning (n = 5) and ache (n 
= 3), and for the arm pain intermittent pain (n = 5), burning, shooting and nerve pain 
(n = 2). For all patients in this group, the maximal pain area was located in the 
neck/upper thoracic area. All patients reported the presence of paraesthesia in their 
arm. Three patients indicated the presence of spontaneous pain. Two patients had 
undergone medical imaging (computed tomography) of their cervical spine, which 
demonstrated no compromise of the exiting nerve root at the relevant spinal level. 
All other patients had no imaging performed. 
6.4.2 Sensory profile and number of abnormal findings 
The QST sensory profiles for each body region (maximal pain area, dermatome and 
foot) and by group (cervical radiculopathy, NSNAP and FM) shown as z-scores are 
illustrated in Figure 6.1A – 6.1C. To allow for easy visual comparison, the z-score 
sensory profiles are also shown for all pain conditions by each area independently 





         
 
 
Figure 6.1 Sensory profiling. The z-score sensory profiles are shown of patients with cervical 
radiculopathy (A), patients with non-specific neck-arm pain associated with heightened nerve 
mechanosensitivity (NSNAP) (B) and patients with fibromyalgia (FM) (C) in the maximal pain area 
(filled square), dermatome (filled circle) and foot (empty triangle). Error bars indicate the standard 
error of measurement. CDT: cold detection threshold; WDT: warm detection threshold; TSL: thermal 
sensory limen; CPT: cold pain threshold; HPT: heat pain threshold; MDT: mechanical detection 
threshold; MPT: mechanical pain threshold; MPS: mechanical pain sensitivity; WUR: wind-up ratio; 
VDT: vibration detection threshold; PPT: pressure pain threshold. 





Figure 6.2 Sensory profiling. The z-score sensory profiles are shown of patients with cervical 
radiculopathy (filled square), patients with non-specific neck-arm pain associated with heightened 
nerve mechanosensitivity (NSNAP) (filled circle) and patients with fibromyalgia (FM) (empty 
triangle) in the maximal pain area (A), dermatome (B) and foot (C). Error bars indicate the standard 
error of measurement. CDT: cold detection threshold; WDT: warm detection threshold; TSL: thermal 
sensory limen; CPT: cold pain threshold; HPT: heat pain threshold; MDT: mechanical detection 
threshold; MPT: mechanical pain threshold; MPS: mechanical pain sensitivity; WUR: wind-up ratio; 
VDT: vibration detection threshold; PPT: pressure pain threshold. 
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6.4.2.1 Patients with cervical radiculopathy 
For patients with cervical radiculopathy, the mean values of all QST parameters were 
within the 95% confidence interval of the reference group (Fig. 6.1A). Patients with 
cervical radiculopathy demonstrated mixed, bi-directional sensory abnormalities, i.e. 
signs of a loss of function as well as a gain of function. Compared to HC, a loss of 
function was demonstrated for the non-nociceptive parameters CDT, WDT, TSL, 
MDT and VDT in the maximal pain area (p ≤ 0.008) and CDT, WDT, TSL and VDT 
in the dermatome (p < 0.03) and for the nociceptive parameter PPT in the dermatome 
(p = 0.038) (Table 6.2). Although MDT was elevated in the dermatome (Fig. 6.1A), 
it did not reach statistical significance compared to HC data (MDT: p = 0.069).  
 
The frequencies of z-score values outside the 95% confidence interval of the HC 
group (Table 6.3) indicating a loss of function (< -1.95) were as follows (in order: 
maximal pain area; dermatome; foot): CDT (39%; 17%; 4%), WDT (26%; 9%; 4%), 
TSL (39%; 13%; 4%), MDT (26%; 13%; 0%), VDT (22%; 22%; 4%) and PPT 
(22%; 17%; 0%). In comparison with HC data, a gain of function was evident for 
one nociceptive parameter (CPT) (Fig 6.1A), data indicating an increased cold 
sensitivity primarily in the maximal pain area (p = 0.001) and in the foot (p = 0.003) 
(Table 6.2). The frequencies of z-scores > 1.95 indicating a gain of function for CPT 
were: 39%, 30% and 30% for the maximal pain area, dermatome and foot 
respectively (Table 6.3). WUR was not consistently present in any of the examined 
body regions (Table 2). DMA was demonstrated by one patient in both the maximal 
pain area and in the dermatome. PHS in the maximal pain area was reported once in 





QST parameters are shown of healthy controls (HC), patients with cervical  
radiculopathy (CxRAD), patients with neck-arm pain associated with heightened  
nerve mechanosensitivity (NSNAP) and patients with fibromyalgia (FM) in the  
maximal pain area (MPA), dermatome (DERM) and foot (FOOT). QST data are  
shown as mean for untransformed data (HPT, VDT) and retransformed mean for 




n = 31 
CxRAD 
n = 23 
NSNAP  
n = 8 
FM 









CDT (°C)     0.003 0.003 0.003 
 MPA 1.31 1.89d, e 1.16 1.57    
 DERMa 1.57 2.68c, e, f 1.55 1.56    
 FOOTa 3.42 3.06 3.86 3.02    
WDT (°C)     0.529 <0.001 0.037 
 MPA 2.65 3.83d, e, f 2.64 2.79    
 DERMa 2.94 4.17c, f 3.14 2.56    
 FOOTa 4.70 6.30c, f 4.42 3.95    
TSL (°C)     0.302 <0.001 0.028 
 MPA 4.26 6.22d, e, g 4.17 4.11    
 DERM 4.71 6.87c, f 5.11 4.03    
 FOOTa 9.39 11.78f 8.84 6.69 c    
CPT (°C)     0.050 <0.001 0.095 
 MPA 7.1 11.16c, g 12.16c, f 24.2 d    
 DERM 6.11 8.08g 7.80g 18.03d    
 FOOT 5.76 9.39c, g 10.59c, f 18.73d    
HPT (°C)     0.183h <0.001h 0.949h 
 MPA 46.6 45.4g 45.1f 39.5d    
 DERM 47.3 46.1f 46.4f 40.8c    
 FOOT 46.3 46.4g 44.0 41.8c    
MDT (mN)     0.193 0.014 0.112 
 MPA 2.11 3.79c, e 1.37 3.08    
 DERM 2.24 4.53f 2.65 1.50    
 FOOT 6.34 10.15 6.67 5.50    
MPT (mN)     0.241h 0.512h 0.282h 
 MPA 66.24 29.85 28.10 31.60    
 DERM 72.81 84.45 34.90 54.68    
 FOOT 58.45 34.92 31.72 42.23    
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n = 31 
CxRAD 
n = 23 
NSNAP  
n = 8 
FM 









MPS (rating 0-100)    0.193i 0.009i 0.034i 
 MPA 0.44 0.45f 0.77 1.90c    
 DERM 0.36 0.34f 0.74 1.38    
 FOOTa, b 0.41 0.66f 1.04 2.10c    
WUR (ratio)     0.050 0.029 0.236 
 MPA 3.80 
(n = 16) 
2.81 
(n = 18) 
2.98 
(n = 8 
4.36 
n = 22) 
   
 DERM 2.77 
(n = 17) 
2.45f 
(n = 15) 
2.15f 
(n = 8) 
4.34c 
(n = 22) 
   
 FOOT 3.30 
(n = 21) 
2.86 
(n = 21) 
2.24 
(n = 8) 
4.04 
(n = 22) 
   
VDT (x/8)     0.133 0.032 0.001 
 MPA 6.1 5.4c 5.2 5.5c    
 DERM 7.0 6.2c 6.6 6.7    
 FOOTa, b 5.9 5.7 5.5 5.4    
PPT (kPa)     0.194j 0.004 0.787j 
 MPA 427 403 390 183    
 DERM 471 572c, e, g 417g 249d    
 FOOT 584 573g 522g 299d    
CDT: cold detection threshold; WDT: warm detection threshold; TSL: thermal sensory 
limen; CPT: cold pain threshold; HPT: heat pain threshold; MDT: mechanical detection 
threshold; MPT: mechanical pain threshold; MPS: mechanical pain sensitivity; WUR: wind-
up ratio; VDT: vibration detection threshold; PPT: pressure pain threshold. 
aSignificantly different to maximal pain area (p < 0.05); bSignificantly different to 
dermatome (p < 0.05); cSignificantly different to HC (p < 0.05); dSignificantly different to 
HC (p < 0.001); eSignificantly different to NSNAP (p < 0.05); fSignificantly different to FM 
(p < 0.05); gSignificantly different to FM (p < 0.001); hadjusted for anxiety; iadjusted for 
depression, jadjusted for gender. 
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Table 6.3 Number of individuals within each group with z-score values outside the 95% confidence interval of healthy control subjects 
(+/- 1.96 standard deviation). 




n = 31 
CxRAD 
n = 23 
NSNAP 
n = 8 
FM 
n = 22 
HC 
n = 26 
CxRAD 
n = 23 
NSNAP 
n = 8 
FM 
n = 22 
HC 
n = 26 
CxRAD 
n = 23 
NSNAP 
n = 8 
FM 
n = 22 
  + - + - + - + - + - + - + - + - + - + - + - + - 
CDT  1 0 1 9 0 0 1 8 0 0 0 4 0 0 0 1 0 2 1 1 0 0 0 0 
WDT  1 0 0 6 0 0 1 1 0 3 0 2 0 0 0 2 0 0 0 1 0 0 0 0 
TSL  0 0 0 9 0 1 1 1 0 0 0 3 0 0 0 1 0 2 1 1 0 0 1 0 
CPT  1 0 9 0 2 0 21 0 0 0 7 0 3 0 18 0 1 0 8 0 3 0 19 0 
HPT  2 0 5 0 1 0 19 0 2 0 6 0 0 0 15 0 0 0 1 0 1 0 10 0 
MDT  0 0 0 6 1 1 1 3 0 0 0 3 0 2 3 1 1 0 0 0 0 0 0 0 
MPT  0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
MPS  1 0 2 0 0 0 7 0 0 0 2 0 0 0 4 0 1 0 1 0 1 0 8 0 
WUR  0 0 0 2 0 0 1 0 0 1 1 2 0 1 3 0 1 0 0 0 0 0 1 0 
VDT  0 0 0 5 0 2 0 5 0 1 0 5 0 3 0 2 0 1 0 1 0 2 0 1 
PPT  0 1 6 5 1 0 15 1 1 0 2 4 1 0 14 0 1 0 0 0 0 0 13 0 
DMA*  0 0 1 0 0 0 3 0 0 0 1 0 0 0 3 0 0 0 0 0 0 0 5 0 
HC: healthy control subjects; CxRAD: cervical radiculopathy; NSNAP: non-specific neck-arm pain associated with heightened nerve mechanosensitivity; 
FM: fibromyalgia;CDT: cold detection threshold; WDT: warm detection threshold; TSL: thermal sensory limen; CPT: cold pain threshold; HPT: heat pain 
threshold; MDT: mechanical detection threshold; MPT: mechanical pain threshold; MPS: mechanical pain sensitivity; WUR: wind-up ratio; VDT: vibration 
detection threshold; PPT: pressure pain threshold; DMA: dynamic mechanical allodynia. 
+: Number of patients with positive individual z-score values, indicating an increased sensitivity compared to normative data (> + 1.96 standard deviation). 
-: Number of patients with negative individual z-score values, indicating a decreased sensitivity compared to normative data (> - 1.96 standard deviation). 




6.4.2.2 Patients with non-specific neck-arm pain associated with heightened 
nerve mechanosensitivity 
For patients with NSNAP, the mean values of all QST parameters were within the 
95% confidence interval of the reference group (Fig. 6.1 B). This group’s dominant 
sensory characteristic was a gain of function for cold pain sensitivity primarily in the 
maximal pain area (p = 0.024) and in the foot (p = 0.008) (Fig. 6.1 B, Table 6.2). 
Two of the 8 patients with NSNAP recorded z-scores for CPT > 1.95 in the maximal 
pain area indicating a gain of function, and three patients demonstrated this gain in 
the dermatome and the foot (Table 6.3). There was a tendency for a loss of function 
in vibration detection in the maximal pain area (Fig. 6.1B), however this observation 
did not reach statistical significance (p = 0.064) (Table 6.2). Two of the 8 patients 
recorded z-scores of < -1.95 indicating a loss of function for VDT in the maximal 
pain area (Table 6.3). WUR was present in all examined body regions (Table 6.2). 
No patients demonstrated DMA in any body region. PHS in the maximal pain area 
was reported twice by one patient and in the foot on three occasions by another 
patient. 
6.4.2.3 Patients with fibromyalgia 
Patients with FM demonstrated z-scores beyond the 95% confidence interval of the 
HC group for CPT and PPT in all body regions and for HPT in the maximal pain 
area and dermatome (Fig. 6.1C). Their sensory profiles were characterised 
predominantly by a gain of function, indicated by increased thermal and pressure 
sensitivity in all body regions (CPT, HPT, PPT p ≤ 0.005) and increased MPS in the 
maximal pain area (p = 0.026) and foot (p < 0.001) (Table 6.2). The following 
frequencies of z-scores were > 1.95 indicating a gain of function (order: maximal 
pain area; dermatome; foot) (Table 6.3): CPT (95%; 82%; 86%), HPT (86%; 68%; 
45%), MPS (32%; 18%; 36%), WUR (4%; 14%; 4%) and PPT (68%; 64%; 59%). In 
addition, patients with FM demonstrated signs of a loss of sensory function with 
elevated VDT in the maximal pain area (p = 0.009). Five patients with FM recorded 
z-scores < -1.95 for VDT indicating a loss of function. WUR was present in all 
examined body regions (Table 6.2). Three patients demonstrated DMA in the 
maximal pain area and dermatome and five patients demonstrated DMA in the foot. 
PHS was reported by one patient in the foot once.  
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6.4.3 Comparison of sensory profiles between groups and body regions 
Sensory profiles differed between groups and also between body regions. An 
ANCOVA of all QST data demonstrated group differences for all variables except 
MPT (Table 6.2). Differences in thermal detection thresholds, MDT and VDT were 
mainly driven by the loss of function seen in patients with cervical radiculopathy 
(Fig. 1). Differences in pain thresholds (CPT, HPT, PPT) and mechanical pain 
sensitivity (MPS) were mainly driven by the increased sensitivity to these stimuli in 
patients with FM.  
 
There were significant differences between tested body regions (Fig. 6.2, Table 6.2) 
with greater thermal and vibration sensation loss in the maximal pain area compared 
to the dermatome (CDT p = 0.031; WDT p = 0.049; VDT p < 0.001) and foot (CDT 
p = 0.002; WDT p = 0.029; VDT p = 0.017) and greater TSL threshold elevation in 
the maximal pain area compared to the foot (p = 0.017). MPS was less dominant in 
the maximal pain area (p = 0.022) and the dermatome (p = 0.002) compared to the 
foot. A significant group by region interaction was evident for CDT (P = 0.003) 
(Table 6.2; Fig. 6.2). Patients with cervical radiculopathy demonstrated significantly 
reduced CDT in the maximal pain area and the dermatome (Fig. 6.2A, B) when 
compared to HC and patients with NSNAP (Table 6.2). There was an association 
between anxiety and HPT in patients with FM, demonstrating higher anxiety scores 
and increased heat sensitivity. Higher depression scores in patients with FM were 
correlated with increased mechanical pain sensitivity. Gender had a significant effect 
on PPT measurements (group*gender p = 0.041). For comparison of PPT in the 
maximal pain area the inclusion of gender in the univariate analysis decreased the 
significance between all 4 groups from significant to non-significant. Further 
pairwise comparison between groups, including gender adjustment, demonstrated 
lowered PPT in patients with FM compared to HC (p = < 0.001) and compared to 
patients with NSNAP (p = 0.011). PPT measurements were significantly lower in 
female than males for all body regions (p < 0.001) 
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6.5 Discussion  
This study revealed differences in the somatosensory phenotype of patients with 
cervical radiculopathy and that of patients with NSNAP. Patients with cervical 
radiculopathy demonstrated a loss of function restricted to the maximal pain area and 
dermatome, evident by hypoaesthesia to non-nociceptive stimuli and to pressure 
pain. These deficits were not present in patients with NSNAP. Increased cold 
sensitivity occurred in both patient groups in their maximal pain area and foot, and 
was the main sensory characteristic in patients with NSNAP. Both neck-arm pain 
groups differed from patients with FM, the latter demonstrating a widespread gain of 
function in most nociceptive parameters and a localised loss of vibration sense in 
their maximal pain area.  
 
Concordant with our hypothesis, patients with cervical radiculopathy were 
characterised by localised sensory abnormalities in the maximal pain area (reduced 
thermal, mechanical and vibration detection) and dermatome (reduced thermal and 
vibration detection and pressure pain sensitivity), indicating a loss of small and large 
sensory fiber function. The presence of these negative sensory signs is indicative of 
peripheral neuronal damage and consistent with the presence of NeP components 
(Hansson 2002; Treede et al. 2008). Loss of function occurred in all primary sensory 
fibers tested (C, Aδ, Aβ), data consistent with previous findings in patients with 
peripheral nerve injuries (Kleggetveit and Jørum 2010) and in patients with lumbar 
radiculopathy (Nygaard and Mellgren 1998), although others studies of patients with 
lumbar radiculopathy report selective loss of function in Aδ fibers (Mosek et al. 
2001) or Aδ and Aβ fibers (Freynhagen et al. 2008). In contrast, Chien et al (Chien et 
al. 2008) did not find elevated CDT in tested areas representative of C6/7/8 
dermatome, but it is unclear if these areas correlated with each individual patient’s 
area of sensory loss. 
 
Patients with cervical radiculopathy demonstrated cold hypersensitivity in the 
maximal pain area, a common sequel of peripheral nerve injury (de Medinaceli et al. 
1997; Kleggetveit and Jørum 2010; Landerholm et al. 2010; Taylor et al. 2010) and 
has been demonstrated locally at the cervical spine in patients with cervical 
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radiculopathy (Chien et al. 2008). The clinical significance of our finding is unclear, 
as the group mean value for CPT fell within the 95% confidence interval of our HC 
group, fell within the DFNS reference data (Magerl et al. 2010) and was also below 
the value of defined cold hyperalgesia (≥ 15°) (Bennett et al. 2006). Nevertheless, 
when evaluating individual results 11 patients demonstrated cold hyperalgesia in 
their maximal pain area. A novel finding was cold hypersensitivity also occurring in 
the foot. Only two patients documented cold hyperalgesia in all body regions and 
only 4 patients showed cold hyperalgesia in both maximal pain area and foot. These 
data suggest a heterogeneity in our patient group i.e. sub-groups may exist within our 
cohort, consistent with data on patients with NeP (Baron et al. 2009; Maier et al. 
2010) and lumbar radiculopathy(Mahn et al. 2011). 
 
Mechanisms underlying cold evoked pain are still not fully understood (Belmonte et 
al. 2009; Viana 2009) and likely include both peripheral (Serra et al. 2009; Wasner et 
al. 2004) and central nervous mechanisms (Craig et al. 2000; Jørum et al. 2003; 
Woolf and Mannion 1999; Yarnitsky and Ochoa 1990). Cold hypersensitivity is not 
necessarily associated with the presence of pain or with nerve damage as evidenced 
in patients with painless peripheral nerve injuries (Kleggetveit and Jørum 2010), by 
patients with FM (Berglund et al. 2002; Blumenstiel et al. 2011; Hurtig et al. 2001; 
Klauenberg et al. 2008; Pfau et al. 2009) and by patients with depression without 
pain (Klauenberg et al. 2008). While psychological factors can enhance pain 
sensitivity (Rhudy and Meagher 2000), our patients with cervical radiculopathy 
demonstrated scores within the normal range for anxiety and depression and 
measurements of CPT were not affected by anxiety or depression. Summarized, the 
significance of the cold hypersensitivity in the foot in our patient cohort remains 
unclear.  
 
Contrary to Chien et al (Chien et al. 2008) who demonstrated widespread increased 
pressure sensitivity in patients with cervical radiculopathy, we did not observe 
mechanical hyperalgesia in our cohort. Apart from differences in body areas 
assessed, Chien et al’s patients demonstrated longer symptom duration (19.7 ± 14.2 
months) and higher disability on the NDI compared to our patients. It is possible that 
the chronicity of symptoms led to altered pain processing in the central nervous 
system, resulting in this hypersensitivity. In our study, 6 patients recorded z-scores > 
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1.96 in their pain area, indicating increased pressure pain sensitivity, and 5 patients < 
-1.96, indicating reduced sensitivity. This dichotomy of pressure pain sensitivity is 
consistent with likely sub-groups of patients with differing somatosensory profiles 
within a radiculopathy cohort, as demonstrated recently in patients with lumbar 
radiculopathy (Mahn et al. 2011). These data highlight the need for individual patient 
assessment in order to determine sensory phenotypes. 
 
Patients with NSNAP did not differ to HC except for the presence of cold 
hypersensitivity in their maximal pain area and foot. No comparative data exist for 
this patient cohort. Three patients with NSNAP used pain descriptors suggestive of 
NeP (spontaneous pain and burning) (Bennett 2001; Dworkin et al. 2007), and they 
all demonstrated a loss of function in vibration detection in their maximal pain area 
compared to HC. Then again, hyposensitivity towards vibration stimuli does not 
necessarily indicate neuronal damage and has been documented in patients with FM 
(Koroschetz et al. 2010) and chronic low back pain (Blumenstiel et al. 2011), 
possibly consistent with neuroplastic changes in the central nervous system. Also 
these findings are in line with tactile hypoaesthesia documented in non-NeP pain 
conditions (Geber et al. 2008; Leffler et al. 2000; Magerl and Treede 2004; 
Westermann et al. 2011). Similar to the radiculopathy group, the group mean for 
CPTs was within the 95% confidence interval of our HC group and other reference 
data (Magerl et al. 2010). Cold hypersensitivity was also observed in the foot, but no 
patient demonstrated cold hypersensitivity in all tested body regions. 
 
Patients with FM were characterised by a widespread gain of function in the majority 
of nociceptive parameters (thermal and pressure pain) and mechanical pain 
sensitivity in their maximal pain area and foot. While our finding of generalised 
increased pressure sensitivity is consistent with previous studies (Blumenstiel et al. 
2011; Klauenberg et al. 2008; Koroschetz et al. 2010; Kosek et al. 1996; Pfau et al. 
2009) and likewise that of increased cold and heat sensitivity (Berglund et al. 2002; 
Blumenstiel et al. 2011; Hurtig et al. 2001; Kosek et al. 1996), others did not report 
increased cold (Klauenberg et al. 2008) or heat sensitivity (Klauenberg et al. 2008; 
Pfau et al. 2009). Our demonstration of increased MPS in patients with FM 
corresponds with some (Blumenstiel et al. 2011), but not with others (Klauenberg et 
al. 2008; Pfau et al. 2009); similarly reduced vibration sense was demonstrated by 
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some (Koroschetz et al. 2010), but not others (Klauenberg et al. 2008; Pfau et al. 
2009). These differing observations are indicative of the heterogeneity of FM and the 
existence of various sub-groups (Giesecke et al. 2003; Hurtig et al. 2001; Rehm et al. 
2010). The demographic characteristics of our patients with FM were consistent with 
previous data (Gormsen et al. 2010; Wolfe et al. 2010). Our results point to a more 
generalised sensory discriminative dysfunction in patients with FM compared with 
our neck-arm pain groups. 
 
Both neck-arm pain groups shared similarities in their demographics and pain 
characteristics, except a larger proportion of patients with cervical radiculopathy 
were on medication compared to patients with NSNAP. While a possible influence 
of medication on pain sensitivity cannot be disregarded, both patient groups were 
similar in their measurements of cold hypersensitivity. Despite commonalities in 
clinical profiles of these two neck-arm pain groups a distinct difference in 
somatosensory profiles was shown. The sensory phenotype of sensory loss in 
patients with radiculopathy is likely reflective of the underlying pathology. Based on 
the recently proposed grading system of NeP (Treede et al. 2008), our patients with 
cervical radiculopathy fulfilled the definition of “definite” NeP. However, this does 
not exclude coexistent nociceptive pain and the presence of mixed pain (Baron and 
Binder 2004), considering the variations in profiles observed in our cohort. Patients 
with NSNAP would be classified as having “possible” or “probable” NeP, depending 
if cold hypersensitivity was regarded as a relevant sensory abnormality for the 
presence of NeP. 
 
Both neck-arm pain groups differed in their sensory phenotypes compared to patients 
with FM, where the somatosensory profile showed mainly increased pain sensitivity 
across nociceptive submodalities in almost all body regions. Such generalised 
heightened sensitivity was not present in our neck-arm pain patient groups and may 
point to differences in the underlying pain mechanisms. In the absence of evidence of 
tissue damage in FM, aberrations in pain inhibitory (Ingvar 2009; Julien et al. 2005; 
Lannersten and Kosek 2010) and pain facilitatory mechanisms (Lannersten and 
Kosek 2010) as well as central sensitisation/augmentation of sensory input (Banic et 
al. 2004; Desmeules et al. 2003; Staud et al. 2008) have been associated with 
enhanced pain sensitivity in FM.  
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Limitations of the study 
The group of patients with NSNAP was comparatively small and a type II error 
cannot be excluded. However, the recruitment of these patients proved to be 
extremely difficult. Out of 464 clinically examined patients with neck-arm pain, only 
8 fulfilled the inclusion criteria of our study. The prevalence of this pain condition 
may be overestimated. As QST parameters vary significantly over body areas (Rolke 
et al. 2006b), comparative HC reference data have to be obtained for all body regions 
that are examined in patients. Numerous researchers have reported similar 
difficulties in this matter (Blumenstiel et al. 2011; Landerholm et al. 2010; Maier et 
al. 2010). Whilst we were able to obtain age matched HC data for all assessed body 
regions, we were not able to gender match these data. The size of some HC reference 
groups was small (n = 8), thus these reference data should not be referred to as 
‘normative’ data. 
 
A further limitation of this study relates to the fact that the experts’ patient 
classification was based on reading notes only and not on a clinical assessment of the 
patient. However while the study design could be strengthened by the experts 
examining the patient, this was not possible for logistic and ethical reasons. 
Assessment by three practitioners would have imposed a considerable burden on the 
patients plus repeated assessment could potentially cause a flare-up of the patient’s 
pain condition raising ethical concerns. 
 
It has been suggested that in patients with unilateral pain, a side-to-side comparison 
of QST data enhances the sensitivity to detect sensory abnormalities (Rolke et al. 




Despite similarities in pain characteristics and sensory signs between the patients 
with cervical radiculopathy and NSNAP, distinct somatosensory profiles were 
demonstrated for each group, possibly reflecting differences in the underlying 
pathophysiology, pain types and associated pain mechanisms. Our data suggest the 
possible presence of sub-groups with differing somatosensory profiles within these 
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two neck-arm pain patient groups. The findings of this study may assist clinicians in 
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7.1 Abstract 
This study investigated in patients with unilateral painful cervical radiculopathy and 
patients with unilateral non-specific neck-arm pain associated with heightened nerve 
mechanosensitivity (NSNAP) side-to-side differences of quantitative sensory testing 
(QST) parameters and the presence of neuropathic pain (NeP) components, using 
QST and the painDETECT (PD-Q) NeP screening questionnaire. All patients 
completed the PD-Q prior to QST. QST was performed in the maximal pain area and 
the affected dermatome in 23 patients with painful C6 or C7 cervical radiculopathy 
and 8 patients with NSNAP following a C6/7 dermatomal pain distribution. Patients 
with cervical radiculopathy demonstrated a significant loss of function in mechanical 
(p ≤ 0.027) and vibration sense (p ≤ 0.002) on the symptomatic side compared to the 
asymptomatic side in both tested body regions and in cold detection (CDT p = 0.019) 
and pressure pain sensitivity (PPT p = 0.001) in the dermatome, findings consistent 
with nerve root damage. Thermal detection was reduced bilaterally, consistent with a 
loss of function. These sensory alterations in the maximal pain area/symptomatic 
side are confirmative for the presence of NeP. In contrast to these QST data, only 
30% of patients with cervical radiculopathy demonstrated a NeP component 
according to the PD-Q score. In patients with NSNAP, a significant side-to-side 
difference was demonstrated for warm detection threshold in the dermatome. The 
PD-Q score indicated that NeP components were unlikely in this group. In 
conclusion, QST data suggest that NeP is common in patients with painful cervical 




Quantitative sensory testing (QST) has been recommended for accurate sensory 
profiling in the assessment of patients with NeP (Haanpää et al. 2011). Using 
laboratory QST in patients with painful cervical radiculopathy and comparison to 
reference data, we recently demonstrated a loss of function to non-nociceptive 
stimuli (thermal, mechanical, vibration detection) in the maximal pain area and the 
affected dermatome (thermal detection, vibration detection) and to nociceptive 
stimuli (pressure pain) in the dermatome, plus a gain of function (cold sensitivity) in 
the maximal pain area. These findings are indicative of peripheral neuronal damage 
and the presence of a NeP component (Haanpää et al. 2011; Treede et al. 2008). In 
contrast, patients with non-specific neck-arm pain (no clinical signs of 
radiculopathy) associated with heightened nerve mechanosensitivity (NSNAP) were 
characterised by a gain of function of a single sensory parameter, cold 
hypersensitivity in their maximal pain area. Heightened nerve mechanosensitivity is 
defined as pain in response to upper limb movement that causes nerve elongation 
(Elvey 1997). Our findings suggest that the mix of nociceptive and NeP components 
varies between these groups. Determination of the “pain mix” is of therapeutic 
relevance (Baron and Tölle 2008), as NeP in particular requires targeted 
management.  
 
In order to investigate further the “pain mix” for each patient group, a side-to-side 
comparison of QST data within each group is recommended (Hansson et al. 2007; 
Rolke et al. 2006a), as patients may have presented with subtle sensory alterations 
not identifiable by comparison to our reference data. Such side comparison is in line 
with standard clinical examination of patients with unilateral pain presentations and 
is considered crucial to establish clinically-relevant abnormalities (Haanpää et al. 
2011). 
 
Further, the use of NeP screening tools for identification of NeP components has 
been recommended (Haanpää et al. 2011). The painDETECT (PD-Q) (Freynhagen et 
al. 2006a), a validated self reported NeP screening tool, has increasingly been 
employed for the identification of NeP in patients with low back and leg pain (Beith 
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et al. 2011; Freynhagen et al. 2006a; Kaki et al. 2005; Prout et al. 2010), however, its 
usefulness in the screening of NeP in patients comparable to our cohorts, has not 
been reported. 
 
Using three assessment tools (previous established QST findings, side-to-side 
difference and PD-Q) this study aimed to further characterise patients with cervical 
radiculopathy and patients with NSNAP and to investigate the presence of NeP 
components in these groups. We hypothesized that: 
1. in patients with cervical radiculopathy, there would be a significant side-to-
side difference between the symptomatic and asymptomatic side in the 
previously documented sensory alterations (hypoaesthesia to non-nociceptive 
stimuli and cold hypersensitivity) in their maximal pain area and the affected 
dermatome (hypoaesthesia to non-nociceptive stimuli and pressure pain),  
2. in patients with NSNAP, there would be a significant side-to-side difference 
between the symptomatic and asymptomatic side in the previously 
documented cold hypersensitivity in their maximal pain area, with greater 
cold hypersensitivity on the symptomatic side, 
3. patients with cervical radiculopathy would be more likely to present with 
NeP components and therefore to score higher on the PD-Q than patients with 
NSNAP. 
4. there would be an association between the clinical parameters of average pain 
intensity over the last 4 weeks and symptom duration and QST parameters 
and PD-Q. 
 
7.3 Materials and methods 
7.3.1 Participants 
Twenty-three patients with painful C6 or C7 cervical radiculopathy (8 female; mean 
age 46.3 ± 9.6 years) and 8 patients with NSNAP following a C6/C7 dermatomal 
distribution (7 female; mean age 45.1 ± 14.9 years) participated in the study. Patients 
were recruited from private clinics and departments of various disciplines 
(physiotherapy, pain management, neurosurgery) at five local metropolitan hospitals 
in Perth, Western Australia, and from the local community via radio and newspaper 
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advertising (see flow chart of recruitment Fig.7.1). All referrals of patients with 
neck/upper limb symptoms to the neurosurgery triage clinic received between 
September 2007 and November 2010 were reviewed by the investigator (author BT). 
Patients in whom the referral indicated the possible presence of a unilateral nerve 
lesion/disease were selected and were clinically examined. For inclusion into the 
study, all participating patients were required to fulfill the inclusion criteria of 
unilateral neck pain and arm pain/paraesthesia in a C6/7 distribution, symptom 
duration of 3 to 18 months and current pain intensity ≥ 2 on a visual analogue scale 
(VAS). Patients with cervical radiculopathy were required to demonstrate signs of 
either C6 or C7 nerve root dysfunction with neurological deficits consistent with the 
affected nerve root level and with compressive radiculopathy (either absent or 
diminished reflexes and/or myotomal weakness and dermatomal sensory deficits of 
light touch and/or vibration sense). Additionally, patients were required to have a 
demonstrable clinically relevant abnormality on imaging studies (Bono et al. 2011; 
Treede et al. 2008) that indicated compromise of the exiting nerve root at the 
relevant spinal level. Inclusion criteria for patients with NSNAP were no clinical 
signs of radiculopathy and evidence of increased peripheral nerve sensitivity to 
mechanical stimuli (Elvey 1997), including pain in response to a nerve provocation 
test in the upper limb (NPTMEDIAN) (Elvey 1997). Exclusion criteria for both groups 
were: evidence of a metabolic or a medical disease; other neurological or psychiatric 
disease; a history of cardiovascular disease; and an insufficient level of English.  
 
Prior to participation, all patients were examined by a highly qualified 
Musculoskeletal Physiotherapist (Master qualification) who had extensive clinical 
experience in triaging patients with suspected nerve lesions and associated NeP to 
ascertain they met the inclusion criteria (BT). The assessment included the patient’s 
history, pain drawings, pain description and pain behaviours, musculoskeletal and 
neurological examination and review of reports of diagnostic tests (imaging, nerve 
conduction studies). While all patients with cervical radiculopathy had undergone 
medical imaging (Computed tomography (CT) n = 1, magnetic resonance imaging n 
= 22), only two patients with NSNAP had a CT performed of the cervical spine. In 
these two patients, CT did not demonstrate any abnormality indicating compromise 
of a nerve root at the relevant spinal level. The diagnostic classification of both 
patient groups was verified by a Fellowship-trained spinal neurosurgeon and a 
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Fellowship–qualified (Fellow of the Australian College of Physiotherapists) 
Specialist in Musculoskeletal Physiotherapy, both of whom were blinded to the 
clinician’s patient classification. Each Fellow independently reviewed the patient 
notes and the results of any medical investigations. Only patients whose clinical 
presentation was confirmed by all three examiners were included in the data analyses 
(see Fig. 7.1).  
 
HC data from our previous study was used to transform QST raw scores into z-
scores. The HC group, consisting of 31 age-matched subjects (15 female, 45.6 ± 12.5 
years), was recruited from the local community. Subjects with a history of current 
pain or a chronic pain condition, or any of the additional exclusion criteria described 
for the patient groups, were excluded (including taking medications known to 
influence pain perception). The study protocol and recruitment procedures were 
approved by the local Ethics Committees of all participating institutions and adhered 



























A battery of questionnaires was used to clinically characterise the patient groups. 
This battery was administered immediately before the QST. All patients completed 
the short form-36 health questionnaire (SF-36v2®) (Ware 2000) to assess health-
related quality of life. The Hospital Anxiety and Depression Scale (HADS) 
(Zigmond and Snaith 1983) was used to screen for anxiety and depression, with two 
outcome scores generated, each with a maximum score of 21 for each parameter. 
Scores of ≤ 10 for each are considered within normal range. Sleep quality over the 
last week was recorded on a 100-cm VAS with the end points 0 cm (good sleep) and 
10 cm (bad sleep) (Hurtig et al. 2001). In addition, to assess fear avoidance 
behaviours, patients completed the Tampa Scale of Kinesiophobia (TSK) (Vlaeyen et 
al. 1995). This questionnaire contains 17 items that relate to fear of movement and 
fear of (re) injury. A score ≥ 40 is considered to indicate significant kinesiophobia 
(Crombez et al. 1999). The Neck Disability Index (NDI) (Vernon and Mior 1991) 
was used to assess the level of patient disability. It is a well-validated ten-item 
questionnaire (Pietrobon et al. 2002; Vernon 2008). Scores of < 4 indicate no 
disability, 5 – 14 mild disability, 15 – 25 moderate disability, 25 – 34 severe 
disability, and > 35 complete disability (Vernon and Mior 1991). The average pain 
intensity over the last week was determined using a VAS with the end points 0 cm 
(no pain) and 10 cm (maximum tolerable pain) (Jensen et al. 1989). The strongest 
and average pain intensity over the last four weeks was recorded on a numeric rating 
scale (NRS) (0 = no pain, 10 = maximum pain) as part of the PD-Q (Freynhagen et 
al. 2006a). The PD-Q (Freynhagen et al. 2006a) consists of one descriptor relating to 
temporal and one to spatial pain characteristics and of seven weighted sensory 
descriptors. The lowest weight for each descriptor is 0, indicating that the person 
does not experience the relevant sensation, and the highest weight is 5, indicating the 
sensation is felt very strongly. PD-Q classifies patients into three groups, defined by 
Freynhagen et al as follows (Freynhagen et al. 2006a): the result is negative = a NeP 
component is unlikely (score 0 – 12), the result is unclear = the result is ambiguous, 
however a NeP component can be present (score 13 – 18), or the result is positive = a 
NeP is likely (score 19 – 38). 
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7.3.3 Quantitative sensory testing 
The standardised QST protocol of the German Research Network on Neuropathic 
Pain (DFNS) was employed using the same equipment and standardised instructions 
as outlined by Rolke et al (Rolke et al. 2006a; Rolke et al. 2006b). The test battery 
comprised the following assessments: cold and warm detection thresholds (CDT, 
WDT); the number of paradoxical heat sensations (PHS) during the procedure of 
alternating warm and cold stimuli (thermal sensory limen (TSL)); cold and heat pain 
thresholds (CPT, HPT); mechanical detection threshold (MDT); mechanical pain 
threshold (MPT); stimulus-response functions: mechanical pain sensitivity (MPS) 
and dynamic mechanical allodynia (DMA); wind-up ratio (WUR); vibration 
detection threshold (VDT) and pressure pain threshold (PPT). For complete 
description see Rolke et al (Rolke et al. 2006a; Rolke et al. 2006b). 
 
QST was performed over the maximal pain area, as indicated by the patients 
(radiculopathy group: upper trapezius muscle n = 4; paravertebral cervical spine n = 
2; paravertebral thoracic spine n = 7; above and below spine scapula n = 2; upper 
arm n = 5; forearm n = 2; just above the elbow n = 1; NSNAP group: upper trapezius 
muscle n = 6; paravertebral thoracic spine n = 2), and the corresponding contralateral 
mirror side. Twenty-six HC subjects were assessed bilaterally in the upper trapezius 
muscle. Thirteen of these subjects were assessed bilaterally in the C6 (thenar 
eminence) and the remaining 13 in the C7 (dorsum hand, n = 13) dermatome. Eight 
HC, including 3 from the trapezius group, were examined unilaterally in all other 
pain areas. Consequently data were available from at least eight health control 
subjects to standardise the patient data in accordance with established methodology 
to standardise the data (Blankenburg et al. 2010). In patients with cervical 
radiculopathy, additional testing was conducted in the exact dermatomal area of 
sensory loss as determined during clinical examination, and for patients with NSNAP 
in the area of distal paraesthesia or pain, plus in the contralateral side for both 
groups. While the QST in the dermatome does not give information about the 
presence of NeP components (Treede et al. 2008), it does assist to further 
characterise each patient group and to detect possible sensory alterations that may be 
indicative of a nerve root lesion. Testing was conducted by one investigator (BT) in a 
laboratory with a constant room temperature. The investigator was blind to the 
results of the questionnaires. As the clinical examination of patients and QST testing 
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were not necessarily performed on the same day, the key inclusion criteria for each 
group (for radiculopathy: signs of nerve root dysfunction, for NSNAP absence of 
nerve root dysfunction and presence of heightened nerve mechanosensitivity) were 
reassessed prior to QST. Patients were asked not to take any analgesics on the day of 
testing. 
7.3.4 Nerve provocation test (NPTMEDIAN) 
The NPTMEDIAN was performed after the QST as described previously (van der Heide 
et al. 2006). The range of elbow extension was measured with an electro-goniometer 
(SG110, Biometrics Ltd, United Kingdom). The patient was asked to press an 
external trigger at the first onset of pain or at the increase of their resting pain (P1) if 
present, and at a second time point when the patient reached their pain tolerance (P2) 
for this movement. Elbow extension was performed to the end of joint range or to 
P2, whichever occurred first. The NPTMEDIAN was performed three times on each 
side and the mean value of three recordings of P1 and P2 was used for analysis. 
Patients who did not report consistently an onset of P1 or P2 in all three trials (i.e. 
they reported an onset in only 1 or 2 trials) were excluded from the analysis (P1 
asymptomatic side n = 3). Four patients with cervical radiculopathy could not be 
tested due to high pain levels and the associated potential for exacerbation of their 
condition. 
7.3.5 Statistical analysis 
SPSS version 17.0 was used for all analyses. An independent T-test was used to 
compare symptom duration, pain intensity, sleep quality, the NDI, TSK and PD-Q 
scores between patient groups. Anxiety and depression scores and the physical and 
mental component summary scores of the SF-36 were compared using the Mann-
Whitney-U Test.  
 
All QST data except HPT and VDT were normally distributed in log-space and were 
log-transformed prior to statistical analysis (Rolke et al. 2006b). Each single QST 
parameter was then z-transformed by using the following expression: Z-score = 
(Xsingle proband – Meanhealthy controls)/SDhealthy controls (Rolke et al. 2006b). This procedure 
provides a site-specific normalisation of QST data for each tested symptomatic body 
region (Rolke et al. 2006b), based on our obtained HC group data (data from the 
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trapezius muscle and dermatomes with left and right body sides pooled). For clarity 
of data presentation, the sign of the resulting z-score was adjusted to reflect the 
individual patient’s sensitivity for each parameter. Z-values above ‘0’ indicated a 
gain of function, meaning the patient was more sensitive to the tested stimulus 
compared with HC, a z-value below ‘0’ indicated a loss of function, pointing to 
reduced sensitivity of the patient. Within each group, z-score QST data were 
compared between sides using a paired T-test, and responses to the NPTMEDIAN using 
Wilcoxon Signed Ranks Test. To examine associations between QST and clinical 
parameters Pearson’s correlations were performed within each group for each of the 
QST parameters (measured in maximal pain area, symptomatic side) and clinical 
parameters (symptom duration, average pain intensity over the last four weeks, PD-Q 
score). Significance was accepted at p < 0.05 for all analyses. 
7.4 Results 
7.4.1 Patient characteristics 
Eleven patients presented with a C6 radiculopathy and 12 patients with a C7 
radiculopathy. In the patients with NSNAP, one patient presented with pain in a C6 
dermatomal distribution and 7 patients with pain in a C7 dermatomal distribution. 
The patients’ pain descriptors are documented in Table 7.1. Both patient groups 
demonstrated clinical signs of heightened nerve mechanosensitivity in the 
symptomatic arm, indicated by a significant side-to-side difference in the range of 
motion of elbow extension deficit at the onset of P1 (p < 0.03) and P2 (p < 0.013) 
between arms (Table 7.2). In both groups, the pain onsets occurred much earlier in 
range in the symptomatic arm compared to the asymptomatic arm. 
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Table 7.1  
Percentage* of all pain descriptors volunteered by patients with 
cervical radiculopathy and patients with non-specific neck-arm pain  
associated with heightened nerve mechanosensitivity (NSNAP) for 
their neck pain and arm pain.  
 Cervical radiculopathy 
(n = 23) 
NSNAP 
(n = 8) 
 Neck pain Arm pain Neck pain Arm pain 
Constant, n 17 (74%) 11 (48%) 5 (62%) 3 (38%) 
Intermittent, n 6 (26%) 12 (52%) 3 (38%) 5 (62%) 













Burning#, n 6 (26%) 7 (30%) 5 (62%) 2 (25%) 
Shooting, n  5 (22%)  2 (25%) 
Electric shock#, n 1 (4%) 3 (13%)   
Nerve pain, n    2 (25%) 
Dead#, n  3 (13%)  2 (25%) 
Numbish#, n 1 (4%)  1 (12%)  
Ache, n 10 (43%) 6 (26%) 3 (37%) 1 (12%) 
Dull, n 7 (30%) 4 (17%)   
Sharp, n 6 (26%) 3 (13%) 1 (12%)  
Heavy, n  2 (9%)   
Deep, n 2 (9%) 2 (9%) 1 (12%) 2 (25%) 
Pain, n 2 (9%) 3 (13%)   
Sore, n 1 (4%)  2 (25%)  
Muscle pain, n 1 (4%)    
Throbbing, n 1 (4%)    
Common descriptors for neuropathic pain are highlighted in grey.  
#Descriptor consistent with descriptor in painDETECT. 
◊Descriptor obtained through specific questioning  
*The percentages do not add to 100% as some patients used several descriptors  




Elbow extension ROM deficit at onset of pain (P1) and at the limitation of  
movement due to pain (P2) in the asymptomatic and symptomatic arm in  
patients with cervical radiculopathy (CxRAD) and patients with non-specific  
neck-arm pain with associated heightened nerve mechanosensitivity (NSNAP).  
Data are presented as medians with interquartile range (IQR). 
 CxRAD◊ NSNAP 
 Asymptomatic Symptomatic Asymptomatic Symptomatic 
P1 (°) 0.0 (24.7)a 23.9 (32.4)* c 25.3 (44.2)b 40.9 (32.0)*  
P2 (°) 0.0 (0.0)c 12.3 (33.1)* c 0.0 (30.8) 34.7 (32.1)*  
◊4 missing cases. 
*Significantly different to asymptomatic side (p < 0.05). 





There were no significant differences between patient groups in age, symptom 
duration, pain intensities, sleep quality, anxiety and depression scores, physical and 
mental components of the SF-36, fear avoidance behaviour and scores on the NDI 
(Table 7.3). NDI scores reflected moderate disability for patients with cervical 
radiculopathy and mild disability for patients with NSNAP. A larger proportion of 




Table 7.3  
Demographics and profiles of patients with cervical radiculopathy (CxRAD) and  
patients with non-specific neck-arm pain associated with heightened nerve  
mechanosensitivity (NSNAP). 
 CxRAD 
(n = 23) 
NSNAP 
(n = 8) 
p 
 
Age (years)* 46.3 (9.6) 45.1 (14.9) 0.833 
Gender (female, n) 8 7  
Symptom duration (months)* 7.6 (4.1) 8.1 (3.0) 0.766 
Average pain intensity during last week (VAS)* 5.2 (2.0) 6.0 (1.5) 0.277 
Maximal pain intensity during last 4 weeks  
(NRS 0-10)* 
7.2 (2.2) 7.6 (0.6) 0.686 
Average pain intensity during last 4 weeks  
(NRS 0-10)* 
5.0 (2.1) 5.1 (0.6) 0.914 
Sleep quality during last week (VAS)*  5.3 (2.7) 5.9 (2.2) 0.591 
Hospital Anxiety and Depression Scale  
Anxiety score (HADS)# 6.0 (5.0) 8.0 (4.2) 0.295 
Within normal range (≤ 10), n  21(91%) 6 (75%)  
Depression score (HADS)# 3.0 (4.0) 3.5 (5.5) 0.982 
Within normal range (≤ 10), n  21 (91%) 8 (100%)  
SF-36    
Physical Component# 40.6 (12.6) 46.4 (12.0) 0.121 
Mental Component# 52.3 (17.4) 48.4 (20.5) 0.187 
Neck Disability Index* 16.2 (7.7) 13.4 (5.9) 0.351 
Tampa Scale of Kinesiophobia* 40.9 (8.1) 36.7 (7.5) 0.211 
painDETECT* 17 (5) 12 (6) 0.038 
Negative: NeP component unlikely, n 2 (9%) 4 (50%)  
Unclear: result ambigious, n 14 (61%) 3 (37%)  
Positive: NeP component likely, n 7 (30%) 1 (12%)  
Patients with medication, n  15 (65.2%) 3 (37.5%)  
Current medication◊    
Selective serotonin reuptake inhibitor, n  1 (4.3%) 1 (12.5%)  
Serotonin-norepinephrine reuptake inhibitor, n 2 (8.7%)   
Tricyclic antidepressant, n 1 (4.3%)   
Antiepileptics, n 2 (8.7%)   
Opioids, n 4 (17.4%)   
Benzodiazepine, n 2 (8.7%)   
Analgesics, n 7 (30.4%) 1 (12.5%)  
Non-steroidal anti-inflammatories, n 7 (30.4%) 2 (25%)  
*Data are mean (SD); #Data are median (IQR); ◊Multiple answers possible. 
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7.4.2 Side-to-side comparison of QST sensory profiles 
Z-score QST sensory profiles of the symptomatic and asymptomatic arms are 
illustrated for each group (cervical radiculopathy Fig 7.2, NSNAP Fig 7.3) in the 
maximal pain area and the dermatome. Healthy controls are represented by a z-score 
of “zero”. In both groups all QST parameters fell within the 95% confidence interval 
of our HC data (i.e. z-score > -1.96 or < 1.96 standard deviation).  
7.4.2.1 Patients with cervical radiculopathy 
In patients with cervical radiculopathy, in the maximal pain area vibration and 
mechanical detection sense were significantly reduced on the symptomatic side 
compared to the asymptomatic side (VDT: p = 0.002; MDT: p = 0.027) (Table 7.4, 
Fig 7.2A). Side-to side comparisons of all other QST parameters in the maximal pain 
area were not significant. In the dermatome, there was a loss of function on the 
symptomatic side in cold detection (CDT: p = 0.019), mechanical detection (MDT: p 
= < 0.001), vibration detection (VDT: p = 0.001) and pressure pain sensitivity (PPT: 
p = 0.011) (Table 7,5, Fig 7.2B). There were no side-to-side differences in any other 
QST parameters. Reports of DMA and PHS were infrequent. One patient with 
cervical radiculopathy demonstrated DMA bilaterally in the maximal pain area and 
on the symptomatic side in the dermatome. PHS was reported by one patient once in 
the maximal pain area on the symptomatic side, and by a different patient once on 
the asymptomatic side. Two patients reported PHS once on the asymptomatic side of 
the dermatome. 
7.4.2.2 Patients with NSNAP 
In patients with NSNAP, in the dermatome, the side-to-side comparison 
demonstrated a significant loss of function on the symptomatic side in WDT (p = 
0.029) (Table 7.5). No other side-to-side comparisons were statistically different. In 
the maximal pain area, there was no side-to-side difference in any QST parameter 
(Table 7.4). No patient with NSNAP demonstrated DMA in any body region. PHS 
was reported by one patient twice on the symptomatic side in the maximal pain area. 
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7.4.3 Correlations between QST and clinical parameters 
In patients with cervical radiculopathy, MDT and VDT in the maximal pain area 
correlated significantly with the average pain intensity over the last 4 weeks (MDT: r 
= 0.418, p = 0.047; VDT: r = -0.491, p = 0.017), indicating the higher the pain 
intensity, the greater the loss of mechanical and vibration detection. The PD-Q score 
correlated significantly with the average pain intensity over the last 4 weeks (r = 
.517, p = 0.011). Symptom duration was not correlated with any measurement. In 
patients with NSNAP, symptom duration correlated significantly with HPT measured 
in the maximal pain area (r = -.770, p = 0.025), the longer the symptom duration, the 
lower the HPT (increased heat sensitivity). Neither average pain intensity over the 
last 4 weeks nor the PD-Q score were correlated with any QST parameter. 
7.4.4 Responses to painDETECT 
Patients with cervical radiculopathy had a significantly higher score on the PD-Q 
compared to patients with NSNAP (Table 7.3). Seven patients (30%) with cervical 
radiculopathy reported a score of ≥ 19, indicating the ‘likely’ presence of NeP (Table 





Figure 7.2 Z-score sensory profiles of the symptomatic (filled circle symbol) and 
asymptomatic (empty square symbol) side in patients with cervical radiculopathy (CxRAD) 
in the maximal pain area (A) and dermatome (B). Error bars indicate the standard error of 
measurement. Healthy control subjects are represented by a z-score of “zero”. CDT: cold 
detection threshold; WDT: warm detection threshold; TSL: thermal sensory limen; CPT: 
cold pain threshold; HPT: heat pain threshold; MDT: mechanical detection threshold; MPT: 
mechanical pain threshold; MPS: mechanical pain sensitivity; WUR: wind-up ratio; VDT: 












Figure 7.3 Z-score sensory profiles of the symptomatic (filled circle symbol) and 
asymptomatic (empty square symbol) side in patients with non-specific neck-arm pain 
associated with heightened nerve mechanosensitivity (NSNAP) in the maximal pain area (A) 
and dermatome (B). Error bars indicate the standard error of measurement. Healthy control 
subjects are represented by a z-score of “zero”. CDT: cold detection threshold; WDT: warm 
detection threshold; TSL: thermal sensory limen; CPT: cold pain threshold; HPT: heat pain 
threshold; MDT: mechanical detection threshold; MPT: mechanical pain threshold; MPS: 
mechanical pain sensitivity; WUR: wind-up ratio; VDT: vibration detection threshold; PPT: 




Table 7.4 QST parameters are shown for the maximal pain area in the symptomatic and asymptomatic sides of patients with cervical  
radiculopathy (CxRAD) and patients with non-specific neck-arm pain associated with heightened nerve mechanosensitivity (NSNAP). Data  
are shown as mean for untransformed data (HPT, VDT) and retransformed mean for log-normally distributed data. 
 MAXIMAL PAIN AREA 
 Cervical radiculopathy  NSNAP 
QST Parameters Asymptomatic side Symptomatic side p  Asymptomatic side Symptomatic side p 
CDT (°C) 1.86 1.89 0.767  1.12 1.16 0.803 
WDT (°C) 3.45 3.83 0.209  2.28 2.64 0.536 
TSL (°C) 5.51 6.22 0.132  3.94 4.17 0.664 
CPT (°C) 9.10 11.16 0.069  10.50 12.16 0.294 
HPT (°C) 45.9 45.4 0.386  45.3 45.1 0.736 
MDT (mN) 2.10 3.79 0.027  1.57 1.37 0.555 
MPT (mN) 23.75 29.85 0.376  19.87 28.10 0.352 
MPS (NRS100) 0.53 0.45 0.328  1.01 0.77 0.166 
WUR (ratio) 2.68a 2.81a 0.579  2.49 2.98 0.548 
VDT (x/8) 5.9 5.4 0.002  5.2 5.2 0.864 
PPT (kPa) 434 403 0.248  366 390 0.290 
an = 18 
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Table 7.5 QST parameters are shown for the dermatome in the symptomatic and asymptomatic sides of patients with cervical radiculopathy  
(CxRAD) and patients with non-specific neck-arm pain associated with heightened nerve mechanosensitivity (NSNAP). Data are shown as mean 
for untransformed data (HPT, VDT) and retransformed mean for log-normally distributed data. 
 DERMATOME 
 Cervical radiculopathy  NSNAP 
QST Parameters Asymptomatic side Symptomatic side p  Asymptomatic side Symptomatic side p 
CDT (°C) 2.12 2.68 0.019  1.43 1.55 0.405 
WDT (°C) 3.43 4.17 0.118  2.25 3.14 0.029 
TSL (°C) 6.15 6.87 0.269  4.2 5.11 0.121 
CPT (°C) 7.56 8.08 0.625  8.4 7.80 0.709 
HPT (°C) 45.6 46.1 0.586  46.2 46.4 0.720 
MDT (mN) 1.18 4.53 <0.001  2.26 2.65 0.683 
MPT (mN)  70.91 84.45 0.465  36.13 34.90 0.867 
MPS (NRS100) 0.39 0.34 0.400  0.84 0.74 0.517 
WUR(ratio) 2.01a 2.45a 0.358  2.04 2.15 0.620 
VDT(x/8) 7.0 6.2 0.001  6.6 6.6 0.926 
PPT (kPa) 492 572 0.011  405 417 0.211 
an = 14
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7.5 Discussion  
This study investigated differences in QST parameters between symptomatic and 
asymptomatic sides and the presence of NeP components in patients with cervical 
radiculopathy and patients with NSNAP, using QST and the PD-Q. In patients with 
cervical radiculopathy, QST findings demonstrated a significant loss of function 
mediated by non-nociceptive sensory fibers in the painful innervation territory of the 
affected nerve root on the symptomatic side compared to the asymptomatic side, 
findings consistent with the characteristics of NeP (Haanpää et al. 2011). The PD-Q 
identified 30% of patients with cervical radiculopathy demonstrating the likely 
presence of NeP. The significant loss in the affected dermatome of cold, mechanical 
and vibration detection and pressure sensitivity, provide data further supporting the 
presence of nerve root damage. In patients with NSNAP, the absence of significant 
side-to-side differences in any QST parameters in the maximal pain area and the 
results of PD-Q suggest that NeP components were unlikely in this group.  
 
Concordant with our hypothesis, patients with cervical radiculopathy demonstrated 
significant side-to-side differences in mechanical and vibration detection in their 
maximal pain area, the symptomatic side being less sensitive to the stimuli than the 
control side. The hypoaesthesia on the symptomatic side is consistent with a loss of 
function due to nerve root damage and with the presence of NeP components (Treede 
et al. 2008). QST data in cervical radiculopathy is scarce, with only one study 
profiling this patient group (Chien et al. 2008), and findings demonstrated bilateral 
cold and pressure pain hypersensitivity in the cervical spine area. Comparison of our 
data to these findings is limited, as the majority of our patients did not have their 
maximal pain area in the cervical spine, plus the cervical spine area tested in the 
Chien et al study (Chien et al. 2008) did not necessarily reflect the maximal pain area 
of these patients. We documented previously that our patients with cervical 
radiculopathy demonstrated increased cold sensitivity in the maximal pain area 
compared to HC subjects. In the current study, although we did not detect a 
significant difference for CPT between sides, the difference approached significance 
(p = 0.069).  
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We have also previously reported a significant loss of thermal detection sense (CDT, 
WDT, TSL) in the maximal pain area compared to HC. Our current data indicate 
thermal hypoaesthesia occurred bilaterally. Contralateral thermal hypoaesthesia has 
been observed in patients with unilateral traumatic partial nerve injury (Leffler and 
Hansson 2008) and with unilateral traumatic trigeminal neuropathy (Jääskeläinen et 
al. 2005). In the latter study, contralateral thermal hypoaesthesia was associated with 
the presence of ipsilateral NeP. This phenomenon was explained by “means of 
increased inhibition or disturbed excitatory connections within the central pathways 
mediating non-noxious thermal information from the contralateral side” 
(Jääskeläinen et al. 2005), this explanation reportedly being in line with peripheral 
nerve damage induced central plasticity (Davis et al. 2011). 
 
The side-to-side analysis of QST data in the dermatome of patients with cervical 
radiculopathy enhanced the sensitivity to detect a loss of Aβ function. MDT in the 
affected dermatome was not statistically different compared to HC, but was then 
compared to the asymptomatic arm, a finding that further supports the presence of 
nerve root damage. Our previously documented loss of thermal detection did not 
significantly differ in the present study from the asymptomatic side, except for CDT 
(difference 0.56º). The interpretation of what entails a clinically significant 
difference for thermal detection thresholds is inconsistent (Landerholm et al. 2010; 
Leffler and Hansson 2008; Rolke et al. 2006a; Treede and Baron 2008). Based on 
clinical judgment, some authors consider a side difference of ≥ ± 1º as pathological 
(Leffler and Hansson 2008), others argue a side difference ± 1º is within normal 
range (Rolke et al. 2006a; Treede and Baron 2008). The bilateral loss of thermal 
detection is consistent with findings in dermatomes of patients with cervical (Chien 
et al. 2008) and lumbar radiculopathy (Freynhagen et al. 2008; Nygaard and 
Mellgren 1998), but contrary to findings of others (Samuelsson and Lundin 2002; 
Zwart and Sand 2002; Zwart et al. 1998). The occurrence of bilateral alterations may 
limit the utility of side comparison of thermal detection testing as a diagnostic 
instrument for small nerve fiber function loss.  
 
A diagnostic grading system of certainty for the presence of NeP has recently been 
proposed, based on pain distribution and a history suggesting a relevant nerve lesion, 
the presence of sensory alterations in the innervation territory of the affected nerve 
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structure and confirmative evidence of a nerve lesion/disease from diagnostic tests 
(Treede et al. 2008). According to this grading system, our patient group with 
cervical radiculopathy demonstrated definite NeP, however this does not exclude the 
simultaneous presence of nociceptive pain. Other structures (e.g. joints, discs, 
muscles) are likely involved in contributing to nociceptive input and potentially 
impacting the total “pain experience”. In our current study, the likely presence of 
mixed pain (Baron and Binder 2004) as reported for patients with lumbar 
radiculopathy (Baron and Tölle 2008; Freynhagen et al. 2006b; Pérez et al. 2009), is 
reflected in the PD-Q scores and the self-volunteered pain descriptors. Patients used 
pain descriptors commonly identified for NeP (Dworkin et al. 2007), some of these 
matching the descriptors used in PD-Q, but patients also used descriptors commonly 
identified for nociceptive pain (Merskey and Bogduk 1994). The fact that 30% of our 
radiculopathy cohort reported a score of ≥ 19, and 65% reported a score ≥ 16, 
suggests that on the continuum between “purely nociceptive” and “purely 
neuropathic” pain (Horowitz 2007), some of these individuals were characterised by 
NeP components more than nociceptive pain. The PD-Q results match our QST data 
to some extent. At a group level, while patients with cervical radiculopathy 
demonstrated sensory changes in the painful innervation territory of the affected 
nerve root, we documented previously that the magnitude and frequency of these 
alterations differed between individuals. This variability highlights the importance of 
individual assessment for the identification of NeP components for patients with 
mixed pain syndromes and furthermore, that the PD-Q should not be used as a 
surrogate for clinical examination. 
 
Contrary to our hypothesis for patients with NSNAP, the previously established cold 
hypersensitivity on the symptomatic side of the maximal pain area was also evident 
on the asymptomatic side. No comparative data exists for this patient group. Bilateral 
cold hypersensitivity has been reported in patients with cervical radiculopathy and 
patients with whiplash associated disorders and has been interpreted to reflect 
augmented central pain processing mechanisms (Chien et al. 2008). Of interest, the 
graphed z-score QST profile (Fig. 7.3) gives the impression of a bilateral lowered 
vibration sense in patients with NSNAP. This was not statistically different between 
sides, nor was it significantly different compared to HC, thus it is not necessarily 
indicative of nerve damage. Hypoaesthesia to vibration has been documented in 
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patients with non-NeP pain (Blumenstiel et al. 2011; Koroschetz et al. 2010), in line 
with reduced tactile sensation in patients with non-NeP (Geber et al. 2008; Voerman 
et al. 2000; Westermann et al. 2011). With the exception of reduced warm detection 
in the symptomatic arm, where the difference between sides was < 1º and of doubtful 
clinical significance, we did not find any side differences for QST parameters in the 
dermatome in patients with NSNAP.  
 
The QST findings in our patients with NSNAP in the current study, do not suggest 
the presence of NeP components and on the whole this is in accordance with the PD-
Q score in this group, with the exception of one individual who scored >19. Apart 
from the descriptor ‘paraesthesia’ being used by all patients, a minority of patients 
used pain descriptors common to NeP. According to the grading system of NeP 
(Treede et al. 2008), and based on the pain distribution and history and the presence 
of cold hypersensitivity on the symptomatic side this patient group would be 
classified as having ‘probable’ NeP. The main characteristic for this group was the 
side-to-side difference in pain response to the NPTMEDIAN, which indicated a 
heightened pain response in the symptomatic arm. Our results suggest that the 
clinical presentation of heightened nerve mechanosensitivity and heightened pain 
responses to the NPTMEDIAN should not equate with the presence of a NeP 
component. It is important to emphasize however, that heightened nerve 
mechanosensitivity can coexist with nerve lesions and NeP, as demonstrated in our 
patients with cervical radiculopathy and another patient group (Chien et al. 2008).  
 
Our data (of the current and previous study), do suggest that this patient group with 
NSNAP does not meet the new definition of NeP, i.e. “pain caused by a lesion or 
disease of the somatosensory nervous system” (Jensen et al. 2011) as the 
combination of clinical examination findings, QST data and available diagnostic 
tests did not provide evidence for the presence of a nerve lesion.  
 
The sample size of our patient group with NSNAP was modest and this might limit 
the power to demonstrate significant side-to-side differences. Our initial sample size 
calculation, based on QST data by Rolke et al (Rolke et al. 2006a), estimated that a 
sample of 25 in each patient group was needed to detect clinically significant 
differences between the symptomatic and asymptomatic arm. Despite extensive 
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recruitment efforts over the period of three years, we were not able to recruit more 
patients fulfilling the criteria for NSNAP inclusion. Based on our recruitment 
strategy, and given the fact that many patients were recruited from a neurosurgery 




Although patients with cervical radiculopathy and patients with NSNAP have 
commonalities in their clinical pain pattern, the dominant pain type differs between 
patient groups, as indicated by the specific QST profiles and associated responses to 
the PD-Q. NeP components were more common in patients with cervical 
radiculopathy, whereas patients with NSNAP were characterised by predominantly 
nociceptive pain components. The side-to-side comparison of QST data enhanced the 
sensitivity to detect sensory alterations. Our somatosensory profiles for these clinical 
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8.1 Abstract 
The painDETECT questionnaire (PD-Q) has been used as a tool to characterise 
sensory abnormalities in chronic pain patients. This study investigated if the self-
reported somatosensory profile of patients with painful cervical radiculopathy and 
patients with fibromyalgia (FM), as characterised by responses to verbal sensory 
descriptors from PD-Q (sensitivity to light touch, cold, heat, slight pressure, feeling 
of numbness in the main area of pain), corresponded with the sensory phenotype as 
demonstrated by quantitative sensory testing (QST). Forty-five patients (28 females, 
46 ± 10 years) completed the PD-Q. Standardised QST of dynamic mechanical 
allodynia, cold and heat pain thresholds, pressure pain thresholds, mechanical and 
vibration detection thresholds (VDT) was recorded from the maximal pain area. 
Comparative QST data from 31 age-matched healthy controls (HC; 15 females) were 
obtained. Patients with radiculopathy demonstrated a match between their self-
reported sensory phenotype and QST sensory phenotype for all sensory descriptors 
except for sensitivity to light touch, and these matches were statistically significant 
compared to HC data. The FM group demonstrated discrepancies between the PD-Q 
and QST sensory phenotypes for all sensory descriptors, indicating that the self-




The traditional approach to classification and management of musculoskeletal and 
neuropathic pain (NeP) according to the aetiological condition has its limitations 
(Baron 2006; Jensen and Baron 2003). A mechanism, or symptom based 
classification approach, (Baron 2006; Jensen and Baron 2003; Woolf et al. 1998) has 
been proposed. This approach is based on the hypothesis that different clinical signs 
and symptoms reflect different underlying pathophysiological mechanisms of pain 
generation (Hansson 2002; Jensen and Baron 2003), with the ultimate aim to target 
treatment to the underlying pain mechanisms. The assessment of symptoms can be 
attained by means of questionnaires such as the Neuropathic Pain Symptom 
Inventory (NPSI) (Attal et al. 2008; Bouhassira et al. 2004; Rüger et al. 2008) and 
the painDETECT questionnaire (PD-Q) (Baron et al. 2009; Freynhagen et al. 2006; 
Mahn et al. 2011) and signs by quantitative sensory testing (QST) (Haanpää et al. 
2011). 
 
QST is a valuable research tool used to investigate clinical sensory phenotypes and 
to help interpret the pain mechanisms underlying associated clinical pain 
presentations (Aasvang et al. 2008; Chien et al. 2008; Taylor et al. 2010; Treede et 
al. 2008). As one specific symptom may be generated by several different underlying 
mechanisms (Woolf and Salter 2000), a combination of positive and negative 
sensory phenomena, namely a symptom profile, may better predict underlying pain 
mechanisms (Baron 2009; Cruccu and Truini 2009). In order to characterise the 
somatosensory profile of patients as precisely as possible, a sophisticated QST 
protocol has been developed comprising all of the somatosensory sub-modalities that 
are mediated by different primary afferents (C-, Aδ-, Aβ-) (Rolke et al. 2006a; Rolke 
et al. 2006b). Using this protocol, sub-groups of NeP patients with distinct 
somatosensory profiles within specific aetiologies have been identified (Maier et al. 
2010; Rolke et al. 2006a) and attempts have been made to correlate the specific 




The PD-Q was originally developed and validated as a screening tool to identify 
patients with likely NeP (Freynhagen et al. 2006), and has been employed in this 
capacity in various patient populations (Gwilym et al. 2009; Jespersen et al. 2010; 
Steegers et al. 2008). Recently it has also been used, as a tool to identify 
somatosensory profiles in patients with lumbar radiculopathy/radicular pain (Mahn et 
al. 2011), in patients with diabetic neuropathy and postherpetic neuralgia (Baron et 
al. 2009) and in patients with fibromyalgia (FM) (Amris et al. 2010; Rehm et al. 
2010). Patients with FM appear to demonstrate similarities to NeP patients in regard 
to their choice of sensory descriptors (Amris et al. 2010; Fishbain et al. 2008; Giske 
et al. 2009; Rehm et al. 2010) and their QST sensory phenotypes (Berglund et al. 
2002; Hurtig et al. 2001; Klauenberg et al. 2008; Kosek et al. 1996; Pfau et al. 2009; 
Staud et al. 2003; Staud et al. 2001). However this does not mean that FM is a NeP 
condition (Hansson et al. 2007; Martinez-Lavin 2007; Treede et al. 2008). Based on 
the responses to verbal sensory descriptors in PD-Q, the four studies (Amris et al. 
2010; Baron et al. 2009; Mahn et al. 2011; Rehm et al. 2010) were able to identify 
sub-groups of patients with distinct symptom profiles.  
 
The PD-Q contains questions relating to evoked pain (light touch, pressure, 
cold/heat) and numbness. However, whilst a correlation between self-reported 
responses to evoked pain (brushing, pressure, cold) and QST has been demonstrated 
for the NPSI questionnaire (Attal et al. 2008), no study to date has documented if 
patients’ subjective responses to sensory descriptors of PD-Q correspond with their 
sensory phenotypes as demonstrated using QST.  
 
The aim of our study was to investigate if the self-reported somatosensory profile of 
patients with painful cervical radiculopathy and of patients with FM, as indicated by 
responses to verbal sensory descriptors items of PD-Q, corresponded with their 
sensory phenotype as demonstrated by QST, using QST data from healthy control 
subjects as reference criteria. 
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8.3 Materials and methods 
8.3.1 Study population 
This study included patients with painful cervical radiculopathy (n = 23), patients 
with FM (n = 22) and age matched healthy controls (HC) (n = 31) (Table 8.1).  
Patients were recruited from general private physiotherapy, medical, and 
neurosurgery practices; physiotherapy and pain management departments at five 
local hospitals; a neurosurgery outpatient department; a neurosurgery triage clinic at 
a large metropolitan hospital; from the local community via radio and newspaper 
advertising and from FM support groups. The study protocol and recruitment 
procedures were approved by the local Ethics Committee of all participating 
institutions and adhered to the ethical guidelines of the Declaration of Helsinki. 
Informed consent was obtained from each subject prior to participation. 
 
The inclusion criteria for patients with cervical radiculopathy were: unilateral pain 
distribution consistent with specific radicular distributions (C6/C7), symptom 
duration of 3 to 18 months, pain intensity ≥ 2 on a visual analogue scale (VAS), 
signs of C6 or C7 nerve root dysfunction such as sensory impairment and motor 
impairment (either myotomal weakness and/or absent or diminished reflexes) and a 
demonstrable clinically relevant abnormality on imaging studies (Bono et al. 2011; 
Treede et al. 2008) indicating compromise of the exiting nerve root at the relevant 
spinal level. Exclusion criteria were: evidence of medical or metabolic disease, a 
history of cardiovascular disease, neurological or psychiatric disease and an 
insufficient level of English. Depending on the mode of recruitment, some of the 
potential subjects underwent an initial phone screening examination to ascertain they 
satisfied the inclusion and exclusion criteria. Prior to inclusion into the study, all 
patients underwent a comprehensive clinical examination in order to ascertain they 
met the inclusion criteria. As no gold standard exists for the diagnosis of painful 
cervical radiculopathy, the consensus of two clinical experts (a Fellow-trained 
neurosurgeon and a Fellow-qualified Specialist in Musculoskeletal Physiotherapy) 
was used to verify the diagnosis, as consistent with a previous study (Freynhagen et 
al. 2008). Using a blinded design, both experts reviewed the patient’s clinical 
records, including the findings of the clinical examination and available 
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investigations. Where there was not consensus between the experts and clinical 
examiner, subjects were excluded from the data analyses.  
 
Patients with FM underwent an initial phone screening examination to ascertain they 
fulfilled the inclusion and exclusion criteria. The diagnostic criteria for FM 
according to the 1990 American College of Rheumatology (ACR) (Wolfe et al. 
1990) were used as inclusion criteria and were current at the time of recruitment. 
These criteria include widespread pain of at least 3 months duration in combination 
with tenderness at 11 or more of 18 specific anatomical sites. Although new 
diagnostic criteria now exist (Wolfe et al. 2010), the clinical profile of our FM group 
appears to also correspond with these new guidelines (Table 8.1). The exclusion 
criteria were the same as for the radiculopathy group. Of the participating 22 
patients, 9 patients had been diagnosed with FM by a rheumatologist, 4 patients by a 
medical specialist (the patient could not remember what type of specialist), 8 patients 
by their general practitioner by exclusion (negative blood tests) and positive tender 
point count, and in one patient the origin of the diagnosis was not recorded. Prior to 
participation, tender point count was verified by means of a pressure algometer 
(probe size 1cm2) (Somedic AB, Farsta, Sweden), and assessing nine paired points as 
defined by the ACR Criteria (Wolfe et al. 1990) and two control points (at the centre 
of the right forearm and the right thumb nail). The algometer was placed on the 
examination site, and pressure was gradually increased by 1 kg/s. The participants 
were asked to press a button when the sensation at the examination site changed from 
pressure to pain. Pressure testing was stopped at that moment and the result recorded 
as positive if maximal pressure was ≤ 4kg. If no pain was elicited at ≤ 4kg, the test 
results were recorded as negative. The average number of tender point ratings of pain 
was 19 (+/- 0.9) from the possible 22. The patient’s clinical history was taken, 
including pain location on a body chart and identification of the main pain area 
nominated as the site to be tested by QST. All patients were requested to refrain from 
non–steroidal anti-inflammatory drugs and analgesics on the day of examination. 
 
HC were recruited from the local community and were excluded if they had a history 
of current pain or a chronic pain condition or fulfilled any of the exclusion criteria 
for the patients, including taking medications which influence pain perception. 
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Table 8.1  
Demographics and profiles of healthy control (HC) subjects, patients with cervical radiculopathy (CxRAD) and patients with fibromyalgia (FM). 
 HC  
(n = 31) 
CxRAD  
(n = 23) 
FM  
(n = 22) 
p-value 
ANOVA 
Age (years), (SD) 45.6 (12.5) 46.3 (9.6) 46.1 (11.5) 0.968 
Gender (female, n) 15 8 20  
Symptom duration (months)*  7.6 (4.1) 124.9 (83.1)c  
Average pain intensity during last week (VAS)*  5.2 (2.0) 7.3 (1.2)c  
Maximal pain intensity during last 4 weeks (NRS 0-10)*  7.2 (2.2) 8.3 (1.2)  
Average pain intensity during last 4 weeks (NRS 0-10)*  5.0 (2.1) 6.2 (1.3)d  
Sleep quality during last week (VAS)*  2.9 (2.6) 5.3 (2.7)b 6.8 (2.3)a <0.001 



























SF-36     
Physical Component# 57.7 (3.7) 40.6 (12.6)a 36.4 (11.9)a,  <0.001## 
Mental Component# 56.0 (7.6) 52.3 (17.4)b 30.8 (21.5)a, d <0.001## 
8-8 
Table 8.1 continued 
 HC  
(n = 31) 
CxRAD  
(n = 23) 
FM  
(n = 22) 
p-value 
ANOVA 
Hospital Anxiety and Depression Scale    
Anxiety score (HADS)# 3.0 (5.0) 6.0 (5.0)b 12.0 (6.2)a, c <0.001## 
Within normal range (≤ 10), n  29 (93%) 21(91%) 7 (32%)  
Depression score (HADS)# 1.0 (1.0) 3.0 (4.0)a 6.0 (4.2)a, d <0.001## 
Within normal range (≤ 10), n  31 (100%) 21 (91%) 19 (86%)  
Patients with medication, n   15 (65.2%) 12 (54.5%)  
Current medicatione     
Selective serotonin reuptake inhibitor, n   1 (4.3%) 7 (31.8%)  
Serotonin-norepinephrine reuptake inhibitor, n  2 (8.7%) 2 (9.1%)  
Tricyclic antidepressant, n  1 (4.3%) 3 (13.6%)  
Tetracyclic antidepressant, n   1 (4.5%)  
Antiepileptics, n  2 (8.7%)   
Opioids, n  4 (17.4%) 1 (4.5%)  
Benzodiazepine, n  2 (8.7%)   
Analgesics, n  7 (30.4%) 3 (13.6%)  
Non-steroidal anti-inflammatories, n  7 (30.4%)   
*Data are mean (SD); #Data are median (IQR); ##Kruskal –Wallis Test; ###Fisher’s Exact Test. 
aSignificantly different to HC (p < 0.001); bSignificantly different to HC (p < 0.05); cSignificantly different to CxRAD (p < 0.001); 
dSignificantly different to CxRAD (p < 0.05) ; eMultiple answers possible
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8.3.2 Questionnaires  
All patients completed the PD-Q. The following questionnaires were employed in 
order to characterise the patients and HC group. Patients and HC subjects completed 
the short form-36 health questionnaire (SF-36) to assess quality of life (Ware 2000) 
and the Hospital Anxiety and Depression Scale (HADS) to screen for the presence of 
psychological factors (Zigmond and Snaith 1983). Individual scores for anxiety and 
depression are generated with a maximum score of 21 for each parameter. Scores of 
≤ 10 for each are considered within normal range. In addition, sleep quality over the 
last week was rated by all subjects on a 100-cm VAS with the end points 0 cm (good 
sleep) and 10 cm (bad sleep) (Hurtig et al. 2001). Sleep disturbance was assessed by 
asking whether the subject awakened tired or non-refreshed; fatigue was assessed by 
asking: “Are you fatigued?” (Wolfe et al. 1990). Both questions allowed for answers: 
“never”, “seldom”, “often or usually”, “always”. “Often or usually” or “always” was 
scored as positive, and other replies as negative. In all patients, average pain intensity 
over the last week was determined with a VAS with the end points 0 cm (no pain) 
and 10 cm (maximum tolerable pain) (Jensen et al. 1989). The strongest and average 
pain intensity over the last four weeks were documented on a numeric rating scale 
(NRS) as part of the PD-Q (0 = no pain, 10 = maximum pain). All questionnaires 
were administered before the QST testing was performed. 
8.3.3 Quantitative sensory testing  
Standardised QST measures were recorded according to the QST protocol of the 
German Research Network on Neuropathic Pain (DFNS) (Rolke et al. 2006a; Rolke 
et al. 2006b). This protocol comprises a battery of standardised tests in the following 
order: thermal detection thresholds for the perception of cold and warm and 
paradoxical heat sensation, cold and heat pain thresholds (CPT, HPT), mechanical 
detection threshold for touch (MDT), mechanical pain threshold for pinprick, a 
stimulus-response-function for pinprick sensitivity and dynamic mechanical 
allodynia (DMA), wind-up ratio to repetitive pinprick stimuli, mechanical detection 
thresholds for vibration (VDT) and pain thresholds to blunt pressure (PPT). Good 
test/retest- and inter-observer-reliability of this protocol has been demonstrated 
(Geber et al. 2011). In our laboratory the Intraclass-Correlation Coefficients (ICC) 
for triplicate measurements on the same day for all measurements of interest were > 
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0.9 (ICC [95% CI] for CPT 0.94 [0.85 - 0.98]; HPT 0.94, [0.85 - 0.98]; VDT 0.93 
[0.84 - 0.98]; PPT 0.92 [0.80 - 0.97]). Measurements were taken from the main pain 
area, as nominated by the patients (upper trapezius muscle n = 18; paravertebral 
cervical spine n = 4, paravertebral thoracic spine n = 11; above and below spine 
scapula n = 3; upper arm n = 6; forearm n = 2, just above the elbow n = 1). HC 
reference data from a parallel study of ours were used for comparison. Measurements 
in the upper trapezius muscle had been obtained in 26 HC and measurements in all 
other pain areas in 8 HC, the latter including 3 HC in the upper trapezius group, 
consistent with established methodology in a previous QST study (Blankenburg et al. 
2010). QST was conducted on each subject by the same investigator in a laboratory 
with a constant room temperature. The investigator was not aware of the patient’s 
responses to the PD-Q. The full QST protocol as outlined above was performed on 
all subjects as part of another concurrent study. However, for the purpose of this 
study, only the following recordings were used to assess the patient’s responses to 
the PD-Q. 
 
PainDETECT question: Is light touching (clothing, a blanket) in this area painful? 
QST test: Pain in response to stroking light touch (DMA) was assessed using a 
cotton wisp (3 mN), a cotton wool tip fixed to an elastic strip (100 mN) and a brush 
exerting a force of 200-400 mN. Subjects were asked to give a pain rating for each 
stimulus on a NRS (0 = no pain, 100 = most intense pain imaginable). This 
assessment forms part of the stimulus-response-function for pinprick sensitivity and 
DMA. Pinprick and light stroking applications were performed five times in a 
randomised sequence. DMA was calculated as the geometric mean of all numerical 
ratings across all three different types of light touch stimuli. 
 
PainDETECT question: Is cold or heat (bath water) in this area occasionally 
painful? 
QST test: CPT and HPT were measured using the MSA Thermotest system (Somedic 
AB, Farsta, Sweden). All thresholds were obtained with ramped stimuli (1° C/s) 
which were terminated when the subject pressed a button. The baseline temperature 
was set at 32˚C; cut-off temperatures were 5˚C and 50˚C. The mean threshold 
temperature of three consecutive measurements was calculated. 
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PainDETECT question: Do you suffer from a sensation of numbness in the areas that 
you marked?  
QST test: The MDT was measured with a standardised set of modified von Frey 
hairs (Optihari2-Set, Marstock Nervtest, Germany) that exert forces upon bending 
between 0.25 and 512 mN. The final threshold was the geometric mean of five series 
of ascending and descending stimulus intensities (Rolke et al. 2006b). A Rydel-
Seiffer tuning fork (64Hz, 8/8 scale) was used to obtain the vibration detection 
threshold (VDT). VDT was measured over bony prominences unless the maximal 
pain area did not exhibit a bony surface (n = 11), in which case, measurements were 
taken over adjacent soft tissue. The threshold was determined as a disappearance 
threshold with three stimulus repetitions (Rolke et al. 2006b). 
 
PainDETECT question: Does slight pressure in this area, e.g., with a finger, trigger 
pain?  
QST test: PPTs were recorded using a pressure algometer with a probe size of 1cm2 
and application rate of 50 kPa/s (Somedic AB, Farsta, Sweden). The subjects were 
asked to push a button when the sensation changed from one of pressure alone to one 
of pressure and pain. Triplicate recordings were taken and the mean values used for 
analysis.  
8.3.4 Statistical analysis 
Data were analysed using the statistical package SPSS vs 17. Each question of the 
PD-Q has five possible scores listed as: never = 0; hardly noticed = 1; slightly = 2; 
moderately = 3; strongly = 4; very strongly = 5 (Freynhagen et al. 2006). We defined 
a score of ≥ 3 (moderately, strongly, very strongly) as a clinically relevant sensory 
disturbance and a positive response and scores of < 3 as a negative response. 
 
QST data were log-transformed prior to statistical analysis except HPT and VDT 
which were normally distributed as raw data (Rolke et al. 2006a; Rolke et al. 2006b). 
To compare and illustrate the patients’ QST data with control data, independently of 
the different units of measurement, the log data of CPT, MDT and PPT and raw data 
of HPT and VDT were z-transformed using the following expression: Z-score = 
(Xsingle proband – Meanhealthy controls)/SDhealthy controls (Rolke et al. 2006b). Z-values were 
calculated based on the included HC group data.  
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To assess any difference in z-score QST parameters between positive and negative 
responders compared to healthy control data, a univariate analysis was performed for 
each patient group. Post hoc comparisons were calculated using LSD-post hoc tests 
for  
(i) all patients giving positive responses and matched HC,  
(ii) all patients giving negative responses and HC  
(iii) patients giving positive responses and patients giving negative responses. 
As CPT, HPT and PPT measurements have been reported to be significantly lower in 
females than males (Rolke et al. 2006a), gender was included in the model for 
analysis of all QST parameters. Measurements of MDT were not affected by gender 
in our study. 
 
Data are presented as mean and standard deviation (SD). Age and sleep quality were 
compared between groups using one-way ANOVA. Post hoc comparisons were 
calculated using LSD-post hoc tests. The frequency of sleep disturbances was 
determined using Fisher’s exact test. Anxiety and depression scores and the physical 
and mental components of the SF-36 were compared between groups using the 
Kruskal-Wallis Test. If there was a difference between groups, further pairwise 
analyses were performed using the Mann-Whitney-U Test. Symptom duration and 
pain intensity were compared between patient groups using an independent-samples 
T-Test. Significance was accepted at p < 0.05 for all analyses. 
8.4 Results 
8.4.1 Clinical profiles 
A summary of the demographics is presented for each group in Table 8.1. Compared 
to patients with radiculopathy, patients with FM demonstrated significantly longer 
symptom duration and higher average pain intensity during the last week (p < 0.001) 
and the last 4 weeks prior to testing (p = 0.026). Both patient groups had 
significantly poorer sleep quality compared to HC and more frequently reported 
signs of increased sleep disturbance and fatigue. Both patient groups scored 
significantly higher anxiety and depression scores on the HADS than HC (for 
radiculopathy: anxiety p = 0.002, depression p < 0.001; for FM: anxiety p < 0.001, 
depression p < 0.001). Compared to patients with radiculopathy, patients with FM 
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scored significantly higher on both parameters (anxiety p < 0.001; depression p = 
0.004). The depression scores were within the normal range for over 85% of patients 
in both groups. Anxiety scores were within the normal range in 91% of patients with 
radiculopathy, but in only 32% of patients with FM. Both patient groups 
demonstrated significantly lower SF-36 physical (radiculopathy p < 0.001; FM p < 
0.001) and mental component summary scores (radiculopathy p = 0.027; FM p < 
0.001) than HC. There was no significant difference in the physical component 
summary score between both patient groups. Patients with FM scored significantly 
lower on the mental component summary score than patients with radiculopathy (p < 
0.001). 
 
8.4.2 Sensory phenotypes  
The z-score QST sensory profiles for CPT, HPT, MDT, VDT and PPT in patients 
with cervical radiculopathy are illustrated in Figure 8.1. There was a significant gain 
in cold, heat and pressure sensitivity in those patients with cervical radiculopathy 
who indicated being sensitive to these QST parameters and a sensory loss in patients 
who indicated feeling numbness. QST parameters of patients responding negative to 
the PD-Q questions were within one SD of the HC data.  
 
The z-score QST sensory profiles of patients with FM are illustrated in Figure 8.2. 
All patients with FM demonstrated a significant gain in cold, heat and pressure 
sensitivity, irrespective of their responses to PD-Q.  
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Figure 8.1 Sensory profiling of patients with cervical radiculopathy (CxRAD). The z-score sensory 
profiles are shown for cold pain threshold (CPT), heat pain thresholds (HPT), mechanical detection 
threshold (MDT), vibration detection threshold (VDT), pressure pain threshold (PPT) in patients 
responding positive (filled square) and negative to verbal descriptors (empty triangle). Healthy control 
subjects are represented by a z-score of “zero”. Data are shown as the mean. Error bars indicate 
thestandard error of measurement. 
*Significantly different from HC (p < 0.05). 
**Significantly different from HC (p < 0.001). 
 
Figure 8.2 Sensory profiling of patients with fibromyalgia (FM). The z-score sensory profiles are 
shown for cold pain threshold (CPT), heat pain thresholds (HPT), mechanical detection threshold 
(MDT), vibration detection threshold (VDT), pressure pain threshold (PPT) in patients responding 
positive (filled square) and negative to verbal descriptors (empty triangle). Healthy control subjects 
are represented by a z-score of “zero”. Data are shown as the mean. Error bars indicate the standard 
error of measurement. 
*Significantly different from HC (p < 0.05). 
**Significantly different from HC (p < 0.001). 
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8.4.3 Patients with cervical radiculopathy  
Sensitivity to light touch 
The PD-Q report indicated sensitivity to light touch in four patients with cervical 
radiculopathy (Table 8.2), and one of these patients demonstrated DMA on QST 
testing. Nineteen patients reported not being sensitive to light touch on PD-Q. None 
of these demonstrated DMA and no HC demonstrated DMA. We did not conduct 
statistical comparisons between groups for DMA due to the small number of subjects 
in some cells. 
 
Sensitivity to cold/heat 
Patients responding being sensitive to cold or heat demonstrated a significantly 
increased sensitivity to cold and heat (p = < 0.001) compared to HC subjects (Table 
8.2). Patients who indicated not being sensitive to cold/heat also demonstrated 
significantly increased cold sensitivity (p = 0.030), but they did not differ in their 
heat pain thresholds when compared to HC. 
 
Sensation of numbness 
Patients who indicated feeling numbness in the area of pain demonstrated a loss of 
sensation, manifesting as a significantly elevated MDT (p = 0.001) and VDT (p < 
0.001) compared to HC data (Table 8.2). Patients who responded as not feeling 
numbness, did not differ in their mechanical detection sensitivity compared to HC 
data. 
 
Sensitivity to slight pressure 
Patients responding being sensitive to pressure demonstrated significantly increased 
pressure sensitivity (p = 0.001) compared to HC (Table 8.2). Patients reporting not 
being sensitive demonstrated a loss of function with significantly reduced pressure 
sensitivity compared to HC (p = 0.036).  
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Table 8.2  
Comparison of each QST parameter between healthy controls (HC), patients with 
cervical radiculopathy (CxRAD) who responded on painDETECT as being sensitive 
to a QST parameter (positive), and patients who responded on painDETECT as being 
not sensitive to a QST parameter (negative). Data are shown as mean (SD) for 
untransformed data and retransformed mean for log-normally distributed data 
(CPT, MDT, PPT). 
 HC  






Is light touching in this 
area painful?  
 n = 4 n = 19  
DMA 0 had DMA 1 had DMA 0 had DMA  
Is cold or heat in this area 
occasionally painful?  n = 5 n = 18 
 
CPT (°C) 7.0  18.8a, c 9.6b  0.001 
HPT (°C) 46.7 (1.9) 41.2 (5.6)b, c 46.5 (3.3) 0.003 
Do you suffer from a  
sensation of numbness in  
the area that you marked? 
 n = 19 n = 4 
 
MDT (mN) 1.9  4.5b  1.7 0.006 
VDT (x/8) 6.1 (0.9) 5.3 (1.2)a 5.8 (0.2) 0.001 
Does slight pressure in 
this area trigger pain?  n = 7 n = 16 
 
PPT (kPa) 439  303b, c  457b   <0.001 
DMA: dynamic mechanical allodynia, CPT: cold pain threshold, HPT: heat pain threshold, 
MDT: mechanical detection threshold, VDT: vibration threshold, PPT: pressure pain 
threshold. 
aSignificantly different to HC (p < 0.001).  
bSignificantly different to HC (p < 0.05). 





8.4.4 Patients with fibromyalgia  
Sensitivity to light touch 
The PD-Q report indicated sensitivity to light touch in four patients with FM (Table 
8.3), and none of these patients demonstrated DMA on QST testing. Eighteen 
patients reported not being sensitive to light touch on PD-Q. Three of these patients 
demonstrated DMA on QST testing.  
 
Sensitivity to cold/heat 
Regardless of PD-Q responses to cold/heat sensitivity, all patients with FM 
demonstrated a significantly increased sensitivity to both thermal stimuli (p < 0.001) 
(Table 8.3). There was no significant difference in CPT and HPT between patients 
responding on PD-Q as being sensitive to these thermal stimuli and those responding 
as not being sensitive. 
 
Sensation of numbness 
Patients responding as feeling numbness in their maximal pain area did not 
demonstrate a significant difference in MDT or VDT compared to HC (Table 8.3). 
Patients responding as not feeling numbness, demonstrated a loss of sensation with a 
significant difference in VDT (p = 0.002) compared to HC, but not in MDT  
(Table 8.3).  
 
Sensitivity to slight pressure 
All patients with FM demonstrated a significantly increased sensitivity to pressure (p 
< 0.001) compared to HC, regardless of a positive or negative PD-Q response  
(Table 8.3).  
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Table 8.3  
Comparison of each QST parameter between healthy controls (HC), patients with 
fibromyalgia (FM) who responded on painDETECT as being sensitive to a QST 
parameter (positive), and patients who responded on painDETECT as being not 
sensitive to a QST parameter (negative). Data are shown as mean (SD) for 
untransformed data and retransformed mean for log-normally distributed data  
(CPT, MDT, PPT). 
 HC  







Is light touching in this 
area painful?  
 n = 4 n = 18  
DMA 0 had DMA 0 had DMA 3 had DMA  
Is cold or heat in this area 
occasionally painful? 
 n = 10 n = 12 
 
CPT (°C) 7.0  21.9a 26.3a <0.001 
HPT (°C) 46.7 (1.9) 39.2 (3.2)a 39.8 (3.5)a <0.001 
Do you suffer from a  
sensation of numbness in  
the area that you marked? 
 n = 7 n = 15 
 
MDT (mN) 1.9  2.9 3.2 0.208 
VDT (x/8) 6.1 (0.9) 6.1 (1.1) 5.2 (1.0)b 0.007 
Does slight pressure in 
this area trigger pain?  n = 18 n = 4 
 
PPT (kPa) 439  182a 186b <0.001 
DMA: dynamic mechanical allodynia, CPT: cold pain threshold, HPT: heat pain threshold, 
MDT: mechanical detection threshold, VDT: vibration threshold, PPT: pressure pain 
threshold. 
aSignificantly different to HC (p < 0.001).  





We investigated if the self-reported somatosensory profile of patients with cervical 
radiculopathy and patients with FM, obtained through the PD-Q, corresponded with 
the somatosensory profile as demonstrated by QST, using HC QST data as reference 
criteria. Patients with cervical radiculopathy demonstrated a match between their 
self-reported sensory phenotype and their QST sensory phenotype for all the sensory 
descriptors except for sensitivity to light touch, and these matches were statistically 
significant compared to HC data. The FM group demonstrated discrepancies between 
the PD-Q and QST sensory phenotypes for all sensory descriptors, indicating that the 
self-reported somatosensory profile did not consistently match the QST 
somatosensory profile.  
 
Clinical and QST somatosensory profile of study groups 
The diagnosis of our patients with painful cervical radiculopathy was based on 
established clinical criteria (Bogduk 2009; Bono et al. 2011; Kuijper et al. 2009), 
including clinically relevant abnormalities on imaging studies as confirmatory test 
for a nerve lesion (Bono et al. 2011; Treede et al. 2008) and validation of diagnosis 
by two clinical experts. According to the newly proposed grading system for NeP 
(Treede et al. 2008), all these radiculopathy patients presented with probable NeP. 
Furthermore, patients responding positive to the PD-Q questions met the criteria for 
definite NeP, as they demonstrated sensory abnormalities in the area of their 
maximal pain. Negative sensory signs, as demonstrated by the elevated MDT and 
VDT, are core signs of NeP due to the reduction of afferent input caused by a nerve 
lesion (Hansson 2002; Jensen and Baron 2003). The majority of our patients (83%) 
reported the presence of numbness, in contrast to only 15% of patients with painful 
lumbar radiculopathy (Mahn et al. 2011). However the latter study did not employ 
specific inclusion criteria of nerve root dysfunction, hence it is possible that patients 
may just have presented with radicular pain, and without any associated nerve 
damage (Merskey and Bogduk 1994). 
 
Besides negative signs, positive sensory symptoms were also identified in our 
patients, manifesting as increased sensitivity to thermal stimuli. Our patients 
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demonstrated cold hypersensitivity/hyperalgesia which is a common sequel of 
peripheral nerve injury (de Medinaceli et al. 1997; Kleggetveit and Jørum 2010; 
Landerholm et al. 2010; Taylor et al. 2010) and has been previously demonstrated in 
patients with cervical radiculopathy (Chien et al. 2008). While the difference in cold 
sensitivity between patients who indicated not being sensitive to cold and HC was 
statistically significant, the clinical significance is questionable as the mean value fell 
within the 95% confidence interval of our HC data and other reference data (Magerl 
et al. 2010) and below the defined value for cold hyperalgesia (≥ 15°) (Bennett 
2006). To our knowledge, no published data exist on heat pain thresholds measured 
specifically in the maximal pain area for a patient cohort with cervical radiculopathy. 
Previously heat hyperalgesia was found in 23% of 121 patients with NeP (Maier et 
al. 2010), and 15 (12.4%) of these 121 patients had a radiculopathy (not specified if 
lumbar or cervical). No comparative QST data exist for the assessment of DMA 
either. DMA did not seem to be a dominant feature in our patient cohort, consistent 
with self-reported responses of the PD-Q in patients with lumbar 
radiculopathy/radicular pain (Mahn et al. 2011). The difference in the somatosensory 
profiles between our patients who responded as positive or negative to the PD-Q 
might reflect the heterogeneity of the clinical pain disorder (Mahn et al. 2011) and 
also reflect the mixed pain types evident in radiculopathies (Baron and Binder 2004; 
Pérez et al. 2007).  
 
Our patients with FM fulfilled the diagnostic criteria according to the ACR (Wolfe et 
al. 1990) and also demonstrated sleep and fatigue disturbance and widespread pain, 
corresponding with the new diagnostic criteria for FM (Wolfe 2010). Their 
demographic features were consistent with previous data (Gormsen et al. 2010). All 
patients, irrespective of their answers to PD-Q, demonstrated increased sensitivity to 
pressure in their area of maximal pain, as documented previously (Blumenstiel et al. 
2011; Klauenberg et al. 2008; Koroschetz et al. 2010; Kosek et al. 1996; Pfau et al. 
2009) and increased cold and heat sensitivity, corresponding with others (Berglund et 
al. 2002; Blumenstiel et al. 2011; Hurtig et al. 2001; Kosek et al. 1996). In contrast, 
other studies did not report increased cold (Klauenberg et al. 2008) or heat sensitivity 
(Klauenberg et al. 2008; Pfau et al. 2009).  
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The differences in findings are indicative of the heterogeneity of FM. Sub-groups of 
patients demonstrating increased thermal sensitivity have been identified (Hurtig et 
al. 2001; Rehm et al. 2010). Our patient cohort might have incorporated a larger 
proportion of patients characterised by increased thermal sensitivity (Rehm et al. 
2010) which may also explain the observed magnitude of thermal sensitivity (z-
scores outside 95% confidence interval of HC data). The generalised enhanced 
sensitivity might be reflective of a more global sensory discriminative dysfunction in 
patients with FM. Further, irrespective of the patients’ responses to the PD-Q 
question of numbness, there was a trend to increased MDT in all patients with FM, 
but this did not reach statistical significance. In comparison, Pfau et al (Pfau et al. 
2009) found significantly increased MDT in patients with FM compared to HC, but 
others did not (Blumenstiel et al. 2011; Kosek et al. 1996). In this regard, tactile 
hypoaesthesia does not necessarily indicate structural damage to tactile pathways 
(Geber et al. 2008) and can be present in clinical pain disorders possibly consistent 
with changes in central nervous system plasticity. Hypoaesthesia was also 
documented by an increased VDT in patients who indicated not feeling numbness. It 
is unclear why this was only observed in these patients and not in patients who 
reported feeling numbness. Sensitivity to light touch is not a consistent feature in 
populations with FM, with a small proportion of our patients demonstrating DMA 
(3/22) as well as in other studies (2/14) (Pfau et al. 2009) and (6/21) (Blumenstiel et 
al. 2011). Klauenberg et al (Klauenberg et al. 2008) did not find any abnormalities 
for 35 subjects with FM, although DMA was not measured in the area of maximal 
pain. 
 
PD-Q somatosensory profiles and QST somatosensory profiles 
The self-reported somatosensory profile of patients with cervical radiculopathy 
corresponded with the somatosensory profile, as demonstrated by QST for all 
sensory descriptors, except for DMA. Therefore, compared to HC, patients who 
indicated sensitivity to a specific sensory parameter did in fact demonstrate that 
sensory alteration. Patients who indicated not being sensitive to a parameter did not 
demonstrate a sensory alteration except for pressure sensitivity. In the latter, the PPT 
was elevated, indicating less sensitivity to pressure, hence this finding still correlated 
with the patients’ self-report response. In contrast, self-reported somatosensory 
profiles in the FM group did not consistently match the QST somatosensory profile. 
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Although all patients who indicated sensitivity to heat/cold and pressure 
demonstrated increased sensitivity for these parameters, those who responded as not 
being sensitive also showed these sensory alterations. Furthermore, compared to HC, 
patients with FM who indicated numbness in the area of their pain did not 
demonstrate significant hypoaesthesia. Patients who reported not feeling numbness 
had a significantly elevated VDT, again demonstrating a discrepancy between 
patients’ self-reported profile and the associated QST sensory profile. 
 
In interpreting our findings in patients with FM, consideration should be given to the 
fact that PD-Q has never been validated for use in this population. It is also possible 
that psychological factors (Giesecke et al. 2003) or altered cognitive function (Dick 
et al. 2008) may have influenced patients’ responses to PD-Q. In addition, it is open 
to debate if the PD-Q, and possibly other NeP screening tools, are suitable for people 
with widespread pain (Bouhassira and Attal 2011; Mulvey and McBeth). Although 
the main pain area in our patients with FM was identified prior to completing the 
PD-Q, most of the patients (n = 20) drew their main area of pain, plus additional pain 
areas on the PD-Q body chart. It is therefore possible that patients answered the 
questions of verbal descriptors for all their pain areas. It is unclear if the indication of 
multiple pain areas on the body chart could explain the discrepancy between 
patients’ perception of sensory stimuli and the associated QST findings, as QST 
parameters were only measured in the area of maximal pain. In contrast, all patients 
with cervical radiculopathy indicated correctly the area of their neck-arm pain and 
associated paraesthesia and also demonstrated good agreement between self-reported 
and QST sensory profiles.  
 
Factors influencing QST outcome 
The painDETECT has five possible scores (never to very strongly) for each question 
of verbal descriptors. As no criteria are currently available to indicate validated cut-
offs defining what constitutes a clinically relevant sensory disturbance, we chose the 
score “moderately” (≥ 3) as our cut-off score. Other researchers defined a clinically 
relevant sensory disturbance if patients marked a score > 3 (strongly and very 
strongly) (Amris et al. 2010; Baron et al. 2009; Mahn et al. 2011; Rehm et al. 2010). 
Consequently, we re-analysed our data using the cut-off scores of slightly, strongly 
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and very strongly. The results remain overall consistent with our previous analyses 
(supplementary material Tables 8.4 – 8.9).  
 
 
Table 8.4.  
Comparison of each QST parameter∞ between healthy controls (HC), patients with  
cervical radiculopathy (CxRAD) who responded on painDETECT as being sensitive  
to a QST parameter (positive), and patients who responded on painDETECT as  
being not sensitive to a QST parameter (negative). The score“slightly” was used as  
the cut-off score for answers on the painDETECT. Data are shown as mean (SD)  
for untransformed data and retransformed mean for log-normally distributed data  
(CPT, MDT, PPT). 
 HC  







Is light touching in this  
area painful? 
 n = 6 n = 17  
DMA 0 had DMA 1 had DMA 0 had DMA  
Is cold or heat in this area 
occasionally painful?  n = 5 n = 18 
 
CPT (°C) 7.0  18.8a, c 9.6b 0.001 
HPT (°C) 46.7 (1.9) 41.2 (5.6)b, c  46.5 (3.3) 0.003 
Do you suffer from a  
sensation of numbness in  
the area that you marked? 
 n = 22 n = 1 
 
MDT (mN) 1.9 3.7b 8.0§ 0.011 
VDT (x/8) 6.1 (0.9) 5.4 (1.1)a 5.8§ 0.002 
Does slight pressure in 
this area trigger pain?  n = 12 n = 11 
 
PPT (kPa) 439 455 353 0.056 
DMA: dynamic mechanical allodynia, CPT: cold pain threshold, HPT: heat pain threshold,  
MDT: mechanical detection threshold, VDT: vibration threshold, PPT: pressure pain  
threshold. 
 aSignificantly different to HC (p < 0.001); bSignificantly different to HC (p < 0.05); 
cSignificantly different to CxRAD negative (p < 0.05). 
§No further analysis performed as only 1 person. 
◊Univariate analysis. 
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Table 8.5.  
Comparison of each QST parameter between healthy controls (HC), patients with  
fibromyalgia (FM) who responded on painDETECT as being sensitive to a QST  
parameter (positive), and patients who responded on painDETECT as being not  
sensitive to a QST parameter (negative). The score “slightly” was used as the 
cut-off score for answers on the painDETECT. Data are shown as mean (SD) for  
untransformed data and retransformed mean for log-normally distributed data  
(CPT, MDT, PPT). 
 HC  







Is light touching in this  
area painful? 
 n = 13 n = 9  
DMA 0 had DMA 2 had DMA 1 had DMA  
Is cold or heat in this area 
occasionally painful?  n = 14 n = 8 
 
CPT (°C) 7.0  22.8a 26.9a < 0.001 
HPT (°C) 46.7 (1.9) 39.2 (3.3)a 40.1 (3.3)a < 0.001 
Do you suffer from a  
sensation of numbness in  
the area that you marked? 
 n = 14 n = 8 
 
MDT (mN) 1.9 2.6 4.1 0.130 
VDT (x/8) 6.1 (0.9) 5.5 (1.2)b 5.4 (0.9) 0.029 
Does slight pressure in this 
area trigger pain?  n = 22 n = 0 
 
PPT (kPa) 439 183a  < 0.001 
DMA: dynamic mechanical allodynia, CPT: cold pain threshold, HPT: heat pain threshold,  
MDT: mechanical detection threshold, VDT: vibration threshold, PPT: pressure pain  
threshold. 
aSignificantly different to HC (p < 0.001). 




Table 8.6.  
Comparison of each QST parameter between healthy controls (HC), patients with  
cervical radiculopathy (CxRAD) who responded on painDETECT as being  
sensitive to a QST parameter (positive), and patients who responded on  
painDETECT as being not sensitive to a QST parameter (negative). The score  
“strongly” was used as the cut-off score for answers on the painDETECT. Data are 
shown as mean (SD) for untransformed data and retransformed mean for  
log-normally distributed data (CPT, MDT, PPT). 
 HC  






Is light touching in this  
area painful? 
 n = 0 n = 23  
DMA 0 had DMA 0 had DMA 1 had DMA   
Is cold or heat in this area 
occasionally painful?  n = 1 n = 22 
 
CPT (°C) 7.0 26.2§ 10.7b <0.001 
HPT (°C) 46.7 (1.9) 36.6§ 45.8 (4.0) 0.004 
Do you suffer from a  
sensation of numbness in  
the area that you marked? 
 n = 11 n = 12 
 
MDT (mN) 1.9 4.5b 3.3b 0.012 
VDT (x/8) 6.1 (0.9) 5.4 (1.2)a 5.4 (1.1)a 0.002 
Does slight pressure in 
this area trigger pain?  n = 5 n = 18 
 
PPT (kPa) 439 335a, c 424 <0.001 
DMA: dynamic mechanical allodynia, CPT: cold pain threshold, HPT: heat pain threshold,  
MDT: mechanical detection threshold, VDT: vibration threshold, PPT: pressure pain  
threshold.  
aSignificantly different to HC (p < 0.001). 
bSignificantly different to HC (p < 0.05). 
cSignificantly different to CxRAD negative (p < 0.001).  




Table 8.7.  
Comparison of each QST parameter between healthy controls (HC), patients with  
fibromyalgia (FM) who responded on painDETECT as being sensitive to a QST  
parameter (positive), and patients who responded on painDETECT as being not  
sensitive to a QST parameter (negative). The score “strongly” was used as the 
cut-off score for answers on the painDETECT. Data are shown as mean (SD) for 
untransformed data and retransformed mean for log-normally distributed data  
(CPT, MDT, PPT). 
 HC  






Is light touching in this  
area painful? 
 n = 1 n = 21  
DMA 0 had DMA 0 had DMA 3 had DMA   
Is cold or heat in this area 
occasionally painful?  n = 5 n = 17 
 
CPT (°C) 7.0 17.4a 29.0a, c < 0.001 
HPT (°C) 46.7 (1.9) 40.5 (3.6)a 39.2 (3.3)a < 0.001 
Do you suffer from a  
sensation of numbness in  
the area that you marked? 
 n = 3 n = 19 
 
MDT (mN) 1.9 7.1 2.7 0.122 
VDT (x/8) 6.1 (0.9) 6.6 (0.8) 5.3 (1.1)b 0.005 
Does slight pressure in 
this area trigger pain?  n = 11 n = 11 
 
PPT (kPa) 439 201b 167a < 0.001 
DMA: dynamic mechanical allodynia, CPT: cold pain threshold, HPT: heat pain threshold, 
MDT: mechanical detection threshold, VDT: vibration threshold, PPT: pressure pain 
threshold. 
aSignificantly different to HC (p < 0.001). 
bSignificantly different to HC (p < 0.05). 
◊Univariate analysis 
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Table 8.8.  
Comparison of each QST parameter between healthy controls (HC), patients with  
cervical radiculopathy (CxRAD) who responded on painDETECT as being sensitive  
to a QST parameter (positive), and patients who responded on painDETECT as being 
 not sensitive to a QST parameter (negative). The score “very strongly” was used as  
the cut-off score for answers on the painDETECT. Data are shown as mean (SD) for 
untransformed data and retransformed mean for log-normally distributed data  
(CPT, MDT, PPT). 
 HC  







Is light touching in this  
area painful? 
 n = 0 n = 23  
DMA 0 had DMA 0 had DMA 1 had DMA   
Is cold or heat in this area 
occasionally painful?  n = 0 n = 23 
 
CPT (°C) 7.0  11.2a <0.001 
HPT (°C) 46.7 (1.9)  45.4 (4.4) 0.033 
Do you suffer from a  
sensation of numbness in  
the area that you marked? 
 n = 2 n = 21 
 
MDT (mN) 1.9 23.4a 3.2a 0.003 
VDT (x/8) 6.1 (0.9) 5.1 (1.3)a 5.4 (1.1)a 0.002 
Does slight pressure in 
this area trigger pain?  n = 1 n = 22 
 
PPT (kPa) 439 344§ 406 0.024 
DMA: dynamic mechanical allodynia, CPT: cold pain threshold, HPT: heat pain threshold, 
MDT: mechanical detection threshold, VDT: vibration threshold, PPT: pressure pain 
threshold 
aSignificantly different to HC (p < 0.05). 
bSignificantly different to CxRAD positive (p < 0.05).  
§No further analysis performed as only 1 person. 
◊Univariate analysis. 
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Table 8.9.  
Comparison of each QST parameter between healthy controls (HC), patients with  
fibromyalgia (FM) who responded on painDETECT as being sensitive to a QST  
parameter (positive), and patients who responded on painDETECT as being not  
sensitive to a QST parameter (negative). The score “very strongly” was used as the  
cut-off score for answers on the painDETECT. Data are shown as mean (SD) for 
untransformed data and retransformed mean for log-normally distributed data  
(CPT, MDT, PPT). 
 HC  






Is light touching in this  
area painful? 
 n = 1 n = 21  
DMA 0 had DMA 0 had DMA 3 had DMA   
Is cold or heat in this area 
occasionally painful?  n = 1 n = 21 
 
CPT (°C) 7.0 28.6§ 24.0◊a < 0.001 
HPT (°C) 46.7 (1.9) 38.5§ 39.6 (3.4)◊a < 0.001 
Do you suffer from a  
sensation of numbness in  
the area that you marked? 
 n = 0 n = 22 
 
MDT (mN) 1.9  3.1 0.075 
VDT (x/8) 6.1 (0.9)  5.5 (1.1)b 0.008 
Does slight pressure in 
this area trigger pain?  n = 1 n = 21 
 
PPT (kPa) 439 85§ 190a < 0.001 
DMA: dynamic mechanical allodynia, CPT: cold pain threshold, HPT: heat pain threshold, 
MDT: mechanical detection threshold, VDT: vibration threshold, PPT: pressure pain 
threshold.  
aSignificantly different to HC (p < 0.001).  
bSignificantly different to HC (p < 0.05). 




Our data support the use of PD-Q as a tool to identify somatosensory profiles in 
patients with painful cervical radiculopathy. The questionnaire could possibly be 
applied in large epidemiological studies to classify patients with cervical 
radiculopathy based on sensory descriptors of PD-Q, as previously documented for 
patients with lumbar radicular pain (Mahn et al. 2011) and for patients with painful 
diabetic neuropathy and postherpetic neuralgia (Baron et al. 2009). However, 
bedside sensory examination would allow a comparison of sensory testing between 
symptomatic and asymptomatic body regions and side-to-side comparison enhances 
the sensitivity to detect sensory abnormalities (Maier et al. 2010; Rolke et al. 2006a).  
 
Caution needs to be applied when making assumptions in the FM population about 
their sensory profiles based upon self-reported sensory descriptors of PD-Q alone. A 
recent cross-sectional cohort survey of 3035 patients with FM (Rehm et al. 2010) 
captured relevant sensory abnormalities, including pressure pain sensitivity (58.3%) 
and thermal hypersensitivity (24%). Amris et al (2010) reported 83% of 81 patients 
with FM indicated pressure sensitivity on PD-Q and 54% indicated thermal 
hypersensitivity. Both studies used a cut-off score > 3 for their analysis. In 
comparison, we had a lower percentage of patients with FM reporting pressure 
(50%) and thermal sensitivity (23%) (Table 8.7), but a larger percentage of patients 
with FM (100%) demonstrated these hypersensitivities as demonstrated by our QST 
data. Our data suggest that there is potential for misclassification if only patient 
reported outcomes are used for sub-grouping.  
 
In conclusion, the data from our study demonstrate correspondence between the self-
reported somatosensory profile of patients with cervical radiculopathy and their 
sensory phenotype as demonstrated by QST. The QST sensory phenotype of patients 
with FM was not consistently reflected by responses to verbal descriptors from the 
PD-Q. Clinicians and researchers should be cautious about relying on PD-Q as a 
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Chapter 9 - Discussion  
Nerve-related spinal neck-arm pain disorders are common musculoskeletal 
conditions that are associated with a negative impact on overall health status 
(Daffner et al. 2003). A neuropathic mechanism is implied in the genesis of some 
disorders such as painful cervical radiculopathies (Haanpää et al. 2009). NeP in 
musculoskeletal pain disorders leads to impaired quality of life and increased 
utilization of health care and is associated with more comorbidities such as anxiety, 
depression and sleep disturbances compared to nociceptive pain disorders 
(Freynhagen et al. 2006a; Saldaña et al. 2010; Schmidt et al. 2009).  
 
The management of patients with NeP remains a challenge (Finnerup et al. 2010), 
indicated by the variability of treatment response among patients with pain related to 
lumbar (Baron et al. 2010b; Brötz et al. 2010) and cervical radiculopathy/radicular 
disorders (Saldaña et al. 2010). The variability may be due to the heterogeneity of 
nerve-related neck-arm pain disorders pertaining to differing aetiologies, clinical 
presentations or varying underlying pain types. Consequently, the characterisation of 
these patients with respect to the mix of NeP and nociceptive pain and the possible 
dominance of one pain type in mixed pain syndromes is of therapeutic relevance as 
NeP conditions require a different therapeutic approach than nociceptive pain 
conditions (Baron et al. 2010a; Harden and Cohen 2003). Furthermore, within one 
aetiology, recent research investigating somatosensory profiles has identified diverse 
sub-groups of patients with NeP (Baron et al. 2009; Maier et al. 2010). Differing 
somatosensory profiles may be associated with different underlying pain 
mechanisms, this providing another possible explanation for individual differences in 
responsiveness to anti-neuropathic drug treatment in patients with radiculopathy 
(Baron et al. 2010b; Saldaña et al. 2010).  
 
Clinical classification systems have been proposed for the characterisation of patients 
with nerve-related neck-arm pain (Elvey 1997; Radhakrishnan et al. 1994), however 
their reliability has never been established in this population. Furthermore, various 
clinical tools such as a grading system of certainty for the presence of NeP (Treede et 
al. 2008); NeP screening questionnaires (Bennett et al. 2007); and laboratory tests 
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(QST) have been recommended for the assessment of NeP components in patients 
with chronic pain (Haanpää et al. 2011). In contrast to the literature investigating 
NeP components in low back and leg pain (Beith et al. 2011; Freynhagen et al. 
2006a; Freynhagen et al. 2006b; Freynhagen et al. 2008; Kaki et al. 2005; Prout et al. 
2010), there has been little research on the assessment of NeP in nerve-related spinal 
neck-arm pain (Chien et al. 2008; Sterling and Pedler 2009). The aim of this thesis 
was to add to the current understanding of neck-arm pain by characterising patients 
with nerve-related neck-arm pain, with a particular emphasis on the assessment of 
NeP in patients with painful cervical radiculopathy and patients with NSNAP. These 
groups were chosen as they have commonalities in their clinical presentation (pain 
characteristics), but may differ in the dominance of underlying pain types. The 
overall aim of the thesis was to investigate the characteristics of patients with nerve-
related neck-arm pain and establish their somatosensory profile. 
 
A series of 5 studies was conducted. The objective of the first study (Chapter 4) was 
to assess the inter-examiner agreement of two musculoskeletal physiotherapists in 
classifying patients with cervical radiculopathy and patients with NSNAP, using 
documented specific clinical classification systems (Elvey 1997; Radhakrishnan et 
al. 1994). Additionally, the diagnostic accuracy of these clinical examiners was 
determined, using the opinion and consensus of two experts (spinal neurosurgeon, 
Specialist in Musculoskeletal Physiotherapy) as the reference criterion. The cohort in 
this study consisted of patients with unilateral neck and arm pain. The pain areas 
may have been causally related or may have been independent from each other. The 
heightened nerve mechanosensitivity could have related to spinal mediated nerve 
sensitivity, as well as to clinically diagnosed distal/peripheral neuropathies, such as 
carpal tunnel syndrome. The findings of this study demonstrated a high percentage 
agreement between the clinical examiners and between these examiners and the two 
experts in identifying and classifying patients with cervical radiculopathy and 
patients with NSNAP.  
 
The second study (Chapter 5) investigated the clinical application of the NeuPSIG 
grading system for the assessment of NeP (Treede et al. 2008) in 152 patients with 
neck-upper limb pain, and the level of agreement in detecting likely NeP between 
this model and two NeP questionnaires (LANSS, PD-Q). The application of the 
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grading system was found to be feasible in this patient cohort. However, its 
implementation required specific expertise and a considerable amount of clinical 
examination time due to the complexity of the patients’ pain presentations. LANSS 
and PD-Q failed to identify a large number of patients clinically classified as having 
NeP, indicating limitations of the screening questionnaires for identifying NeP in 
patients with neck-arm pain of mixed aetiology and mixed pain type.  
 
The third and fourth studies of this thesis were designed to characterise patients with 
cervical radiculopathy and patients with NSNAP using QST and to explore 
differences or commonalities in sensory parameters and underlying pain types.  
In contrast to patients with NSNAP in Study 1, additional inclusion criteria were 
required for patients with NSNAP in order to ensure more homogeneity. Patients 
with NSNAP had to present with a dermatomal C6/7 pain distribution and absence of 
clinical signs of radiculopathy. The specific dermatomal pain distribution was chosen 
to match closely the pain distribution of patients with C6 or C7 radiculopathy. Study 
3 (Chapter 6) addressed the hypotheses that somatosensory profiles would differ 
between patients with cervical radiculopathy and patients with NSNAP, and that the 
sensory profiles of both groups would differ from a positive control group (patients 
with FM). HC data were used as reference data for all groups. The QST profile of 
patients with cervical radiculopathy was distinct from that of patients with NSNAP. 
Patients with cervical radiculopathy were characterised predominantly by a loss of 
function in non-nociceptive stimuli in their maximal pain area and affected 
dermatome, findings consistent with nerve root damage and the presence of NeP 
(Haanpää et al. 2011; Treede et al. 2008). In addition, patients with cervical 
radiculopathy demonstrated a gain of function (cold hypersensitivity) in their 
maximal pain area and ipsilateral foot. This gain in cold sensitivity was also evident 
in patients with NSNAP in their maximal pain area and foot and defined the sensory 
phenotype for this patient group. Patients with NSNAP were predominantly 
characterised by nociceptive pain. Both patient groups differed in their 
somatosensory profiles from patients with FM, the latter demonstrating a widespread 
gain of function in most nociceptive parameters. 
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In order to further characterise patients with cervical radiculopathy and patients with 
NSNAP and to determine the presence of NeP components for each group, a side 
comparison of QST data was performed and the PD-Q applied (Study 4, Chapter 7). 
The QST findings increased the evidence for the presence of nerve root damage in 
patients with cervical radiculopathy, indicated by a significant loss of function in 
cold, mechanical and vibration detection and pressure sensitivity in the affected 
dermatome. The QST findings further supported the presence of NeP in these 
patients, with evidence of lowered mechanical and vibration sense on the 
symptomatic side of their maximal pain area compared to the asymptomatic side. At 
a group level, the PD-Q score did not suggest the presence of NeP, but PD-Q 
identified 30% of individuals as having NeP components. In patients with NSNAP, 
side comparison of QST data and the PD-Q score did not provide evidence for the 
presence of NeP. The findings rather indicated nociceptive pain as the dominant pain 
type in this group. 
 
The PD-Q has been used not only as a discriminative tool for NeP, but also for the 
characterisation of somatosensory profiles in patients with lumbar radiculopathy 
(Mahn et al. 2011) and other NeP conditions (Baron et al. 2009) as well as in patients 
with FM (Amris et al. 2010; Rehm et al. 2010). Hence the final study of this 
dissertation (Chapter 8) explored the correspondence between the self-reported 
somatosensory profiles established by responses to PD-Q, and sensory phenotypes 
demonstrated by QST in patients with cervical radiculopathy and patients with FM. 
Patients with radiculopathy demonstrated a match between their self-reported 
sensory phenotype and QST sensory phenotype for all sensory descriptors except for 
sensitivity to light touch, supporting its use for characterisation of this patient group. 
In patients with FM, the self-reported sensory phenotype did not consistently 
correspond with the QST sensory phenotype.  
 
In this discussion chapter, the application and utility of the clinical and laboratory 
tools used in this thesis for the somatosensory characterisation of patients with nerve-
related neck-arm pain, will be discussed. The strengths and limitations of this 
research; recommendations for future research; and the implications for clinical 
practice will also be presented.  
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9.1 Clinical classification systems 
The fundamental method of identification of NeP is the clinical examination, which 
is aimed at recognising in patients the existence of NeP, localizing the lesion and 
diagnosing the causative disease or event. The latter two aspects were relevant in the 
first study of this thesis (Chapter 4), a study that investigated the inter-examiner 
agreement in classifying patients with cervical radiculopathy and NSNAP, using 
specific classification systems. It has to be emphasized that the presentation of 
heightened nerve mechanosensitivity is not a diagnosis in its own right, as it is not a 
disease entity like radiculopathy, rather it is a clinical feature seen in patients with 
neck-arm pain. It is well documented in the physiotherapy literature (Butler 2000; 
Elvey and Hall 1997; Hall and Elvey 2005; Shacklock 1995) and its assessment has 
been accepted as common clinical practice (Petty and Moore 2001). However, the 
identification of this clinical sign and its differentiation from cervical radiculopathy 
is important as it directs the treatment approach.  
 
The research in this thesis demonstrated a high percentage agreement between the 
clinical examiners in classifying the two patient groups, consistent with findings 
from another classification study of patients with low back-related leg pain (Schäfer 
et al. 2009). Furthermore, high diagnostic accuracy of both examiners in identifying 
these two patient groups was demonstrated. Similarly, high diagnostic accuracy of 
one examiner was further demonstrated in the Studies 3 and 4 (Chapter 6, 7), with 
agreement in classification of 31 of 34 patients classification (91%) between the 
clinical examiner and clinical experts. These results are important as they 
demonstrate effective clinical diagnostic skills that are critical for physiotherapists as 
first contact practitioners and in extended scope of practice areas such as triaging 
patients in neurosurgery clinics or emergency departments (Anaf and Sheppard 2007; 
Lau et al. 2008). High diagnostic accuracy and the risk-benefit implications of 
making wrong diagnostic decisions are of particular significance for patients where 
the causative disease may warrant specific treatment such as surgical or 
pharmaceutical intervention instead of or in addition to physical therapies.  
 
The classification systems for identifying patients with cervical radiculopathy and 
patients with NSNAP were shown to be clinically feasible and reliable in this patient 
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cohort. However, some limitations were identified in strictly applying these systems. 
Strict adherence as applied in the research setting can limit clinical reasoning which 
is an important aspect of clinical decision making (Christensen et al. 2005). For 
example, Category II of the classification system for radiculopathy (see Chapter 4, 
Table 4.1) specifies that, in the absence of any imaging results, three clinical signs of 
nerve root impairment have to be present for the diagnosis of radiculoapthy: a 
sensory dermatomal change, a myotomal change and a diminished reflex. Therefore, 
this category encompasses criteria for the presence of a combined motor and sensory 
radiculopathy, but does not allow for a differentiation between the two. This issue is 
clinically important as each condition is indicative of a nerve root lesion and may 
need specific intervention. An example would be a patient with a pure sensory 
radiculopathy (no motor impairment) who may present with NeP, requiring targeted 
treatment. In contrast, a patient with a pure motor radiculopathy may not experience 
any pain and may not need any intervention, as long as their function was not 
significantly impaired. Moreover, Category II of the classification system is 
compromised if muscle strength tests cannot be performed due to pain inhibition, 
negating one criterion for the presence of motor nerve root impairment. Furthermore, 
the presence of neck and/or arm pain should be listed in this category, if the system 
is used for the classification of painful radiculopathies. 
 
To our knowledge, no comparative studies exist which assess inter-examiner 
agreement in the classification of patients with cervical radiculopathy or patients 
with NSNAP. To some extent, the findings can be compared to an inter-rater 
reliability study of a classification system for 40 patients with neural low back–
related leg pain (Schäfer et al. 2009), although patients were classified into four 
groups: 1) central sensitisation, defined by the authors when patients demonstrated a 
score of ≥ 12 on the LANSS; 2) denervation, defined as a LANSS score < 12 and the 
presence of clinical signs of nerve root damage; 3) peripheral nerve sensitisation, 
where the first two classification did not apply and patients presented with increased 
peripheral nerve mechanosensitivity and 4) musculoskeletal (patients not meeting 
any of the above criteria). Group 2 in the Schäfer et al study (2009) equates to our 
patients with cervical radiculopathy, except that in our study the LANSS was not 
used for classification. Group 3 equates to patients with clinical signs of heightened 
nerve mechanosensitivity and group 4 equates to others (patients not fulfilling the 
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criteria for cervical radiculopathy or heightened nerve mechanosensitivity). 
Similarities between Schäfer et al’s study and ours do exist, as both studies employed 
experienced clinical examiners, the classifications were applied in a hierarchical 
order and both studies reported 80% agreement between clinical examiners in 
classifying patient groups. However, while Schäfer et al (2009) commented that the 
ease of application of a hierarchical order is advantageous, this system has 
limitations as the categories were treated as being mutually exclusive. Such 
separation is not consistent with clinical pain presentations. For example, heightened 
nerve mechanosensitivity can coexist with pain presentation of denervation, as 
documented in patients with low back–related leg pain (Schäfer et al. 2009), in 
patients with cervical radiculopathies (Study 4) (Chien et al. 2008; Wainner et al. 
2003) and in patients with carpal tunnel syndrome (Wainner et al. 2005). Although 
the differentiation between the clinical presentation of painful cervical radiculopathy 
and NSNAP is important, they should not be regarded as being mutually exclusive, 
as these could be viewed as disorders on a clinical continuum. For example, 
pathological conditions attacking the nerve from the outside might initially cause 
nociceptive nerve trunk pain and subsequently also cause nerve damage and 
therefore be associated with NeP (Marchettini et al. 2006). The patient would 
therefore present with co-existing nociceptive and NeP.  
 
Considering that both clinical examiners in our study were highly skilled and 
experienced, it is unclear if less experienced physiotherapists would achieve similar 
agreements in classifying these patient groups, and this aspect of clinical application 
of classification warrants further research. Moreover, the sample size of patients with 
NSNAP classified by the expert was small (n = 9), and the implication of such small 
sample size is discussed in detail under section 9.3. Summarized, patients with 
cervical radiculopathy and patients with NSNAP can be reliably identified, using the 
two documented clinical classifications systems, although a combination of the two 
may increase the likelihood of accurate classification for less experienced clinicians. 
 
Similar to the classification of the patients with cervical radiculopathy and patients 
with NSNAP, the recommended classification of patients with NeP relies on a 
combination of items (Treede et al. 2008). The NeuPSIG grading system of certainty 
for the presence of NeP, is based on pain distribution and a history suggesting a 
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relevant nerve lesion, the presence of sensory alterations in the innervation territory 
of the affected nerve structure and confirmative evidence of a nerve lesion/disease 
from diagnostic tests (Treede et al. 2008). Study 2 (Chapter 5) is the first study to 
demonstrate the application of this grading system in a large cohort of patients with 
neck-upper limb pain, and applying this classification system proved to be feasible in 
this clinical cohort. However, several considerations have to be discussed, 
considering that this model has been recommended for use in primary care settings 
(Haanpää et al. 2009). The first criterion of this grading system relates to the 
presence of pain within a distinct neuroanatomically plausible distribution. In our 
Studies 3 and 4, patients with cervical radiculopathy as well as patients with NSNAP 
both met this criterion. Both groups presented with pain following a C6 or C7 
dermatomal distribution, however the dominant underlying pain types differed 
between groups. Additionally, the pain distribution in patients with radiculopathy 
may not always follow a dermatomal pattern (Murphy et al. 2009; Slipman et al. 
1998). Furthermore, coexisting musculoskeletal disorders are common in patients 
with suspected cervical radiculopathy (Cannon et al. 2007) and can mimic nerve 
lesions (Lauder 2002). Thus, the pain distribution alone does not necessarily indicate 
the presence of NeP. 
 
It has been suggested that the assessment of sensory alterations is the most important 
part of the clinical examination of NeP (Haanpää et al. 2011). While the sensory 
testing in the patient’s maximal pain area is not difficult to perform, the 
interpretation of the findings of sensory aberrations can be challenging for the 
following reasons: 
1) The presence of a sensory alteration is not necessarily indicative of NeP, as 
sensory changes can be present in non-NeP conditions, as documented in 
patients with FM in Study 3 and 5 (Chapter 6, 8) and other patient 
populations (Blumenstiel et al. 2011; Leffler et al. 2000; Westermann et al. 
2011). 
2) Sensory aberrations have been reported in referred pain areas in patients with 
musculoskeletal pain (Leffler et al. 2000), thus symptoms and signs may to 
some extent mimic NeP states. As for patients with neck-arm pain, 
musculoskeletal conditions are common in patients with suspected cervical 
radiculopathy (Cannon et al. 2007) and can mimic cervical radiculopathy 
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(Lauder 2002). The patient cohort in Study 2 gives an example, as 54% of 
patients indicated the neck/trapezius/scapula/shoulder area as their main area 
of pain and these areas also correlate with specific cervical nerve root 
distributions (Tanaka et al. 2006). Further, a musculoskeletal pain disorder 
and a non-painful nerve lesion may coexist (for example nociceptive neck 
pain coexisting with a non-painful motor radiculopathy), and the pain 
distribution of nociceptive pain may be located in the same area as the 
innervation territory of the affected nerve structure. Thus, sensory alterations 
may be misinterpreted as a sign of the presence of NeP. 
3) It has been recommended that findings in the painful area should be 
compared with findings on the contralateral mirror side in unilateral pain 
conditions (Haanpää et al. 2011). However, limitations to this approach are 
also evident as sensory changes may exist bilaterally, as seen in patients with 
cervical radiculopathy (Chien et al. 2008), in patients with trigeminal 
neuropathy (Jääskeläinen et al. 2005; Leffler and Hansson 2008) and also in 
patients with non-NeP (Leffler et al. 2003). Hence, the asymptomatic side 
may be misleading as a true control (Baron 2006). Our patients with cervical 
radiculopathy (Study 4, Chapter 7) presented with bilateral reduced thermal 
detection in the maximal pain area, therefore the asymptomatic side was not a 
true control for the side comparison of thermal detection. However, the 
asymptomatic area was effective as a control for identifying differences in 
mechanical and vibration detection between sides. 
4) Sensory alterations may occur without any tissue damage. The presence of 
cold hypersensitivity is an example. While cold hypersensitivity is a common 
sequel of nerve injuries (Landerholm et al. 2010; Taylor et al. 2010), it has 
also been documented in patients with no identifiable underlying pathology 
such as FM, as documented in Studies 3 and 5 and by others (Berglund et al. 
2002; Blumenstiel et al. 2011; Hurtig et al. 2001). Furthermore, patients with 
depression and without pain presented with cold hypersensitivity (Klauenberg 
et al. 2008). 
 
Summarized, the findings of sensory aberrations in patients with suspected NeP have 
to be interpreted in light of the overall clinical examination findings. The frequency 
of sensory aberrations tends to increase with the likelihood of the presence of NeP, 
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as evident in the patient cohort with neck-arm pain in Study 2 and in others 
(Rasmussen et al. 2004). Hence, clinicians may use this information as a further hint 
for the determination of the predominant underlying pain type, as patients with NeP 
are likely to demonstrate more than one sensory alteration. 
 
Another important element in the determination of the presence of NeP in patients 
with neck-arm pain is the evidence for the presence of a nerve lesion/disease. 
Imaging studies such as a CT scan or MRI are accepted as diagnostic tests to confirm 
nerve root compression (Treede et al. 2008). However, degenerative changes of the 
cervical spine are common and can be easily interpreted as false positive findings 
(Matsumoto et al. 1998) if not put into the context of the overall clinical examination 
findings. For example, our patients with NSNAP presented with a C6/7 dermatomal 
pain distribution, but no clinical signs of a radiculopathy. If imaging studies for these 
patients revealed any abnormality indicating compression of the C6 or C7 nerve root 
on the symptomatic side, this finding may be misinterpreted as a confirmation of a 
radiculopathy. Likewise, false negative findings may also be misleading, as for 
example in the case of Parsonage Turner Syndrome associated with NeP. This pain 
condition mimicked cervical radiculopathy, but in this case MRI findings were 
negative (Feinberg et al. 2007). The clinician should be aware of these limitations of 
diagnostic tests in order to correctly classify NeP.  
 
Identification of a NeP component in mixed pain presentations may be more difficult 
than identification of ‘typical’ NeP conditions such as postherpetic neuralgia as 
various degrees of neuropathic components may be present, also referred to as pain 
‘being more or less neuropathic’ (Attal and Bouhassira 2004; Bennett et al. 2006). 
The diagnosis of NeP and application of this grading system to patient pain disorders 
can be straight forward, as in the case of postherpetic neuralgia after shingles or NeP 
after a known surgical nerve lesion. In both cases, the history provides information 
on the cause of the pain disorder, plus the pain is localized to a single body area. 
However, this diagnostic approach does require a considerable time allocation and 
specific expertise for the classification of patients with complex and mixed pain 
presentations as seen in the current study. Applicability in primary care settings for 
such patient populations may be limited, given the time-constraints in general 
practice (Bindman et al. 2007; Campbell 2007) and possible lack of adequate skills 
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(Bennett et al. 2007). Furthermore, the identification of NeP does not exclude the 
coexistence of nociceptive pain.  
 
There is a challenge for clinicians to identify the dominant underlying pain type. The 
assessment of self-reported pain descriptors may aid in the determination of the 
predominant pain type. In both Studies 2 and 4, the descriptor ‘electric shock’ was 
only used by patients with NeP and the descriptor of ‘spontaneous’ pain was most 
common in patients with NeP. However, single descriptors are not discriminative for 
NeP and nociceptive pain (Behrman et al. 2007; Hansson et al. 2007), rather a 
combination of items can discriminate between the two, as demonstrated with the use 
of various NeP screening tools (Bennett 2001; Bennett et al. 2005; Bouhassira et al. 
2005; Krause and Backonja 2003). Nevertheless, these clusters of sensory verbal 
descriptors were obtained in patients with ‘classical’ NeP conditions. Using 
descriptors of two NeP questionaires (Galer and Jensen 1997; Krause and Backonja 
2003), Behrman et al (2007) demonstrated that patients with mixed pain 
presentations (radiculopathies) were much more difficult to classify than patients 
with NeP polyneuropathies. Similarly, our patients in Study 2 and 4 (Chapter 5, 7) 
would be difficult to classify purely based on their sensory descriptors, as an overlap 
of NeP and nociceptive pain descriptors was demonstrated between the patient 
groups. While further questionnaires were developed to assess pain qualities related 
to NeP as well as non-NeP pain (Dworkin et al. 2009; Jensen et al. 2006), these 
questionnaires are not screening tools to identify NeP. Before NeP questionnaires 
can be generalised to all types of NeP, it has to be determined if the NeP component 
in the population studied has similar pain descriptors to the NeP in the original 
validation study of the questionnaire (Bouhassira et al. 2005). This issue will be 
further discussed in section 9.2. 
 
In Studies 3 and 4, common NeP descriptors were more frequently used for the 
description of patients’ arm pain than patients’ neck pain, suggesting that where 
multiple symptom areas exist, the assessment of pain descriptors for each symptom 
area may further assist in identification of pain types. This approach was employed 
in a recent study on patients with low back and leg pain (Attal et al. 2011) in which 
the DN4 questionnaire was applied independently to both the patient’s back and leg 
pain. Based on the DN4 score, 52% of patients with lumbar radiculopathy presented 
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with nociceptive back pain and neuropathic leg pain while others presented with 
neuropathic back pain and nociceptive leg pain. These results demonstrate well the 
coexistence of two pain types within separate body regions in patients with 
radiculopathy. However, mixed neuropathic and nociceptive mechanisms may also 
account for pain in the same body area (Baron and Binder 2004). Therefore, while it 
has to be noted that pain descriptors would never be used in isolation for the 
diagnosis of NeP, more data on the usefulness of pain descriptors in the 
determination of dominant pain types in patients with mixed pain presentations is 
needed.  
 
It is unclear how confident health professionals in primary care are in identifying 
NeP in patients with chronic pain disorders. Data from a general practice research 
database in the UK suggest sub-optimal NeP management for patients with 
predominantly NeP and for patients with mixed pain disorders (including back/neck 
pain) (Gore et al. 2007). It has not been established whether the sub-optimal 
management occurs as a result of lack of knowledge on how to identify patients with 
NeP or lack of knowledge on how to manage patients with NeP. In a survey amongst 
European neurologists (n = 745) participants frequently mentioned that NeP in 
patients with radiculopathy remains undiagnosed because of a lack of knowledge. 
Similarly, few data exist on physiotherapists’ knowledge in the identification of NeP 
in musculoskeletal pain disorders. A recent Delphi survey of 103 expert clinicians 
(31 pain physicians and 72 musculoskeletal physiotherapists) established clinical 
indicators of nociceptive, peripheral neuropathic and central mechanisms of 
musculoskeletal pain (Smart et al. 2010). Based on these clinical indicators and using 
the statistical method of logistic regression analysis, a discriminatory cluster of 
symptoms and signs predictive of each mechanism was identified in patients with 
low back (±) leg pain. According to this analysis, a cluster of three criteria was 
predictive of the dominance of peripheral NeP: ‘history of nerve injury/pathology’; 
‘pain referral in a dermatomal or cutaneous nerve distribution’; and ‘pain/symptom 
provocation with movement tests that move/load/compress neural tissue’ (Smart et 
al. 2011, p5). The predictive value of this cluster approach was 86.3%. The first two 
criteria, a history of nerve injury and pain referral in a dermatomal or cutaneous 
nerve distribution, are consistent with the first two criteria of the NeuPSIG grading 
system for NeP (Treede et al. 2008).  
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In this thesis, the results of Study 4 do not necessarily support the argument that pain 
referral in a dermatomal distribution and pain provocation in response to a nerve 
provocation test are indicative of NeP, as patients with NSNAP (and these two 
clinical features) were characterised by mainly nociceptive pain. However, a few 
considerations apply to the studies by Smart et al (2010;  2011). Firstly, the former 
definition for NeP, that is “pain initiated or caused by a primary lesion or 
dysfunction of the nervous system” (Merskey and Bogduk 1994, p212), was used in 
developing the clinical indicators. Under this definition, clinical signs of heightened 
nerve mechanosensitivity could be interpreted as a dysfunction of the nervous system 
because neural tissues demonstrate lowered compliance to movement tests. 
However, this criterion does not meet the new definition of NeP that requires a nerve 
lesion or disease of the somatosensory nervous system to be present. More data are 
needed to investigate how prevalent the feature of heightened nerve 
mechanosensitivity is in patients with painful nerve lesions and NeP. Secondly, 
mixed pain presentations (for example mixed nociceptive/neuropathic, mixed 
neuropathic/central sensitisation) were excluded in the Smart et al (2011) regression 
analysis. Hence, similar to the classification study of Schäfer et al (2009), pain 
disorders were classified as being mutually exclusive and this does not reflect the 
clinical spectrum of patients with low back pain disorders (or with nerve-related 
neck-arm pain).  
 
Furthermore, a sensory deficit in the innervation territory of a lesioned nerve 
structure is a diagnostic criterion of NeP (Haanpää et al. 2011; Treede et al. 2008), 
but this criterion did not get any mention in this classification system for peripheral 
NeP. In contrast, using logistic regression analysis, Scholz et al (2009) documented a 
cluster of physical examination discriminative indicators for the differentiation of 
lumbar radicular pain (radicular pain being defined in this context as NeP with 
clinical signs of nerve root impairment) and lumbar axial pain, which incorporated a 
deficit in the detection of cold sensation and pinprick hypoalgesia. Interestingly, a 
positive straight leg raise test was also included in this cluster, for this clinical sign 
has not been mentioned before as a criterion for the presence of NeP. However, the 
diagnostic accuracy of the developed standardised evaluation of pain (combination of 
interview items and physical examination items) was still high when the straight-leg-
raising test was excluded from the analysis (area under the curve 0.85 compared to 
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0.98), indicating that the straight-leg-raising test is not that important as a single 
discriminative factor in this cohort. The Scholz et al (2009) study demonstrated that a 
combination of pain-related symptoms and signs is useful in differentiating axial and 
radicular low back pain and this approach is consistent with the NeuPSIG grading 
system comprising neuroanatomically related pain distribution and sensory 
aberrations. 
 
Summarized, the NeuPSIG grading system was feasible for the identification of NeP 
in patients with neck-arm pain of mixed aetiologies and mixed pain types. However, 
for our study population this diagnostic approach required a considerable time 
allocation and specific skills, both of which may not be available in primary care 
settings. Clinician’s lack of time or skill has been acknowledged (Bennett et al. 
2007) and NeP screening tools, for example the LANSS and PD-Q, have been 
developed in order to assist health professionals in identifying potential patients with 
NeP. 
9.2 Neuropathic pain screening tools 
NeP screening tools are recommended for the use by non-specialists and in primary 
care (Bennett et al. 2007; Haanpää et al. 2011). However, our results (Chapter 5) 
suggest that the LANSS and PD-Q may not be suitable tools for the identification of 
NeP in patients with neck-arm pain of mixed aetiology and mixed pain types. We 
found LANSS had a sensitivity of 22% and PD-Q a sensitivity of 64% in patients 
with neck-arm pain, much lower than those sensitivities reported in the original 
developmental studies (Bennett 2001; Freynhagen et al. 2006a).  
 
One explanation for the lowered sensitivity of both questionnaires may be the 
differences in clinical characteristics of the studied patient cohorts. Both 
questionnaires were validated in specific pain clinic patient populations with and 
without NeP. Importantly, patients with mixed pain presentations were excluded 
from both studies (Bennett 2001; Freynhagen et al. 2006a). Patients with NeP 
included those with ‘typical’ NeP conditions such as postherpetic neuralgia, painful 
neuropathy and nerve traumas. In the LANSS study, 7 out of 30 patients with NeP 
had a radiculopathy (lumbar radiculopathy n = 5, cervical radiculopathy n = 2) 
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(Bennett 2001). In the PD-Q study, the number of patients with NeP radiculopathy 
was not mentioned (Freynhagen et al. 2006a). In fact, the latter study did not provide 
any information on the proportion of patients in each group or each group’s pain 
characteristics. In contrast to the validation studies, our 152 patients with neck-arm 
pain in Study 2 presented with a wide spectrum of pain presentations of mixed 
aetiology. Some conditions, such as radiculopathies and carpal tunnel syndrome were 
likely to include NeP, whereas others were predominantly nociceptive 
musculoskeletal conditions, such as mechanical neck pain.  
 
Our patients’ choice of pain descriptors to some extent differed to the defined pain 
descriptors listed in the NeP screening tools. In the validation study of LANSS 
(Bennett 2001), a significant association between allodynia and hyperalgesia was 
noted for patients with NeP. In contrast, in our neck-arm pain study (Study 2), 
hyposensitivity occurred more frequently than hypersensitivity. Our data are 
consistent with findings in patients with lumbar radiculopathy (Scholz et al. 2009), 
and in patients with various chronic suspected NeP conditions (Rasmussen et al. 
2004), and in our patients with cervical radiculopathy (Chapters 6, 7). In the LANSS 
tool, only allodynia is scored as a relevant sensory alteration in response to light 
touch, but not hypoaesthesia. Allodynia was demonstrated in only 5 of our 152 
patients. Furthermore, only 6 of our patients reported symptoms of possible 
autonomic nervous system dysfunction, such as color changes of the skin in the 
painful area. These observations suggest that allodynia and autonomic dysfunction 
are not frequently- reported characteristics for these patients with nerve-related neck-
arm pain. Both items (allodynia and autonomic dysfunction) yield the highest score 
(score = 5) that is obtainable for a question in LANSS. The high score associated 
with a relatively rare characteristic is consistent with the low sensitivity of LANSS in 
our patient population. This finding demonstrates the limitation associated with 
validation of a questionnaire in a dichotomous patient sample (NeP/non-NeP) and 
the application to a heterogeneous sample. Splitting patients into two categories may 
limit the ability to generalise results to a mixed pain clinical population. 
 
The LANSS may be most useful for the identification of NeP in patient cohorts who 
demonstrate mainly positive sensory signs rather than negative sensory signs. 
Heterogeneity of patients with NeP in regard to their sensory characteristics 
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/somatosensory profiles has been demonstrated by use of QST (Maier et al. 2010; 
Rolke et al. 2006a) and the PD-Q (Baron et al. 2009; Mahn et al. 2011). In the two 
latter studies, in patients with NeP due to diabetic neuropathy and postherpetic 
neuralgia and in patients with lumbar radiculopathy, two sub-groups of patients were 
characterised by burning pain, paraesthesia, numbness and lack of hyperalgesia and 
allodynia. If this sensory profile was assessed by LANSS, a score ≥ 12 may not be 
reached, thus this patient group would be incorrectly classified as having 
predominantly nociceptive pain. Similarly, a patient with postherpetic neuralgia, 
characterised by the presence of mainly negative signs/loss of function (Rolke et al. 
2006a), may score much lower on the LANSS than a patient with the same aetiology, 
but who is characterised by the presence of mainly positive signs manifesting as 
hyperalgesia and allodynia in various QST submodalities (Rolke et al. 2006a).  
 
There are indications that the cut-off score of LANSS may have to be adjusted for 
identification of NeP components in differing populations from the original 
population studied. A recent study in patients with spinal cord injuries demonstrated 
that the appropriate cut-off value of LANSS, the PD-Q and NPQ for the population 
studied was lower than in the original studies (Hallström and Norrbrink 2011). The 
cut-off value of LANSS dropped from ≥ 12 to ≥ 4 and the cut-off value of PD-Q 
from ≥ 19 to ≥ 8. Interestingly, the cut-off score for the DN4 did not differ to its 
original study and DN4 was most sensitive out of all questionnaires (sensitivity: DN4 
93%, LANSS 36%, PD-Q 68%, NPQ 50%; specificity: DN4 75%, LANSS 100%, 
PD-Q 83%, NPQ 100%). In our Study 2, there were 48 cases where results of 
LANSS and clinical classification were discordant. In 35 of these the clinical 
classification was definite NeP. The LANSS scores for 16 of the 35 were 10 or 11 
points, just short of the published cut off of 12. With a cut-off score of 10, sensitivity 
of LANSS would have increased to 58%. However, at the same time, specificity 
would have reduced from 88% to 73%, thus a change in cut-off points may improve 
sensitivity, but compromise specificity.  
 
Given the bias of LANSS towards identifying NeP components characterised by 
predominantly sensory gains, the validity of this questionnaire applied in patients 
with mixed pain may be limited. The inclusion of patients with mixed pain 
presentations has been reported to reduce the sensitivity of LANSS (from 85.9% to 
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81.8%) in a cohort of 156 patients with chronic pain (Rejas et al. 2006), whereby 
specificity did not alter much (from 90.3% to 89.4%). However the proportion of 
patients with mixed pain was small (14%) and unfortunately, the type of patient 
population/aetiologies was not mentioned in the study making a comparison with our 
data difficult.  
 
The DN4 may be more suitable for the identification of NeP in mixed pain 
presentations than LANSS or PD-Q. The diagnostic accuracy of the LANSS and 
DN4 questionnaire was compared in a cohort of 180 patients of which 59 patients 
had clinically classified nociceptive pain and 121 patients had clinically classified 
definite or probable NeP (Treede et al. 2008; Unal-Cevik et al. 2010). Fifty-two 
percent of the latter comprised patients with cervical or lumbar radiculopathy. The 
sensitivities of LANSS and DN4 were 70% and 95% respectively, the specificity of 
both tests was 97%. However, the patients with radiculopathy demonstrated 
predominantly NeP, thus it is unclear if DN4 would perform better than LANSS in a 
mixed patient cohort similar to those in Study 2. Independent of the various patient 
populations studied, LANSS has demonstrated high specificity in all studies (Bennett 
2001; Hallström and Norrbrink 2011; Mercadante et al. 2009; Potter et al. 2003; 
Unal-Cevik et al. 2010; Yucel et al. 2004), including Study 2 in this thesis, 
suggesting its usefulness in ruling out NeP in patients with chronic pain disorders. 
 
The PD-Q was specifically designed to identify NeP components in patients with low 
back pain with and without referred pain (Freynhagen et al. 2006a). Hence it was 
anticipated that the questionnaire may be transferable to patients with neck-arm pain. 
One concerning factor of the PD-Q emerging from this thesis, is its openness to 
individual interpretation as a self-reported tool. Patients are asked to mark their 
maximal pain area on the body chart of the PD-Q and each item descriptor is 
supposed to relate to this marked body area. In Study 2, 35% of patients with neck-
arm pain either didn’t mark a pain area at all or marked multiple pain areas, some of 
which were unrelated to each other. Thus, it remains unclear which pain area these 
patients were referring to when they gave their responses in PD-Q. In addition, many 
patients experienced paraesthesia in their upper limb, but not in their pain area, thus 
creating confusion about how to answer the two questions about the presence of 
paraesthesia (tingling, numbness) in the area of pain. Other studies using the PD-Q 
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have not commented in regard to misinterpretations of PD-Q or the difficulty with 
multiple pain areas (Amris et al. 2010; Baron et al. 2009; Beith et al. 2011; 
Freynhagen et al. 2006a; Hallström and Norrbrink 2011; Jespersen et al. 2010; Prout 
et al. 2010; Rehm et al. 2010), except one study reporting missing data on the PD-Q 
(Junker et al. 2008). Thus, it is unknown if the study in this thesis is the only one 
observing these discrepancies, although this would seem unlikely. Then again, as 
documented in Chapter 8, patients with cervical radiculopathy correctly marked their 
pain/symptom area in the body chart of PD-Q without being given prior instructions. 
Perhaps the combination of: a) the fact that their pain areas were causally related; b) 
they did not have other/additional pain areas; and c) patients were in a research 
environment concentrating just on neck-arm pain yielded a better accuracy in 
matching responses to the item descriptors and the relevant pain areas.  
 
One explanation why the PD-Q only identified 30% of patients with cervical 
radiculopathy as having NeP (Study 4), may relate to the discriminative ability of 
NeP screening tools, as it has been proposed that these tools are only reliable when 
applied to one specific painful area (Bouhassira and Attal 2011). It is possible, that 
the independent application of PD-Q to both pain areas (neck and arm pain) may 
increase the sensitivity of the PD-Q, as previously demonstrated for the DN4 in 
patients with lumbar radiculopathy (Attal et al. 2011). Additionally, a future study 
will have to investigate if the lowered sensitivity of PD-Q may be related to a 
mismatch between the pain descriptors reported by the patients and the pain 
descriptors included in PD-Q. For example, in patients with radicular leg pain, sub-
groups with distinct sensory profiles were identified, and one sub-group presented 
with only one dominant sensory descriptor contained in the PD-Q (Mahn et al. 
2011). 
 
Another possible explanation may be the weighing of the item descriptors. In the 
study of patients with spinal cord injuries (Hallström and Norrbrink 2011), cut-off 
levels for discriminating NeP were low in the weighted items of PD-Q and it was 
suggested that the intensity of the sensory descriptor may not be that important for 
discrimination, but simply its presence or absence. Lastly, NeP screening tools are 
suggested to be less feasible in patients with multiple pain locations and with 
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widespread pain (Bouhassira and Attal 2011), consistent with our results in patients 
with neck-arm pain (Study 2) and in patients with FM (Study 5). 
 
Reliability studies of PD-Q are scarce with only one study reporting moderate 
reliability (Kappa 0.59; 95% CI 0.34 to 0.85) of the Swedish version of the 
questionnaire in patients with central NeP (Hallström and Norrbrink 2011). No study 
documented reliability in other patient cohorts, using either the original German 
version of PD-Q (Hallström and Norrbrink 2011) or other translated versions, nor do 
reports on further validation studies exist, suggesting a possible compromise of the 
validity of the PD-Q outside the documented settings and cohorts. Hence, PD-Q 
outcomes have to be interpreted in light of these limitations. 
 
In conclusion, the diagnostic accuracy of LANSS and PD-Q in identifying NeP was 
limited in our patients with neck-arm pain of mixed aetiology and mixed pain type(s) 
(Study 2) and in our patients with cervical radiculopathy (Study 4). Future research is 
recommended, aiming to define the pain descriptors and sensory characteristics that 
are able to better discriminate NeP from non-NeP in patients with neck-arm pain and 
to further analyse the appropriate cut-off values of LANSS and PD-Q for 
discriminating NeP in such patient cohorts. Furthermore, the reliability of PD-Q 
needs to be investigated in patients with peripheral NeP related to musculoskeletal 
conditions. 
 
NeP screening tools are not meant to be used in isolation for the diagnosis of NeP, as 
they do fail to identify 10-20% of patients with NeP (Bennett et al. 2007) and do not 
provide information about the causal lesion or the location of the affected nerve 
structure(s). Furthermore, it has been demonstrated in patients with low back and leg 
pain that the exploration of sensory symptoms in interview format for the distinction 
between NeP and non-NeP, was less sensitive than the physical examination items 
(Scholz et al. 2009). Hence, the physical assessment of sensory profiles, using 
bedside examination, or more sophisticated QST, plays an important role in better 
discriminating pain types, as documented in section 9.4. For the interpretation of the 
findings from our QST studies (section 9.4), certain considerations are relevant. 
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9.3 The samples 
Patient samples 
Despite extensive recruitment efforts and numerous referring sources, it was not 
possible to recruit more subjects into the QST studies (Chapters 6 – 8), within the 
given timeframe of this thesis. The methods employed for the studies were robust 
and the inclusion/exclusion criteria for patients with cervical radiculopathy and 
patients with NSNAP were tight. Our strict selection criteria add strength to the 
studies as they ensured our study groups were homogenous. However, the strict 
inclusion criteria brought with them the compromise of obtaining smaller sample 
sizes than anticipated and also limit the generalisability of our findings. The patient 
cohort in Study 2 demonstrated that patients with neck-arm pain frequently present 
with co-morbidities, for example diabetes and thyroid dysfunction, that were not 
present in our patient cohorts in the QST studies. Thus, the patient cohorts in the 
QST studies may not reflect the clinical spectrum of patients with cervical 
radiculopathy and patients with NSNAP. 
 
The sample size of patients with NSNAP was small, thus a type II error cannot be 
excluded from our studies. A post-hoc power analysis demonstrated ß values ≤ 0.65 
for the comparison of QST parameters that did not differ between patients with 
NSNAP and HC and for the comparison of QST parameters that did not differ 
between sides in patients with NSNAP. The small sample size might reflect that 
NSNAP as a discrete disorder is far less prevalent than clinically reported and may 
occur more frequently in coexistence with nerve lesions including radiculopathy. 
Comparable data exist in patients with nerve-related low back and leg pain (Schäfer 
et al. 2009) where out of 40 patients, only 10% demonstrated features of heightened 
nerve mechanosensitivity as a discrete disorder (without any clinical signs of nerve 
root dysfunction), but in 57% heightened nerve mechanosensitivity coexisted with 
clinical signs of nerve damage. 
 
Apart from patients not fulfilling the inclusion and exclusion criteria of the study, 
another limitation for recruitment was the time needed for the performance of the 
QST protocol. The QST of each body area tested typically required 30 minutes, thus 
in total the assessment time for 5 body regions came to 2.5 hours. In addition, the 
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questionnaires had to be completed prior to QST, which took 15 to 30 minutes, and 
the NPTMEDIAN was performed after the QST testing. Several patients fulfilling the 
inclusion criteria of the study were unable to participate due to time constraints. 
 
HC sample 
In addition to the patient groups recruited, we recruited a sample of healthy control 
subjects. QST data from these subjects were used to transform the patient data to 
standardise the values obtained in a variety of different units of measures into 
standard deviation units that can more readily be compared between parameters and 
body regions measured. The method of z-transformation used in this thesis was that 
proposed by Rolke et al (2006b). Prior to the commencement of data collection, 
based on clinical observations, it was anticipated that most patients would nominate 
the upper trapezius muscle as their main pain area. Consequently early in the data 
collection period, QST parameters were measured in 26 HC subjects in the upper 
trapezius muscle. However, during the course of the study it became apparent that 
patients indicated a variety of other body regions as their main pain area. Although 
some studies have calculated patient z-scores using HC reference data from different 
body regions it has been recognized as a limitation (Blumenstiel et al. 2011; Maier et 
al. 2010). The importance of this limitation was discussed with DFNS, who 
recommended site matched data should be collected from a minimum of 8 HC 
subjects for each site. Therefore additional HC subjects were recruited and QST data 
collected from the seven additional sites patients had indicated to be their maximal 
pain. Due to time constraints it was not possible to gender-match this additional HC 
data.  
 
Ultimately, data for z-score transformation were available from at least 8 HC for 
every site measured in the patient groups. This sample size is in accordance with 
established methodology by DFNS for data standardisation (Blankenburg et al. 
2010). However, in our opinion this sample size is small and caution should be 
applied in interpreting the findings from a sample of 8 subjects to be ‘normative’ or 
suggesting that values outside the 95% CI around the mean of such a small sample 
could be regarded as ‘abnormal’ (Krumova et al. 2010). Therefore, patient QST data 
in this thesis have to be interpreted in light of this caveat. 
On a further note, some of our HC data measured over the dorsum of the foot and the 
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C6/7 dermatome(s) were different from the reference data obtained by DFNS over 
the foot and the dorsum of the hand (see Table 9.1), suggesting that our HC group 
was less sensitive to thermal pain, mechanical detection and vibration detection 
compared to the DFNS normative data. There was no obvious explanation for these 
differences. The differences in measured thermal sensitivity are unlikely due to the 
equipment as the thermostat was regularly calibrated, including trips to Sweden 
during the course of the study. We speculated the reduced sensitivity of our cohort 
may be a geographical effect as individuals in the southern hemisphere are more 
exposed to environmental influences such as sun light and UV radiation compared to 
individuals in the northern hemisphere. While speculative, such exposure may cause 
thickening of the epidermis resulting in reduced sensitivity. However, a CPT of 9º 
over the hand, similar to DFNS data, has been reported in another Australian HC 
group (Chien et al. 2008), suggesting variances in Australian HC cohorts and not 
supporting the concept of sun damaged skin reducing sensitivity. Mechanical 
detection was not measured in the latter study and the methodology of vibration 
detection differed from ours, limiting a comparison of findings for those parameters. 
Regardless of the reasons, these differences in the comparative HC data across 
laboratories and studies, highlights the importance of using HC data measured in the 






Table 9.1  
A comparison of our healthy control QST data (foot/dermatome) and the data of the 
German Research Network on Neuropathic Pain (DFNS) (Rolke et al. 2006a) 
 Current study DFNS 
 Age 20 – 65 years 
48% female  
Female ≥ 40 years Male ≥ 40 
years 
QST parameter FOOT 
CDT (°C) 3.42 2.61 3.39 
WDT (°C) 4.70 4.37 6.21 
TSL (°C) 9.39 7.57 10.33 
CPT (°C) 5.8 10.8 8.0 
HPT (°C) 46.3 45.02 47.0 
MDT (mN) 6.3 2.2 3.0 
MPT (mN) 58 62 103 
MPS (NRS100) 0.41 0.77 0.51 
WUR (ratio) 3.30 2.51 2.59 
VDT (x/8) 5.9 7.0 6.8 
PPT (kPa) 584 535 570 
 HAND 
CDT (°C) 1.57 1.44 1.35 
WDT (°C) 2.94 2.01 2.08 
TSL (°C) 4.71 3.22 3.05 
CPT (°C) 6.11 10.43 7.29 
HPT (°C) 47.3 44.1 45.8 
MDT (mN) 2.24 1.17 0.90 
MPT (mN) 73 71 116 
MPS (NRS100) 0.36 0.63 0.50 
WUR (ratio) 2.77 2.24 1.97 
VDT (x/8) 7.0 7.7 7.6 
PPT (kPa) 471 441 516 
Differences between data of current study and DFNS data are highlighted in grey 
 
9.4 Sensory profiling 
The recognition of patients with differing pain syndromes presenting with similar 
clinical profiles is important because this directs the provision of targeted treatment. 
Our patients with cervical radiculopathy and our patients with NSNAP in Study 3 
and 4, were similar in regard to demographics and clinical characteristics such as 
pain distribution, pain descriptors, degree of disability, impact of their pain on 
physical and mental status, sleep quality, fear avoidance behaviours and anxiety and 
depression scores. However, QST proved to be a useful adjunct in identifying the 
underlying pain type in each patient group and in identifying the difference between 
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the groups in regard to their underlying pain types. The use of QST profiling was 
important to distinguish groups because the presence of radiculopathy alone does not 
imply the presence of NeP, as a nerve lesion can be pain free (Landerholm et al. 
2010). 
 
Distinct somatosensory profiles were identified for patients with cervical 
radiculopathy and patients with NSNAP. Patients with cervical radiculopathy were 
characterised by a loss of function in non-nociceptive stimuli in their maximal pain 
area (thermal, mechanical and vibration detection) compared to HC, findings 
consistent with neural damage and the presence of NeP, and consistent with findings 
in patients with lumbar radicular pain (Scholz et al. 2009). In our patients, the 
presence of nerve root damage was further supported by the findings of a loss of 
function of thermal and vibration detection as well as pressure sensitivity in the 
affected dermatome compared to HC, and by a loss of function of mechanical 
detection, identified by the side difference in MDT between the symptomatic and 
asymptomatic side. The dermatomal loss of function in all sensory fibers tested is in 
accordance with previous findings using QST in patients with lumbar radiculopathy 
(Nygaard and Mellgren 1998). In contrast, Chien et al (Chien et al. 2008) using QST 
in patients with cervical radiculopathy, did not report reduced cold detection in tested 
dermatomes, however it is unclear if these dermatomal areas corresponded with each 
individual patient’s area of sensory loss. 
 
Considering the argument that our HC samples for z-transformation were quite small 
(section 9.3) and that the QST data of our patients were within the 95% confidence 
interval of our HC reference data, the side-to-side comparison of QST data was 
valuable in further establishing which sensory alterations on the symptomatic side 
were characteristic for the patient group with radiculopathy (Study 4, Chapter 7). The 
reduction in mechanical and vibration detection in the maximal pain area was further 
highlighted by the significant side difference in these parameters. Likewise, cold 
detection, mechanical and vibration detection and pressure sensitivity in the affected 
dermatome were significantly reduced compared to the asymptomatic side. Our data 
support the notion that a side comparison can enhance the sensitivity to detect 
sensory aberrations (Haanpää et al. 2011; Rolke et al. 2006a), and that such a side 
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comparison should be part of the standard clinical examination of patients with 
unilateral pain presentations.  
 
However, side comparison is less meaningful in case of the presence of bilateral 
sensory aberrations, as already discussed under section 9.1, and evidenced by the 
bilateral thermal hypoaesthesia demonstrated in our patients with cervical 
radiculopathy (Study 4). The parameters of mechanical and vibration detection were 
more discriminative for the identification of sensory loss and of NeP components in 
our patient cohort than thermal detection thresholds. Hence, the assessment of MDT 
and VDT may be considered as first-line assessment in patients with cervical 
radiculopathy, consistent with the examination of touch hypoaesthesia employed in 
the DN4. Both tools, the DN4 and LANSS, do not incorporate the physical 
assessment of thermal sensitivity. 
 
Patients with cervical radiculopathy were further characterised by the presence of 
cold hypersensitivity in their maximal pain area compared to HC, consistent with 
QST findings in patients with peripheral nerve injury (de Medinaceli et al. 1997; 
Kleggetveit and Jørum 2010; Landerholm et al. 2010; Taylor et al. 2010) 
and with findings at the cervical spine in patients with cervical radiculopathy (Chien 
et al. 2008). The significance of the cold hypersensitivity in our patients with 
cervical radiculopathy seemed unclear initially, as the group mean value for CPT 
was below the value of defined cold hyperalgesia (≥ 15°) and fell within our 95% CI 
HC reference data. However the side-difference for CPT was close to significant, 
consistent with a trend towards heightened sensitivity on the symptomatic side. 
Further evaluation of individual results revealed the presence of cold hyperalgesia in 
48% of patients, suggesting that a sub-group of patients within the cohort was 
characterised by cold hypersensitivity. Moreover, a sub-group of patients with cold 
hyperalgesia was also identified in Study 5 (Chapter 8), as patients reporting cold 
sensitivity on the PD-Q also demonstrated an average CPT of 19° (i.e.; by definition 
these patients experienced a cold hypersensitivity).  
 
Our data indicate the existence of sub-groups of patients with distinct sensory 
alterations within the same aetiology of cervical radiculopathy as reflected by the 
proportion of patients demonstrating increased pressure sensitivity in their maximal 
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pain area (z-score outside 95% CI of our HC data), while others demonstrated 
reduced pressure sensitivity (Study 3). Similarly, sub-groups with altered pressure 
sensitivity compared to HC were identified using the PD-Q (Study 5, Chapter 8). 
Patients who reported being sensitive to pressure, presented with a significantly 
lowered PPT compared to HC and compared to patients who reported not being 
sensitive to pressure. The self-reported somatosensory profiles of patients with 
cervical radiculopathy obtained through the PD-Q and confirmed by QST findings, 
demonstrated additional differences between patients in regards to measures of HPT, 
MDT and VDT. Patients indicating thermal sensitivity were significantly more 
sensitive to heat compared to HC. Patients indicating feeling numbness in their pain 
area demonstrated a loss in mechanical and vibration detection, but this was not the 
case for patients not reporting numbness. These data suggest heterogeneity in our 
patient group, consistent with data reported in other patient groups with NeP (Baron 
et al. 2009; Mahn et al. 2011; Maier et al. 2010). Somatosensory heterogeneity 
within a clinical disorder highlights the need for an individual patient assessment in 
order to determine sensory phenotypes and implement appropriately matched 
management.  
 
The fact that the self-reported somatosensory profiles of our patients with cervical 
radiculopathy matched the QST sensory profile suggests that the PD-Q can be used 
as a tool to characterise these patients, and that the PD-Q is able to identify sub-
groups based on sensory symptoms. These findings are consistent with previous data 
in patients with lumbar radiculopathy/radicular pain (Mahn et al. 2011) and in 
patients with postherpetic neuralgia and diabetic neuropathy (Baron et al. 2009). It 
has been proposed that the individual pattern of sensory symptoms may reflect the 
underlying pain-generating mechanisms and furthermore that the sensory profiling of 
patients may open up avenues to stratify patients in clinical trials (Baron et al. 2009). 
For example, in patients with thermal hypersensitivity, drugs that potentially act on 
thermosensitive transient receptor channels involved in mediating cold and heat 
sensitivity (Knowlton et al. 2010; Obata et al. 2005) may be useful. Our data may 
help to explain some of the variability in responsiveness to anti-neuropathic drug 
treatments in patients with radiculopathy (Baron et al. 2010b; Saldaña et al. 2010) 
and may direct clinicians in the most appropriately targeted choice of pharmaceutical 
intervention. The self-reported somatosensory profiles however included only 
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sensory descriptors that could be verified by QST, thus a future study would be 
valuable to investigate if all self-reported responses match with the clinical 
examination findings. For example, the presence of burning pain, tingling sensation 
and sudden pain attacks cannot be assessed by QST. Findings in this thesis suggest 
that the PD-Q should not be used for somatosensory profiling in patients with FM 
and the argument for this proposition is outlined in Chapter 5. 
 
Patients with NSNAP were characterised by the presence of cold hypersensitivity in 
their maximal pain area compared to HC, however there was no difference in cold 
sensitivity between the symptomatic and asymptomatic side. No comparative data 
exists for this patient group. It is debatable whether the bilateral cold hypersensitivity 
evident in this group should be interpreted as satisfying a criterion for NeP as the 
NeuPSIG grading system does not specify which type of sensory alteration (loss or 
gain of function) is considered as a confirmatory test (Treede et al. 2008) although 
negative signs are reported as a hallmark for NeP (Dworkin 2002). As discussed 
already under section 9.1 (page 9-10), the finding of just one sensory alteration in the 
maximal pain area of our patients with NSNAP has to be interpreted in context of the 
overall examination findings. The factors that would argue against the presence of 
cold hypersensitivity as an indicator for NeP in our patients with NSNAP include: (i) 
no confirmative diagnostic test for the presence of nerve root compression; (ii) no 
sensory loss indicative of nerve damage; and (iii) cold hypersensitivity can be 
present in the absence of pain (Klauenberg et al. 2008) and tissue damage (Berglund 
et al. 2002; Hurtig et al. 2001; Klauenberg et al. 2008; Pfau et al. 2009).  
 
Our data suggest that NeP components were unlikely in this patient group, although 
the small sample size may have limited the power to detect significant differences. 
For example, the VDT was lower in patients with NSNAP compared to HC. 
However, hypoaesthesia to vibration occurred bilaterally and has been demonstrated 
in patients with non-NeP such as in our patients with FM, and also by others 
(Blumenstiel et al. 2011; Koroschetz et al. 2010). Additionally, tactile hypoaesthesia 
has also been documented in patients with nociceptive pain (Geber et al. 2008; 
Voerman et al. 2000; Westermann et al. 2011).  
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Neuropathic components have been investigated in patient groups similar to our 
patients with NSNAP (Greening and Lynn 1998; Greening et al. 2003; Moloney et 
al. 2010; Tucker et al. 2007; Voerman et al. 2000). The studies by Greening et al ( 
1998; 2003), Moloney et al (2010) and Tucker et al (2007) included patients with 
non-specific arm pain (office work-related upper limb disorders associated with 
repetitive movements) whereas the study by Voerman et al (2000) examined patients 
with dermatomal neck-arm pain in the absence of any neurological signs. Tactile 
hypoaesthesia (Voerman et al. 2000) and vibration hypoaesthesia (Greening and 
Lynn 1998; Greening et al. 2003) were found in the dermatomal areas tested. These 
sensory deficits are suggestive of nerve damage, however this does not necessarily 
equate to the presence of NeP. In contrast, our QST data recorded from the 
dermatome of patients with NSNAP did not suggest any signs of nerve root damage. 
Taking into account the clinical presentation of our patients with NSNAP, including 
clinical examination findings and QST findings, it is most likely that nociceptive 
pain was the predominant underlying pain type.  
 
A novel finding in both our patient groups with nerve-related neck-arm pain was that 
of cold hypersensitivity in the foot. No comparative data exists as Chien et al (2008) 
did not measure CPT in the foot. Contrary to our patients with FM, who 
demonstrated widespread cold hyperalgesia in all three body regions tested, none of 
our patients demonstrated cold hypersensitivity in the dermatome, consistent with 
previous data (Chien et al. 2008). Only two of our patients with cervical 
radiculopathy recorded cold hyperalgesia in all body regions and only 4 patients 
recorded cold hyperalgesia in both the maximal pain area and foot. Hence, the 
presence of cold hyperalgesia was not consistent, and this was also the case for 
patients with NSNAP. As discussed in Chapter 6, the mechanisms underlying cold 
pain are not yet fully understood (Belmonte et al. 2009; Viana 2009) and may even 
not be associated with the presence of pain (Klauenberg et al. 2008). Therefore the 
significance of cold hypersensitivity in the foot in our patient cohorts with neck-arm 
pain remains unclear. 
 
Underlying pain mechanisms in patients with nerve-related neck-arm pain differ 
from those in patients with FM. Patients with FM were characterised by 
predominantly increased pain sensitivity across nociceptive submodalities in almost 
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all the body regions tested. Such generalised enhanced sensitivity was not present in 
our patient groups with neck-arm pain and may be reflective of a more global 
sensory discriminative dysfunction in patients with FM. Alterations in pain 
inhibitory (Ingvar 2009; Julien et al. 2005; Lannersten and Kosek 2010) and pain 
facilitatory mechanisms (Lannersten and Kosek 2010) and central augmentation of 
sensory input (Banic et al. 2004; Desmeules et al. 2003; Staud et al. 2008) may all 
account for the enhanced pain sensitivity in patients with FM. 
 
The clinical sign of heightened nerve mechanosensitivity may or may not be 
associated with NeP. The findings in our patients with NSNAP suggest that the 
clinical presentation of heightened nerve mechanosensitivity as a discrete disorder 
does not equate with NeP. However, as already described in section 9.1 (page 9-7), it 
can coexist with nerve lesions (Chien et al. 2008; Wainner et al. 2003; Wainner et al. 
2005) and NeP, as observed in our patients with cervical radiculopathy. In fact, 
heightened nerve mechanosensitivity in the lower limb, as identified by the straight 
leg raise test, was reported to be part of a cluster of physical examination 
discriminative indicators for NeP in lumbar radiculopathy patients (Scholz et al. 
2009). A future study will have to investigate, if the presence of heightened nerve 
mechanosensitivity in the upper limb in patients with cervical radiculopathy (and 
patients with other nerve-related upper limb pain) may also be identified as a 
discriminative factor for NeP.  
 
Cluster analyses have been suggested to be useful in determining the positive 
predictive value of clinical examination findings for the diagnosis of NeP conditions 
(Scholz et al. 2009; Smart et al. 2011), as well as for clustering pain descriptors to 
discriminate between different pain types (Baron et al. 2009; Rehm et al. 2010; 
Scholz et al. 2009). Numerous literature (Haanpää et al. 2011; Hansson 2002; Scholz 
et al. 2009; Treede et al. 2008) including our findings in this dissertation support the 
concept that the identification of NeP is not based on single examination test, but on 
a combination of clinical findings. Combining patient interview and physical 
examination findings, Scholz et al (2009) developed a new assessment tool for the 
assessment of NeP in patients with lumbar radiculopathy and axial low back pain. 
This tool exceeded the diagnostic accuracy of the DN4 in the Scholz patient cohort. 
Similar to the study by Scholz et al (2009) and based on our findings in this 
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dissertation, a cluster analysis would be valuable to determine the most 
discriminative items in patients with nerve-related neck-arm pain, incorporating all 
criteria for the classification of NeP according to the NeuPSIG grading system, pain 
descriptors and physical examination findings such as sensory alterations and clinical 
signs of heightened nerve mechanosensitivity. Such an analysis was not possible in 
our studied cohorts due to small sample sizes and was considered beyond the scope 
of the current thesis. However, this is an approach that we will consider as a future 
research direction.  
 
The significant impact of psychosocial factors on pain and disability in patients with 
persistent pain has been widely documented (Linton 2000; Linton et al. 2008; Linton 
et al. ; Vlaeyen et al. 1995). In our studies, the psychometric data were collected in 
order to better characterise the patient groups with neck-arm pain and to investigate 
their effect on pain measures (Rhudy and Meagher 2000). Our findings suggest that 
psychosocial factors did not play a significant role on QST pain measures in our 
patient cohorts with neck-arm pain. Although both groups demonstrated significantly 
higher anxiety and depression scores compared to HC, the scores were within the 
normal range for anxiety in over 75% of patients and for depression in over 91% of 
patients. Furthermore, the documented association between anxiety and heat 
sensitivity and depression and mechanical pain sensitivity was evident only for 
patients with FM, but not for patients with neck-arm pain. Patients with nerve related 
neck-arm pain did not differ statistically in their score of fear avoidance behaviours, 
although patients with cervical radiculopathy demonstrated a score of 40.9, just 
above the score of ≤ 40 that is considered to indicate significant kinesiophobia 
(Crombez et al. 1999). However, in this context fear avoidance behaviour is 
appropriate as these patients did demonstrate a nerve lesion and any aggravation of 
symptoms is may be provocative of further nerve damage and increased NeP. 
Comorbidities such as anxiety, depression and sleep disturbances are common in 
patients with nerve-related neck-arm pain and in patients with NeP (Freynhagen et 
al. 2006a; Saldaña et al. 2010; Starkweather). Recognition of these factors is 





Considerations for QST measures 
Participant’s responses to QST may be influenced by factors such as cognitive 
deficits, fatigue, distraction or intention to deceive (Backonja et al. 2009). The latter 
was rather unlikely in our patient cohorts, as none of our patients were involved in a 
current compensation claim. Considering that intense pain can act as a distraction, 
the patients’ pain levels were monitored throughout the testing and adequate breaks 
were provided. While all participants were able to complete the full QST session, our 
conclusion is, using the DFNS protocol, not to assess more than 5 body regions 
(equating to testing of 2.5 hours) to minimize the potential effect of fatigue and 
inattention on participants’ responses. Although blinding of the QST examiner is 
recommended (Haanpää et al. 2011), for logistic reasons this was not possible in our 
studies. 
9.5 Clinical implications 
Evidence from this dissertation indicates that patients with nerve-related neck-arm 
pain are heterogeneous. Despite patients presenting with similar pain characteristics 
and sensory symptoms, the clinical presentation and the mix of nociceptive and NeP 
components varied between the two specific neck-arm pain groups studied and even 
between individuals within one group. Our patients with cervical radiculopathy were 
characterised by predominantly NeP components, whereas patients with NSNAP as a 
discrete disorder demonstrated predominantly nociceptive pain. This information is 
valuable for health care providers as this may assist in directing treatment to the 
underlying pain type(s) and ultimately translate as improved patient outcomes.  
 
Our observations suggest that NSNAP as a discrete disorder is not as prevalent as 
may be commonly thought, and that clinical signs of heightened nerve 
mechanosensitivity may rather coexist with disorders of nerve lesions than exist in 
isolation. Similar observations have been reported in patients with low back-related 
leg pain (Schäfer et al. 2009). However, clinical signs of heightened nerve 
mechanosensitivity do not equate with NeP and they may or may not be associated 
with NeP.  
 
9-32 
In order to determine the aetiology/type of a clinical pain presentation and the 
dominant underlying pain type(s), each patient should be individually assessed with a 
comprehensive clinical examination comprising the assessment of musculoskeletal as 
well as neural structures and a neurological examination including sensory testing in 
the patient’s maximal pain area. In patients with unilateral pain, examination 
findings should be compared between the symptomatic and asymptomatic side as 
this comparison will provide information on what is an ‘abnormal’ finding for the 
patient. The clinical classification systems for the identification of patients with 
cervical radiculopathy and patients with NSNAP were shown to be reliable tools and 
should be used in conjunction. Furthermore, the grading system of NeP (Treede et al. 
2008) proved to be a useful guideline for the identification of NeP in patients with 
neck-arm pain. Although the application of this system may require specific skills, 
Musculoskeletal Physiotherapists may be well equipped for this task, based on their 
level of training and clinical reasoning skills. 
 
Clinicians should not rely solely on the patient’s pain descriptors, as they do not 
indicate the aetiology of a pain disorder (Attal et al. 2008) nor is any pain descriptor 
pathognomonic. Our findings indicate that patients with cervical radiculopathy and 
patients with NSNAP use pain descriptors common for nociceptive as well as NeP, 
reflecting the presence of a mixed pain syndrome. 
 
Based on the lower diagnostic accuracy documented in our studies, the LANSS and 
PD-Q are not useful tools in identifying NeP in patients with neck-arm pain. 
However, the PD-Q may be used for establishing the somatosensory profile of 
patients with cervical radiculopathy provided the questionnaire is strictly applied to 
the patient’s symptomatic main pain area.  
Patients with nerve-related neck-arm pain do frequently present with comorbidities 
such as sleep disturbance, anxiety and depression and these factors need to be 





9.6 Directions for future research 
In consideration of the research findings presented in this thesis and the 
acknowledged limitations of the studies, the following recommendations are made: 
• A larger study with greater power is required to confirm the preliminary QST 
findings presented for patients with cervical radiculopathy, patients with 
NSNAP and HC. This should also include a larger sample size of HC subjects 
to allow generalisability. A greater number in each patient group will allow 
further determination of specific sub-groups within each patient cohort. 
• A future study should consider a cluster analysis of clinical examination 
findings, incorporating pain characteristics/pain descriptors, physical 
examination findings including sensory testing and responses to neural 
provocation tests and possibly results of NeP screening tools, to determine 
the most discriminative items for the identification of NeP in patients with 
neck-arm pain. 
• In order to determine further the usefulness of NeP screening tools in the 
identification of NeP in patients with neck-arm pain of mixed pain type, a 
future study should aim to define the pain descriptors that are able to 
discriminate NeP from non-NeP in these patient cohorts and to analyse the 
appropriate cut-off values of LANSS and PD-Q for discriminating NeP in 
this patient cohort. 
• If the PD-Q is to be used in further studies, its reliability has to be established 
in order to strengthen its validity. It might be valuable to compare the 
outcome of PD-Q when patients are provided specific instructions on how to 
complete the questionnaire, compared to the current format which does not 
provide instruction. 
• In order to support the use of the PD-Q as a tool for characterisation of 
somatosensory profiles, a future study should explore if self-reported 
responses match with clinical examination findings. 
• To help inform the development of targeted interventions for patients with 
musculoskeletal conditions and NeP, further research should investigate the 
confidence of primary care health practitioners in identifying NeP and, in 




The series of studies conducted in this doctoral thesis has highlighted the 
heterogeneity of patients with nerve-related neck-arm pain in regard to their clinical 
presentations as well as pain characteristics, somatosensory profiles and dominant 
underlying pain types. This heterogeneity exists, not only between patients with 
differing aetiology, such as patients with cervical radiculopathy and patients with 
NSNAP, but also in patients with the same aetiology. The enhanced knowledge 
gained about these pain presentations and their underlying pain mechanisms may 
assist clinicians in “matching” interventions to patients with the potential for better 
clinical outcome. Furthermore, the findings of this thesis have contributed to the 
reliability and validity of clinical classification systems used to identify patients with 
painful cervical radiculopathy and patients with NSNAP, and to identify NeP in 
patients with nerve-related neck-arm pain. 
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PATIENT INFORMATION SHEET 
 
Study A 
Project title: Do physiotherapists agree on a diagnosis for patients with 
neck and arm pain? 
 
 
Principal Investigator:  Brigitte Tampin, PhD student 
Project Supervisor:  A/Prof Kathy Briffa 
Co-Supervisor:   Dr Helen Slater 
 
 
Purpose of Research 
There are a number of different reasons why people can have neck and arm 
pain. It is important to identify the cause of the pain so that treatment can be 
directed at the specific cause. Physiotherapists use certain examination 
protocols for the assessment of patients with neck/arm pain, but the 
interpretation of their findings might vary between therapists. The purpose of 
this study is to examine if two experienced physiotherapists come to the same 
conclusion about the cause of your pain. 
 
Your role 
You will be examined by two qualified and experienced physiotherapists (the 
principal investigator and one other) on two separate occasions. Each 
examination will take approximately one hour. Your medical history will be 
taken and a physical examination conducted. This will involve the assessment 
of movements of your neck and arm and a range of tests of sensation in the 
neck and arm. All tests will only be performed just to the point of pain onset. 
 
Risks and Discomforts 
You may experience some very momentary discomfort during the testing of 
sensations. You may also experience some minor increase of symptoms similar to 
what you might expect after a standard physiotherapy treatment. 
 
Benefits 
Physiotherapists need to diagnose patients with neck/arm pain accurately so 
that the correct treatment can be given to these patients. Although the results 
of this study will importantly add to the body of knowledge in diagnosing 
patients with neck/arm pain, the examination you will undertake and the 
results gained will probably not directly benefit you, but aim to benefit the 
Division of Health Sciences 
School of Physiotherapy 
Telephone +61 8 9266 3618 
Facsimile  +61 8 9266 3699 
Email physio@curtin.edu.au 
Web www.physiotherapy.curtin.edu.au  
 
Appendix 2: Patient information sheets and consent forms  
A2-3 




You will be issued a study number instead of using your name, which will 
remain confidential to the principle investigator and the project supervisors. 
All the data (information) recorded will be stored on computer within the 
School of Physiotherapy, Curtin University of Technology. Access to this 
information will be via password only. This password will only be known to 
the principal investigator and to the project supervisors. The results of this 
study will be reported, but it will not be possible to identify individual 
subjects. Following the study period, the data will be held in a secure place for 
7 years. After this time it will be destroyed. This is a requirement of Curtin 
University of Technology. 
 
Refusal or Withdrawal 
If you consent to participate in this study, you will be free to withdraw at any 
time, without fear of prejudice. If you do decide to withdraw from the study 
you would be asked to contact the Principle Investigators at the earliest 




This study has been approved by the Curtin University Human Research 
Ethics Committee (Approval Number HR 117/2007). The Committee is 
comprised of members of the public, academics, lawyers, doctors and pastoral 
carers. Its main role is to protect participants. If needed, verification of 
approval can be obtained either by writing to the Curtin University Human 
Research Ethics Committee, c/- Office of Research and Development, Curtin 
University of Technology, GPO Box U1987, Perth, 6845 or by telephoning 
9266 2784 or by emailing hrec@curtin.edu.au 
 
If you would like further information about the study, please feel free to 
contact me on 9266 3667 or 0409 883 548 or by email: 
brigitte.tampin@postgrad.curtin.edu.au. Alternatively, you can contact my 
supervisor A/Prof Kathy Briffa on 9266 3666 or by email: 
K.Briffa@exchange.curtin.edu.au or my co-supervisor Dr Helen Slater on 
9266 3099, or by email: H.Slater@curtin.edu.au 
 
 
Thank you very much for your involvement in this research, your 
participation is greatly appreciated. 
 












Investigation of somatosensory characteristics in patients with 
neck/upper limb pain.  
 
This study has been approved by the Curtin University Human Research 
Ethics Committee (Approval Number HR 117/2007). 
 
 
I __________________________________________ consent to participate in 
this study. I have read the Information Sheet and understand the consequences 
and risks associated with participation in the study. The Principal Investigators 
has answered my questions regarding all aspects of the study. I understand that 
all information provided is treated as confidential. I give my permission for any 
results from this study to be used in any report or research paper, on the 
understanding that anonymity will be preserved. I understand that I retain the 
right to withdraw from this study at any time, and without prejudice. I 
undertake to contact the Researcher (Tel: 9266-3667) at the earliest 
opportunity should I wish to exercise this right. On withdrawal of my consent I 
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SIR CHARLES GAIRDNER HOSPITAL 
 
Participant Information Sheet 
 
Study title: Do physiotherapists agree on a diagnosis for patients with 
neck and arm pain? 
 
Principal Investigator:  Brigitte Tampin, PhD student 
Project Supervisor:   A/Prof Kathy Briffa 
Co-Supervisor:   Dr Helen Slater 
SCGH Investigator:  Dr Roger Goucke 
 
Please take time to read the following information carefully and discuss it with 
your friends, family and general practitioner if you wish. Ask us any question if 
some part of the information is not clear to you or if you would like more 
information. Please do this before you sign this consent form.  
 
Who is funding this study? 
Brigitte Tampin is supported in her study by a postgraduate scholarship from 




Should you have questions about the study you may contact: 
 
Brigitte Tampin   Phone No. 9266 3667, 0409 883 548 
     After hours:   0409 883 548 
A/Prof Kathy Briffa   Phone No.  9266 3666 
Dr Helen Slater   Phone No.     9266 3099 
Dr Roger Goucke    Phone No.     9346 3263 
 
All study participants will be provided with a copy of the Information Sheet and 
Consent Form for their personal records. 
 
You may decide to be in the study or not take part at all. If you do decide to 
take part in this study, you may stop at any time. However, before you decide, 
it is important that you understand why this research is being done and what it 
will involve.  
 
Whatever your decision, this decision will not lead to any penalty or affect your 
regular medical care or any benefit to which you are otherwise entitled.  
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The following information sheet will explain the study and will include 
details such as: 
o Why this study might be suitable for you; 
o The type, frequency and risks of any tests or procedures required by 
the study; 
o The nature of your participation including how many visits you will make 
to the hospital; 
o Your rights and responsibilities. 
 
What is the purpose of the study? 
There are a number of different reasons why people can have neck and arm 
pain. It is important to identify the cause of the pain so that treatment can be 
directed at the specific cause. Physiotherapists use certain examination 
protocols for the assessment of patients with neck/arm pain, but the 
interpretation of their findings might vary between therapists. The purpose of 
this study is to examine if two experienced physiotherapists come to the same 
conclusion about the cause of your pain and if their conclusion is supported by 
the judgement of a neurologist and a specialist in musculoskeletal therapy. 
 
Why is this study suitable to me? 
You have been experiencing neck and/or arm pain for a longer time and you 
have been referred to see a neurosurgeon at Sir Charles Gairdner Hospital. 
Your name has been registered on a waiting list, however waiting times for an 
appointment can amount to over a year. The hospital has set up a 
Comprehensive Spinal Care Clinic, comprising of a neurosurgeon, pain 
specialist and a physiotherapist, in order to reduce these long waiting periods. 
Patients are initially assessed by a highly qualified and experienced 
physiotherapist who will then discuss further management with the patient and 
refer them on to the medical specialists, if needed. 
This research study will give you the opportunity to reduce your waiting time 
for an appointment. You will be examined by a physiotherapist as mentioned 
above. However you are under no obligation to take part in the study as 
outlined in the next paragraph. 
 
How long will I be in this study? 
You would have to attend the Department of Pain Management at Sir Charles 
Gairdner Hospital or the Physiotherapy Clinic at the School of Physiotherapy, 
Curtin University of Technology, whichever one is more convenient to you. 
You will be examined independently by two physiotherapists; each 
assessment will take about one hour. It might be possible to schedule your 
visit in such a way that your assessments will be performed on the same day, 
one after the other, which would mean you only have to attend once for two 
hours in total. Otherwise your assessments will be on two different days for 
one hour.  
 
What will happen if I decide to be in this study? 
You will be examined by two qualified and experienced physiotherapists (the 
principal investigator and one other) on two independent consultations. Each 
examination will take approximately one hour. Your medical history will be 
taken and a physical examination conducted. This will involve the assessment 
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of movements of your neck and arm and a range of tests of sensation in the 
neck and arm. All tests will only be performed just to the point of pain onset.  
After your visit, the clinical notes which the physiotherapists took during your 
consultation, might be given to a neurologist and to a specialist in 
musculoskeletal therapy for further diagnostic opinion. 
 
Are there any reasons I should not be in this study?: 
The physiotherapy assessment is an examination which is standard clinical 
practice in any Physiotherapy department. The principal investigator will 
discuss with you any exclusion criteria in detail and will be directed at ensuring 
that the examination is both safe and appropriate for you. 
 
What are the costs to me? 
There will be no charge for the examination by the two physiotherapists. 
Transport to and from the clinic where examination will take place will not be 
provided. 
 
What are the possible benefits of taking part?  
Physiotherapists need to diagnose patients with neck/arm pain accurately so 
that the correct treatment can be given to these patients. Although the results 
of this study will importantly add to the body of knowledge in diagnosing 
patients with neck/arm pain, the results gained will probably not directly benefit 
you, but aim to benefit future patients by assisting physiotherapists in making 
accurate diagnoses. 
 
However, the clinical examination which is performed by highly qualified 
physiotherapists would benefit you. By taking part in this study, you would 
reduce your waiting time for an appointment at the Department of Pain 
Management plus you will be given advice and direction on further 
management of your neck/arm pain.  
 
What are the possible side effects, risks and discomforts of taking part? 
You may experience some very momentary discomfort during the testing of 
sensations. You may also experience some minor increase of symptoms 
similar to what you might expect after a standard physiotherapy treatment. 
 
Will my taking part in this study be kept confidential? 
The researchers will need to collect personal data about you, which may be 
sensitive, e.g. date of birth and relevant health information. The researchers 
may also need to get some of your health information from other health 
service providers, e.g another hospital, pathology laboratory, radiographer, GP 
or other medical specialist. 
 
Any personal or health information will be kept private and confidential. It will 
be stored securely and only authorised persons, who understand it must be 
kept confidential, will have access to it. Your study details will be given a 
number so that your identity will not be apparent. The clinical notes taken 
during your examination will be kept at the School of Physiotherapy at Curtin 
University of Technology during the study and in a locked archive for 5 years 
from the time the study is closed. After this time they will be destroyed. This is 
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a requirement of Curtin University of Technology. Some data/information will 
be stored on a computer at the School of Physiotherapy at Curtin University of 
Technology. Access to this information will be via password only. This 
password will only be known to the principal investigator and to the project 
supervisors. 
 
Authorised representatives of the Hospital Human Research Ethics 
Committee, and Research Governance may require access to your study 
records to verify study procedures and/or data. In all cases when dealing with 
your information, these people are required to comply with privacy laws that 
protect you. 
 
The results of the research will be made available to other health professionals 
through medical journals or meetings, but you will not be identifiable in these 
communications. By taking part in this study you agree not to restrict the use 
of any data even if you withdraw. Your rights under any applicable data 
protection laws are not affected. 
 
Will I find out the results of the study? 
A summary of the study findings will be forwarded to each participant.  
 
Who has reviewed the study? 
The Sir Charles Gairdner Hospital Human Research Ethics Committee has 
reviewed this study and has given its approval for the conduct of this research. 
In doing so this study conforms to the principles set out by the National 
Statement on Ethical Conduct in Research involving Humans and according to 
the Good Clinical Practice Guidelines. 
 
This study has also been approved by the Curtin University Human 
Research Ethics Committee (Approval Number HR 117/2007). If needed, 
verification of approval can be obtained either by writing to the Curtin 
University Human Research Ethics Committee, c/- Office of Research and 
Development, Curtin University of Technology, GPO Box U1987, Perth, 








                                  CONSENT FORM 
 
Do physiotherapists agree on a diagnosis for patients with neck and arm 
pain? 





Date of Birth: _______________ 
1. I have been given clear information (verbal and written) about this study 
and have been given time to consider whether I want to take part. 
2. I have been told about the possible advantages and risks of taking part in 
the study and I understand what I am being asked to do. 
3. I have been able to have a member of my family or a friend with me while I 
was told about the study. I have been able to ask questions and all 
questions have been answered satisfactorily. 
4. I know that I do not have to take part in the study and that I can withdraw at 
any time during the study without affecting my future medical care.  My 
participation in the study does not affect any right to compensation, which I 
may have under statute or common law. 
5. I agree to take part in this research study and for the data obtained to be 
published provided my name or other identifying information is not used. 
 
If you are unclear about anything you have read in the Participant 
Information Sheet or this Consent Form, please speak to your principal 
investigator before signing this Consent Form. 
 
 
Name of Participant   Signature of Participant  Date 
 
 
Name of Investigator  Signature of Investigator  Date 
 
The Sir Charles Gairdner Hospital Human Research Ethics Committee has 
given ethics approval for the conduct of this project.  If you have any ethical 
concerns regarding the study you can contact the secretary of the Sir Charles 
Gairdner Hospital Human Research Ethics Committee on telephone No. (08) 
9346.2999 
All study participants will be provided with a copy of the Information 
Sheet and Consent Form for their personal records. 
 
 





Participant Information Sheet 
 
Study title: Do physiotherapists agree on a diagnosis for patients with 
neck and arm pain? 
 
Principal Investigator:  Brigitte Tampin, PhD student 
Project Supervisor:   A/Prof Kathy Briffa 
Co-Supervisor:   Dr Helen Slater 
SMHAS Investigators: Dr Stephanie Davies 
     Stuart Waters  
 
Please take time to read the following information carefully and discuss it with 
your friends, family and general practitioner if you wish. Ask us any question if 
some part of the information is not clear to you or if you would like more 
information. Please do this before you sign this consent form.   
 
Who is funding this study? 
Brigitte Tampin is supported in her study by a postgraduate scholarship from 




Should you have questions about the study you may contact: 
 
Brigitte Tampin   Phone No. 9266 3667, 0409 883 548 
     After hours:   0409 883 548 
A/Prof Kathy Briffa   Phone No.  9266 3666 
Dr Helen Slater   Phone No.     9266 3099 
Dr Stephanie Davies  Phone No.  9431 3296 
Stuart Waters    Phone No.  9431 2533 
 
All study participants will be provided with a copy of the Information Sheet and 
Consent Form for their personal records. 
 
You may decide to be in the study or not take part at all. If you do decide to 
take part in this study, you may stop at any time. However, before you decide, 
it is important that you understand why this research is being done and what it 
will involve.  
 
Whatever your decision, this decision will not lead to any penalty or affect your 
regular medical care or any benefit to which you are otherwise entitled.  
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The following information sheet will explain the study and will include 
details such as: 
o Why this study might be suitable for you; 
o The type, frequency and risks of any tests or procedures required by 
the study; 
o The nature of your participation including how many visits you will make 
to the hospital; 
o Your rights and responsibilities. 
 
What is the purpose of the study? 
There are a number of different reasons why people can have neck and arm 
pain. It is important to look for possible factors contributing to pain so that 
treatment can be directed at these factors. Physiotherapists use certain 
examination protocols for the assessment of patients with neck/arm pain, but 
the interpretation of their findings might vary between therapists. The purpose 
of this study is to examine if two experienced physiotherapists come to the 
same conclusion about the cause of your pain and if their conclusion is 
supported by the judgement of a neurosurgeon and a specialist in 
musculoskeletal therapy. 
 
Why is this study suitable to me? 
You are invited to take part in this study as you experience one sided neck 
and/or arm pain. Your participation would give you the opportunity to be 
examined by two very qualified and experienced physiotherapists who will give 
you feedback on their diagnosis and advice on further management of your 
neck/arm pain.  
 
How long will I be in this study? 
You would have to attend Fremantle Hospital or the School of Physiotherapy, 
Curtin University of Technology or the principal investigator’s  Physiotherapy 
Practice in Fremantle, whichever one is more convenient to you. You will be 
examined independently by two physiotherapists; each assessment will take 
about one hour. It might be possible to schedule your visit in such a way that 
your assessments will be performed on the same day, one after the other, 
which would mean you only have to attend once for two hours in total. 
Otherwise your assessments will be on two different days for one hour.  
 
What will happen if I decide to be in this study? 
You will be examined independently by two qualified and experienced 
physiotherapists (the principal investigator and one other). Each examination 
will take approximately one hour. Your medical history will be taken and a 
physical examination conducted. This will involve the assessment of 
movements of your neck and arm and a range of tests of sensation in the neck 
and arm.  All tests will only be performed just to the point of pain onset. After 
your visit, the clinical notes which the physiotherapists took during your 
consultation, will be given to a neurosurgeon and to a specialist in 
musculoskeletal therapy for further diagnostic opinion. 
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Are there any reasons I should not be in this study? 
The physiotherapy assessment is an examination which is standard clinical 
practice in any Physiotherapy department. The principal investigator will 
discuss with you any exclusion criteria in detail and will be directed at ensuring 
that the examination is both safe and appropriate for you. 
 
What are the costs to me? 
There will be no charge for the examination by the two physiotherapists. 
Transport to and from the clinic where examination will take place will not be 
provided, however your travel expenses will be reimbursed with a $20 
voucher. 
 
What are the possible benefits of taking part?  
Physiotherapists need to diagnose patients with neck/arm pain accurately so 
that the correct treatment can be given to these patients. Although the results 
of this study will importantly add to the body of knowledge in diagnosing 
patients with neck/arm pain, the results gained will probably not directly benefit 
you, but aim to benefit future patients by assisting physiotherapists in making 
accurate diagnoses. 
 
However, the clinical examination which is performed by highly qualified 
physiotherapists would benefit you. You will be given advice and direction on 
further management of your neck/arm pain.  
 
What are the possible side effects, risks and discomforts of taking part? 
You may experience some very momentary discomfort during the testing of 
sensations. You may also experience some minor increase of symptoms 
similar to what you might expect after a standard physiotherapy treatment. 
 
Will my taking part in this study be kept confidential? 
The researchers will need to collect personal data about you, which may be 
sensitive, e.g. date of birth and relevant health information. The researchers 
may also need to get some of your health information from other health 
service providers, e.g another hospital, pathology laboratory, radiographer, GP 
or other medical specialist. 
 
Any personal or health information will be kept private and confidential. It will 
be stored securely and only authorised persons, who understand it must be 
kept confidential, will have access to it. Your study details will be given a 
number so that your identity will not be apparent. The clinical notes taken 
during your examination will be kept at the School of Physiotherapy at Curtin 
University of Technology during the study and in a locked archive for 5 years 
from the time the study is closed. After this time they will be destroyed. This is 
a requirement of Curtin University of Technology.  Some data/information will 
be stored on a computer at the School of Physiotherapy at Curtin University of 
Technology. Access to this information will be via password only. This 
password will only be known to the principal investigator and to the project 
supervisors. 
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Authorised representatives of the Hospital Human Research Ethics 
Committee, and Research Governance may require access to your study 
records to verify study procedures and/or data. In all cases when dealing with 
your information, these people are required to comply with privacy laws that 
protect you. 
 
The results of the research will be made available to other health professionals 
through medical journals or meetings, but you will not be identifiable in these 
communications. By taking part in this study you agree not to restrict the use 
of any data even if you withdraw. Your rights under any applicable data 
protection laws are not affected. 
 
Will I find out the results of the study? 
A summary of the study findings will be forwarded to each participant.  
 
Who has approved the study? 
The South Metropolitan Area Health Service Human Research Ethics 
Committee has given approval for the conduct of this research. In doing so this 
study conforms to the principles set out by the National Statement on Ethical 
Conduct in Human Research and according to the Good Clinical Practice 
Guidelines. 
This study has also been approved by the Curtin University Human 
Research Ethics Committee (Approval Number HR 117/2007). If needed, 
verification of approval can be obtained either by writing to the Curtin 
University Human Research Ethics Committee, c/- Office of Research and 
Development, Curtin University of Technology, GPO Box U1987, Perth, 
6845 or by telephoning 9266 2784 or by emailing hrec@curtin.edu.au 
 




                                  CONSENT FORM 
 
Do physiotherapists agree on a diagnosis for patients with neck and arm 
pain? 
 
Investigators: Brigitte Tampin, A/Prof Kathy Briffa, Dr. Helen Slater,  




Date of Birth: _______________ 
 
1. I have been given clear information (verbal and written) about this study 
and have been given time to consider whether I want to take part. 
2. I have been told about the possible advantages and risks of taking part 
in the study and I understand what I am being asked to do. 
3. I have been able to have a member of my family or a friend with me 
while I was told about the study. I have been able to ask questions and 
all questions have been answered satisfactorily. 
4. I know that I do not have to take part in the study and that I can 
withdraw at any time during the study without affecting my future 
medical care. My participation in the study does not affect any right to 
compensation, which I may have under statute or common law. 
5. I agree to take part in this research study and for the data obtained to 
be published provided my name or other identifying information is not 
used. 
If you are unclear about anything you have read in the Participant 
Information Sheet  or this Consent Form, please speak to your principal 
investigator before signing this Consent Form. 
 
 
Name of Participant   Signature of Participant  Date 
 
 
Name of Investigator  Signature of Investigator  Date 
 
The South Metropolitan Area Health Service Human Research Ethics 
Committee has given ethics approval for the conduct of this project. If you 
have any ethical concerns regarding the study you can contact the Chair of the 
SMHAS Human Research Ethics Committee on telephone No. (08) 9431 
2929. 
All study participants will be provided with a copy of the Information 
Sheet and Consent Form for their personal records. 
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Participant Information Sheet 
 
Study title: Do physiotherapists agree on a diagnosis for patients with 
neck and arm pain? 
 
Principal Investigator:  Brigitte Tampin, PhD student 
Project Supervisor:  A/Prof Kathy Briffa 
Co-Supervisor:   Dr Helen Slater 
SMHAS Investigators: Andrew Walton 
 
Please take time to read the following information carefully and discuss it with 
your friends, family and general practitioner if you wish. Ask us any question if 
some part of the information is not clear to you or if you would like more 
information. Please do this before you sign this consent form. 
 
Who is funding this study? 
Brigitte Tampin is supported in her study by a postgraduate scholarship from 




Should you have questions about the study you may contact: 
 
Brigitte Tampin   Phone No. 9266 3667, 0409 883 548 
     After hours:   0409 883 548 
A/Prof Kathy Briffa   Phone No.  9266 3666 
Dr Helen Slater   Phone No.     9266 3099 
Andrew Walton   Phone No.  93343777 
 
All study participants will be provided with a copy of the Information Sheet and 
Consent Form for their personal records. 
 
You may decide to be in the study or not take part at all. If you do decide to 
take part in this study, you may stop at any time. However, before you decide, 
it is important that you understand why this research is being done and what it 
will involve.  
 
Whatever your decision, this decision will not lead to any penalty or affect your 
regular medical care or any benefit to which you are otherwise entitled.  
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The following information sheet will explain the study and will include 
details such as: 
o Why this study might be suitable for you; 
o The type, frequency and risks of any tests or procedures required by 
the study; 
o The nature of your participation including how many visits you will make 
to the hospital; 
o Your rights and responsibilities. 
 
What is the purpose of the study? 
There are a number of different reasons why people can have neck and arm 
pain. It is important to look for possible factors contributing to pain so that 
treatment can be directed at these factors. Physiotherapists use certain 
examination protocols for the assessment of patients with neck/arm pain, but 
the interpretation of their findings might vary between therapists. The purpose 
of this study is to examine if two experienced physiotherapists come to the 
same conclusion about the cause of your pain and if their conclusion is 
supported by the judgement of a neurosurgeon and a specialist in 
musculoskeletal therapy. 
 
Why is this study suitable to me? 
You are invited to take part in this study as you experience one sided neck 
and/or arm pain. Your participation would give you the opportunity to be 
examined by two very qualified and experienced physiotherapists who will give 
you feedback on their diagnosis and advice on further management of your 
neck/arm pain.  
 
How long will I be in this study? 
You would have to attend Fremantle Hospital or the School of Physiotherapy, 
Curtin University of Technology or the principal investigator’s  Physiotherapy 
Practice in Fremantle, whichever one is more convenient to you. You will be 
examined independently by two physiotherapists; each assessment will take 
about one hour. It might be possible to schedule your visit in such a way that 
your assessments will be performed on the same day, one after the other, 
which would mean you only have to attend once for two hours in total. 
Otherwise your assessments will be on two different days for one hour.  
 
What will happen if I decide to be in this study? 
You will be examined independently by two qualified and experienced 
physiotherapists (the principal investigator and one other). Each examination 
will take approximately one hour.  Your medical history will be taken and a 
physical examination conducted. This will involve the assessment of 
movements of your neck and arm and a range of tests of sensation in the neck 
and arm.  All tests will only be performed just to the point of pain onset. After 
your visit, the clinical notes which the physiotherapists took during your 
consultation, will be given to a neurosurgeon and to a specialist in 
musculoskeletal therapy for further diagnostic opinion. 
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Are there any reasons I should not be in this study? 
The physiotherapy assessment is an examination which is standard clinical 
practice in any Physiotherapy department. The principal investigator will 
discuss with you any exclusion criteria in detail and will be directed at ensuring 
that the examination is both safe and appropriate for you. 
 
What are the costs to me? 
There will be no charge for the examination by the two physiotherapists. 
Transport to and from the clinic where examination will take place will not be 
provided, however your travel expenses will be reimbursed with a $20 
voucher. 
 
What are the possible benefits of taking part?  
Physiotherapists need to diagnose patients with neck/arm pain accurately 
so that the correct treatment can be given to these patients. Although the 
results of this study will importantly add to the body of knowledge in 
diagnosing patients with neck/arm pain, the results gained will probably not 
directly benefit you, but aim to benefit future patients by assisting 
physiotherapists in making accurate diagnoses. 
 
However, the clinical examination which is performed by highly qualified 
physiotherapists would benefit you. You will be given advice and direction on 
further management of your neck/arm pain.  
 
What are the possible side effects, risks and discomforts of taking part? 
You may experience some very momentary discomfort during the testing of 
sensations. You may also experience some minor increase of symptoms 
similar to what you might expect after a standard physiotherapy treatment. 
 
Will my taking part in this study be kept confidential? 
The researchers will need to collect personal data about you, which may be 
sensitive, e.g. date of birth and relevant health information. The researchers 
may also need to get some of your health information from other health 
service providers, e.g another hospital, pathology laboratory, radiographer, GP 
or other medical specialist. 
 
Any personal or health information will be kept private and confidential. It will 
be stored securely and only authorised persons, who understand it must be 
kept confidential, will have access to it. Your study details will be given a 
number so that your identity will not be apparent. The clinical notes taken 
during your examination will be kept at the School of Physiotherapy at Curtin 
University of Technology during the study and in a locked archive for 5 years 
from the time the study is closed. After this time they will be destroyed. This is 
a requirement of Curtin University of Technology.  Some data/information will 
be stored on a computer at the School of Physiotherapy at Curtin University of 
Technology. Access to this information will be via password only. This 
password will only be known to the principal investigator and to the project 
supervisors. 
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Authorised representatives of the Hospital Human Research Ethics 
Committee, and Research Governance may require access to your study 
records to verify study procedures and/or data. In all cases when dealing with 
your information, these people are required to comply with privacy laws that 
protect you. 
 
The results of the research will be made available to other health professionals 
through medical journals or meetings, but you will not be identifiable in these 
communications. By taking part in this study you agree not to restrict the use 
of any data even if you withdraw. Your rights under any applicable data 
protection laws are not affected. 
 
Will I find out the results of the study? 
A summary of the study findings will be forwarded to each participant.  
 
Who has approved the study? 
The South Metropolitan Area Health Service Human Research Ethics 
Committee has given approval for the conduct of this research. In doing so this 
study conforms to the principles set out by the National Statement on Ethical 
Conduct in Human Research and according to the Good Clinical Practice 
Guidelines. 
This study has also been approved by the Curtin University Human Research 
Ethics Committee (Approval Number HR 117/2007). If needed, verification of 
approval can be obtained either by writing to the Curtin University Human 
Research Ethics Committee, c/- Office of Research and Development, Curtin 
University of Technology, GPO Box U1987, Perth, 6845 or by telephoning 
9266 2784 or by emailing hrec@curtin.edu.au 




                                  CONSENT FORM 
Do physiotherapists agree on a diagnosis for patients with neck and arm 
pain? 
 





Date of Birth: _______________ 
 
1. I have been given clear information (verbal and written) about this study 
and have been given time to consider whether I want to take part. 
2. I have been told about the possible advantages and risks of taking part 
in the study and I understand what I am being asked to do. 
3. I have been able to have a member of my family or a friend with me 
while I was told about the study.  I have been able to ask questions and 
all questions have been answered satisfactorily. 
4. I know that I do not have to take part in the study and that I can 
withdraw at any time during the study without affecting my future 
medical care.  My participation in the study does not affect any right to 
compensation, which I may have under statute or common law. 
5. I agree to take part in this research study and for the data obtained to 
be published provided my name or other identifying information is not 
used. 
If you are unclear about anything you have read in the Participant 
Information Sheet or this Consent Form, please speak to your principal 
investigator before signing this Consent Form. 
 
 
Name of Participant   Signature of Participant  Date 
 
 
Name of Investigator  Signature of Investigator  Date 
 
The South Metropolitan Area Health Service Human Research Ethics 
Committee has given ethics approval for the conduct of this project.  If you 
have any ethical concerns regarding the study you can contact the Chair of the 
SMHAS Human Research Ethics Committee on telephone No. (08) 9431 
2929. 
All study participants will be provided with a copy of the Information 
Sheet and Consent Form for their personal records 
 






Participant Information Sheet 
 
Study title: Do physiotherapists agree on a diagnosis for patients with 
neck and arm pain? 
 
Principal Investigator:  Brigitte Tampin, PhD student 
Project Supervisor:  A/Prof Kathy Briffa 
Co-Supervisor:   Dr Helen Slater 
SMHAS Investigators: David Veldman 
 
Please take time to read the following information carefully and discuss it with 
your friends, family and general practitioner if you wish. Ask us any question if 
some part of the information is not clear to you or if you would like more 
information. Please do this before you sign this consent form.  
 
Who is funding this study? 
Brigitte Tampin is supported in her study by a postgraduate scholarship from 




Should you have questions about the study you may contact: 
 
Brigitte Tampin   Phone No. 9266 3667, 0409 883 548 
     After hours:   0409 883 548 
A/Prof Kathy Briffa   Phone No.  9266 3666 
Dr Helen Slater   Phone No.     9266 3099 
David Veldman   Phone No.  9592 0762 
 
All study participants will be provided with a copy of the Information Sheet and 
Consent Form for their personal records. 
 
You may decide to be in the study or not take part at all. If you do decide to 
take part in this study, you may stop at any time. However, before you decide, 
it is important that you understand why this research is being done and what it 
will involve.  
 
Whatever your decision, this decision will not lead to any penalty or affect your 
regular medical care or any benefit to which you are otherwise entitled.  
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The following information sheet will explain the study and will include 
details such as: 
o Why this study might be suitable for you; 
o The type, frequency and risks of any tests or procedures required by 
the study; 
o The nature of your participation including how many visits you will make 
to the hospital; 
o Your rights and responsibilities. 
 
What is the purpose of the study? 
There are a number of different reasons why people can have neck and arm 
pain. It is important to look for possible factors contributing to pain so that 
treatment can be directed at these factors. Physiotherapists use certain 
examination protocols for the assessment of patients with neck/arm pain, but 
the interpretation of their findings might vary between therapists. The purpose 
of this study is to examine if two experienced physiotherapists come to the 
same conclusion about the cause of your pain and if their conclusion is 
supported by the judgement of a neurosurgeon and a specialist in 
musculoskeletal therapy. 
 
Why is this study suitable to me? 
You are invited to take part in this study as you experience one sided neck 
and/or arm pain. Your participation would give you the opportunity to be 
examined by two very qualified and experienced physiotherapists who will give 
you feedback on their diagnosis and advice on further management of your 
neck/arm pain.  
 
How long will I be in this study? 
You would have to attend Fremantle Hospital or the School of Physiotherapy, 
Curtin University of Technology or the principal investigator’s  Physiotherapy 
Practice in Fremantle, whichever one is more convenient to you. You will be 
examined independently by two physiotherapists; each assessment will take 
about one hour. It might be possible to schedule your visit in such a way that 
your assessments will be performed on the same day, one after the other, 
which would mean you only have to attend once for two hours in total. 
Otherwise your assessments will be on two different days for one hour.  
 
What will happen if I decide to be in this study? 
You will be examined independently by two qualified and experienced 
physiotherapists (the principal investigator and one other). Each examination 
will take approximately one hour.  Your medical history will be taken and a 
physical examination conducted. This will involve the assessment of 
movements of your neck and arm and a range of tests of sensation in the neck 
and arm.  All tests will only be performed just to the point of pain onset. After 
your visit, the clinical notes which the physiotherapists took during your 
consultation, will be given to a neurosurgeon and to a specialist in 
musculoskeletal therapy for further diagnostic opinion. 
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Are there any reasons I should not be in this study? 
The physiotherapy assessment is an examination which is standard clinical 
practice in any Physiotherapy department. The principal investigator will 
discuss with you any exclusion criteria in detail and will be directed at ensuring 
that the examination is both safe and appropriate for you. 
 
What are the costs to me? 
There will be no charge for the examination by the two physiotherapists. 
Transport to and from the clinic where examination will take place will not be 
provided, however your travel expenses will be reimbursed with a $20 
voucher. 
 
What are the possible benefits of taking part?  
Physiotherapists need to diagnose patients with neck/arm pain accurately 
so that the correct treatment can be given to these patients. Although the 
results of this study will importantly add to the body of knowledge in 
diagnosing patients with neck/arm pain, the results gained will probably not 
directly benefit you, but aim to benefit future patients by assisting 
physiotherapists in making accurate diagnoses. 
 
However, the clinical examination which is performed by highly qualified 
physiotherapists would benefit you. You will be given advice and direction on 
further management of your neck/arm pain.  
 
What are the possible side effects, risks and discomforts of taking part? 
You may experience some very momentary discomfort during the testing of 
sensations. You may also experience some minor increase of symptoms 
similar to what you might expect after a standard physiotherapy treatment. 
 
Will my taking part in this study be kept confidential? 
The researchers will need to collect personal data about you, which may be 
sensitive, e.g. date of birth and relevant health information. The researchers 
may also need to get some of your health information from other health 
service providers, e.g another hospital, pathology laboratory, radiographer, GP 
or other medical specialist. 
 
Any personal or health information will be kept private and confidential. It will 
be stored securely and only authorised persons, who understand it must be 
kept confidential, will have access to it. Your study details will be given a 
number so that your identity will not be apparent. The clinical notes taken 
during your examination will be kept at the School of Physiotherapy at Curtin 
University of Technology during the study and in a locked archive for 5 years 
from the time the study is closed. After this time they will be destroyed. This is 
a requirement of Curtin University of Technology.  Some data/information will 
be stored on a computer at the School of Physiotherapy at Curtin University of 
Technology. Access to this information will be via password only. This 
password will only be known to the principal investigator and to the project 
supervisors. 
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Authorised representatives of the Hospital Human Research Ethics 
Committee, and Research Governance may require access to your study 
records to verify study procedures and/or data. In all cases when dealing with 
your information, these people are required to comply with privacy laws that 
protect you. 
 
The results of the research will be made available to other health professionals 
through medical journals or meetings, but you will not be identifiable in these 
communications. By taking part in this study you agree not to restrict the use 
of any data even if you withdraw. Your rights under any applicable data 
protection laws are not affected. 
 
Will I find out the results of the study? 
A summary of the study findings will be forwarded to each participant.  
 
Who has approved the study? 
The South Metropolitan Area Health Service Human Research Ethics 
Committee has given approval for the conduct of this research. In doing so this 
study conforms to the principles set out by the National Statement on Ethical 
Conduct in Human Research and according to the Good Clinical Practice 
Guidelines. 
 
This study has also been approved by the Curtin University Human Research 
Ethics Committee (Approval Number HR 117/2007). If needed, verification of 
approval can be obtained either by writing to the Curtin University Human 
Research Ethics Committee, c/- Office of Research and Development, Curtin 
University of Technology, GPO Box U1987, Perth, 6845 or by telephoning 
9266 2784 or by emailing hrec@curtin.edu.au 




                                  CONSENT FORM 
Do physiotherapists agree on a diagnosis for patients with neck and arm 
pain? 





Date of Birth: _______________ 
1. I have been given clear information (verbal and written) about this study 
and have been given time to consider whether I want to take part. 
2. I have been told about the possible advantages and risks of taking part 
in the study and I understand what I am being asked to do. 
3. I have been able to have a member of my family or a friend with me 
while I was told about the study. I have been able to ask questions and 
all questions have been answered satisfactorily. 
4. I know that I do not have to take part in the study and that I can 
withdraw at any time during the study without affecting my future 
medical care. My participation in the study does not affect any right to 
compensation, which I may have under statute or common law. 
5. I agree to take part in this research study and for the data obtained to 
be published provided my name or other identifying information is not 
used. 
If you are unclear about anything you have read in the Participant 
Information Sheet  or this Consent Form, please speak to your principal 
investigator before signing this Consent Form. 
 
 
Name of Participant   Signature of Participant  Date 
 
 
Name of Investigator  Signature of Investigator  Date 
 
The South Metropolitan Area Health Service Human Research Ethics 
Committee has given ethics approval for the conduct of this project.  If you 
have any ethical concerns regarding the study you can contact the Chair of the 
SMHAS Human Research Ethics Committee on telephone No. (08) 9431 
2929. 
All study participants will be provided with a copy of the Information 
Sheet and Consent Form for their personal record. 
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ROYAL P ERTH HOSPITAL 
Do physiotherapists agree on a diagnosis for patients with neck and arm 
pain? 
 
Principal Investigator:  Brigitte Tampin, PhD student 
RPH Investigator:   Dr Helen Slater, Pain Medicine Centre, RPH 
Project Supervisor:   A/Prof Kathy Briffa 
 
Please take time to read the following information carefully and discuss it with 
your friends, family and general practitioner if you wish. Ask us any question if 
some part of the information is not clear to you or if you would like more 
information. Please do this before you sign this consent form.   
 
Who is funding this study? 
Brigitte Tampin is supported in her study by a postgraduate scholarship from 




Should you have questions about the study you may contact: 
 
Brigitte Tampin   Phone No. 9266 3667, 0409 883 548 
     After hours:   0409 883 548 
Dr Helen Slater   Phone No.     9266 3099 
 
All study participants will be provided with a copy of the Information Sheet and 
Consent Form for their personal records. Participation is voluntary. 
 
You may decide to be in the study or not take part at all. If you do decide to 
take part in this study, you may stop at any time. However, before you decide, 
it is important that you understand why this research is being done and what it 
will involve. Whatever your decision, this decision will not lead to any penalty 
or affect your regular medical care or any benefit to which you are otherwise 
entitled.  
 
The following information sheet will explain the study and will include details 
such as: 
o Why this study might be suitable for you; 
o The type, frequency and risks of any tests or procedures required by 
the study; 
o The nature of your participation including how many visits you will make 
to the hospital; 
o Your rights and responsibilities. 
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What is the purpose of the study? 
There are a number of different reasons why people can have neck and 
arm pain. It is important to look for possible factors contributing to pain so 
that treatment can be directed at these factors. Physiotherapists use 
certain examination protocols for the assessment of patients with neck/arm 
pain, but the interpretation of their findings might vary between therapists. 
The purpose of this study is to examine if two experienced physiotherapists 
come to the same conclusion about the cause of your pain and if their 
conclusion is supported by the judgement of a neurosurgeon and a 
specialist in musculoskeletal therapy. 
 
Why is this study suitable to me? 
You are invited to take part in this study as you experience one sided neck 
and/or arm pain. Your participation would give you the opportunity to be 
examined by two very qualified and experienced physiotherapists who will 
give you feedback on their diagnosis and advice on further management of 
your neck/arm pain.  
 
How long will I be in this study? 
If you agree to participate, we will ask you to attend the School of 
Physiotherapy, Curtin University of Technology or the principal investigator’s  
Physiotherapy Practice in Fremantle, whichever one is more convenient to 
you. You will be examined independently by two physiotherapists; each 
assessment will take about one hour. It might be possible to schedule your 
visit in such a way that your assessments will be performed on the same day, 
one after the other, which would mean you only have to attend once for two 
hours in total. Otherwise your assessments will be on two different days for 
one hour.  
 
What will happen if I decide to be in this study? 
You will be examined independently by two qualified and experienced 
physiotherapists (the principal investigator and one other). Each examination 
will take approximately one hour. Your medical history will be taken and a 
physical examination conducted. This will involve the assessment of 
movements of your neck and arm and a range of tests of sensation in the neck 
and arm.  All tests will only be performed just to the point of pain onset. After 
your visit, the clinical notes which the physiotherapists took during your 
consultation, will be given to a neurosurgeon and to a specialist in 
musculoskeletal therapy for further diagnostic opinion. 
 
Are there any reasons I should not be in this study? 
The physiotherapy assessment is an examination which is standard clinical 
practice in any Physiotherapy department. The principal investigator will 
discuss with you any exclusion criteria in detail and will be directed at ensuring 
that the examination is both safe and appropriate for you. 
 
What are the costs to me? 
There will be no charge for the examination by the two physiotherapists. 
Transport to and from the clinic where examination will take place will not be 
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provided, however your travel expenses will be reimbursed with a $20 
voucher. 
 
What are the possible benefits of taking part?  
Physiotherapists need to diagnose patients with neck/arm pain accurately so 
that the correct treatment can be given to these patients. Although the results 
of this study will importantly add to the body of knowledge in diagnosing 
patients with neck/arm pain, the results gained will probably not directly benefit 
you, but aim to benefit future patients by assisting physiotherapists in making 
accurate diagnoses. 
 
However, the clinical examination which is performed by highly qualified 
physiotherapists would benefit you. You will be given advice and direction on 
further management of your neck/arm pain.  
 
What are the possible side effects, risks and discomforts of taking part? 
You may experience some very momentary discomfort during the testing of 
sensations. You may also experience some minor increase of symptoms 
similar to what you might expect after a standard physiotherapy treatment. 
 
What if something goes wrong during the study? 
In the event that you suffer an adverse event or a medical accident during this 
study that arises from your participation in the study, you will be offered all full 
and necessary treatment by Royal Perth Hospital. The Ethics Committee has 
approved this study on the basis (amongst others) that the reported risk of 
such an event is either small or acceptable in terms of the risk you face as a 
result of your current illness. No provisions have been made in this trial to offer 
trial subjects who suffer an adverse reaction monetary compensation, but the 
absence of such a provision does not remove your rights to seek 
compensation under common law 
 
Will my taking part in this study be kept confidential? 
The researchers will need to collect personal data about you, which may be 
sensitive, e.g. date of birth and relevant health information. The researchers 
may also need to get some of your health information from other health 
service providers, e.g. another hospital, pathology laboratory, radiographer, 
GP or other medical specialist. The investigators will adhere to usual 
standards of confidentiality in the collection and handling of your personal 
information and the standards of the Privacy Act 1988 will apply to the way 
your information is handled. 
 
Any personal or health information will be kept private and confidential. It will 
be stored securely and only authorised persons, who understand it must be 
kept confidential, will have access to it. Your study details will be given a 
number so that your identity will not be apparent. The clinical notes taken 
during your examination will be kept at the School of Physiotherapy at Curtin 
University of Technology during the study and in a locked archive for 5 years 
from the time the study is closed. After this time they will be destroyed. This is 
a requirement of Curtin University of Technology. Some data/information will 
be stored on a computer at the School of Physiotherapy at Curtin University of 
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Technology. Access to this information will be via password only. This 
password will only be known to the principal investigator and to the project 
supervisors. 
 
Authorised representatives of the RPH Ethics Committee, and Research 
Governance may require access to your study records to verify study 
procedures and/or data. In all cases when dealing with your information, these 
people are required to comply with privacy laws that protect you. 
 
The results of the research will be made available to other health professionals 
through medical journals or meetings, but you will not be identifiable in these 
communications. By taking part in this study you agree not to restrict the use 
of any data even if you withdraw. Your rights under any applicable data 
protection laws are not affected. 
 
Will I find out the results of the study? 
A summary of the study findings will be forwarded to each participant.  
 
Who has approved the study? 
This study has been approved by the Curtin University Human Research 
Ethics Committee (Approval Number HR 117/2007) and the Royal Perth 
Hospital Human Research Ethics Committee (EC RA-09/008). If you have any 
concerns about the conduct of the study or questions about your rights as a 
research participant, please contact the Chairman of the RPH Ethics 









                                  CONSENT FORM 
 
Do physiotherapists agree on a diagnosis for patients with neck and arm 
pain? 
 




Date of Birth: _______________ 
 
1. I have been given clear information (verbal and written) about this study 
and have been given time to consider whether I want to take part. 
 
2. I have been told about the possible advantages and risks of taking part 
in the study and I understand what I am being asked to do. 
 
3. I have been able to have a member of my family or a friend with me 
while I was told about the study.  I have been able to ask questions and 
all questions have been answered satisfactorily. 
 
4. I know that I do not have to take part in the study and that I can 
withdraw at any time during the study without affecting my future 
medical care.  My participation in the study does not affect any right to 
compensation, which I may have under statute or common law. 
 
5. I agree to take part in this research study and for the data obtained to 
be published provided my name or other identifying information is not 
used. 
 
If you are unclear about anything you have read in the Participant 
Information Sheet or this Consent Form, please speak to your principal 
investigator before signing this Consent Form. 
 
 
Name of Participant   Signature of Participant  Date 
 
 
Name of Investigator  Signature of Investigator  Date 








PATIENT INFORMATION SHEET 
Study B 
 
Project title: Investigating your sensitivity to touch, movement, pressure 
and temperature sensations in the neck and upper limbs 
 
Principal Investigator:  Brigitte Tampin, PhD student 
Project Supervisor:  A/Prof Kathy Briffa 
Co-Supervisor:   Dr Helen Slater 
 
Purpose of Research 
Neck and upper limb pain can affect how your nerves interpret touch, 
movement, pressure and temperature sensations. This study will examine how 
your pain affects these sensations in both your painful and non-painful arm.  
 
Your role 
You will be required to attend the School of Physiotherapy on one occasion for 
approximately three hours. Firstly, you will be asked to fill out questionnaires 
which will ask you about your pain, loss of function due to pain, emotional stress, 
fear of movement and your overall quality of life. Secondly, you will undergo 
some sensation testing which will involve testing the sensitivity to heat and cold, 
to light touch and pressure, to pin-prick and vibration. During these testing 
procedures you will be asked to identify the presence (yes/no) and the quality of 
the stimulus, i.e. whether you feel touch, prick, pain etc. If you feel any pain, you 
will be asked to press a stop button immediately at the first painful sensation and 
the testing will be stopped. For vibration testing you will be asked to say when 
you stop to feel the vibration. All testing will be performed on the top of both of 
your hands, in the area where you feel most pain and its opposite side (for healthy 
controls bilaterally in the lower neck) and on one foot. In addition, the sensation 
of pressure over three nerves in your arms will be examined.  
 
Finally, the movement of your elbow will be measured in both arms. You will be 
required to lie on your back. Your arm to be tested will be positioned comfortably 
away from your side, supported by the couch, and hold in this position by a frame. 
A splint will be attached to your hand which helps to control the wrist position. A 
measuring device called a goniometer will be attached to your forearm to allow 
for exact measurements of the elbow movement to be made. Your elbow will be 
initially bent at 90 degrees and then slowly straightened over 10 seconds by the 
examiner. You will be asked to press a trigger button when (1) you feel any onset 
of pain for the first time and (2) when you want the movement to be stopped. This 
process will be repeated 3 times. The testing procedure has been used in previous 
studies by the principal investigator. 
 
Division of Health Sciences 
School of Physiotherapy 
Telephone +61 8 9266 3618 
Facsimile  +61 8 9266 3699 
Email physio@curtin.edu.au 
Web www.physiotherapy.curtin.edu.au  
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Risks and Discomforts 
You may experience some very momentary discomfort during the testing of 
sensations. You may also experience some post-assessment exacerbation of 




This project aims to help establish what sensations are affected by pain and what 
this might mean in terms of diagnosis. Although the results of this study will 
importantly add to the body of knowledge in the diagnosis of patients with 
neck/arm pain of nerve origin, the examination you will undertake and the results 
gained will probably not directly benefit you, but aim to benefit the wider clinical 
population by assisting physiotherapists in making accurate diagnoses. 
 
Confidentiality 
You will be issued a study number instead of using your name, which will remain 
confidential to the principle investigator and the project supervisors. All the data 
(information) recorded will be stored on computer within the School of 
Physiotherapy, Curtin University of Technology. Access to this information will 
be via password only. This password will only be known to the principal 
investigator and to the project supervisors. The results of this study will be 
reported, but it will not be possible to identify individual subjects. Following the 
study period, the data will be held in a secure place for 7 years. After this time it 
will be destroyed. This is a requirement of Curtin University of Technology. 
 
Refusal or Withdrawal 
If you consent to participate in this study, you will be free to withdraw at any 
time, without fear of prejudice. If you do decide to withdraw from the study you 
would be asked to contact the Principle Investigators at the earliest opportunity. In 
the event that you withdraw, all of your data would be destroyed.  
 
Further Information 
This study has been approved by the Curtin University Human Research Ethics 
Committee (Approval Number HR 117/2007). The Committee is comprised of 
members of the public, academics, lawyers, doctors and pastoral carers.  Its main 
role is to protect participants.  If needed, verification of approval can be obtained 
either by writing to the Curtin University Human Research Ethics Committee, c/- 
Office of Research and Development, Curtin University of Technology, GPO Box 
U1987, Perth, 6845 or by telephoning 9266 2784 or by emailing 
hrec@curtin.edu.au 
 
If you would like further information about the study, please feel free to contact 
me on 9266 3667 or 0409 883 548 or by email: 
brigitte.tampin@postgrad.curtin.edu.au. Alternatively, you can contact my 
supervisor A/Prof Kathy Briffa on 9266 3666 or by email: 
K.Briffa@exchange.curtin.edu.au or my co-supervisor Dr Helen Slater on 9266 
3099, or by email: H.Slater@curtin.edu.au 
 
Thank you very much for your involvement in this research, your participation is 
greatly appreciated. 












Project title: Investigating your sensitivity to touch, movement, pressure 
and temperature sensations in the neck and upper limbs 
 
Principal Investigator:  Brigitte Tampin, PhD student 
Project Supervisor:  A/Prof Kathy Briffa 
Co-Supervisor:   Dr Helen Slater 
 
Purpose of Research 
Neck and upper limb pain can affect how nerves interpret touch, movement, 
pressure and temperature sensations. This study will examine these sensations. 
Your participation in the study will allow us to compare the responses in people 
with pain with responses in people who have no neck and upper limb pain.  
 
Your role 
You will be required to attend the School of Physiotherapy on one occasion for 
approximately three hours. Firstly, you will be asked to fill out questionnaires 
which will ask you about pain, loss of function due to pain, emotional stress, fear 
of movement and your overall quality of life. Secondly, you will undergo some 
sensation testing which will involve testing the sensitivity to heat and cold, to 
light touch and pressure, to pin-prick and vibration. During these testing 
procedures you will be asked to identify the presence (yes/no) and the quality of 
the stimulus, i.e. whether you feel touch, prick, pain etc. If you feel any pain, you 
will be asked to press a stop button immediately at the first painful sensation and 
the testing will be stopped. For vibration testing you will be asked to say when 
you stop to feel the vibration. All testing will be performed on the top of both of 
your hands, on both sides of your lower neck and on one foot. In addition, the 
sensation of pressure over three nerves in your arms will be examined.  
 
Finally, the movement of your elbow will be measured in both arms. You will be 
required to lie on your back. Your arm to be tested will be positioned comfortably 
away from your side, supported by the couch, and hold in this position by a frame. 
A splint will be attached to your hand which helps to control the wrist position.  A 
measuring device called a goniometer will be attached to your forearm to allow 
for exact measurements of the elbow movement to be made. Your elbow will be 
initially bent at 90 degrees and then slowly straightened over 10 seconds by the 
examiner. You will be asked to press a trigger button when (1) you feel any onset 
of pain for the first time and (2) when you want the movement to be stopped. This 
process will be repeated 3 times. The testing procedure has been used in previous 
studies by the principal investigator. 
Division of Health Sciences 
School of Physiotherapy 
Telephone +61 8 9266 3618 
Facsimile  +61 8 9266 3699 
Email physio@curtin.edu.au 
Web www.physiotherapy.curtin.edu.au  
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Risks and Discomforts 




This project aims to help establish what sensations are affected by pain and what 
this might mean in terms of diagnosis. Although the results of this study will 
importantly add to the body of knowledge in the diagnosis of patients with 
neck/arm pain of nerve origin, the examination you will undertake and the results 
gained will not directly benefit you as you do not have any pain. However, the 




You will be issued a study number instead of using your name, which will remain 
confidential to the principle investigator and the project supervisors. All the data 
(information) recorded will be stored on computer within the School of 
Physiotherapy, Curtin University of Technology. Access to this information will 
be via password only. This password will only be known to the principal 
investigator and to the project supervisors. The results of this study will be 
reported, but it will not be possible to identify individual subjects. Following the 
study period, the data will be held in a secure place for 7 years. After this time it 
will be destroyed. This is a requirement of Curtin University of Technology. 
 
Refusal or Withdrawal 
If you consent to participate in this study, you will be free to withdraw at any 
time, without fear of prejudice. If you do decide to withdraw from the study you 
would be asked to contact the Principle Investigators at the earliest opportunity. In 
the event that you withdraw, all of your data would be destroyed.  
 
Further Information 
This study has been approved by the Curtin University Human Research Ethics 
Committee (Approval Number HR 117/2007). The Committee is comprised of 
members of the public, academics, lawyers, doctors and pastoral carers. Its main 
role is to protect participants.  If needed, verification of approval can be obtained 
either by writing to the Curtin University Human Research Ethics Committee, c/- 
Office of Research and Development, Curtin University of Technology, GPO Box 
U1987, Perth, 6845 or by telephoning 9266 2784 or by emailing 
hrec@curtin.edu.au. If you would like further information about the study, please 
feel free to contact me on 9266 3667 or 0409 883 548 or by email: 
brigitte.tampin@postgrad.curtin.edu.au. Alternatively, you can contact my 
supervisor A/Prof Kathy Briffa on 9266 3666 or by email: 
K.Briffa@exchange.curtin.edu.au or my co-supervisor Dr Helen Slater on 9266 
3099, or by email: H.Slater@curtin.edu.au 
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Sir Charles Gairdner Hospital 
 
Participant Information Sheet 
 
Study title: Investigating your sensitivity to touch, movement, 
pressure and temperature sensations in the neck and upper limbs 
 
Principal Investigator:  Brigitte Tampin, PhD student 
Project Supervisor:  A/Prof Kathy Briffa 
Co-Supervisor:   Dr Helen Slater 
SCGH Investigator: Dr Roger Goucke 
 
Please take time to read the following information carefully and discuss it with 
your friends, family and general practitioner if you wish. Ask us any question if 
some part of the information is not clear to you or if you would like more 
information. Please do this before you sign this consent form.   
 
Who is funding this study? 
Brigitte Tampin is supported in her study by a postgraduate scholarship from 




Should you have questions about the study you may contact: 
 
Brigitte Tampin   Phone No. 9266 3667, 0409 883 548 
     After hours:   0409 883 548 
A/Prof Kathy Briffa   Phone No.  9266 3666 
Dr Helen Slater   Phone No.     9266 3099 
Dr Roger Goucke    Phone No.     9346 3263 
 
 
All study participants will be provided with a copy of the Information Sheet and 
Consent Form for their personal records. 
 
You may decide to be in the study or not take part at all. If you do decide to 
take part in this study, you may stop at any time. However, before you decide, 
it is important that you understand why this research is being done and what it 
will involve.  
Whatever your decision, this decision will not lead to any penalty or affect your 
regular medical care or any benefit to which you are otherwise entitled.  
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The following information sheet will explain the study and will include 
details such as: 
o Why this study might be suitable for you; 
o The type, frequency and risks of any tests or procedures required by 
the study; 
o The nature of your participation including how many visits you will make 
to the hospital; 
o Your rights and responsibilities. 
 
What is the purpose of the study? 
Neck and upper limb pain can affect how your nerves interpret touch, 
movement, pressure and temperature sensations. This study will examine how 
your pain affects these sensations in both your painful and non-painful arm.  
 
Why is this study suitable to me? 
You are invited to take part in this study as you experience neck and/or arm 
pain relating to specific nerve in the neck. The study aims to help establish 
what sensations are affected by pain and what this might mean in terms of 
diagnosis. 
 
How long will I be in this study? 
You would have to attend the School of Physiotherapy, Curtin University of 
Technology, on one occasion for approximately three hours. 
 
What will happen if I decide to be in this study? 
Firstly, you will be asked to fill out questionnaires which will ask you about 
your pain, loss of function due to pain, emotional stress, fear of movement and 
your overall quality of life. Secondly, you will undergo some sensation testing 
which will involve testing the sensitivity to heat and cold, to light touch and 
pressure, to pin-prick and vibration. During these testing procedures you will 
be asked to identify the presence (yes/no) and the quality of the stimulus, i.e. 
whether you feel touch, prick, pain etc. If you feel any pain, you will be asked 
to press a stop button immediately at the first painful sensation and the testing 
will be stopped. For vibration testing you will be asked to say when you stop to 
feel the vibration. All testing will be performed on the top of both of your hands, 
in the area where you feel most pain and its opposite side and on one foot. In 
addition, the sensation of pressure over three nerves in your arms will be 
examined.  
 
Finally, the movement of your elbow will be measured in both arms. You will 
be required to lie on your back. Your arm to be tested will be positioned 
comfortably away from your side, supported by the couch, and hold in this 
position by a frame. A splint will be attached to your hand which helps to 
control the wrist position. A measuring device called a goniometer will be 
attached to your forearm to allow for exact measurements of the elbow 
movement to be made. Your elbow will be initially bent at 90 degrees and then 
slowly straightened over 10 seconds by the examiner. You will be asked to 
press a trigger button when (1) you feel any onset of pain for the first time and 
(2) when you want the movement to be stopped. This process will be repeated 
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3 times. The testing procedure has been used in previous studies by the 
principal investigator. 
 
Are there any reasons I should not be in this study? 
Each potential participant will undergo a clinical examination (see paragraph 
below: “What are the possible benefits of taking part?”) which will serve to 
establish if your pain condition fits the inclusion criteria for the study. Only 
persons who present with a pain condition that is related to nerves coming 
from a specific segment in the neck (between the 5th and 7th neck bone) could 
be included in the study. Further to this, participants should not have diabetes 
or a history of any vascular disease (impaired blood circulation). The principal 
investigator will discuss with you after the clinical examination if you fulfil the 
inclusion criteria. 
 
What are the costs to me? 
There will be no charge for the examination by the principal investigator. 
Transport to and from Curtin University will not be provided, however a free 
parking permit will be given to you. 
 
What are the possible benefits of taking part?  
You have been experiencing neck and/or arm pain for a longer time and you 
have been referred to see a neurosurgeon at Sir Charles Gairdner Hospital. 
The hospital has set up a Comprehensive Spinal Care Clinic at the 
Department of Pain Management, comprising of a neurosurgeon, pain 
specialist and physiotherapist, in order to reduce these long waiting periods. 
Patients are initially assessed by a highly qualified and experienced 
physiotherapist who will then discuss further management with the patient and 
refer them on to the medical specialists, if needed. 
 
This research study will give you the opportunity to reduce your waiting time 
for an appointment. You will be examined by a physiotherapist as mentioned 
above. However, you are under no obligation to take part in the study of 
sensitivity testing. 
 
This project of sensitivity testing aims to help establish what sensations are 
affected by pain and what this might mean in terms of diagnosis. Although the 
results of this study will importantly add to the body of knowledge in the 
diagnosis of patients with neck/arm pain of nerve origin, the examination you 
will undertake and the results gained will probably not directly benefit you, but 
aim to benefit future patients by assisting physiotherapists in making accurate 
diagnoses. 
 
What are the possible side effects, risks and discomforts of taking part? 
You may experience some very momentary discomfort during the testing of 
sensations. You may also experience some post-assessment exacerbation of 
symptoms similar to what you might expect after a standard physiotherapy 
treatment. 
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How will my safety by ensured? 
The equipment which is used to measure your heat and cold pain threshold 
has a safety cut off temperature. This means when a certain temperature has 
been reached, the temperature goes automatically back to the starting 
temperature of 32°C which is like your body temperature. Therefore no harm 
can be done to you. In addition you will be asked to press a stop button 
immediately at the first painful sensation and the testing will be stopped. 
 
Will my taking part in this study be kept confidential? 
The principal investigator will need to collect personal data about you, which 
may be sensitive, e.g. date of birth and relevant health information. She may 
also need to get some of your health information from other health service 
providers, e.g. another hospital, pathology laboratory, radiographer, GP or 
other medical specialist. 
 
Any personal or health information will be kept private and confidential. It will 
be stored securely and only authorised persons, who understand it must be 
kept confidential, will have access to it. Your study details will be given a 
number so that your identity will not be apparent. All data/information will be 
recorded on a computer at the School of Physiotherapy at Curtin University of 
Technology. Access to this information will be via password only. This 
password will only be known to the principal investigator and to the project 
supervisors. Any hard copies as well as backed up electronic copies will be 
kept at the School of Physiotherapy at Curtin University of Technology during 
the study and in a locked archive for 5 years from the time the study is closed. 
After this time they will be destroyed. This is a requirement of Curtin University 
of Technology. 
 
Authorised representatives of the Hospital Human Research Ethics 
Committee, and Research Governance may require access to your study 
records to verify study procedures and/or data. In all cases when dealing with 
your information, these people are required to comply with privacy laws that 
protect you. 
 
The results of the research will be made available to other health professionals 
through medical journals or meetings, but you will not be identifiable in these 
communications. By taking part in this study you agree not to restrict the use 
of any data even if you withdraw. Your rights under any applicable data 
protection laws are not affected. 
 
Will I find out the results of the study? 
A summary of the study findings will be forwarded to each participant.  
 
Who has reviewed the study? 
The Sir Charles Gairdner Hospital Human Research Ethics Committee has 
reviewed this study and has given its approval for the conduct of this research. 
In doing so this study conforms to the principles set out by the National 
Statement on Ethical Conduct in Research involving Humans and according to 
the Good Clinical Practice Guidelines. 
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This study has also been approved by the Curtin University Human 
Research Ethics Committee (Approval Number HR 117/2007). If needed, 
verification of approval can be obtained either by writing to the Curtin 
University Human Research Ethics Committee, c/- Office of Research and 
Development, Curtin University of Technology, GPO Box U1987, Perth, 
6845 or by telephoning 9266 2784 or by emailing hrec@curtin.edu.au 
 




                                  CONSENT FORM 
 
Investigating your sensitivity to touch, movement, pressure and 
temperature sensations in the neck and upper limbs 





Date of Birth: _______________ 
 
1. I have been given clear information (verbal and written) about this study 
and have been given time to consider whether I want to take part. 
2. I have been told about the possible advantages and risks of taking part 
in the study and I understand what I am being asked to do. 
3. I have been able to have a member of my family or a friend with me 
while I was told about the study. I have been able to ask questions and 
all questions have been answered satisfactorily. 
4. I know that I do not have to take part in the study and that I can 
withdraw at any time during the study without affecting my future 
medical care.  My participation in the study does not affect any right to 
compensation, which I may have under statute or common law. 
5. I agree to take part in this research study and for the data obtained to 
be published provided my name or other identifying information is not 
used. 
 
If you are unclear about anything you have read in the Participant 
Information Sheet or this Consent Form, please speak to the principal 
investigator before signing this Consent Form. 
 
 
Name of Participant   Signature of Investigator   Date 
 
 
Name of Investigator  Signature of Investigator   Date 
 
The Sir Charles Gairdner Hospital Human Research Ethics Committee has 
given ethics approval for the conduct of this project.  If you have any ethical 
concerns regarding the study you can contact the secretary of the Sir Charles 
Gairdner Hospital Human Research Ethics Committee on telephone No. (08) 
9346.2999 
All study participants will be provided with a copy of the Information 
Sheet and Consent Form for their personal records. 





Participant Information Sheet 
 
Study title: Investigating your sensitivity to touch, movement, 
pressure and temperature sensations in the neck and upper limbs 
 
Principal Investigator:  Brigitte Tampin, PhD student 
Project Supervisor:  A/Prof Kathy Briffa 
Co-Supervisor:   Dr Helen Slater 
SMHAS Investigators: Dr Stephanie Davies 
     Stuart Waters  
 
Please take time to read the following information carefully and discuss it with 
your friends, family and general practitioner if you wish. Ask us any question if 
some part of the information is not clear to you or if you would like more 
information. Please do this before you sign this consent form.   
 
Who is funding this study? 
Brigitte Tampin is supported in her study by a postgraduate scholarship from 




Should you have questions about the study you may contact: 
 
Brigitte Tampin   Phone No. 9266 3667, 0409 883 548 
     After hours:   0409 883 548 
A/Prof Kathy Briffa   Phone No.  9266 3666 
Dr Helen Slater   Phone No.     9266 3099 
Dr Stephanie Davies   Phone No.  9431 3296 
Stuart Waters   Phone No.  9431 2533 
 
All study participants will be provided with a copy of the Information Sheet and 
Consent Form for their personal records. 
You may decide to be in the study or not take part at all. If you do decide to 
take part in this study, you may stop at any time.  However, before you decide, 
it is important that you understand why this research is being done and what it 
will involve.  
 
Whatever your decision, this decision will not lead to any penalty or affect your 
regular medical care or any benefit to which you are otherwise entitled.  
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The following information sheet will explain the study and will include 
details such as: 
o Why this study might be suitable for you; 
o The type, frequency and risks of any tests or procedures required by 
the study; 
o The nature of your participation including how many visits you will make 
to the hospital; 
o Your rights and responsibilities. 
 
What is the purpose of the study? 
Pain can affect how your nerves interpret touch, movement, pressure and 
temperature sensations. This study will examine how your pain affects 
these sensations in your upper body.  
 
Why is this study suitable to me? 
You are invited to take part in this study as you experience neck and/or arm 
pain relating to a specific nerve in the neck or you have been diagnosed with 
fibromyalgia. The study aims to help establish what sensations are affected by 
pain and what this might mean in terms of diagnosis. 
 
How long will I be in this study? 
You would have to attend the School of Physiotherapy, Curtin University of 
Technology, on one occasion for approximately three hours. 
 
What will happen if I decide to be in this study? 
Firstly, you will be asked to fill out questionnaires which will ask you about 
your pain, loss of function due to pain, emotional stress, fear of movement and 
your overall quality of life. Secondly, you will undergo some sensation testing 
which will involve testing the sensitivity to heat and cold, to light touch and 
pressure, to pin-prick and vibration. During these testing procedures you will 
be asked to identify the presence (yes/no) and the quality of the stimulus, i.e. 
whether you feel touch, prick, pain etc. If you feel any pain, you will be asked 
to press a stop button immediately at the first painful sensation and the testing 
will be stopped. For vibration testing you will be asked to say when you stop to 
feel the vibration. All testing will be performed on the top of both of your hands, 
in the area where you feel most pain and its opposite side and on one foot. In 
addition, the sensation of pressure over three nerves in your arms will be 
examined.  
 
Finally, the movement of your elbow will be measured in both arms. You will 
be required to lie on your back. Your arm to be tested will be positioned 
comfortably away from your side, supported by the couch, and hold in this 
position by a frame. A splint will be attached to your hand which helps to 
control the wrist position. A measuring device called a goniometer will be 
attached to your forearm to allow for exact measurements of the elbow 
movement to be made. Your elbow will be initially bent at 90 degrees and then 
slowly straightened over 10 seconds by the examiner. You will be asked to 
press a trigger button when (1) you feel any onset of pain for the first time and 
(2) when you want the movement to be stopped. This process will be repeated 
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3 times. The testing procedure has been used in previous studies by the 
principal investigator. 
 
Are there any reasons I should not be in this study? 
Each potential participant will undergo a clinical examination which will serve 
to establish if your pain condition fits the inclusion criteria for the study. Only 
persons who present with a pain condition that is related to nerves coming 
from a specific segment in the neck (between the 5th and 7th neck bone) and 
persons with fibromyalgia could be included in the study. Further to this, 
participants should not have diabetes or a history of any vascular disease 
(impaired blood circulation). The principal investigator will discuss with you 
after the clinical examination if you fulfil the inclusion criteria. 
 
What are the costs to me? 
There will be no charge for the examination by the principal investigator. 
Transport to and from Curtin University will not be provided, however a free 
parking permit will be given to you. Your travel expenses will be reimbursed 
with a $20 voucher. 
 
What are the possible benefits of taking part?  
This project of sensitivity testing aims to help establish what sensations are 
affected by pain and what this might mean in terms of diagnosis. Although the 
results of this study will importantly add to the body of knowledge in the 
diagnosis of patients with neck/arm pain of nerve origin, the examination you 
will undertake and the results gained will probably not directly benefit you, but 
aim to benefit future patients by assisting physiotherapists in making accurate 
diagnoses. However, if you wish, the results of your individual assessment can 
be given to you for further discussion with your doctor or other health 
professionals. 
 
What are the possible side effects, risks and discomforts of taking part? 
You may experience some very momentary discomfort during the testing of 
sensations. You may also experience some post-assessment exacerbation of 
symptoms similar to what you might expect after a standard physiotherapy 
treatment. 
 
How will my safety be ensured? 
The equipment which is used to measure your heat and cold pain threshold 
has a safety cut off temperature. This means when a certain temperature has 
been reached, the temperature goes automatically back to the starting 
temperature of 32°C which is like your body temperature. Therefore no harm 
can be done to you. In addition you will be asked to press a stop button 
immediately at the first painful sensation and the testing will be stopped. 
 
Will my taking part in this study be kept confidential? 
The principal investigator will need to collect personal data about you, which 
may be sensitive, e.g. date of birth and relevant health information. She may 
also need to get some of your health information from other health service 
providers, e.g. another hospital, pathology laboratory, radiographer, GP or 
other medical specialist. 
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Any personal or health information will be kept private and confidential. It will 
be stored securely and only authorised persons, who understand it must be 
kept confidential, will have access to it. Your study details will be given a 
number so that your identity will not be apparent. All data/information will be 
recorded on a computer at the School of Physiotherapy at Curtin University of 
Technology. Access to this information will be via password only. This 
password will only be known to the principal investigator and to the project 
supervisors. Any hard copies as well as backed up electronic copies will be 
kept at the School of Physiotherapy at Curtin University of Technology during 
the study and in a locked archive for 5 years from the time the study is closed. 
After this time they will be destroyed. This is a requirement of Curtin University 
of Technology. 
 
Authorised representatives of the Hospital Human Research Ethics 
Committee, and Research Governance may require access to your study 
records to verify study procedures and/or data. In all cases when dealing with 
your information, these people are required to comply with privacy laws that 
protect you. 
 
The results of the research will be made available to other health professionals 
through medical journals or meetings, but you will not be identifiable in these 
communications. By taking part in this study you agree not to restrict the use 
of any data even if you withdraw. Your rights under any applicable data 
protection laws are not affected. 
 
Will I find out the results of the study? 
A summary of the study findings will be forwarded to each participant.  
 
Who has approved the study? 
The South Metropolitan Area Health Service Human Research Ethics 
Committee has given approval for the conduct of this research In doing so this 
study conforms to the principles set out by the National Statement on Ethical 
Conduct in Human Research and according to the Good Clinical Practice 
Guidelines. 
 
This study has also been approved by the Curtin University Human 
Research Ethics Committee (Approval Number HR 117/2007). If needed, 
verification of approval can be obtained either by writing to the Curtin 
University Human Research Ethics Committee, c/- Office of Research and 
Development, Curtin University of Technology, GPO Box U1987, Perth, 
6845 or by telephoning 9266 2784 or by emailing hrec@curtin.edu.au 




                                  CONSENT FORM 
Investigating your sensitivity to touch, movement, pressure and 
temperature sensations in the neck and upper limbs 
Investigators: Brigitte Tampin, A/Prof Kathy Briffa, Dr. Helen Slater, Dr 




Date of Birth: _______________ 
 
1. I have been given clear information (verbal and written) about this study 
and have been given time to consider whether I want to take part. 
2. I have been told about the possible advantages and risks of taking part 
in the study and I understand what I am being asked to do. 
3. I have been able to have a member of my family or a friend with me 
while I was told about the study. I have been able to ask questions and 
all questions have been answered satisfactorily. 
4. I know that I do not have to take part in the study and that I can 
withdraw at any time during the study without affecting my future 
medical care. My participation in the study does not affect any right to 
compensation, which I may have under statute or common law. 
5. I agree to take part in this research study and for the data obtained to 
be published provided my name or other identifying information is not 
used. 
If you are unclear about anything you have read in the Participant 
Information Sheet or this Consent Form, please speak to the principal 
investigator before signing this Consent Form. 
 
 
Name of Participant   Signature of Participant                 Date 
 
 
Name of Investigator  Signature of Investigator  Date 
 
The South Metropolitan Area Health Service Human Research Ethics 
Committee has given ethics approval for the conduct of this project. If you 
have any ethical concerns regarding the study you can contact the Chair of the 
SMHAS Human Research Ethics Committee on telephone No. (08) 9431 
2929. 
All study participants will be provided with a copy of the Information 
Sheet and Consent Form for their personal records. 




PARTICIPANT INFORMATION SHEET 
 
Study title: Investigating your sensitivity to touch, movement, 
pressure and temperature sensations in the neck and upper limbs 
 
Principal Investigator:  Brigitte Tampin, PhD student 
Project Supervisor:  A/Prof Kathy Briffa 
Co-Supervisor:   Dr Helen Slater 
SMHAS Investigators: Andrew Walton 
 
Please take time to read the following information carefully and discuss it with 
your friends, family and general practitioner if you wish. Ask us any question if 
some part of the information is not clear to you or if you would like more 
information. Please do this before you sign this consent form.   
 
Who is funding this study? 
Brigitte Tampin is supported in her study by a postgraduate scholarship from 




Should you have questions about the study you may contact: 
 
Brigitte Tampin   Phone No. 9266 3667, 0409 883 548 
     After hours:   0409 883 548 
A/Prof Kathy Briffa   Phone No.  9266 3666 
Dr Helen Slater   Phone No.     9266 3099 
Andrew Walton   Phone No.  93343777 
 
All study participants will be provided with a copy of the Information Sheet  
and Consent Form for their personal records. 
 
You may decide to be in the study or not take part at all. If you do decide to 
take part in this study, you may stop at any time. However, before you decide, 
it is important that you understand why this research is being done and what it 
will involve.  
 
Whatever your decision, this decision will not lead to any penalty or affect your 
regular medical care or any benefit to which you are otherwise entitled.  
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The following information sheet will explain the study and will include 
details such as: 
o Why this study might be suitable for you; 
o The type, frequency and risks of any tests or procedures required by 
the study; 
o The nature of your participation including how many visits you will make 
to the hospital; 
o Your rights and responsibilities. 
 
What is the purpose of the study? 
Pain can affect how your nerves interpret touch, movement, pressure and 
temperature sensations. This study will examine how your pain affects these 
sensations in your upper body.  
 
Why is this study suitable to me? 
You are invited to take part in this study as you experience neck and/or arm 
pain relating to a specific nerve in the neck or you have been diagnosed with 
fibromyalgia. The study aims to help establish what sensations are affected by 
pain and what this might mean in terms of diagnosis. 
 
How long will I be in this study? 
You would have to attend the School of Physiotherapy, Curtin University of 
Technology, on one occasion for approximately three hours. 
 
What will happen if I decide to be in this study? 
Firstly, you will be asked to fill out questionnaires which will ask you about 
your pain, loss of function due to pain, emotional stress, fear of movement and 
your overall quality of life. Secondly, you will undergo some sensation testing 
which will involve testing the sensitivity to heat and cold, to light touch and 
pressure, to pin-prick and vibration. During these testing procedures you will 
be asked to identify the presence (yes/no) and the quality of the stimulus, i.e. 
whether you feel touch, prick, pain etc. If you feel any pain, you will be asked 
to press a stop button immediately at the first painful sensation and the testing 
will be stopped. For vibration testing you will be asked to say when you stop to 
feel the vibration. All testing will be performed on the top of both of your hands, 
in the area where you feel most pain and its opposite side and on one foot. In 
addition, the sensation of pressure over three nerves in your arms will be 
examined.  
 
Finally, the movement of your elbow will be measured in both arms. You will 
be required to lie on your back. Your arm to be tested will be positioned 
comfortably away from your side, supported by the couch, and hold in this 
position by a frame. A splint will be attached to your hand which helps to 
control the wrist position. A measuring device called a goniometer will be 
attached to your forearm to allow for exact measurements of the elbow 
movement to be made. Your elbow will be initially bent at 90 degrees and then 
slowly straightened over 10 seconds by the examiner. You will be asked to 
press a trigger button when (1) you feel any onset of pain for the first time and 
(2) when you want the movement to be stopped. This process will be repeated 
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3 times. The testing procedure has been used in previous studies by the 
principal investigator. 
 
Are there any reasons I should not be in this study? 
Each potential participant will undergo a clinical examination which will serve 
to establish if your pain condition fits the inclusion criteria for the study. Only 
persons who present with a pain condition that is related to nerves coming 
from a specific segment in the neck (between the 5th and 7th neck bone) and 
persons with fibromyalgia could be included in the study. Further to this, 
participants should not have diabetes or a history of any vascular disease 
(impaired blood circulation). The principal investigator will discuss with you 
after the clinical examination if you fulfil the inclusion criteria. 
 
What are the costs to me? 
There will be no charge for the examination by the principal investigator. 
Transport to and from Curtin University will not be provided, however a free 
parking permit will be given to you. Your travel expenses will be reimbursed 
with a $20 voucher. 
 
What are the possible benefits of taking part?  
This project of sensitivity testing aims to help establish what sensations are 
affected by pain and what this might mean in terms of diagnosis. Although the 
results of this study will importantly add to the body of knowledge in the 
diagnosis of patients with neck/arm pain of nerve origin, the examination you 
will undertake and the results gained will probably not directly benefit you, but 
aim to benefit future patients by assisting physiotherapists in making accurate 
diagnoses. However, if you wish, the results of your individual assessment can 
be given to you for further discussion with your doctor or other health 
professionals. 
 
What are the possible side effects, risks and discomforts of taking part? 
You may experience some very momentary discomfort during the testing of 
sensations. You may also experience some post-assessment exacerbation of 
symptoms similar to what you might expect after a standard physiotherapy 
treatment. 
 
How will my safety be ensured? 
The equipment which is used to measure your heat and cold pain threshold 
has a safety cut off temperature. This means when a certain temperature has 
been reached, the temperature goes automatically back to the starting 
temperature of 32°C which is like your body temperature. Therefore no harm 
can be done to you. In addition you will be asked to press a stop button 
immediately at the first painful sensation and the testing will be stopped. 
 
Will my taking part in this study be kept confidential? 
The principal investigator will need to collect personal data about you, which 
may be sensitive, e.g. date of birth and relevant health information. She may 
also need to get some of your health information from other health service 
providers, e.g. another hospital, pathology laboratory, radiographer, GP or 
other medical specialist. 
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Any personal or health information will be kept private and confidential. It will 
be stored securely and only authorised persons, who understand it must be 
kept confidential, will have access to it. Your study details will be given a 
number so that your identity will not be apparent. All data/information will be 
recorded on a computer at the School of Physiotherapy at Curtin University of 
Technology. Access to this information will be via password only. This 
password will only be known to the principal investigator and to the project 
supervisors. Any hard copies as well as backed up electronic copies will be 
kept at the School of Physiotherapy at Curtin University of Technology during 
the study and in a locked archive for 5 years from the time the study is closed. 
After this time they will be destroyed. This is a requirement of Curtin University 
of Technology. 
 
Authorised representatives of the Hospital Human Research Ethics 
Committee, and Research Governance may require access to your study 
records to verify study procedures and/or data. In all cases when dealing with 
your information, these people are required to comply with privacy laws that 
protect you. 
 
The results of the research will be made available to other health professionals 
through medical journals or meetings, but you will not be identifiable in these 
communications. By taking part in this study you agree not to restrict the use 
of any data even if you withdraw. Your rights under any applicable data 
protection laws are not affected. 
 
Will I find out the results of the study? 
A summary of the study findings will be forwarded to each participant.  
 
Who has approved the study? 
The South Metropolitan Area Health Service Human Research Ethics 
Committee has given approval for the conduct of this research In doing so this 
study conforms to the principles set out by the National Statement on Ethical 
Conduct in Human Research and according to the Good Clinical Practice 
Guidelines. 
 
This study has also been approved by the Curtin University Human Research 
Ethics Committee (Approval Number HR 117/2007). If needed, verification of 
approval can be obtained either by writing to the Curtin University Human 
Research Ethics Committee, c/- Office of Research and Development, Curtin 
University of Technology, GPO Box U1987, Perth, 6845 or by telephoning 
9266 2784 or by emailing hrec@curtin.edu.au 
 




                                  CONSENT FORM 
Investigating your sensitivity to touch, movement, pressure and 
temperature sensations in the neck and upper limbs 
 





Date of Birth: _______________ 
1. I have been given clear information (verbal and written) about this study 
and have been given time to consider whether I want to take part. 
2. I have been told about the possible advantages and risks of taking part 
in the study and I understand what I am being asked to do. 
3. I have been able to have a member of my family or a friend with me 
while I was told about the study. I have been able to ask questions and 
all questions have been answered satisfactorily. 
4. I know that I do not have to take part in the study and that I can 
withdraw at any time during the study without affecting my future 
medical care. My participation in the study does not affect any right to 
compensation, which I may have under statute or common law. 
5. I agree to take part in this research study and for the data obtained to 
be published provided my name or other identifying information is not 
used. 
If you are unclear about anything you have read in the Participant 
Information Sheet or this Consent Form, please speak to the principal 
investigator before signing this Consent Form. 
 
 
Name of Participant   Signature of Participant                 Date 
 
 
Name of Investigator  Signature of Investigator  Date 
 
The South Metropolitan Area Health Service Human Research Ethics 
Committee has given ethics approval for the conduct of this project. If you 
have any ethical concerns regarding the study you can contact the Chair of the 
SMHAS Human Research Ethics Committee on telephone No. (08) 9431 
2929. 
All study participants will be provided with a copy of the Information 
Sheet and Consent Form for their personal records. 




Participant Information Sheet 
 
Study title: Investigating your sensitivity to touch, movement, 
pressure and temperature sensations in the neck and upper limbs 
 
Principal Investigator:  Brigitte Tampin, PhD student 
Project Supervisor:  A/Prof Kathy Briffa 
Co-Supervisor:   Dr Helen Slater 
SMHAS Investigators: David Veldman 
 
Please take time to read the following information carefully and discuss it with 
your friends, family and general practitioner if you wish. Ask us any question if 
some part of the information is not clear to you or if you would like more 
information. Please do this before you sign this consent form.   
 
Who is funding this study? 
Brigitte Tampin is supported in her study by a postgraduate scholarship from 




Should you have questions about the study you may contact: 
 
Brigitte Tampin   Phone No. 9266 3667, 0409 883 548 
     After hours:   0409 883 548 
A/Prof Kathy Briffa   Phone No.  9266 3666 
Dr Helen Slater   Phone No.     9266 3099 
David Veldman   Phone No.  9592 0762 
 
All study participants will be provided with a copy of the Information Sheet  
and Consent Form for their personal records. 
 
You may decide to be in the study or not take part at all. If you do decide to 
take part in this study, you may stop at any time.  However, before you decide, 
it is important that you understand why this research is being done and what it 
will involve.  
 
Whatever your decision, this decision will not lead to any penalty or affect your 
regular medical care or any benefit to which you are otherwise entitled.  
 
Appendix 2: Patient information sheets and consent forms  
A2-53 
The following information sheet will explain the study and will include 
details such as: 
o Why this study might be suitable for you; 
o The type, frequency and risks of any tests or procedures required by 
the study; 
o The nature of your participation including how many visits you will make 
to the hospital; 
o Your rights and responsibilities. 
 
What is the purpose of the study? 
Pain can affect how your nerves interpret touch, movement, pressure and 
temperature sensations. This study will examine how your pain affects these 
sensations in your upper body.  
 
Why is this study suitable to me? 
You are invited to take part in this study as you experience neck and/or arm 
pain relating to a specific nerve in the neck or you have been diagnosed with 
fibromyalgia. The study aims to help establish what sensations are affected by 
pain and what this might mean in terms of diagnosis. 
 
How long will I be in this study? 
You would have to attend the School of Physiotherapy, Curtin University of 
Technology, on one occasion for approximately three hours. 
 
What will happen if I decide to be in this study? 
Firstly, you will be asked to fill out questionnaires which will ask you about 
your pain, loss of function due to pain, emotional stress, fear of movement and 
your overall quality of life. Secondly, you will undergo some sensation testing 
which will involve testing the sensitivity to heat and cold, to light touch and 
pressure, to pin-prick and vibration. During these testing procedures you will 
be asked to identify the presence (yes/no) and the quality of the stimulus, i.e. 
whether you feel touch, prick, pain etc. If you feel any pain, you will be asked 
to press a stop button immediately at the first painful sensation and the testing 
will be stopped. For vibration testing you will be asked to say when you stop to 
feel the vibration. All testing will be performed on the top of both of your hands, 
in the area where you feel most pain and its opposite side and on one foot. In 
addition, the sensation of pressure over three nerves in your arms will be 
examined.  
 
Finally, the movement of your elbow will be measured in both arms. You will 
be required to lie on your back. Your arm to be tested will be positioned 
comfortably away from your side, supported by the couch, and hold in this 
position by a frame. A splint will be attached to your hand which helps to 
control the wrist position. A measuring device called a goniometer will be 
attached to your forearm to allow for exact measurements of the elbow 
movement to be made. Your elbow will be initially bent at 90 degrees and then 
slowly straightened over 10 seconds by the examiner. You will be asked to 
press a trigger button when (1) you feel any onset of pain for the first time and 
(2) when you want the movement to be stopped. This process will be repeated 
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3 times. The testing procedure has been used in previous studies by the 
principal investigator. 
 
Are there any reasons I should not be in this study? 
Each potential participant will undergo a clinical examination which will serve 
to establish if your pain condition fits the inclusion criteria for the study. Only 
persons who present with a pain condition that is related to nerves coming 
from a specific segment in the neck (between the 5th and 7th neck bone) and 
persons with fibromyalgia could be included in the study. Further to this, 
participants should not have diabetes or a history of any vascular disease 
(impaired blood circulation). The principal investigator will discuss with you 
after the clinical examination if you fulfil the inclusion criteria. 
 
What are the costs to me? 
There will be no charge for the examination by the principal investigator. 
Transport to and from Curtin University will not be provided, however a free 
parking permit will be given to you. Your travel expenses will be reimbursed 
with a $20 voucher. 
 
What are the possible benefits of taking part?  
This project of sensitivity testing aims to help establish what sensations are 
affected by pain and what this might mean in terms of diagnosis. Although the 
results of this study will importantly add to the body of knowledge in the 
diagnosis of patients with neck/arm pain of nerve origin, the examination you 
will undertake and the results gained will probably not directly benefit you, but 
aim to benefit future patients by assisting physiotherapists in making accurate 
diagnoses. However, if you wish, the results of your individual assessment  
can be given to you for further discussion with your doctor or other health 
professionals. 
 
What are the possible side effects, risks and discomforts of taking part? 
You may experience some very momentary discomfort during the testing of 
sensations. You may also experience some post-assessment exacerbation of 
symptoms similar to what you might expect after a standard physiotherapy 
treatment. 
 
How will my safety be ensured? 
The equipment which is used to measure your heat and cold pain threshold 
has a safety cut off temperature. This means when a certain temperature has 
been reached, the temperature goes automatically back to the starting 
temperature of 32°C which is like your body temperature. Therefore no harm 
can be done to you. In addition you will be asked to press a stop button 
immediately at the first painful sensation and the testing will be stopped. 
 
Will my taking part in this study be kept confidential? 
The principal investigator will need to collect personal data about you, which 
may be sensitive, e.g. date of birth and relevant health information. She may 
also need to get some of your health information from other health service 
providers, e.g. another hospital, pathology laboratory, radiographer, GP or 
other medical specialist. 
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Any personal or health information will be kept private and confidential. It will 
be stored securely and only authorised persons, who understand it must be 
kept confidential, will have access to it. Your study details will be given a 
number so that your identity will not be apparent. All data/information will be 
recorded on a computer at the School of Physiotherapy at Curtin University of 
Technology. Access to this information will be via password only. This 
password will only be known to the principal investigator and to the project 
supervisors. Any hard copies as well as backed up electronic copies will be 
kept at the School of Physiotherapy at Curtin University of Technology during 
the study and in a locked archive for 5 years from the time the study is closed. 
After this time they will be destroyed. This is a requirement of Curtin University 
of Technology. 
 
Authorised representatives of the Hospital Human Research Ethics 
Committee, and Research Governance may require access to your study 
records to verify study procedures and/or data. In all cases when dealing with 
your information, these people are required to comply with privacy laws that 
protect you. 
 
The results of the research will be made available to other health professionals 
through medical journals or meetings, but you will not be identifiable in these 
communications. By taking part in this study you agree not to restrict the use 
of any data even if you withdraw. Your rights under any applicable data 
protection laws are not affected. 
 
Will I find out the results of the study? 
A summary of the study findings will be forwarded to each participant.  
 
Who has approved the study? 
The South Metropolitan Area Health Service Human Research Ethics 
Committee has given approval for the conduct of this research In doing so this 
study conforms to the principles set out by the National Statement on Ethical 
Conduct in Human Research and according to the Good Clinical Practice 
Guidelines. 
 
This study has also been approved by the Curtin University Human Research 
Ethics Committee (Approval Number HR 117/2007). If needed, verification of 
approval can be obtained either by writing to the Curtin University Human 
Research Ethics Committee, c/- Office of Research and Development, Curtin 
University of Technology, GPO Box U1987, Perth, 6845 or by telephoning 
9266 2784 or by emailing hrec@curtin.edu.au 
 




                                  CONSENT FORM 
Investigating your sensitivity to touch, movement, pressure and 
temperature sensations in the neck and upper limbs 





Date of Birth: _______________ 
 
1. I have been given clear information (verbal and written) about this study 
and have been given time to consider whether I want to take part. 
2. I have been told about the possible advantages and risks of taking part 
in the study and I understand what I am being asked to do. 
3. I have been able to have a member of my family or a friend with me 
while I was told about the study. I have been able to ask questions and 
all questions have been answered satisfactorily. 
4. I know that I do not have to take part in the study and that I can 
withdraw at any time during the study without affecting my future 
medical care. My participation in the study does not affect any right to 
compensation, which I may have under statute or common law. 
5. I agree to take part in this research study and for the data obtained to 
be published provided my name or other identifying information is not 
used. 
If you are unclear about anything you have read in the Participant 
Information Sheet or this Consent Form, please speak to the principal 
investigator before signing this Consent Form. 
 
 
Name of Participant   Signature of Participant                 Date 
 
 
Name of Investigator  Signature of Investigator  Date 
 
The South Metropolitan Area Health Service Human Research Ethics 
Committee has given ethics approval for the conduct of this project. If you 
have any ethical concerns regarding the study you can contact the Chair of the 
SMHAS Human Research Ethics Committee on telephone No. (08) 9431 
2929. All study participants will be provided with a copy of the Information 
Sheet and Consent Form for their personal records 
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ROYAL PERTH HOSPITAL 
Investigating your sensitivity to touch, movement, pressure and 
temperature sensations in the neck and upper limbs 
 
Principal Investigator:  Brigitte Tampin, PhD student 
RPH Investigator:   Dr Helen Slater, Pain Medicine Centre, RPH 
Project Supervisor:   A/Prof Kathy Briffa 
 
Please take time to read the following information carefully and discuss it with 
your friends, family and general practitioner if you wish. Ask us any question if 
some part of the information is not clear to you or if you would like more 
information. Please do this before you sign this consent form.  
 
Who is funding this study? 
Brigitte Tampin is supported in her study by a postgraduate scholarship from 




Should you have questions about the study you may contact: 
 
Brigitte Tampin   Phone No. 9266 3667, 0409 883 548 
     After hours:   0409 883 548 
Dr Helen Slater   Phone No.     9266 3099 
All study participants will be provided with a copy of the Information Sheet and 
Consent Form for their personal records. 
 
Participation is voluntary 
You may decide to be in the study or not take part at all. If you do decide to 
take part in this study, you may stop at any time. However, before you decide, 
it is important that you understand why this research is being done and what it 
will involve. Whatever your decision, this decision will not lead to any penalty 
or affect your regular medical care or any benefit to which you are otherwise 
entitled.  
 
The following information sheet will explain the study and will include 
details such as: 
o Why this study might be suitable for you; 
o The type, frequency and risks of any tests or procedures required by 
the study; 
o The nature of your participation including how many visits you will make 
to the hospital; 
o Your rights and responsibilities. 
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What is the purpose of the study? 
Pain can affect how your nerves interpret touch, movement, pressure and 
temperature sensations. This study will examine how your pain affects these 
sensations in your upper body.  
 
Why is this study suitable to me? 
You are invited to take part in this study as you experience neck and/or arm 
pain relating to a specific nerve in the neck. The study aims to help establish 
what sensations are affected by pain and what this might mean in terms of 
diagnosis. 
 
How long will I be in this study? 
If you agree to participate, we will ask you to attend the School of 
Physiotherapy, Curtin University of Technology, or Sir Charles Gairdner 
Hospital on one occasion for approximately three hours. 
 
What will happen if I decide to be in this study? 
Firstly, you will be asked to fill out questionnaires which will ask you about 
your pain, loss of function due to pain, emotional stress, fear of movement and 
your overall quality of life. Secondly, you will undergo some sensation testing 
which will involve testing the sensitivity to heat and cold, to light touch and 
pressure, to pin-prick and vibration. During these testing procedures you will 
be asked to identify the presence (yes/no) and the quality of the stimulus, i.e. 
whether you feel touch, prick, pain etc. If you feel any pain, you will be asked 
to press a stop button immediately at the first painful sensation and the testing 
will be stopped. For vibration testing you will be asked to say when you stop to 
feel the vibration. All testing will be performed on the top of both of your hands, 
in the area where you feel most pain and its opposite side and on one foot. In 
addition, the sensation of pressure over three nerves in your arms will be 
examined.  
 
Finally, the movement of your elbow will be measured in both arms. You will 
be required to lie on your back. Your arm to be tested will be positioned 
comfortably away from your side, supported by the couch, and hold in this 
position by a frame. A splint will be attached to your hand which helps to 
control the wrist position. A measuring device called a goniometer will be 
attached to your forearm to allow for exact measurements of the elbow 
movement to be made. Your elbow will be initially bent at 90 degrees and then 
slowly straightened over 10 seconds by the examiner. You will be asked to 
press a trigger button when (1) you feel any onset of pain for the first time and 
(2) when you want the movement to be stopped. This process will be repeated 
3 times. The testing procedure has been used in previous studies by the 
principal investigator. 
 
Are there any reasons I should not be in this study? 
Each potential participant will undergo a clinical examination which will serve 
to establish if your pain condition fits the inclusion criteria for the study. Only 
persons who present with a pain condition that is related to nerves coming 
from a specific segment in the neck (between the 5th and 7th neck bone) could 
be included in the study. Further to this, participants should not have diabetes 
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or a history of any vascular disease (impaired blood circulation). The principal 
investigator will discuss with you after the clinical examination if you fulfil the 
inclusion criteria. 
 
What are the costs to me? 
There will be no charge for the examination by the principal investigator. 
Transport to and from Curtin University or Sir Charles Gairdner Hospital will 
not be provided, however parking fees will be reimbursed plus, your travel 
expenses will be reimbursed with a $20 voucher. 
 
What are the possible benefits of taking part?  
This project of sensitivity testing aims to help establish what sensations are 
affected by pain and what this might mean in terms of diagnosis. Although the 
results of this study will importantly add to the body of knowledge in the 
diagnosis of patients with neck/arm pain of nerve origin, the examination you 
will undertake and the results gained will probably not directly benefit you, but 
aim to benefit future patients by assisting physiotherapists in making accurate 
diagnoses. However, if you wish, the results of your individual assessment can 
be given to you for further discussion with your doctor or other health 
professionals. 
 
What are the possible side effects, risks and discomforts of taking part? 
You may experience some very momentary discomfort during the testing of 
sensations. You may also experience some post-assessment exacerbation of 
symptoms similar to what you might expect after a standard physiotherapy 
treatment. 
 
How will my safety be ensured? 
The equipment which is used to measure your heat and cold pain threshold 
has a safety cut off temperature. This means when a certain temperature has 
been reached, the temperature goes automatically back to the starting 
temperature of 32°C which is like your body temperature. Therefore no harm 
can be done to you. In addition you will be asked to press a stop button 
immediately at the first painful sensation and the testing will be stopped. 
 
What if something goes wrong during the study? 
In the event that you suffer an adverse event or a medical accident during this 
study that arises from your participation in the study, you will be offered all full 
and necessary treatment by Royal Perth Hospital.  The Ethics Committee has 
approved this study on the basis (amongst others) that the reported risk of 
such an event is either small or acceptable in terms of the risk you face as a 
result of your current illness No provisions have been made in this trial to offer 
trial subjects who suffer an adverse reaction monetary compensation, but the 
absence of such a provision does not remove your rights to seek 
compensation under common law. 
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Will my taking part in this study be kept confidential? 
The principal investigator will need to collect personal data about you, which 
may be sensitive, e.g. date of birth and relevant health information. She may 
also need to get some of your health information from other health service 
providers, e.g. another hospital, pathology laboratory, radiographer, GP or 
other medical specialist. The investigators will adhere to usual standards of 
confidentiality in the collection and handling of your personal information and 
the standards of the Privacy Act 1988 will apply to the way your information is 
handled. 
 
Any personal or health information will be kept private and confidential. It will 
be stored securely and only authorised persons, who understand it must be 
kept confidential, will have access to it. Your study details will be given a 
number so that your identity will not be apparent. All data/information will be 
recorded on a computer at the School of Physiotherapy at Curtin University of 
Technology. Access to this information will be via password only. This 
password will only be known to the principal investigator and to the project 
supervisors. Any hard copies as well as backed up electronic copies will be 
kept at the School of Physiotherapy at Curtin University of Technology during 
the study and in a locked archive for 5 years from the time the study is closed. 
After this time they will be destroyed. This is a requirement of Curtin University 
of Technology. 
 
Authorised representatives of the RPH Ethics Committee, and Research 
Governance may require access to your study records to verify study 
procedures and/or data. In all cases when dealing with your information, these 
people are required to comply with privacy laws that protect you. 
 
The results of the research will be made available to other health professionals 
through medical journals or meetings, but you will not be identifiable in these 
communications. By taking part in this study you agree not to restrict the use 
of any data even if you withdraw. Your rights under any applicable data 
protection laws are not affected. 
 
Will I find out the results of the study? 
A summary of the study findings will be forwarded to each participant.  
 
Who has approved the study? 
This study has been approved by the Curtin University Human Research 
Ethics Committee (Approval Number HR 117/2007) and the Royal Perth 
Hospital Human Research Ethics Committee (EC RA-09/008). If you have any 
concerns about the conduct of the study or questions about your rights as a 
research participant, please contact the Chairman of the RPH Ethics 
Committee, Professor Frank van Bockxmeer on (08) 9224 2244. 
 





                                  CONSENT FORM 
 
Investigating your sensitivity to touch, movement, pressure and 
temperature sensations in the neck and upper limbs 
 




Date of Birth: _______________ 
 
1. I have been given clear information (verbal and written) about this study 
and have been given time to consider whether I want to take part. 
2. I have been told about the possible advantages and risks of taking part 
in the study and I understand what I am being asked to do. 
3. I have been able to have a member of my family or a friend with me 
while I was told about the study. I have been able to ask questions and 
all questions have been answered satisfactorily. 
4. I know that I do not have to take part in the study and that I can 
withdraw at any time during the study without affecting my future 
medical care. My participation in the study does not affect any right to 
compensation, which I may have under statute or common law. 
5. I agree to take part in this research study and for the data obtained to 
be published provided my name or other identifying information is not 
used. 
 
If you are unclear about anything you have read in the Participant 
Information Sheet or this Consent Form, please speak to the principal 
investigator before signing this Consent Form. 
 
 
Name of Participant   Signature of Investigator   Date 
 
 











PATIENT SCREENING FORMS AND 
CLINICAL ASSESSMENT FORMS 
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SCREENING FORM FOR PATIENTS WITH NECK/ARM PAIN 
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Age 18-65  
Only one sided neck/arm pain  
Tingling/numbness in arm/hand  
Weakness in arm or hand  
Symptom duration 3-18 months  
VAS ≥ 2 maximal pain area  
Diagnostic imaging tests  
Other diagnostic tests  












Back injury with sciatica/ back surgery  
Thyroid dysfunction  
Endocrine or allergic disorders, diabetes  
Inflammatory joint disease  
Cardiovascular or pulmonary disease  
Morbid obesity  
Cardiac or peripheral vascular disease  
Central nervous system disease (stroke, epilepsy etc)  
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TEL:        DOB: 
 
































































SENSITIVITY TO COLD:  
 





















W.L (Weight loss): 
 
 
C/CE (Cord, cauda equina signs):   STER (steroid intake): 
 
 
V.A. (signs of vertebral artery insufficiency):  





Name Dosage Duration Effect 
    
    
    
    
    





















CERVICAL :   SHOULDER: 
FLEX:   FLEX: 
EXT:   ABD: 
RROT:   ABD with Cx CLLF  
LROT:   (slight shoulder girdle fix): 
RLF:   ABD with wrist Ext 
LLF:   (slight shoulder girdle fix): 
 




 ABD ER SUP WE EL EXT REL WE 
LEFT       
RIGHT       
 
NPTRADIAL 
  DEP WF PRON IR EL EXT ABD REL WF 
LEFT        
RIGHT        
 
NPTULNAR 
 DEP ABD ER PRON WE EL FLE REL WE 
LEFT        
RIGHT        
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NERVE TRUNK PALPATION: N = Normal, H=Hyperalgesia, Hypo 
=Hypoalgesia 
Median nerve 
 Axilla: sup brachial artery Pronator tunnel Carpal tunnel 
LEFT    





Supinator tunnel Wrist: Snuff box 
LEFT    
RIGHT    
 
Ulnar nerve 
 Axilla (inf brachial artery) Cubital tunnel Guyons canal 
LEFT    
RIGHT    
 
OTHER as applicable 
 Spinal nerves 








LEFT     
RIGHT     
 
MOTION PALPATION TESTING PIVMS Cx 
  C4/5 C5/6 C6/7 C7/T1 
Up Slope L     
 R     
Down Slope L     
 R     
 
PAIVMs 
PA C4 C5 C6 C7 
Unilateral L     
Unilateral R     
Central     
 
AP C4 C5 C6  
Unilateral L     
Unilateral R     
OTHER TESTS 























ACHILLES   
KNEE JERK   
 
OTHER LEFT RIGHT 
BABINSKI   
CLONUS   
GAIT   
 
BALANCE 













SCAP ELEV (C4) 
 
  
SHOULD ABD (C5) 
 
  
ELB FLEX (C5/6)   
 
ELB EXT (C6/7)   






INTRINS. (T1)   
OTHER   
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SENSATION  INTENSITY 
N = normal 
Less = Hypoaesthesia 
Loss = Analgesia 
More = Hyperaesthesia 
QUALITY 








 LEFT RIGHT 
 INTENSITY QUALITY INTENSITY QUALITY 
COTTON 
WOOL 
    
PIN PRICK      
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Pain upper/lower quarter, left and right  
Blood tests  
Erythrocyte sedimentation rate EST  
Hematology count  
Liver enzymes  
Creatinine kinase  
Rheumatoid factor  
Antinuclear antibodies  
Thyroid dysfunction  
Cardiovascular or pulmonary disease  
Chronic asthma  
Morbid obesity  
Cardiac or peripheral vascular disease  
Endocrine or allergic disorders, diabetes  
Inflammatory joint disease  
Upper limb injuries  
Polyneuropathy/ nerve injuries (carpal tunnel, sciatica etc)  
Central nervous system disease (stroke, epilepsy etc)  
Psychiatric disorder (Bipolar Depression, psychosis etc)  




Appendix 3: Screening/clinical assessment forms 
A3-12 







TEL:        DOB: 
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Cardiac or peripheral vascular disease  
Endocrine or allergic disorders (diabetes, hyper/hypothyroidism)  
Inflammatory joint disease  
Upper limb injuries  





W.L (Weight loss): 
 
 
C/CE (Cord, cauda equina signs):   STER (steroid intake): 
 
 
V.A. (signs of vertebral artery insufficiency) :  




Name Dosage Duration Effect 
    
    
    
    
    
















Tender points Fibromyalgia 
Tender points Left ≥4kg Right ≥4kg 
Occiput: suboccipital muscle insertion     
Trapezius: midpoint of the upper border     
Supraspinatus: origins, above scapula spine 
near the medial border  
    
Gluteal: upper outer quadrants of buttocks in 
anterior fold of muscle 
    
Greater trochanter: posterior to trochanteric 
prominence 
    
Lower cervical: anterior aspects of the 
intertransverse spaces at C5-7 
    
Second rib: at second costochondral junctions,  
just lateral to the junctions on upper surfaces 
    
Lateral epicondyle: 2 cm distal to epicondyle     
Knee: medial fat pad proximal to the joint line     
     
Control points     
Right thumb nail     
At the center of right forearm     
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LANSS PAIN SCALE 




This pain scale can help to determine whether the nerves that are carrying your pain signals are 
working normally or not. It is important to find this out in case different treatments are needed to 
control your pain.  
 
A. PAIN QUESTIONNAIRE 
 
• Think about how your pain has felt over the last week. 
• Please say whether any of the descriptions match your pain exactly.  
 
1) Does your pain feel like strange, unpleasant sensations in your skin? Words 
like pricking, tingling, pins and needles might describe these sensations. 
 
a)  NO - My pain doesn’t really feel like this.................................   (0) 
 
b)  YES - I get these sensations quite a lot.........................................  (5) 
 
2) Does your pain make the skin in the painful area look different from 
normal? Words like mottled or looking more red or pink might describe the 
appearance. 
 
a)  NO - My pain doesn’t affect the colour of my skin.....................  (0) 
 
b)  YES - I’ve noticed that the pain does make my skin look different from normal  (5) 
 
 
3) Does your pain make the affected skin abnormally sensitive to touch?  
Getting unpleasant sensations when lightly stroking the skin, or getting pain 
when wearing tight clothes might describe the abnormal sensitivity. 
 
a)  NO - My pain doesn’t make my skin abnormally sensitive in that area.......... (0) 
 
b)  YES - My skin seems abnormally sensitive to touch in that area..................... (3) 
 
4) Does your pain come on suddenly and in bursts for no apparent reason 
when you’re still. Words like electric shocks, jumping and bursting describe 
these sensations. 
 
a)  NO - My pain doesn’t really feel like this ............................................  (0) 
 
b)  YES - I get these sensations quite a lot .................................................  (2) 
 
5) Does your pain feel as if the skin temperature in the painful area has 
changed abnormally? Words like hot and burning describe these sensations 
 
a)  NO - I don’t really get these sensations................................................  (0) 
 
b)  YES - I get these sensations quite a lot .................................................  (1) 
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B. SENSORY TESTING 
 
Skin sensitivity can be examined by comparing the painful area with a contralateral 





Examine the response to lightly stroking cotton wool across the non-painful 
area and then the painful area.  If normal sensations are experienced in the non-
painful site, but pain or unpleasant sensations (tingling, nausea) are experienced 
in the painful area when stroking, allodynia is present. 
 
 a) NO, normal sensation in both areas ...........................................   (0) 
 
 b) YES, allodynia in painful area only ............................................  (5) 
 
 
2) ALTERED PIN-PRICK THRESHOLD  
Determine the pin-prick threshold by comparing the response to a 23 gauge 
(blue) needle mounted inside a 2 ml syringe barrel placed gently on to the skin in 
a non-painful and then painful areas. 
 
If a sharp pin prick is felt in the non-painful area, but a different sensation is 
experienced in the painful area e.g. none / blunt only (raised PPT) or a very 
painful sensation (lowered PPT), an altered PPT is present. 
 
If a pinprick is not felt in either area, mount the syringe onto the needle to 
increase the weight and repeat. 
 
a) NO, equal sensation in both areas ......................    (0) 
 







Add values in parentheses for sensory description and examination findings to 
obtain overall score. 
 
 
TOTAL SCORE (maximum 24) ................................................ 
 
If score < 12, neuropathic mechanisms are unlikely to be contributing to the patient’s 
pain 
If score ≥ 12, neuropathic mechanisms are likely to be contributing to the patient’s 
pain 








































PAIN (over last week) 




   0                10 
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Hospital Anxiety and Depression Scale (HADS) 
 
Clinicians are aware that emotions play an important part in most illnesses. If your  
clinician knows about these feelings she or he will be able to help you more. This  
questionnaire is designed to help your clinician to know how you feel. Read each  
item and place a firm tick in the box opposite the reply which comes closest to how 
you have been feeling in the past week. Don’t take too long over your replies; your 
immediate reaction to each item will probably be more accurate than a long  
thought-out response. 
 
I feel tense or ‘wound up’:        A 
Most of the time              3 
A lot of the time             2 
From time to time, occasionally           1 
Not at all              0 
 
I still enjoy the things I used to enjoy:      D 
Definitely as much             0 
Not quite so much             1 
Only a little               2 
Hardly at all               3 
 
I get a sort of frightened feeling as if something awful is about to happen: A 
Very definitely and quite badly           3 
Yes, but not too badly              2 
A little, but it doesn’t worry me            1 
Not at all              0 
 
I can laugh and see the funny side of things     D 
As much as I always could             0 
Not quite so much now             1 
Definitely not so much now             2 
Not at all               3 
 
Worrying thoughts go through my mind      A 
A great deal of the time             3 
A lot of the time              2 
From time to time but not too often            1 
Only occasionally              0 
 
I feel cheerful          D 
Not at all              3 
Not often                2 
Sometimes               1 
Most of the time              0 
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I can sit at ease and feel relaxed       A 
Definitely              0 
Usually              1 
Not often               2 
Not at all              2 
 
I feel as if I am slowed down       D 
Nearly all the time              3 
Very often               2 
Sometimes              1 
Not at all              0 
 
I get a sort of frightened feeling like ‘butterflies’ in the stomach  A 
Not at all              0 
Occasionally               1 
Quite often              2 
Very often               3 
 
I have lost interest in my appearance      D 
Definitely              3 
I don’t take as much care as I should            2 
I many not take quite as much care            1 
I take just as much care as ever            0 
 
I feel restless as if I have to be on the move     A 
Very much indeed             3 
Quite a lot              2 
Not very much              1 
Not at all               0 
 
I look forward with enjoyment to things      D 
As much as I ever did              0 
Rather less than I used to             1 
Definitely less than I used to            2 
Hardly at all              3 
 
I get sudden feelings of panic       A 
Very often indeed              3 
Quite often               2 
Not very often              1 
Not at all              0 
 
I can enjoy a good book or radio or TV programme    D 
Often                0 
Sometimes              1 
Not often               2 
Very seldom               3 
 
Now check that you have answered all the questions 
 




For office use only: 
Questions relating to anxiety are indicted by an ‘A’ while those relating to 
depression are shown as ‘D’ 
 
 
A:      Borderline 8-10 
 





Zigmond AS, Snaith, RP. The Hospital Anxiety and Depression Scale. Acta 





















VERBAL INSTRUCTIONS  
FOR PERFORMING 








Rolke R, Baron R, Maier C, Tölle TR, Treede R-D, Beyer A, Binder A, Birbaumer 
N, Birklein F, Bötefür IC, Braune S, Flor H, Huge V, Klug R, Landwehrmeyer GB, 
Magerl W, Maihöfner C, Rolko C, Schaub C, Scherens A, Sprenger T, Valet M, 
Wasserka B. Quantitative sensory testing in the German Research Network on 




Permission for reprint of “Verbal instructions for performing quantitative sensory 
testing” was granted by the International Association for the Study of Pain on 22nd of 
March 2011 (page A5-4). 
 
Appendix 5: Verbal instructions for QST 
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Test 1. Thermal testing procedures (CDT, WDT, TSL, PHS, CPT, HPT). 
“A temperature test of your skin will be performed. First we are testing your ability 
to detect a change of temperature to ´cool´ or ´warm´. A special device that cools or 
warms your skin will be placed over your… (specify practice area, control and test 
areas). Secondly another temperature test of your skin will be performed to find the 
temperature that feels ´painfully cold or hot´.” 
 
Instructions for testing of cold detection threshold (CDT). 
“Please press the stop-button as soon as you feel the slightest change of temperature 
to ´cold´. Then the thermode will warm up to starting temperature. This procedure 
will start in a few seconds and will be repeated a total of 3 times.” 
 
Instructions for testing of warm detection threshold (WDT). 
“Please press the stop-button as soon as you feel the slightest change of temperature 
to ´warm´. Then the thermode will cool down to starting temperature. This procedure 
will start in a few seconds and will be repeated a total of 3 times.” 
 
Instructions for testing of thermal sensory limen (TSL). 
“Please press the stop-button as soon as you feel the slightest change of temperature 
to ´warm´ or ´cold´, and say as you do so whether the sensation you feel is warm or 
cold. Then the test continues immediately without prior warming up or cooling down 
to normal skin temperature. This procedure will be repeated a total of 6 times in a 
row and start in a few seconds.” 
 
Instructions for testing of paradoxical heat sensations (PHS) during the TSL 
procedure. 
Instruction to the investigator: Some subjects will report a sensation of “warm” or 
“hot” or “painfully hot” upon cold stimulation during the TSL procedure. These 
reports have to be marked as “paradoxical heat sensation”. 
 
Instructions for testing of cold pain threshold (CPT). 
“The temperature of the skin will decrease to ´cold´. Eventually a painful component 
will be added to the sensation of ´cold´, and it will change in quality from cold to, for 
example, ´aching´, ´stinging´, or ´burning´. Please press the stop button immediately 
at the first painful sensation. After pressing the stop-button the thermode will warm 
up to starting temperature. This procedure will start in a few seconds and will be 
repeated a total of 3 times.” 
 
Instructions for testing of heat pain threshold (HPT). 
“The temperature of the skin will increase to ´warm´ and a few moments later to 
´hot´. Eventually a painful component will be added to the sensation of ´hot´, and it 
will change in quality from ´hot´ to, for example, ´burning´ or ´stinging hot´. Please 
press the stop-button immediately at the first ´burning´ or ´stinging hot´ sensation. 
Then the thermode will cool down to starting temperature. This procedure will start 
in a few seconds and will be repeated a total of 3 times.” 
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Test 2. Testing of the mechanical detection threshold (MDT). 
“This is a test of your ability to detect light touch. I will press these hairs to your 
skin (specify practice area, and control and test areas). Please say ´Yes´, if you feel 
the slightest light touch.” 
 
Test 3. Testing of the mechanical pain threshold (MPT). 
“This is a test of your ability to detect a sensation of ´pricking´ or ´stinging´. Blunt 
needles that increase in sharpness will be pressed gently against your skin (specify 
practice area, and control and test areas). At first you may be able to feel them, but 
not feel that they are ´pricking´ or ´stinging´ in any way. However, eventually a 
component of slight ´pricking´ or ´stinging´ will be added to this sensation. Please 
say “sharp”, immediately as you feel the slightest ´pricking´ or ´stinging´ sensation! 
If you feel the needle touching your skin without any ´pricking´ or ´stinging´, please 
say “blunt”. 
 
Test 4. Testing of stimulus-/response-functions (MPS and ALL). 
“This is a test of your ability to feel different intensities of pain. As in the previous 
test, blunt needles that increase in sharpness will be pressed gently against your 
skin. In between you will be touched by gently moving stimuli. Some of these stimuli 
will be accompanied by a sensation that has a ´pricking´, ´burning´ or ´scraping´ 
quality, some may not be ´pricking´, ´burning´ or ´scraping´ at all, and some you 
may not even be able to detect. Please give a number between ´0´ and ´100´ for the 
´prickingness´, ´sharpness´ or ´strongness of the burning or scraping sensation´ of 
each stimulus. 
´0´ indicating no pain or any kind of ´slightly pricking, stinging, burning or scraping 
sensation´. ´100´ indicating most intense pain, pricking, stinging, burning or 
scraping imaginable.” 
 
Test 5. Performing the ´wind-up´ procedure (WUR). 
“This is a test of repeated pinpricks, using the same kind of blunt needle that was 
used in the last two tests. I will now apply a single pinprick. Please give a number 
between ´0´ and ´100´ for the ´prickingness´ or ´sharpness´ of that stimulus. 
´0´ again indicating no pain or any kind of ´slightly pricking or stinging sensation´. 
´100´ indicating most intense pain, pricking or stinging imaginable.” 
 
Continue, when the subject has rated the single pinprick stimulus: 
“I will now apply a series of 10 pinpricks in a row. Please give a number between 
´0´ and ´100´ for the prickingness or sharpness over that whole series of 10 
pinpricks. 
´0´ indicating no pain or any kind of ´slightly pricking or stinging sensation´. 
´100´ indicating most intense pain imaginable.” 
 
Test 6. Testing of the vibration detection threshold (VDT). 
“This is a test of your ability to detect vibration. Now I will put this tuning fork, once 
I have made it vibrate, on your… (specify practice area, control and test areas, and 
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place the tuning fork over a bony part of the referring area). Please tell me if you feel 
any vibration, and say ´Now´ immediately that this vibration disappears. This 
procedure will be repeated a total of 3 times.” 
 
Test 7. Testing of the pressure pain threshold (PPT). 
“This is a test of your sensitivity to deep pain. Now I will press this pressure meter 
against your… (specify practice area, and control and test areas), and will gradually 
increase the pressure. Please say ´Now´ as soon as the pressure starts to be painful. 
This procedure will be repeated a total of 3 times.” 
 
  ----------------------------------------------------------------- 
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RECORDING SHEETS FOR  
QUANTITATIVE SENSORY TESTING 
 
 




ID number:_________Date:________Room temperature:______________________ 
      
Order of testing:_______________________________________________________ 
 
Control area:______________________Test area:____________________________ 
 
VAS before QST:__________________  
 
THERMAL TESTING 
Control Area       Symptomatic Area 



































































































MDT Mechanical detection threshold (von Frey filaments)  MPT Mechanical pain threshold 
(pinprick) 
(start with 16mN)      (start with 8mN) 
 
Control Area  Symptomatic Area  Control Area           Symptomatic Area 
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SR FUNCTION: MPS: pinprick; ALL: brush (BR), Q-tip (QT), cotton wool (CW) 
 
Control Area   
 VAS/ 
100 
  VAS/ 
100   
VAS/ 
100   
VAS/ 
100   
VAS/ 
100 
128   CW   32   256   BR  
CW   256   128   8   32  
32   128   BR   CW   16  
256   8   CW   QT   128  
BR   32   16   128   512  
8   QT   256   64   CW  
16   BR   512   32   64  
QT   64   8   512   256  
512   16   64   BR   QT  




100   
VAS/ 
100   
VAS/ 
100   
VAS/ 
100   
VAS/ 
100 
8   16   QT   512   64  
QT   BR   64   16   512  
256   512   8   64   QT  
64   32   512   BR   16  
CW   64   256   QT   8  
512   128   16   32   BR  
128   QT   CW   8   256  
16   CW   BR   128   32  
32   8   128   256   CW  
BR   256   32   CW   128  
 
WUR; wind up (series of 10 stimuli/       VDT; Vibration detection     PPT; pressure pain 
single stimulus)       threshold    threshold kPa 
(256 mN for foot and hand)          
 
Control Area  Sympt Area        Control     Sympt        Control      Sympt 
VAS  VAS  /8  /8     
Single  Series  Single  Series  /8  /8     
      /8  /8     
             
             
             
             
 
 










Degree of shoulder abduction:  
 
 
Symptomatic side  Control side 
P1 P2  P1 P2 
     
     
     
 
 
 
Symptoms produced: 
 
 
 
 
 
 
 
 
 
